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Abstract
The creation and transmission of nerve impulses involve a variety of membrane
proteins such as secondary transporters, receptors and ion channels. These struc-
tures are related to a number of neurodegenerative and auto-immune diseases, and
the investigation of their properties may bring an important contribution to the
treatment of such illnesses. In this thesis we use molecular dynamics simulations
to study glutamate transporters and receptors, as well as toxin binding to human
potassium channels. We apply a variety of techniques in computational biology such
as ligand docking, parameterization of molecules, homology modeling, free energy
perturbation and potential of mean force.
We start by studying in detail the archaeal aspartate transporter GltPh, which
has crystal structures available and is a homolog of the human glutamate trans-
porters. We first locate the third sodium ion binding site, which is not present in
the crystal data, and show that this site is also conserved in the EAATs. We then
perform molecular dynamics simulations in the outward and inward facing states of
GltPh, calculating the ligand affinities in both conformations and the order of ligand
binding/unbinding. We also investigate the nature of the aspartate-sodium coupling
in these transporters, as well as the differences in the gating mechanism between
the outward and inward states. From the GltPh structure, we build models for the
human glutamate transporters (EAATs), for which there are no crystal structures.
Besides the ligands present in GltPh, the EAATs also bind a proton and a potassium
during the transport cycle. We use our models to attempt to locate the potassium
and proton binding sites, using free energy perturbation calculations to locate the
potassium site and pKa calculations to explain the mechanism of proton transport.
We also use molecular dynamics simulations to investigate the gating differences
between the archaeal and human transporters.
The glutamate receptor GluA2 binds to a variety of agonists and antagonists,
with high-resolution structures of the complexes. It plays an essential role in the
transmission of nerve impulses, also serving as a target to potential drugs. We
calculate the standard binding free energy of five small molecules to the ligand
binding domain of this receptor, using a free energy perturbation approach that
produces results with very good agreement to experimental values. We show that
this method is effective for polar and charged ligands, and can be applied to many
biological systems, providing an useful tool in computer aided drug design.
Finally, we develop a method based on free energy perturbation that can be
used to calculate the binding free energy differences of peptide toxin mutants to
Kv potassium channels, producing very good agreement to potential of mean force
and experimental results. We use it to obtain a ShK mutant that is selective for
the Kv1.1 channel over Kv1.3, and therefore may be used in the treatment of auto-
immune diseases.
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3.1 Structure of GltPh with bound aspartate, Na1 and Na2 (PDB 2NWX).
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(TM)1, TM2, TM4 and TM5 (coloured in grey), TM3 (blue), TM6
(green), TM7 (orange), TM8 (magenta), hairpin (HP)1 (yellow) and
HP2 (red). Bound aspartate is in stick representation and Na1(1)
and Na2(2) are indicated as green spheres. (B) Close-up of the sub-
strate binding site that has been rotated 90o around the vertical axis
(coloured as in A). Aspartate 312 (D312) and threonine 92 (T92) are
shown in stick representation. Figures were made using Pymol98. . . 40
3.2 Comparison of the Na3 and Na3’ sites. Snapshots of the Na3’ (A) and
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the crystal structure (green backbone) with that obtained from MD
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(A) Closed structure (PDB 2NWX) vs. Na3’ site, (B) Open structure
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3.4 T92A and S93A mutations in GltPh have reduced Na
+ affinity. (A)
Size exclusion column profile for wild type GltPh (dark blue), T92A
(red), S93A (green), N310A (pink) and D312A (cyan). (B) Uptake
of 100 nM 3H-L-aspartate in the presence of 100 mM NaCl for GltPh
(black squares), T92A (white squares), S93A (grey squares), N310A
(white triangles) and D312A (black triangles). Control levels are
from uptake performed in the presence of internal buffer (100 mM
KCl, 20 mM HEPES/Tris pH 7.5) (C) 3H-L-aspartate concentration-
dependent transport in the presence of 100 mM NaCl by GltPh (black
squares), T92A (white squares) and S93A (grey squares). (D) Na+
concentration-dependent transport of 100 nM 3H-L-aspartate for GltPh
(black squares), T92A (white squares) and 500 nM 3H-L-aspartate for
S93A (grey squares). Data in (C) and (D) are normalised to the max-
imal velocity of transport and all data are from the mean of at least
3 separate experiments ± s.e.m. . . . . . . . . . . . . . . . . . . . . . 48
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3.5 T130A and T131A mutations in EAAT1 have reduced Na+ affinity.
(A) Amino acid alignment of TM3 and TM7. Alignment was made
using ClustalW2102 and adjusted manually. T130A and T131A mu-
tations in EAAT1 have reduced Na+ affinity. (A) Amino acid align-
ment of TM3 and TM7. Alignment was made using ClustalW2102
and adjusted manually. Amino acid sequences are; human (h)EAAT1
(NP 004163.3), hEAAT2 (NP 004162.2), hEAAT3 (NP 004161.4); hEAAT4
(NP 005062.1); hEAAT5 (NP 006662.3); hASCT1 (NP 003029.2); Py-
rococcus horikoshii GltPh (NP 143181); Escherichia coli GltPEc (EGT70436.1);
Bacillus stearothermophilus GltTBs (P24943.1). Red shading indi-
cates the residues that form the Na3 site, grey shading indicates con-
served residues and black shading indicates residues absolutely con-
served. (B) Average current activated by the application of 100 µM L-
glutamate to oocytes clamped at -60 mV expressing EAAT1 (black),
T130A (white) and T131A (grey). Red shading indicates the residues
that form the Na3 site, grey shading indicates conserved residues
and black shading indicates residues absolutely conserved. (B) Av-
erage current activated by the application of 100 µM L-glutamate
to oocytes clamped at -60 mV expressing EAAT1 (black), T130A
(white) and T131A (grey). (C) L-glutamate concentration-dependent
currents for EAAT1 (black), T130A (white) and T131A (grey). (D)
Na+ concentration-dependent currents in the presence of 300 µM
L-glutamate for EAAT1 (black circles), and 1 mM L-glutamate for
T130A (white circles) and T131A (grey circles). Data in (C) are nor-
malised to the current at saturating glutamate concentrations and all
data are from the mean of at least 3 separate experiments ± s.e.m. . 50
3.6 The third Na+ binding site in GltPh. (A) The coordination of the Na3
binding site identified in this study. TM3 (blue) and TM7 (orange)
are shown in cartoon and the coordinating residues are shown in stick
representation and labelled. Na3 is shown as a yellow sphere. (B) The
area of the Na3 site in the inward occluded structure of GltPh (PDB
3KBC); colouring as in A. (C) Na+ binding site on the rotor ring
(c ring) of the F-Type Na+ ATPase from Ilyobacter tartaricus (PDB
1YCE). V63, S66 are from the A subunit and Q32, E65 are from the B
subunit of the c ring. Na+ ion is shown as a yellow sphere. (D) One
protomer of GltPh with bound aspartate, Na1, Na2 and Na3. The
transport domain is shown in colour; TM3 (blue), TM6 (green), HP1
(yellow), TM7 (orange), HP2 (red) and TM8 (purple) and the 3 Na+
ions are shown as green spheres and numbered. (E) The proposed
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Steps 3-4 denote the translocation of the binding site across the mem-
brane with 3 Na+, H+, and glutamate bound to EAAT3, while steps
7-8 denote the same with only K+ bound. Step 2 shows the binding
of the Na2 ion, which binds after the substrate and the closure of
the HP2 gate. Step 5 shows the opposite happening in the intracel-
lular media, assuming that the binding and unbinding of ligands are
symmetrical. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
xxvi LIST OF FIGURES
6.2 Binding of glutamate to EAAT3 with a protonated vs deprotonated
E374 side chain. (A) Glutamate substrate (in green) bound to EAAT3
in the closed outward state with a protonated E374 side chain. (B)
The same but with a deprotonated E374 side chain. Glutamate is
stable in A for 20 ns, but becomes unstable in B, losing most of the
contacts after 10 ns of simulations. . . . . . . . . . . . . . . . . . . . 115
6.3 Gating motions in the outward- and inward-facing conformations of
EAAT3. Time evolution of the S332(Cα)–V411(Cα) distance in the
outward-facing conformation with (A) no ligands bound to the trans-
porter, and (B) only the Na1 and Na3 ions bound to the transporter.
The same for the inward-facing conformation with (C) no ligands
bound to the transporter, and (D) only the Na1 and Na3 ions bound
to the transporter. The color code for the subunits are A (black), B
(red), and C (green). . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
6.4 Comparison of gate opening in the outward- and inward-facing con-
formations of EAAT3. (A) Overlap between the closed (grey) and
the open (purple) states in the outward EAAT3. Glutamate and
three Na+ ions bound to the transporter, as well as the S331, D444
and R445 residues are indicated. (B) The same for the inward-facing
state, showing a large movement of HP1, HP2 and TM8. The con-
tacts made by the insertion of the R445 side-chain between HP1 and
TM8 are also shown. The dark shade of grey in the closed state indi-
cates the position of the residues from part C below. (C) Comparison
of the IC-gate opening (black) with the EC-gate opening (red). The
RMSD of the Cα atoms at the tips of HP1 and HP2 is obtained by
aligning the open and closed states and calculating the RMSD from
2 ns of MD simulations. . . . . . . . . . . . . . . . . . . . . . . . . . 119
6.5 Effect of the D455N mutation on sodium binding. (A) The distance
between the Na1 ion and the side-chain carboxyl/carboxamide carbon
atom of the residue D455 during its mutation from aspartate to an
asparagine (black, red and green), and to a protonated aspartate
(blue, yellow and brown) in the presence of the Na3 ion. In the first
case, Na1 leaves the binding site in 2 out of 3 chains, and in the
second case, Na1 leaves the binding site in all chains. (B) The new
coordination of Na1 when the D455N mutation is performed in the
absence of the Na3 ion. This site has the coordination of the carbonyl
oxygens of N366 and N451, as well as the side chain oxygens of D368
and N455. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
LIST OF FIGURES xxvii
6.6 Three potential sites for binding of a K+ ion. (A) Site 1 is obtained
by replacing Na1 by a K+ ion and equilibrating the system for 10 ns
in the absence of other ligands (B) Site 2 is obtained by restraining
K+ close to the E374 carboxyl group and equilibrating the system for
10 ns with no other ligands bound. (C) Site 3 is obtained by placing
a K+ ion near glutamate α-N atom and equilibrating the system for
10 ns in the absence of other ligands. . . . . . . . . . . . . . . . . . . 123
6A.1 The aligment used to build our models, from Ref.14, showing the
sequences of archaeal aspartate transporters, and human glutamate
and neutral amino acid transporters. . . . . . . . . . . . . . . . . . . 133
6A.2 (A) The model for the outward-facing state of EAAT3 including the
4B-4C loop 50-residue segment—which is not present in our model–
placed at the position proposed in Ref.146 (shown in red). The posi-
tion of the HP2 segment in the open state, which is the segment that
goes through conformational changes during the opening, is shown
in blue. The substrate and sodium ions in the binding site are also
shown. (B) The same for the inward-facing model of EAAT3, showing
the segments that undergo conformational changes during the inward
opening in blue, namely, HP1, HP2 and TM8. In both cases, the
bound ligands and the conformational changes that happen during
the opening of EAAT3 are not in proximity to the 4B-4C loop. . . . . 134
6A.3 (A) DOPE per-residue score for the 2NWX crystal structure (red) and
the EAAT3 model in the outward-facing state (black). The residues
are numbered according to the GltPh sequence. (B) The same for the
3KBC crystal structure (red) and the EAAT3 model in the inward-
facing state (black). . . . . . . . . . . . . . . . . . . . . . . . . . . . 135
6A.4 Ramachandran plots for the templates and models used in this study.(A)
2NWX crystal structure.(B) EAAT3 model in the outward-facing
conformation.(C) 3KBC crystal structure.(D) EAAT3 model in the
inward-facing conformation. . . . . . . . . . . . . . . . . . . . . . . . 136
6A.5 RMSD of the protein backbone during 60 ns of simulations with all
ligands bound and the protonated E374 side-chain, in the outward
(black) and inward (red) states of EAAT3. The system shows no
large conformational changes after 10 ns, which indicates that the
models are stable. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
6A.6 Convergence of the TI results in the calculation of the binding free
energies of K+, and also the K+/Na+ selectivity. In all graphs the
negative of the forward and the backward transformations results are
shown with black and red lines, respectively. (A) Interaction free
energy and (B) selectivity of the K+ ion at site 1. (C,D) The same
for the site 2. (E,F) The same for site 3. . . . . . . . . . . . . . . . . 138
xxviii LIST OF FIGURES
6A.7 Comparison of the conformations around the TM7–TM8 region in the
GltTk crystal structure (A) and in our simulations of the apo state of
EAAT3 (B). Conformational changes that are observed between the
loaded and apo states of the crystal structures are captured in our
apo state model of EAAT3. Only the functionally important residues
in this region are indicated explicitly. . . . . . . . . . . . . . . . . . . 139
7.1 The thermodynamic cycle used in the FEP/TI calculations: A repre-
sents the side-chain of interest, H is the proton, the indices p and d
refer to the protonated and deprotonated states, and the subscripts
m and pr indicate that A is in the bulk solvent (model compound)
and in the protein, respectively. . . . . . . . . . . . . . . . . . . . . . 143
7.2 The model compounds used in our free energy calculations in bulk.
(A) N-acetyl-L-isoasparagine is used for aspartate, (B) N-acetyl-L-
isoglutamine is used for glutamate. The colors are cyan for carbon
atoms, blue for nitrogen atoms, red for oxygen and white for hydrogens.145
7.3 DOPE per-residue score for the 4KY0 crystal structure (black) and
our EAAT3 model in the apo outward-facing state (red). The residues
are numbered according to the GltTk sequence. . . . . . . . . . . . . . 147
7.4 (A) The substrate binding site in the outward-facing fully-bound
state, showing the bound glutamate (in green) and the titratable
residues in this region. (B) The binding sites of the Na1 and Na3
ions in the same state of EAAT3, coordinated by the D455 and D368
side chains, respectively. . . . . . . . . . . . . . . . . . . . . . . . . . 149
7.5 (A) The region around E374 (purple) in the fully bound state, where
this residue is buried under a series of hydrophobic residues from the
HP2 and TM7 segments. (B) After the removal of the substrate and
the Na2 ion, the HP2 gate opens and the E374 side-chain is hydrated. 151
7.6 (A) The region between E374 (purple) and the D368 and D455 side-
chains, which has water molecules located mostly on the surface of
the protein, resulting in reduced dielectric screening. (B) The same
area but now in the presence of the bound K+ at site 1. We see that,
in addition to the presence of the positively charged K+ ion, the side
chain of D368 is also hydrated. (C) The substrate binding site with
a K+ ion bound at site 3, which now has a positive charge instead of
the negatively charged substrate, reducing the pKa of E374. . . . . . 155
8.1 The thermodynamic cycle used in the FEP calculations, where the
restraints are applied on the ligand in bulk solution and released while
it is at the binding site. . . . . . . . . . . . . . . . . . . . . . . . . . . 161
8.2 Structures of the five ligands considered in this study. . . . . . . . . . 168
LIST OF FIGURES xxix
8.3 Plots of the FEP (first column) and TI (second column) calculations
for the electrostatic (A, B) and LJ (C, D) interactions in CNQX, re-
spectively. The graphs E-H show the same for DNQX. The black lines
indicate the forward transformations and the red lines, the negative
of the backward transformations. . . . . . . . . . . . . . . . . . . . . 171
8.4 A snapshot of the DNQX complex in the open state of the recep-
tor showing the hydrophobic interaction between the double ring of
DNQX and the ring of the Y450 residue. The same pattern is also
observed in the CNQX complex. . . . . . . . . . . . . . . . . . . . . . 173
8.5 Same as Fig. 8.3 but for ACPA. Plots of the FEP (first column) and
TI (second column) calculations for the electrostatic (A, B) and LJ
(C, D) interactions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
8.6 Snapshots of the ACPA, glutamate and AMPA complexes in the open
state of the receptor. The critical E705 side chain has no interactions
with ACPA but makes salt bridges with the α-amino group of gluta-
mate and AMPA (indicated by dotted lines). . . . . . . . . . . . . . . 175
8.7 Plots of the FEP (first column) and TI (second column) calculations
for the electrostatic (A, B) and LJ (C, D) interactions in glutamate.
We also show the PMF as a function of the distance between the
ligand α-amino and the receptor E705 side-chain carboxyl group in
the apo (E) and bound (F) states of the receptor. The range of the
confinement potential is indicated by the vertical dotted lines. . . . . 176
8.8 Same as Figure 8.7 but for AMPA. In this case, the range of the
confinement potential is 5.5–6.5A˚. . . . . . . . . . . . . . . . . . . . 178
8A.1 CHARMM parameters for ACPA. . . . . . . . . . . . . . . . . . . . . 181
8A.2 CHARMM parameters for AMPA. . . . . . . . . . . . . . . . . . . . . 182
8A.3 CHARMM parameters for CNQX. . . . . . . . . . . . . . . . . . . . . 183
8A.4 CHARMM parameters for DNQX. . . . . . . . . . . . . . . . . . . . 184
9.1 The thermodynamic cycle used in the free energy calculations. The
superscript 0 denotes amino acids with no charges on the side chain
atoms. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191
9.2 The K18A mutation does not change the binding modes of ShK to
Kv1.1 and Kv1.3 channels. Snapshots of ShK[K18A] (yellow with
colored side chains) and ShK (transparent orange) in complex with
Kv1.1 and Kv1.3 are superposed to show that there is a good over-
lap between the toxin backbones, and all the important interactions
identified in the ShK complexes are preserved in the ShK[K18A] com-
plexes. To give the full picture, two views of the cross sections of the
complex, depicting the monomers C and A (left panel) and D and B
(right panel) are presented. Only the residues involved in binding are
indicated explicitly. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195
xxx LIST OF FIGURES
9.3 Convergence of the FEP and TI calculations. (A) Convergence of the
FEP calculations for discharging/charging of the K18 in ShK in the
binding site/bulk. Running averages of ∆Gi for windows at λ = 0
(black), λ = 0.2 (red), λ = 0.4 (green), λ = 0.6 (blue), λ = 0.8 (yellow)
and λ = 0.999 (magenta) are plotted as a function of the production
time for Kv1.1 (left) and Kv1.3 (right). (B) Similar to A but showing
the convergence of the FEP calculations for transformation of the
uncharged Lys side chain to that of Ala. (C) Convergence of the TI
calculations for discharging/charging of K18 in ShK in the binding
site/bulk. Running averages of the ∆G values obtained from the TI
calculations are plotted as a function of the production time for Kv1.1
(left) and Kv1.3 (right). Both the forward (black) and the negative
of the backward (red) results are shown to check for hysteresis effects,
which remain well below 1 kcal/mol for both channels. . . . . . . . . 197
9.4 Comparison of the PMFs for the unbinding of ShK and ShK[K18A]
from the Kv1.1 and Kv1.3 channels. . . . . . . . . . . . . . . . . . . . 199
9.5 ShK[K18A] is selective for Kv1.3 over Kv1.1 channels and preferen-
tially targets TEM lymphocytes in vitro and in vivo. (A) Effects of
ShK (black squares) and ShK[K18A] (open circles) on Kv1.3 cur-
rents measured by whole-cell patch-clamp on L929 fibroblasts sta-
bly transfected with mKv1.3. The two left panels show whole-cell
Kv1.3 currents before (control) and after perfusion of ShK[K18A]
(left panel) or ShK (middle panel). The panel on the right shows
the Kv1.3 currents remaining after steady-state block is reached with
the different concentrations of ShK and its analog, fitted to a Hill
equation (N = 5-6 cells per concentration).(B) Effects of ShK (black
squares) and ShK[K18A] (open circles) on Kv1.1 currents measured
by whole-cell patch-clamp on L929 fibroblasts stably transfected with
mKv1.1. The two left panels show whole-cell Kv1.1 currents before
(control) and after perfusion of ShK[K18A] (left panel) or ShK (mid-
dle panel). The panel on the right shows the Kv1.1 currents remaining
after steady-state block is reached with the different concentrations
of ShK and its analog, fitted to a Hill equation (N = 6-7 cells per
concentration).(C) Effects of ShK (black squares) and ShK[K18A]
(open circles and dashed line) on the proliferation of rat TEM cells
measured in vitro by the incorporation of [3H] thymidine into the
DNA of dividing cells (N = 3). (D) Effects of ShK (black squares)
and ShK[K18A] (open circles and dashed line) on the proliferation of
rat splenocytes (mainly na¨ıve/TCM cells; N = 3).(E) Effects of the
subcutaneous administration of 100 µg/kg ShK[K18A] on an active
DTH reaction elicited against ovalbumin. Data show the difference
in challenged and non-challenged ear thickness in vehicle-treated rats
and ShK[K18A]-treated rats (N = 6/group). . . . . . . . . . . . . . . 202
LIST OF FIGURES xxxi
9A.1 The LC profile of ShK[K18A]. . . . . . . . . . . . . . . . . . . . . . . 204
9A.2 ESI-MS analysis of ShK[K18A]. The mass of the peptide calculated
from the predicted amino acid sequence (3998 Da), compared well to
the electrospray mass spectrometry (ESI-MS, 3998 Da). . . . . . . . . 204
9A.3 The 1D 1H NMR spectrum of wild-type ShK and ShK[K18A] at pH
4.8, acquired on a Bruker Avance 600 MHz spectrometer at 20oC. . . 205
9A.4 The amide and aromatic region of 1H NMR spectra of wild-type ShK
and ShK[K18A] at pH 4.8, acquired on a Bruker Avance 600 MHz
spectrometer at 20oC. . . . . . . . . . . . . . . . . . . . . . . . . . . 205
9A.5 Deviation from random coil chemical shifts (4) of the HN (A), Hα (B),
and Hβ (C) resonances of wild-type ShK and ShK[K18A] at 20oC and
pH 4.8. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206
9A.6 Convergence of the Kv1.x-ShK[K18A] PMFs from 2 ns block data
analysis. To reduce fluctuations, we use a large sampling size (2 ns),
which is slid in 0.5 ns steps over the range of the data. In Kv1.1, the
PMFs drop monotonically until 3.5-5.5 ns, after which they fluctuate
around a base line. In Kv1.3, equilibration occurs earlier, presumably
due to the stronger binding. To decide more precisely which part of
the data should be discarded for equilibration, we have constructed
PMFs from 0.5 ns blocks in Figure 9A.7. . . . . . . . . . . . . . . . . 207
9A.7 Convergence of the Kv1.x-ShK[K18A] PMFs from 0.5 ns block data
analysis. In Kv1.1, the first 4.5 ns of data are discarded as equilibra-
tion, and the final PMF is determined from the last 2.5 ns of data.
In Kv1.3, the first 1.5 ns of data are discarded, and the final PMF is
determined from the last 5 ns of data. . . . . . . . . . . . . . . . . . . 208
9A.8 The E353(O2)R29(N2) pair distances in ShK and ShK[K18A] PMFs
as a function of the channel-toxin distance in Kv1.1. In the case
of ShK[K18A], the pair decouple for z > 35 A˚, which explains the
earlier flattening of the corresponding PMF in Figure 9.4. The bump
in the Kv1.1-ShK PMF around z = 43 A˚ (Figure 9.4) can be traced
back to the temporary re-engagement of R29 with E353 facilitated by
rotation of the toxin. . . . . . . . . . . . . . . . . . . . . . . . . . . . 209
xxxii LIST OF FIGURES
List of Abbreviations
Kv Voltage-gated potassium channel
PMF Potential of mean force
VMD Software for visualization of molecular dynamics.
MD Molecular dynamics
NAMD Software for nanoscale molecular dynamics
POPE 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine
EAAT Excitatory amino acid transporter
MODELLER Software to build homology models
NpT Constant number of particles, pressure and temperature
NV T Constant number of particles, volume and temperature
PDB Protein data bank
RMSD Root mean square deviation
PME Particle mesh Ewald, method to calculate electrostatics.
CMAP Backbone correction terms in CHARMM
CHARMM Chemistry at Harvard macromolecular mechanics
HADDOCK A protein-protein docking program
COM Center of mass
FEP Free energy perturbation
TI Thermodynamic Integration
LJ Lenard-Jones potential
WHAM Weighted histogram analysis method
Chapter 1
Introduction
1.1 Nerve impulses
The creation and transmission of nerve impulses play a central role in neuron-to-
neuron communication, allowing information to be extracted and processed within
the nervous system. These impulses rely on the polarity of the lipid membrane,
and its ability to generate and propagate action potentials1. A typical neuron has
a resting potential of around −70 mV compared to the extracellular side. In an
action potential, the voltage across the membrane suddenly reverses, making the
inside positive relative to the outside, and then abruptly reverses again, after which
the resting potential is restored. The changes in voltage that produce an action
potential are caused by a brief, large influx of sodium ions and a brief, large eﬄux of
potassium ions (Figure 1.1A). This flux is controlled by voltage-sensitive ion chan-
nels, which have the ability to selectively allow or block the passage of a particular
ion through the cell membrane. They also rely on concentration gradients, which
are maintained by active transporters such as the sodium and potassium pumps.
The action potential allows a nerve impulse to travel through the neuron axon until
it reaches another nerve cell, where there is a synapse.
A synapse is the interface between two neurons, where the nerve impulse can
be transmitted electrically or chemically. Electrical synapses, altough a minority,
are found in all nervous systems, including the human brain. Here two commu-
nicating neurons come extremely close and are linked together by an intercellular
specialization called a gap junction2. These synapses are extraordinarily fast, since
passive current flow across the gap junction is virtually instantaneous. Chemical
synapses, on the other hand, are dependent on the release and recognition of neu-
rotransmitters. Information is transmitted across a chemical synapse in four basic
steps (Figure 1.1B):
1. Neurotransmitter molecules are synthesized and stored in vesicles in the axon
terminal.
2. Neurotransmitter vesicles are transported to the presynaptic membrane and neu-
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Figure 1.1: (A) The steps involved in the transmission of the action potential through
the membrane, in which the potassium and sodium channels open in response to an applied
voltage. (B) The four stages in the release of the neurotransmitter in the nerve synapses,
from its synthesis in the presynaptic cell to its inactivation by enzymes and membrane
transporters. Figure adapted from Ref.1
rotransmitters are released in response to an action potential.
3. Neurotransmitters interact with the receptors on the membrane of the target cell
located on the other side of the synapse.
4. Neurotransmitters are inactivated (or they will continue to work indefinitely).
These steps depend on a number of cell structures like enzymes, RNA, lipid vesicles,
calcium channels, transmitter receptors and transporters.
Despite the great variety of chemical synapses, neurotransmitters can be divided
in two classes: excitatory or inhibitory. In other words, a neurotransmitter either
increases or decreases the probability that the neuron with which it comes to contact
will produce an action potential. The most important excitatory neurotransmitter
in the human brain is the amino acid glutamate, and the glutamate receptor proteins
play a major role in step 3 listed above3,4. They can be divided into metabotropic
and ionotropic, depending on their mechanism5. Metabotropic glutamate receptors
induce an indirect biochemical process, like the activation of biochemical cascades
and the modification of other proteins. The ionotropic glutamate receptor, on the
other hand, couple the binding of the glutamate molecule to the opening of an ion
channel, which is fundamental for neurotransmission at the nerve synapses6. They
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also serve as potential drug targets for the treatment of numerous neurodegenerative
conditions. There are several ligands that are known to bind to these receptors,
either as agonists or antagonists. In the past years, crystal structures of the ligand
binding domains (LBD)7,8 and amino terminal domains (ATD)9,10 from different
ionotropic receptors were determined. More recently, the crystal structure of the
full-length eukaryotic AMPA receptor (iGluA2) was reported11, shedding light into
the mechanism of substrate recognition and the conformational changes happening
upon substrate binding. In this thesis we study the free energy of binding of five
ligands to the GluA2 receptor LBD, presenting a method to accurately calculate
the binding free energy of polar and charged ligands using free energy perturbation
(FEP). This protocol can be applied to many systems, and we present it as a good
alternative for rational drug design.
Glutamate transporters, known as Excitatory Amino Acid Transporters (EAATs)
in mammals, are membrane proteins responsible for clearing the excess glutamate
released at the synapses after the transmission of the nerve impulse (step 4 above)12.
Extracellular glutamate can be toxic to neurons in high concentrations, and mal-
functioning of glutamate transporters has been implicated in many pathological
conditions including cerebral ischemia, amyotrophic lateral sclerosis and Alzheimer’s
disease. The EAATs are sodium- and potassium-dependent secondary transporters,
and they use the concentration gradient of these two ions to transport glutamate
into the intracellular media. They cotransport 3 Na+ ions and a proton with the
substrate, and countertransport one K+ ion at each transport cycle13. Five EAATs
have been identified in humans, called EAAT1-EAAT5. Because they are embedded
in a lipid environment, the EAATs are very difficult to crystallize, and therefore no
crystal structures of these transporters are available. To overcome this limitation,
the crystal structure of the homologous archaeal aspartate transporter from Pyro-
coccus Horikoshii, called GltPh, was determined in 2004
14. Further crystal structures
of this transporter, identifying the sodium and substrate binding sites, as well as
different conformations of the protein during the transport cycle, have been unveiled
since then15,16. Even though GltPh has around 36% homology to the EAATs and its
transport mechanism does not involve potassium or a proton, the substrate binding
site and the tertiary/quaternary structure of GltPh shows very good agreement to
previous experimental studies on the EAATs. This similarity opened up the pos-
sibility of producing EAATs homology models based on GltPh to understand their
transport mechanism. This is the main focus of this thesis — we perform compu-
tational studies on GltPh and in EAAT3 homology models. Our goal is to identify
the binding sites of the substrate, proton and ions; the mechanism of ligand bind-
ing and release; and the local conformational changes happening in the transporter
upon ligand binding/unbinding.
The voltage-gated potassium channels (Kv), besides their importance for the
transmission of the action potential through the neuron membrane, are also essential
for maintaining cellular homeostasis and contribute to numerous biological process in
non-excitable cells17. Peptide toxin blockers of Kv1 potassium channels, such as the
4 Chapter 1 Introduction
ones found in sea anemone and scorpion, may be good alternative for the treatment
of auto-immune diseases because the blocking of potassium channel Kv1.3 inhibits
T cell proliferation18. Since the Kv1.1 channel is present in the central nervous
system, Kv1.3/Kv1.1 selectivity is necessary for the use these toxins as therapeutic
drugs. Computational studies are able to find mutations in these toxins that can
increase this selectivity, by performing docking and free energy calculations. The
free energy methods we use to investigate the glutamate transporters and receptors
were applied to these channel-toxin complexes, and the results are also presented in
this thesis.
1.2 Glutamate transporters
L-glutamate is the major excitatory neurotransmitter in the human brain, and there-
fore this molecule is highly abundant in the central nervous system. Even though
the concentration of glutamate in the brain is estimated to be around 5–15 mM
per wet net weight, the extracellular concentration of this neurotransmitter is in
the order of 3–4 µM12. This gives a several-thousand fold glutamate concentration
gradient between the extracellular and intracellular media, and there is a number of
reasons for this discrepancy. First, it is essential to keep a high signal-to-noise ratio
for synaptic transmissions. If glutamate is not quickly removed from the synaptic
cleft after receptor activation, the postsynaptic cell could not respond to subsequent
messages that the presynaptic cell might send. Second, glutamate can be reused
once it is transported back to the intracellular media, by accumulating into vesicles
that are subsequently used for neurotransmitter release. Third, large extracellular
concentrations of glutamate have been associated with neuronal death due to exces-
sive activation of glutamate receptors. There is a scarcity of extracellular enzymes
that can metabolize glutamate, leaving cellular uptake as the only quick way to
remove this neurotransmitter from the nerve synapses. There are many different
glutamate transporters characterized so far, having distinct mechanisms and loca-
tions within the cell tissue. Some are sodium and potassium-dependent, which is
the case of the EAATs, the main focus of this thesis. There are also glutamate
transporters that work by exchanging glutamate with another amino acid like cys-
teine or glycine, which are sodium independent. In mitochondria, glutamate can
be taken up by proton-glutamate symporters or aspartate-glutamate antiporters.
Finally, there are transporters that work inside neurons by carrying glutamate into
the synaptic vesicles, using the membrane potential and an inward concentration
gradient of protons as driving force.
Due to their high concentration on glial cells, the EAATs play an important role
in glutamate uptake from synapses. Five subtypes have been identified in humans,
called EAAT1-5. Within a single species, they share 50–60% amino acid sequence
identity with each other, and also the same transport mechanism. The EAATs are
secondary transporters, using as a driving force the concentration gradients of Na+
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and K+, which are directed to the outside and inside the cell, respectively. Mal-
functioning in the EAATs has been associated with numerous neuronal diseases,
like ischemia, amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and epilepsy.
In the case of ischemia, it has been observed that large amounts of glutamate are
released into the extracelullar fluid when the energy supply of the brain is com-
promised. Studies have shown that this release might be related to the reversed
operation of the glutamate transporters, which may cause the collapse of ion gra-
dients due to overactivation of glutamate receptors19. Patients with ALS show an
increased glutamate concentration in cerebrospinal fluid, as well as a reduced expres-
sion of EAAT2 transporters, which might be related to the excitotoxic mechanisms
in ALS20. Reduced expression of the EAAT2 transporters, or the occurrence of
splice variants, has also been linked to the onset of Alzheimer’s disease, and the
inhibition of glutamate transport might aggravate this condition21. Even though
there is no direct evidence that defective glutamate uptake is related to epilepsy,
increased levels of glutamate are observed in epileptic patients prior to the onset
of seizures22. Furthermore, reduced expression of glutamate transporters in mice
brings the development of epilepsy and neurodegeneration23.
Many mutagenesis and functional experiments have been performed on human
EAATs in the past years, as well as on its rodent homologs. These studies have
revealed the main features of the tertiary and quaternary structures, the transport
stoichiometry, and the residues involved in ligand binding and selectivity. Hydropho-
bicity profiles initially revealed that the EAATs consist of six transmembrane seg-
ments in the N-terminal, organized as α-helices24. Two additional transmembrane
segments and two reentrant loops were identified by experiments with cysteine-
substituted residues25,26, based on their interaction with the biotinylated sulfhydryl
reagent 3-N -maleimidyl(propionyl)biocytin (BM), both from the outside and inside
of the cell (Figure 1.2). Furthermore, immunocytochemical data showed that both
the C- and N-termini are located intracellularly27. Regarding the transport stoi-
chiometry, functional studies show that, at each transport cycle, three sodium ions
and one proton are co-transported with glutamate, and one potassium ion is coun-
tertransported13 (Figure 1.3). The binding of the substrate is coupled to sodium,
since glutamate cannot bind in the absence of this ion. At each half-cycle, the whole
binding site is translocated across the membrane, with either Glu/3Na+/H+ or K+
bound to the transporter. This process is electrogenic, with a net charge of +2 mov-
ing into the cell, and therefore can be increased by a negative membrane potential.
In the absence of potassium, or if the binding of this ion is impaired, the EAATs
work as exchangers, completing only the steps 1–6 in Figure 1.3. By increasing the
potassium concentration in the extracellular media, these transporters can also work
in reverse mode, thereby leaking glutamate from the cell28.
In all EAATs, there is also an anion conductance that is thermodinamically
independent from the transport process, but is coupled to substrate and sodium
binding. This conductance is more pronounced for larger anions such as SCN− and
NO−3 , and less for Cl
− and F− 29. This feature of the EAATs is very important
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for functional experiments, since the SCN− and NO−3 conductances can be used to
probe the binding of different ligands to the these transporters30,31. Regarding the
residues involved in ligand binding, mutagenesis experiments point to an arginine
and an aspartate residues interacting with the substrate α-amino and side-chain
carboxyl groups, respectively32,33. A serine residue located in the HP2 segment is
involved in the sodium/lithium selectivity in EAAT2, as well as the ability of lithium
to support transport34. Aspartate residues close to the substrate binding site are
shown to be involved in the binding of sodium and potassium to the EAATs, since
their neutralization affects the binding properties of these ions30.
Figure 1.2: (A) The topology of the EAAT1 transporter obtained by hydropathy profiles
and cysteine substitution experiments. The transmembrane domains are indicated by
Arabic numerals, and the reentrant loops are indicated by roman numerals. Residues
that react with 3-N -maleimidyl(propionyl)biocytin (BM) from the outside (filled circles)
or from the inside (stars) are indicated by their position number.
An important step in our understanding of the EAATs came in 2004, with the
first crystal structure of the sodium-coupled archaeal transporter GltPh, which shares
an overall 36% sequence similarity with the human glutamate transporters14. In con-
trast to the EAATs, GltPh does not require the cotransport of a proton or the coun-
tertransport of a potassium ion for the completion of the transport cycle, and is also
selective for aspartate35. Despite the relatively low homology, GltPh shows structural
features that are very similar to the predicted structure of the EAATs. The 2004
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Figure 1.3: Cartoon showing the functional mechanism of the EAAT transporters. Steps
3-4 denote the translocation of the binding site across the membrane with 3Na+, H+, and
glutamate bound, while steps 7-8 denote the same with only K+ bound. Step 2 shows
the last ion to bind to the outward-facing transporter, which happens after the binding of
substrate. Step 5 shows the opposite happening in the intracellular media, assuming that
the binding and unbinding of ligands are symmetrical.
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structure has the archaeal transporter in the extracellular(EC)-facing holo state of
GltPh, with the substrate and an unknown number of sodium ions bound. GltPh
is assembled as a trimer, with three identical subunits connected by non-covalent
bonds (Figure 1.4A). Each monomer has 8 transmembrane segments, called TM1 to
TM8, and 2 reentrant loops, or hairpins, called HP1 and HP2. HP1 is sequentially
located between TM6 and TM7, and HP2 between TM7 and TM8 (Figure 1.4B). A
subsequent crystal structure from 2007, also in the outward-facing state, identified
the binding sites from the substrate and two Na+ ions, called Na1 and Na215. It
revealed that these sites are formed mainly by residues located in segments HP1,
TM7, HP2 and TM8, with this region having an homology of around 60% between
GltPh and the EAATs. Furthermore, almost all residues involved in ligand bind-
ing are similar in these two transporters. By using the non-transportable blocker
TBOA as a substrate, the same study identified the HP2 segment as the gate that
opens/closes the aspartate binding site to the solvent in the EC-facing state. Molec-
ular dynamics studies have related the opening of the HP2 gate to substrate and
Na2 binding, and proposed that the latter binds after the substrate and stabilizes
the transporter in the closed conformation36. Even though only two sodium ions are
present in the 2007 crystal structure, radioactive-labeled experiments have shown
that a third sodium ion is cotransported with the substrate in GltPh
37. Molecular
dynamics simulations and mutagenesis experiments have located the binding site for
this third sodium, called Na3, which is also conserved in the EAATs38. They con-
cluded that Na3 should be the first ligand to bind, followed by Na1, aspartate and
Na2. The mechanism of substrate translocation was unknown until the release of a
crystal structure in the closed intracellular(IC)-facing state of the GltPh transporter,
also with 2 sodium ions and the substrate bound16. Unfortunately, the gating mech-
anism for the IC-state could not be determined due to the lack of substrates that
would stabilize this structure in the open conformation. It has been initially sug-
gested that HP1 would work as the IC gate, but molecular dynamics studies have
shown that both HP1 and HP2 are involved in the opening/closure of binding site
in this case39. More recently, an asymmetric trimer of GltPh with an intermediate
state between the outward and inward conformations was also resolved, which will
help solving the mechanism of substrate translocation across the membrane40.
The main focus of this thesis is using computational techniques to investigate
the properties of the GltPh transporter, such as the location of the Na3 binding
site, the mechanism of binding and release of the different ligands, as well as the
gating properties in the outward and inward states of GltPh. Once we characterize
the archaeal transporter, we use it as a template to create homology models for the
human glutamate transporter EAAT3. By performing molecular dynamics simula-
tions on EAAT3, we investigate the coordination of the different ligands, and their
conservation between GltPh and EAAT3. We also attempt to locate the proton and
the potassium binding sites, which are not present in GltPh, as well as identifying
the gating differences between the two transporters. Finally, we use rigorous pKa
calculations to unveil the mechanism of proton transport in the EAATs, and how
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Figure 1.4: (A) The crystal structure of the GltPh trimer, with the substrate and two
sodium ions bound in each chain (PDB ID: 2NWX) (B) An individual monomer from the
same structure, showing the transmembrane segments in the same coloring scheme of Fig.
1.2. HP1 is colored red, TM7 colored orange, HP2 purple and TM8 green.
that is related to the binding and unbinding of the other ligands to the transporter.
1.3 Ionotropic glutamate receptors
The ionotropic glutamate receptors are ligand-gated ion channels, coupling the in-
teraction with glutamate to the opening of an ion channel in the plasma mem-
brane6. These receptors can be divided in three major categories, according to
their selectivity for the agonists AMPA (GluA1-GluA4), NMDA (GluN1, GluN2A–
GluN2D,GluN3A–GluN3B) and kainate (GluK1-GluK5). As mentioned in the pre-
vious section, overactivation of the glutamate receptors can be related to several
neurodegenerative disorders like ischemia and epilepsy. In addition, these proteins
are potential targets for therapeutic drugs for neuropathic pain, Parkinson’s disease,
and schizophrenia. Due to the critical role that NMDA and AMPA receptors play
on learning and memory, they can also serve as the base for cognitive enhancement
treatments.
The AMPA receptors form hetero or homotetrameric structures, and each sub-
unit can be divided into four domains: an amino-terminal domain (ATD) that
participates in subtype-specific receptor assembly, trafficking and modulation; a
ligand-binding domain (LBD) central to agonist/competitive antagonist binding and
to activation gating; a transmembrane domain (TMD) that forms the membrane-
spanning ion channel; and a cytoplasmic carboxy-terminal domain involved in re-
ceptor localization and regulation (Figure 1.5A). There are several crystal structures
10 Chapter 1 Introduction
for the LBD and the ATD domains of different AMPA receptors, and recently the
three dimensional structure of a full rat GluA2 receptor determined their location
in the protein and relative to the membrane11. The LBD is organized as a tetramer,
located in the extracellular media, with each monomer assembled as a clamshell
structure composed of two globular domains, called S1 and S2. Agonists like AMPA
and glutamate bind strongly to the LBD, bringing the opening of the coupled ion
channel (TMD) and the flow of cations through the membrane. Antagonists like
CNQX and DNQX, in contrast, bind to the LBD with high-affinity but block the
receptor activation. This discrepancy has been linked to the conformational changes
happening in the receptor LBD upon ligand binding. The distance between the S1
and S2 lobes exhibits large fluctuations in the absence of substrates, and shows dif-
ferent degrees of opening depending on the ligand bound (Figure 1.5B and 1.5C).
The mechanism of ligand binding and the associated conformational changes in the
receptor for different substrates have been investigated using MD simulations, using
a variety of methods to calculate the free energies involved in the process41,42. It
was found that agonist binding changes the conformational landscape of the receptor
LBD by strongly favouring the closed conformation, and this closure accounts for
most of the free energy of binding of these molecules. Antagonist binding energeti-
cally favours the open state, and the full closure of the LBD is not permitted. This
difference in the LBD opening for agonists and antagonists may be transmitted to
the TMD, which would explain the different response of the receptor for these two
classes of substrates.
In the present thesis we calculate the standard binding free energy of polar and
charged ligands to the GluA2 ligand-binding domain (S1S2J), using a free energy
perturbation (FEP) method developed initially to calculate the binding affinity of
aspartate to the GltPh transporter (Chapter 4). FEP calculations often have conver-
gence problems for charged ligands like glutamate and aspartate43, which motivated
us to develop a detailed mathematical and statistical framework to compute the
standard binding free energies of such molecules. This method has great poten-
tial on rational drug design, since it enables the calculation of the affinity of small
molecules to a number of different proteins. GluA2 S1S2J has high resolution struc-
tures available in complex with a variety of agonists and antagonists, as well as in
the apo state. We choose for our calculations the agonists AMPA, glutamate and
ACPA; and the antagonists CNQX and DNQX. There are experimental values for
the binding affinities of these ligands available in the literature, which can be di-
rectly compared to the results we obtained using FEP. Ligand affinities calculated by
other computational methods like umbrella sampling and metadynamics have also
been reported, and therefore we can check the consistency of different free energy
methods used in molecular dynamics simulations. Due to the fact that FEP calcu-
lations allow a separation of electrostatic and Lennard-Jones contributions to the
binding free energies, we were also able to discuss the nature of the ligand-receptor
interactions, showing that they can be mostly hydrophobic or hydrophilic depending
on the substrate.
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Figure 1.5: (A) The crystal structure of the full GluA2 receptor (PDB ID: 3KG2),
showing the amino terminal domain (ATD), the ligand binding domain (LBD) and the
transmembrane domain (TMD) (B) An individual monomer from the tetrameric LBD
bound to agonist AMPA (PDB ID: 1FTM), with the S1 and S2 domains closer to each
other (closed conformation). (C) The same structure now bound to the antagonist DNQX,
with the S1 and S2 lobes exhibiting a larger separation between them (open conformation).
12 Chapter 1 Introduction
1.4 Voltage-gated potassium channels as thera-
peutic targets
Kv1 potassium channels, besides their importance in excitable cells such as nerve
and muscle, are essential for maintaining homeostasis and controlling cell prolif-
eration. For example, in cancer cells expression patterns of Kv1.3 and Kv1.5 are
remodelled, and in some cases, a correlation has been established between protein
abundance and grade of tumour malignancy44. The Kv1.3 potassium channels are
also expressed in T and B lymphocytes. Blocking of Kv1.3 inhibits T cell prolif-
eration, hence Kv1.3 blockers could be used in treatment of autoimmune diseases
such as multiple sclerosis (MS), rheumatoid arthritis, and Type 1 and Type 2 di-
abetes mellitus18. The animal kingdom provides a great number of peptides that
can target and effectively block the potassium Kv1 channels, in the form of toxins
from cone snails, sea anemones and scorpions. A Kv1.3 blocker from sea anemone,
called ShK, has a picomolar affinity for Kv1.3, and it has been used as a template
for the development of immunosuppressant drugs in the past years45,46. It has also a
similar affinity for Kv1.1, which is present in the central nervous system and should
not be targeted. Increasing the Kv1.3/Kv1.1 selectivity, therefore, is essential in the
development of new drug leads based on ShK. This can be achieved by mutating one
or more residues in the toxin peptide, and more than 400 ShK analogs have been
developed for this purpose.
Computational methods provide a powerful tool in this line of research, allowing
identification of the binding modes and the calculation of the binding free energy for
different toxin analogs. To identify the binding position of the toxin one can use a
program like HADDOCK, followed by molecular dynamics simulations to refine the
complex structure47. For the calculation of the binding free energy, the potential
of mean force (PMF) is used, obtained by umbrella sampling and the weighted
histogram analysis method (WHAM). This method is computationally costly, and
therefore it would be interesting to develop a cheaper alternative. In this thesis
we develop a method based on free energy perturbation (FEP), that can be used to
calculate the binding free energy of toxin mutants in cases when the binding mode is
not affected by the mutation (Chapter 9). We analyse the increase in Kv1.1/Kv1.3
selectivity when the K18A mutation is performed in ShK, and compare the results
we obtain using FEP to the experimental and PMF ones.
Chapter 2
Theory and methods
Albert Einstein, in one of his famous 1905 papers, explained Brownian motion as
the collision of small particles with surrounding atoms moving at high velocities,
proving the atomic theory of matter48. It also corroborated the idea, introduced
by Rudolf Clausius and James Clerk Maxwell, that macroscopic properties of a
particular system like volume, temperature and pressure can be derived from the
underlying mechanics of its fundamental particles. The development of quantum
theory in the 20th century revealed the atomic structure, giving a mathematical
description of the electron energy levels in terms of electromagnetic interactions and
the discretization of energy. All these findings laid the ground for the development
of Statistical Mechanics. Statistical Mechanics treats systems with a large number
of particles statistically, making the connection between measurable quantities and
the fundamental interactions between its constituents. It is the method of choice if
we want to obtain a mathematical description of life and the processes involved in
it. Even the most complex biochemical reactions can be seen as the movement and
interaction of electron orbitals, defined by elements that have different properties
according to the particles present in their nuclei. Mechanisms like self-assembly,
essential to the formation of living cells, can be explained in terms of local elec-
tromagnetic interactions and the laws of diffusion. The intricate conformational
changes observed in macromolecules, such as proteins and DNA, can be described
by the free energies involved in the process, arising from electrostatic interactions
and chemical bonds between individual atoms.
Ideally, one should use sophisticated quantum mechanical calculations to model
all biological processes, in order to capture all the degrees of freedom and provide
the most rigorous solutions. In practice this is not possible due to the complexity of
systems with only a few thousand atoms, which are beyond the current capability of
supercomputers if we want to achieve experimental time scales. Quantum mechan-
ical simulations from first principles (ab initio), based on density-functional theory
and the Car-Parrinello method49,50, have been a large step in that direction. Nowa-
days it is possible to perform ab initio simulations on systems with a few thousand
atoms in a picosecond time scale. Although suitable for small systems involving
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chemical reactions, this time scale is still very short to describe the dynamics of
macromolecules. Fortunately, we can approximate the quantum mechanical aspects
of a system to a few classical parameters, greatly simplifying the calculations. Al-
though this approach does not allow chemical reactions to take place, it has been
widely used in the past years for investigation of a great number of systems, and is
commonly known as all-atom classical molecular dynamics simulations (MD)51. It
works by combining a force field, which assigns a few parameters for the properties
of different atoms and molecules, to a numerical integration scheme, which describes
the evolution of the system over time using Newton’s equation of motion. The time
scales that can be simulated today are in the nano and microsecond range, still
far away from the time scales involved in most laboratory experiments. In many
cases they do not allow for an efficient sampling of the system, and that severely
limits the macroscopic properties that can be extracted from them. To overcome
that limitation, there are several methods that can simulate only the relevant states
for a given calculation, and that has greatly increased the success of MD calcula-
tions for phenomena like protein conformational changes and affinity for different
ligands. Examples include free energy perturbation (FEP)52, umbrella sampling53
and metadynamics54.
In this chapter we present a description of main aspects involved in molecular
dynamics, like the force field parameters and the numerical integration method used
on the time evolution of our model. We discuss the ensemble used in our simulations,
how the atomic interactions are calculated, and the boundary conditions of the
system. For proteins that do not have an available crystal structure, we explain how
models can be built using the structure of homologous proteins. We also describe
how we can use quantum mechanical calculations to obtain parameters for molecules
that are not present in the force field database, as well as a docking method, which
are very important for the investigation of possible drug leads. Finally, we show the
physical-mathematical background of the enhanced sampling methods used in this
thesis, and we apply them to our systems.
2.1 Molecular Dynamics Simulations
Classical MD simulations reduce the complexity of a quantum mechanical system
to few simple parameters, like sizes and partial charges assigned to individual atoms
and spring constants for chemical bonds, angles and dihedrals. They can also take
into account polarization of charges, which we don’t utilize in the present thesis. The
time evolution of the system is done in small steps by using the Verlet algorithm,
which solves Newton’s equation of motion at each step using the initial coordinates
and the force field parameters. Additional tools are used to calculate electrostatic
interactions without truncation and to keep the system in a given temperature or
pressure. The systems are built from the known crystal structures of proteins or
homology models, which are inserted in a membrane or in solution using a visualiza-
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tion software. In this section we discuss the physical background of our simulations,
showing how the potential at each atom is calculated and how the equation of motion
is solved at each time step.
2.1.1 Force Fields
There are plenty of classical force fields available in the literature, such as CHARMM55,
AMBER56 and GROMOS57. We use CHARMM for all of our simulations, so this is
the force field we are going to describe in detail here. CHARMM is a non-polarizable
force field, which assigns for each atom a Lennard-Jones (LJ) potential and a charge.
All particles are considered spherically symmetrical. The partial charge reflects the
shifting of the electronic cloud in covalent bonds towards the more electronegative
atoms, such as the oxygen atom in the water molecule, and it can have negative
or positive values depending on the molecule properties. In the case of ions, the
charge assigned is the electric charge of the cation or anion of interest. The elec-
trostatic energy between two molecules is then calculated using the usual Coulomb
interaction:
UCoul(r12) =
q1q2
4piε0r12
, (2.1)
where q1 and q2 are the charges or partial charges of atoms 1 and 2, and r12 is the
distance between the point charges located at their centers of mass. This potential
has an infinite range, which can be computationally very costly if we use periodic
boundary conditions. To circumvent this problem we use the Ewald summation,
which we explain in the next sections. For each atom we also assign a size, that is,
two parameters that are used to calculate a Lennard Jones (LJ) potential between
a pair of atoms58. This is also called a 12-6 potential, and it combines an attraction
term for larger distances and a hard-core repulsion term for distances close to the
atomic scale:
ULJ(r12) = ε
[(
σ
r12
)12
− 2
(
σ
r12
)6]
, (2.2)
where ε is the value of the potential between atoms 1 and 2 at its minimum, and
σ the associated distance between their centers of mass. This equation is valid for
atoms with the same ε and σ values. When the two atoms are different, the new
values are calculated according to:
ε12 =
√
ε1ε2, σ12 =
1
2
(σ1 + σ2). (2.3)
The r−6 term in equation 2.2 describes the attraction between atoms at larger dis-
tances, known as the Van der Waals interaction. The r−12 term represents the Pauli
repulsion at short ranges due to overlapping electron orbitals. The LJ interactions
have a very small value for distances much larger than the σ value, therefore this
potential is truncated during the molecular dynamics simulations, as we are going
to explain in section 2.1.3.
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Figure 2.1: Examples of the four bonded parameters used in the CHARMM force field,
shown in a glutamate molecule. The bond distance (r), angle (θ), dihedral (φ) and im-
proper dihedral (ϕ) are shown in black, red, yellow and green, respectively.
Classical force fields do not allow for chemical reactions, and therefore all co-
valent bonds have to be assigned prior to the simulation. Most molecules are not
rigid, being able to sample multiple conformations when in solution. An accurate
description of the conformational transitions of macromolecules is essential for the
understanding of how biological processes take place. This can be achieved by, in
addition to non-bonded atomic interactions, also creating a set of parameters for
bonded interactions in a given molecule (Figure 2.1). In CHARMM a covalent bond
is created using an harmonic approximation, by assigning a minimum value and a
spring constant for the distance between two atoms. In the same fashion, a given
angle between three atoms in a molecule is restrained by an harmonic oscillator.
Impropers also have harmonic potentials, involving four atoms at a time, and are
used to maintain the planarity of molecular groups. Dihedrals, on the other hand,
have a different expression that includes a dihedral force constant, the multiplicity
of the function and a phase shift. This is necessary because torsion angles often have
more than one minimum, as the case of a hydroxyl group attached to a aromatic
ring. Putting all the bonded and non-bonded terms together, we have the complete
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set of interactions in the CHARMM force-field:
U =

∑
bonds
1
2
Kr(r − r0)2
+
∑
angles
1
2
Kθ(θ − θ0)2 |
+
∑
impropers
1
2
Kϕ(ϕ− ϕ0)2
+
∑
dihedrals
1
2
Vφ(1 + cos(nφ− γ)
+∑
pairs
(UCoul + ULJ). (2.4)
Here r, θ, ϕ and φ represent a given bond distance, angle, improper and dihedral,
respectively. r0, θ0, and ϕ0 are the positions where the potential energy is zero,
with Kr, Kθ and Kϕ as the associated spring constants. In the case of dihedrals,
Vφ is the force constant, n is the multiplicity and γ is the phase shift. With all the
terms involved in the calculations of the potential energies, we can now discuss the
thermodynamic ensembles and the time evolution of our simulations.
2.1.2 Ensembles
An ensemble is a collection of all possible systems which have different microscopic
states but have an identical macroscopic or thermodynamic state. There exist dif-
ferent ensembles with different characteristics. The microcanonical ensemble (NVE)
is characterized by a fixed number of atoms, N, a fixed volume, V, and a fixed en-
ergy, E. This corresponds to an isolated system. The canonical ensemble (NVT) is a
collection of all systems whose thermodynamic state is characterized by a fixed num-
ber of atoms, a fixed volume, and a fixed temperature, T. The isothermal-isobaric
ensemble (NPT) has a fixed number of atoms, a fixed temperature, and a fixed
pressure, P. The grand canonical ensemble (µVT) is defined by a fixed volume, a
fixed temperature, and a fixed chemical potential, µ. For any ensemble, the average
of any dynamic property can be obtained from:
〈A〉 =
∑
i
Aipi (2.5)
where the angled brackets denote an ensemble average, Ai is the value of A in
the state i, and pi represents the probability of observing the i-th state. The idea
behind molecular dynamics simulations is that if one allows the system to evolve
in time indefinitely, that system will eventually pass through all possible states.
Even though we can use this to calculate time averages, experimental observables
are assumed to be ensemble averages. This leads us to the ergodic hypothesis,
which states that, if we sample a system for long enough, the time average equals
the ensemble average. Therefore, in a molecular dynamics simulation, one should
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generate enough representative conformations such that the following equality is
satisfied:
〈A〉time = 〈A〉ensemble (2.6)
If this is the case, experimentally relevant information concerning structural, dy-
namic and thermodynamic properties may then be calculated using a feasible amount
of computer resources. Because the simulations are of fixed duration, one must be
certain to sample a sufficient amount of phase space.
In biological systems the temperature and pressure are usually kept constant, so
our simulations are always carried out in the NPT ensemble. The partition function
for the NPT ensemble is:
∆(N,P, T ) =
∑
V
e−βPV
∑
i
e−βEi(N,V ), (2.7)
where β = 1/kBT and i are the possible states of the system, with an energy given
by Ei. The isothermal-isobaric partition function is directly related to the Gibbs
free energy by the expression:
G(N,P, T ) = −kBT ln ∆(N,P, T ). (2.8)
The Gibbs free energy is the amount of useful work that can be extracted from
a given system at constant temperature and pressure. It plays a major role in
chemistry because it describes the spontaneity of a process in these conditions, by
combining enthalpic and entropic contributions. It is also related to the equilibrium
constant between two states by the expression:
∆G = −kBT lnKeq (2.9)
where ∆G is the free energy difference between the two states and Keq is the equi-
librium constant. In order to accurately calculate the free energies of binding and
conformational changes in proteins using molecular dynamics, we always use the
Gibbs free energy.
2.1.3 Numerical Integration
We use the software NAMD59 for all our simulations, so here we describe how this
program solves the equation of motion at each time step. We also account for other
features of NAMD that are used to keep the temperature and pressure constant, as
well as calculate long-range electrostatic interactions.
Biological systems are chaotic, which means that they will exhibit a completely
different outcome even if we make the slightest changes in the initial conditions.
Therefore, rather than the actual time evolution of the model, MD simulations are
useful to obtain a good ensemble of states and from these states extract relevant
properties of the system. The chain of states created in a molecular dynamics
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simulation, each of them defined by values for the position and momentum of all
atoms, follows Newton’s equation of Motion:
mi
d2ri(t)
dt2
= −∇iU({ri}) (2.10)
where −∇iU({ri}) is the force acting on the atom i as a function of all atomic
coordinates and the force field parameters. ri and mi are the coordinates and mass
of the atom i, respectively. The acceleration d2ri(t)/dt
2 leads to a change in the
atom’s velocity and position within a discrete time step ∆t. This time has to be
sufficiently short to capture the fastest motions of the system, which usually come
from the vibrations of chemical bonds and angles. The fastest vibrational modes
come from bonds that involve hydrogens, due to the small mass of this atom, and
they would require a time step of no more than 1 femtosecond. We always use a time
step of 2 femtoseconds, so we have to use the SHAKE60 algorithm in order to keep
these bonds rigid during the simulation. To solve equation 2.10 in NVE ensemble,
NAMD uses the Verlet method61. The velocity-Verlet method obtains the position
and velocity for each atom at the next time step (rn+1, vn+1) from the current one
(rn, vn), assuming the force Fn = F ({rn}) is already computed, in the following
way:
vn+1/2 = vn +
Fn
m
∆t
2
, (2.11)
rn+1 = rn + vn+1/2 ∆t, (2.12)
Fn+1 = F ({rn+1}), (2.13)
vn+1 = vn+1/2 +
Fn+1
m
∆t
2
, (2.14)
where m is the mass of the particle. We can see that the forces and positions
are calculated once and the velocities are calculated twice at each step. The NVE
ensemble does not have a constant pressure or temperature, and therefore is not
interesting for the systems we want to simulate.
In order to obtain an ensemble that has a constant temperature, one has to
modify Eq. 2.10 in a way that does not affect the short-time trajectories. NAMD
does that by coupling the system to a temperature reservoir, done in a stochastic
way by using the Langevin equation62:
m
dv
dt
= F (r)− γv +
√
2γkBT
m
R(t) (2.15)
where m is the mass, v is the velocity, F is the force, r is the position, γ is the friction
coefficient, T is the temperature and R(t) is a univariate Gaussian random process.
Coupling to the reservoir is modeled by adding the fluctuating (the last term) and
dissipative (−γv term) forces to the Newtonian equations of motion (Eq. 2.10). To
integrate the Langevin equation, NAMD uses the Bru¨nger–Brooks–Karplus (BBK)
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method63, a natural extension of the Verlet method for the Langevin equation. This
adds a stochastic element to the simulations, which means that molecular dynamics
simulations that use this method are no longer deterministic.
In order to work in the NPT ensemble, we also need to use a method to keep
the pressure constant while varying the volume of the simulation cell. NAMD pro-
vides constant pressure simulation using a modified Nose´-Hoover method65 in which
Langevin dynamics is used to control fluctuations in the barostat. An additional
variable, e, is used to represent a piston that can compress or expand the system
volume. Langevin dynamics is then applied to this piston, giving the following
equations:
de
dt
=
1
3V
dV
dt
(2.16)
d2e
dt2
=
3V
W
(p− p0)− γede
dt
+Re, (2.17)
〈R2e〉 = 2γekT/h, (2.18)
W = 3Nτ 2kT, (2.19)
where analogous values of the Langevin terms are denoted by the subscript e, and
the weight factor W is the effective mass of the piston defined through the oscillation
period, τ . The work done by this piston on the system volume affects the atomic
velocities and accelerations as (de/dt)r and −(de/dt)v. In practice, the friction
coefficients γ and γe determine the degree to which simulations are coupled to the
thermostat and barostat. The decay constant τ is always scaled with 1/γe such that
piston behaviour is close to critical damping. Larger decay values tend to prioritize
equilibration, but affect system evolution and sampling rates. Thus, properties
such as the self-diffusion rate of water are amongst those affected by these coupling
parameters.
All simulations performed make use of periodic boundary conditions, which
means that the simulation box is replicated infinitely on the three coordinate axes.
This is necessary to avoid edge effects on the small systems we simulate, but it
also brings problems to the calculation of the non-bonded interactions. Both the
electrostatic and the LJ potentials have an infinite range, which becomes computa-
tionally costly since the number of interactions grows with the square of the number
of atoms. If we include the interactions with all the periodic cells, such calculation
becomes prohibitive. In the case of the Lennard-Jones potential (Eq. 2.2), the in-
teraction energy becomes very small for distance values much larger than σ, so we
can safely use a cut off distance. The σ12 values for pairs of atoms are typically
smaller then 5 A˚, so for distances greater then 12 A˚ the LJ interaction is set to
zero. To avoid a discontinuity in the LJ potential, this potential is gradually re-
duced starting from 10 A˚ until 12 A˚. The same approach cannot be used for the
electrostatic interactions, since in this case the magnitude decreases with 1/r. The
solution in this case is to use the Ewald summation66, which separates the electro-
static interactions in two parts. The first is a short-range potential, calculated using
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the equation for the Coulomb interaction (Eq. 2.1), which converges quickly in the
three spatial coordinates. The second is a long range potential, that is calculated
by taking advantage of the periodicity of the system, and converges quickly in the
Fourier space. By dividing the system into a grid, these calculations can be done
even faster, and this method is known as the Particle Mesh Ewald (PME)67. We use
PME for all of our systems, and to avoid artifacts from the electrostatic calculations
the total net charge of the simulation cell must always be zero. This is done by
adding or removing ions from the system, which is usually kept at a physiological
concentration of NaCl.
Each model we investigate has different features, like being in solution or im-
mersed in a lipid membrane. They also vary concerning the size of the simulation
cell, the number of atoms and the simulation parameters. The way we build our sys-
tems, as well as the minimization and equilibration procedures, are also important.
We discuss these and further details of our simulations in the respective chapters for
each of the proteins we study, since they can be different depending on the model.
2.2 Docking of ligands to proteins
Although the binding free energy of ligands to proteins can be measured using a
variety of experiments, often we don’t have the crystal structure of the complex.
This severely limits our molecular understanding of the binding mechanism, and
how a particular ligand could be modified to increase or decrease the affinity for a
particular channel or receptor. Docking programs like ZDock68 and HADDOCK69
aim to fill this gap, by using several steps to predict the binding modes using a
scoring function based on the protein and ligand parameters. They can be applied
to small ligands, like the ones we bind to the glutamate receptor, as well as large toxin
peptides, such as ShK binding to Kv1.1 and Kv1.3. We use HADDOCK followed by
MD refinement for all our docking purposes, so in this section we discuss the main
aspects of this method.
HADDOCK has first been developed for protein-protein docking, but has since
been applied to a variety of protein-ligands, protein-peptides and protein-DNA/RNA
complexes. It is based on Ambiguous Interaction Restraints, in which a few residues
that are experimentally shown to be involved in binding can be chosen to narrow
the search for the possible binding poses. It combines three steps: 1) Randomiza-
tion and rigid body energy minimization; 2) semi-flexible simulated annealing; 3)
flexible explicit solvent refinement. In the first step the two molecules are separated
in space and considered rigid, with their rotation and translation randomized and
then minimized in turns. This step can be performed in vacuum or in a solvated
environment, and generally 1000 or 2000 different complexes are obtained from this
procedure. The best structures from step one, typically a few hundred, will be sub-
jected to step two, a semi-flexible simulated annealing (SA) in torsion angle space.
Here HADDOCK performs high temperature body searches followed by simulated
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annealing, adding flexibility to the side-chains and backbones of chosen residues in
the final stages. Step three is a further refinement of the complexes obtained from
step 2, keeping the residues flexible and performed with a layer of 8 A˚ of explicit
solvent around the complex.
The final structures are clustered using the pairwise backbone RMSD at the in-
terface, then analyzed and ranked according to their average intermolecular energies
calculated using the OPLS non-bonded parameters. The binding mode that is con-
sidered the most likely is based on the energy score and the formation of clusters. A
large ensemble of low energy structures that have similar binding modes is a good
indication of the correct complex formation, even if they don’t provide the absolute
lower energies. The complex chosen is further refined using molecular dynamics
simulations, by slowly releasing restraints applied on both molecules and perform-
ing equilibrium simulations of several nanoseconds. During our simulations, this
step was found to be especially important for the side chain interactions involving
hydrophobic residues.
2.3 Parametrization of molecules
The CHARMM force field provides simulation parameters for proteins, nucleic acids,
lipids and carbohydrates. This limits the number of structures that we can treat
with MD, since often it is necessary to include an organic molecule in our simu-
lations that is not fully parameterized in CHARMM. This could be the case of a
possible drug lead or a non-natural amino acid. The CHARMM General Force Field
(CGenFF)70 allows one to obtain missing parameters for a given molecule that can
be readily used in any NAMD simulation, assigned by analogy to existing molecules
on the CGenFF database. Unfortunately, this analogy is not always satisfactory,
and the parameters have to be validated by combining quantum mechanics (QM)
and molecular mechanics (MM) simulations. This is the case of four molecules for
which we measure the affinity to the glutamate receptor: AMPA, ACPA, DNQX
and CNQX. In this section we describe how to include a new molecule in a MD sim-
ulation, starting with the download of the 3-dimensional structure from a chemical
database, followed by determination of the CGenFF parameters and their valida-
tion using QM simulations. We show as examples some of the molecules listed
above, for which we have successfully obtained CHARMM parameters to use in our
simulations.
2.3.1 Obtaining the initial parameters
We first download the three dimensional structure of the molecule of interest, which
can be done in a chemical database such as Chemspider (http://www.chemspider.com/)
or PubChem (https://pubchem.ncbi.nlm.nih.gov/). There is a number of possible
formats for this structure, like .mol, .mol2 or .sdf. The CGenFF online tool only
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accepts molecules in .mol2 format, so we use the program OpenBabel71 to con-
vert files from any other format to .mol2. OpenBabel also provides additional
tools, like defining the protonation states of titratable groups for a specified pH.
Once we have the file in the desired format, we use the online tool from Param-
Chem (https://www.paramchem.org/) to obtain the initial parameters based on
the CGenFF force field, which are assigned by analogy to molecules that have simi-
lar groups as the one we wish to parameterize. The output file is called a stream file,
and it contains all information needed to include our molecule in a MD simulation.
Each atom is assigned an atom type, which has associated LJ parameters to account
for its size. These atom types are going to be used to decide which parameters are
missing in CGenFF, and also to assign new ones by similarity to parameterized
molecules. They involve the partial charges of each atom and the missing bond,
angle, dihedral and improper parameters (Fig. 2.2). They also come with a penalty,
an indication of how good the analogy is and therefore how reliable are the assigned
parameters. Penalties larger than 10 indicate that some basic validation is recom-
mended, and larger than 50 indicate that extensive validation is needed. We can see
in the example that a few parameters have to be validated due the large penalties,
so we have performed QM simulations using Gaussian0972 to optimize them, which
we describe next.
2.3.2 Optimizing the molecule geometry and calculating the
partial charges
The first step in using QM simulations for parameter validation is to perform a
geometry minimization. This is done to obtain the optimal structure of our target
molecule, which is going to be used in the subsequent steps. For that purpose
we use the program Gaussian09, using the 6-31G basis set including single first
polarization functions. The geometry optimization combines an initial Hartree-
Fock (HF) calculation followed by a Møller-Plesset correlation energy correction,
truncated at second-order (MP2). We also obtain the MP2 Merz-Kollman charges
for each atom, in order to compare them to the values assigned by ParamChem.
There is usually good agreement between the two. In the case of a big discrepancy,
it is important to remember that the CHARMM force field is empirical and it is
fitted to the solvation energies of different molecules. That means that directly
using the charges assigned by Gaussian might not always be the best alternative,
due to effects like polarization, which are not taken into account in a classical MD
simulation.
The next step is a further optimization of the partial charges with water molecules,
using the minimized geometry from the previous step. This is done by perform-
ing QM simulations to compute the scaled HF minimum interaction energies and
distances between the model compound and individual water molecules. In Fig.
2.3 we show an example of all the water molecules used in the case of the ligand
DNQX, with each QM simulation containing only one water molecule at a time.
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Figure 2.2: Part of the output file from ParamChem for the ACPA molecule. This file
contains the missing parameters, a value for each of them assigned by analogy, as well as
the associated penalties. The partial charges section is in blue, and the others follow the
coloring scheme from Fig. 2.1. We have several penalty values over 50, so this molecule
requires further optimization using QM simulations.
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Figure 2.3: The minimized DNQX molecule with the interacting water molecules that
are used in the QM and the MM simulations. These simulations are performed with one
water molecule at a time, and the partial charges are adjusted to obtain good agreement
between QM and MM.
We perform the same procedure in MM simulations by using the optimized DNQX
geometry, the molecule parameters we have so far, and the TIP3 model for water.
The goal is to obtain good agreement between the interaction energies from the QM
and the MM simulations, by performing multiple MM simulations and adjusting the
partial charges of each atom until satisfactory agreement between the two methods
is obtained. When this objective is met, we turn to the bond and angle equilibrium
values and force constants.
2.3.3 Bond and angle equilibrium values and force constants
The missing parameters may also include bonds and angles for which there are no
values available in the CGenFF. If the penalties are high enough, we should also
validate these parameters of our model compound. This is the case for the isoxazole
ring of AMPA, with an hydroxyl group and a methyl group attached to it, which
has bond and angle penalties with values over 40. We have parametrized this group
separately, before attaching it to the rest of the molecule and calculating the addi-
tional parameters. To obtain the bond and angle equilibrium values we perform a
geometry minimization in CHARMM, and compare it to the QM minimized struc-
ture. We adjust the bond and angle values in the stream file until there is good
agreement between the bond distances and angle values obtained by QM and MM
geometry minimization.
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Figure 2.4: The vibrational modes of the isoxazole ring attached to a hydroxyl and a
methyl group, which is part of the parametrization for the AMPA molecule. The QM
result (left) and the MM result (right) show good agreement, since they reproduce sim-
ilar vibrational modes. The different components that contribute to each mode are a
combination of bonded interactions, which are assigned according to Pulay et al.73.
The calculation for the force constants is based on the reproduction of the scaled
MP2 vibrational spectrum. This is done by computing force constants, the resulting
vibrational frequencies and the intensities in an MP2/6-31G* Gaussian simulation,
using as an input the optimized geometry obtained previously. The same vibrational
modes can be calculated in CHARMM, using the VIBRAN command and the MM
minimized structure. This step also involves the creation of a U MATRIX (UMAT),
that transforms the molecule’s internal coordinates to the local internal valence
coordinates as outlined in Pulay et al.73. This procedure gives as an output two
vibrational spectra, one from the QM and one from the MM simulations. Here
we change the bond and angle force constants and perform MM simulations until
there is good agreement between the vibrational modes obtained by Gaussian and
CHARMM. We give as an example in Fig. 2.4 the two spectra obtained for the
AMPA isoxazole ring using the two methods, after we adjust the force constants
in the stream file. We can see that the main vibrational modes, as well as the
contribution from the different components, show good agreement. Therefore we
can move to the next step in the parameterization, which is the calculation of the
dihedral force constants, multiplicities and phase shifts.
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2.3.4 Calculation of the dihedral parameters
To calculate the dihedral parameters we perform potential energy scans using QM
simulations, by rotating the torsional angle of interest and minimizing the molecule
conformation at each dihedral value. The initial structure is the optimized geometry
of the target molecule, and here also the MP2 optimization, as well as the 6-31G
basis set, is used. The potential energy scan is done in discrete steps, by choosing a
range and an increment for the dihedral of interest. The range does not necessarily
has to be 360 degrees, as it can be smaller in the case of rigid molecules, and the
increment is usually around two degrees. At each dihedral value the minimum of the
MP2 potential energy is calculated, together with the atomic coordinates for this
minimum. These coordinates are going to be used as inputs for the MM calculations,
where CHARMM calculates the same potential energies at each dihedral value, based
on the parameters we have defined so far in our stream file. With the potential
energies of both QM and MM calculations, we can now plot them as a function as
the dihedral value, and find the optimal dihedral parameters that show the best
agreement between the two methods. We show in Fig. 2.5 the potential energy
scans for the missing dihedrals of the CNQX compound, after we adjust the dihedral
parameters. In the graph we have both the QM and the MM results, and we can
see the good agreement between them.
Correctly describing the torsional angles is very important for MD simulations,
since these are the bonded parameters that have the largest variation for molecules
in solution. This is because they often have more than one minima, and the energy
barriers between these minima can be overcome in the time scales of our simulations.
They play a great role in the conformational changes of proteins, so they have to
be properly adjusted to correctly describe the time evolution of our system. We
have not mentioned the impropers in our parameterization validation, since in all
molecules we have parameterized they have large force constants around a single
minima, as well as a penalty below 5. Therefore, they did not call for refined
parameterization procedure as is the case for the bonds, angles and dihedrals.
2.3.5 Re-optimization of the other parameters
The partial charges were the first parameters we calculated, and after that we have
made important structural changes in our target molecule. These changes can affect
the interaction energy of water molecules, so we have to check if any further charge
optimizations are needed. This is done by repeating the procedure on the second
paragraph of section 2.3.2 with the new values for the bonded parameters. The
other steps also might need further optimization if the charges are reassigned, so
the parameterization process is iterative. Once the stream file provides satisfactory
agreement between the QM and the MM interactions in all steps, it is ready to be
used in a simulation. Often there is a trade-off between parameters, which imposes
a limit to the accuracy on the description of a QM system using CHARMM. Never-
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Figure 2.5: Potential energy scans for six different dihedrals (numbered one to six)
belonging to the CNQX molecule, which required QM validation. The first five dihedral
scans used 60 steps with 2 degrees increments, with a total of 120 degrees each, and the last
scan used 60 steps with 3 degree increments, totaling 180 degrees. Each potential energy
scan is calculated in a separate simulation. The agreement between the potential energy
scan using QM (black) and MM (red) is very good, which means that the parameters have
been successfully optimized.
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theless, the procedure described here is very effective, as we show in the calculations
of the binding free energies of AMPA, ACPA, CNQX and DNQX to the glutamate
receptor in Chapter 8.
2.4 Homology Modeling
Membrane proteins may be very difficult to crystallize, limiting the number of sys-
tems we can build in order to perform MD simulations. To overcome this limitation,
one can construct models based on the known structure of homologous proteins.
This is the case for the human glutamate transporters (EAATs), for which no crys-
tal structure has been resolved yet, even though the main elements of the tertiary
structure were determined using other methods. The homology between two pro-
teins is obtained by aligning their amino acid sequence, and checking for residue
similarity in equivalent positions. The closest homolog of the EAATs whose crys-
tal structure has been resolved is the archaeal transporter GltPh, which shares an
overall 36% sequence identity with the human transporters. It is also a homolog
of the neutral amino acid transporters ASCT1 and ASCT2, with a 23% homology.
As explained in the introduction, GltPh also conserves the main structural elements
present in the EAATs, as well as the majority of residues involved in ion and sub-
strate binding. Therefore, we use GltPh as a template for building EAAT and ASCT
models using sequence alignment and the program MODELLER74. We also check
for the quality of the structures we obtain using a variety of scoring methods. The
alignment, model building and model evaluation are outlined in the next sections.
2.4.1 Sequence alignment
Obtaining the correct sequence alignment between the template and the target pro-
tein constitutes one of the most important steps in homology modeling. This align-
ment is done by comparing the amino acid sequence of two proteins, and aligning
equivalent regions based on their sequence similarity. It can include gaps and in-
sertions, which are caused by creation and deletion of residues during evolution. In
the case of homology modelling, the alignment includes the sequences of the tem-
plate and the target proteins. It can be performed using more than two amino acid
sequences, as in the case of multiple alignment for a whole family of proteins, or for
a target protein that has more than one template crystal structure. MODELLER
has a built-in tool to perform sequence alignments, loosely based on the program
COMPARER75, which provides additional options like imposing gap penalties and
using structural information from the template sequence. Another alignment tool
can be found in the Swiss Model server, by using the program T-COFFEE76. Swiss
Model also provides a template search using BLAST77, which is useful if we have a
given target sequence and we wish to find the closest homologs that can be used as
template structures. We have used these tools to align the sequences of the human
30 Chapter 2 Theory and methods
transporters to the GltPh transporter, and obtained very similar results to the align-
ment provided in Ref14. We chose to use the alignment provided in this reference
to build our models, since it also includes the sequences from other archaeal and
human neutral transporters. By converting it to FASTA format, we use it as the
starting point for MODELLER to build our EAATs models, which we explain in
the next section.
2.4.2 Building the models
MODELLER implements comparative protein structure modeling through satisfac-
tion of spatial restraints78. It can perform many additional tasks, including de novo
modeling of loops in protein structures and optimization of various models of protein
structure. It also allows for the inclusion of restraints on distances, angles, dihe-
drals, as well as the secondary structure of a particular region. MODELLER works
by imposing spatial restraints on the protein according to a probability distribution
function (pdf) p(x), which is integrated to give:
p(x1 < x < x2) =
∫ x2
x1
p(x)dx, (2.20)
where the term on the left side is the probability of an event x to be found within
the boundaries x1 and x2. The pdf is always a function of x and other specified
variables:
p(x) = p(x, a, b, c...) (2.21)
These variables are determined according to stereochemical restraints, the template
structure and a database of known protein structures. The stereochemical restraints
include the bond distances, angles, dihedrals, Coulomb’s law and Van der Waals re-
pulsion between pairs of atoms, as well as specified disulphide bonds. The values for
these interactions are based on the CHARMM22 parameter set. The restraints based
on the template structure are applied on the Cα–Cα distances, the main chain N-O
distances, the main chain conformation, and the residue side chain conformations.
Additional terms can be added to the pdf above, if we wish to restrain a particular
feature of the system such as an angle or a dihedral between atoms. They also allow
for the creation of a secondary structure like an α-helix or a β-bridge in a given
segment of the target protein, if this sequence has no equivalent on the template.
This was the case for a 50 residue loop that is present in the EAATs but not in GltPh,
that was proposed to be an α-helix by FRET studies, and is discussed further in
the results section. MODELLER is also capable of producing homology models that
include bound ligands in the alignment, such as ions or amino acid substrates. This
is useful if we want to model a given protein that has the same ligands bound as the
template structure, since their presence is also taken into account in the calculation
of the spatial restraints. That was the case for all of our models, since GltPh and the
EAATs share the same ligands and their binding sites are believed to be conserved.
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We have produced homology models for EAAT1, EAAT2, EAAT3, ASCT1 and
ASCT2, all using GltPh as a template. In this thesis we focus on the results from
the EAAT3 model, since this is the one we have investigated further in Chapters 6
and 7.
2.4.3 Evaluating the models
We have built 20 models for each transporter using the method explained above,
and performed different model evaluation procedures to choose the best ones to
use in our MD simulations. We have used three separate methods: the QMEAN
(Qualitative Model Energy ANalysis), a composite scoring function ranging from 0 to
1, which describes the major geometrical aspects of protein structures79; the DFIRE
(Distance-scaled, Finite Ideal-gas REference), a potential based on a database of
non-homologous proteins80; and the DOPE (Discrete Optimized Protein Energy),
an atomic distance-dependent statistical potential calculated from a sample of native
structures74. The first two are available on the Swiss Model Server, and the last one
is built into the program MODELLER. The model for each transporter that had
the best quality, based on the methods above, was chosen for the MD simulations.
The scores obtained for the models, as well as the system creation and equilibration
procedures, are discussed in further detail in Chapters 6 and 7.
2.5 Free energy methods
Calculating the free energies involved in different biological processes is one of the
main goals of MD simulations. If one could perform simulations for a sufficient
amount of time, the partition function in Eq. 2.7 could be directly obtained, as well
as the probability of the system to be in any given state. Since this is not feasible
in all-atom simulations, we can associate the probability ratio of two macroscopic
properties of our system to the free energy difference between them, according to
the equation:
∆G12 = −kBT ln
(
P1
P2
)
= −kBT lnKeq (2.22)
This expression can be calculated using a reasonable amount of computational re-
sources, as long as we find ways to sample the relevant states of the system and
their associated free energies. This can be done in many ways, like performing an
alchemical transformation or adding a biasing potential along a chosen reaction co-
ordinate. In this section we discuss the free energy methods that we use in this
thesis: the Free Energy Perturbation (FEP), Thermodynamic Integration (TI)52
and the Potential of Mean Force (PMF)53. The first two are calculated by mu-
tating or inserting a given molecule in the system in small steps, and the third by
introducing biasing potentials along a given reaction coordinate and obtaining the
PMF using the Weighted Histogram Analysis Method (WHAM)81. In section 2.5.1
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we explain the Free Energy Perturbation (FEP) and the Thermodynamic Integra-
tion (TI) methods, which have a similar formalism. In section 2.5.2 we discuss the
application of umbrella sampling to obtain a given Potential of Mean Force (PMF).
2.5.1 Free Energy Perturbation and Thermodynamic Inte-
gration
Molecular dynamics simulations sample a given state of the system with a probability
proportional to e
−G
kBT , and therefore they seek out preferentially the lowest free energy
regions of configurational space. For densities typical of molecular liquids, the high-
and low-energy regions of configurational space are sufficiently well separated that
a conventional simulation of practical length will never adequately sample the high-
energy regions that contribute significantly to the ensemble average expression for
free energy. However, in molecular systems the free energy problem can be seen in
terms of a free energy difference between two states, ∆G. If we associate the initial
and final states to Hamiltonians given by H0 and H1, respectively, this free energy
difference can be cast in terms of a coupling parameter. Let us assume that the
Hamiltonian of the system, H, depends on a continuous parameter λ, such that as
λ is varied from 0 to 1, H(λ) passes smoothly from H0 to H1. In the perturbation
method one introduces a hybrid Hamiltonian H(λ) = (1 − λ)H0 + λH1, where H0
represents the Hamiltonian for the initial state and H1 for the final state of the
system. The interval between H0 and H1 can be divided into n subintervals with
{λi, i = 1, . . . , n−1}, and for each subinterval the free energy difference is calculated
from the ensemble average:
∆Gi = −kBT ln〈exp[−(H(λi+1)−H(λi))/kBT ]〉λi . (2.23)
The subscript λi indicates that, even though we are using two different Hamiltonians,
the averaging is over the ensemble of configurations representative of the initial
state of the system. This means that there must be significant overlap between the
configurational space of equilibrated systems using the H(λi+1) and H(λi) sets of
interactions. This can be achieved by choosing appropriate subintervals, or windows,
for λ. Successful application of the perturbation method is commonly limited to
free energy differences of < 2kT, or ∼ 1.5 kcal mol. Consequently, the free energy
difference between two adjacent lambda values should be less than ∼1.5 kcal/mol.
The total free energy difference ∆G is then simply given by the sum:
∆G =
∑
i
∆Gi (2.24)
This calculation should also be done in the opposite direction, H1 to H0, which is
commonly called the backward FEP calculation. The discrepancy or hysteresis in
these two estimates of ∆G gives an estimate of the statistical uncertainty in the
result, and it arises from configurations sampled in H(λi) and not in H(λi+1), and
vice versa.
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The Thermodynamic Integration method is similar to the FEP method described
above, but here we obtain the ensemble average of the derivative, ∂H(λ)
∂λ
, and integrate
over λ to obtain the final value of the free energy difference:
∆G =
∫ 1
0
〈
∂H(λ)
∂λ
〉
λ
dλ. (2.25)
The best way to solve this integral is to obtain ∂H(λ)
∂λ
for a finite set of λ values,
and use them to numerically solve the integral above. We always use the Gaussian
quadrature, which is an integration method that uses a weighted sum of function
values at specified points within the domain of integration:∫ 1
0
f(x) =
n∑
i=1
ωif(xi) (2.26)
An n-point Gaussian quadrature rule yields an exact result for polynomials of degree
2n− 1 or less, and in our calculations we use a value for n between 7 and 12. As we
explain in the next paragraph, most of our alchemical free energy calculations are
divided into an electrostatic and a Lennard-Jones (LJ) term for quicker convergence.
The calculations related to the electrostatic interactions can always be approximated
by a 7-point quadrature, but the LJ interactions calculations often require 9 or 12
points due to the steepness of the ∆G curve close to the end points.
FEP/TI calculations can bring serious convergence problems in the end points
when we have the insertion/deletion of particles in a given system. This problem
is often related to the high values of the LJ potential when the distance between
two atoms, r12, approaches zero. Even if we use very small λ subintervals, there is
always a singularity for the LJ potential at r12 = 0, and that causes instability for
values of lambda close to 0 and 1. The solution is to add a term to the expression of
the Lennard-Jones potential (Eq. 2.2)82, where r12 is scaled with lambda according
to the expression:
r12 =
√
r212 + c(1− λ), (2.27)
where c is the value of the shift coefficient, which is specified in the NAMD input file.
Even though this does not affect the initial and final states of the FEP calculations,
it modifies the LJ interaction into a soft core potential for 0 < λ < 1, so that
particles can be smoothly added to the system. We find that c values between 4.0
and 7.0 are suitable for our calculations, so we always use shift coefficients in this
range. The use of a soft core potential, on the other hand, is not compatible with
an electrostatic potential that is −∞ for opposite charges when r12 = 0. Therefore,
we separate the Lennard-Jones and the electrostatic contributions during the FEP
calculations, by first creating a neutral molecule and then charging it, or vice-versa.
Further details about our FEP/TI calculations, as well as how to use restraints
to calculate the entropic contributions of ligand binding free energies, are explained
in Chapter 8.
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2.5.2 Potential of Mean Force
When a particular transformation can be described in terms of a physical coordi-
nate, like a distance or a dihedral, the calculation of the potential of mean force
(PMF) becomes a very useful tool to calculate the free energy difference between
two states. There are many methods that can be used to calculate the PMF, like
metadynamics54, adaptative biasing force83 and umbrella sampling53. The main
idea behind these methods is to introduce a bias in the system, so that it visits
states that are essential for the calculation of the free energy, but cannot be sam-
pled during equilibrium simulations due to their low probability. This is the case for
the unbound states of ligands that have a high affinity84, or intermediate states in
protein conformational transitions41. In this thesis we use umbrella sampling, which
consists of harmonic potentials applied as a function of a reaction coordinate, that
restrain the system in a particular region of the phase space. By using the bias-
ing potential as an input, the PMF can be obtained using the Weighted Histogram
Analysis Method (WHAM). The PMF is then numerically integrated to obtain the
final value of the free energy. In the next paragraphs we discuss each of these steps,
as well as how they apply to our calculations.
By choosing an appropriate reaction coordinate, we can apply harmonic poten-
tials at different positions along the latter so that its whole extent is sampled at a
relatively low computational cost. This method is called umbrella sampling, and we
use it to calculate the binding affinity of different toxins to the Kv1.1 and Kv1.3
potassium channels, as well as to separately calculate the influence of a salt bridge in
the binding free energy of AMPA and Glutamate to the GluA2 receptor. Umbrella
sampling can be done in multiple dimensions, although they bring a larger compu-
tational cost, since the number of simulations varies exponentially with the number
of dimensions we choose. We use a one dimensional PMF, which is enough for our
purposes, as well as a reaction coordinate defined by a distance between two groups
of atoms. To create the states along this distance, also called windows, we perform
steered molecular dynamics (SMD) simulations starting from the structure with the
lowest free energy. We then use this path to create the umbrella windows, which
are simulated until good convergence is obtained. Generally the SMD windows are
not yet equilibrated properly, so we have to run a few nanoseconds of equilibration
and then production for each window. The distance between each window, as well
as the force constants, can have different values depending on the system. The im-
portant thing is to have sufficient overlap between adjacent windows84, so that the
whole path is sampled properly. In Figure 2.6A we show the biased histogram as
a function of the distance between the α-amino group of glutamate and the GluA2
E705 residue side chain carboxyl group, for each of the windows we simulate. The
distance between windows is 0.5 A˚, ranging from 2.5 A˚ to 9.0 A˚, with an harmonic
biasing potential of 8 (kcal/mol)/A˚2 centered at the distance value for each win-
dow. This histogram cannot be directly used to calculate the free energy, due to the
strong bias applied on the system, which has to be removed in order to obtain the
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unbiased PMF.
To remove the applied bias on the histogram of Fig. 2.6A, and obtain the
unbiased PMF of the system, we use the WHAM method81. WHAM provides a
scheme for obtaining the optimal estimate of the unbiased probability distribution
from biased probability distributions in the presence of biasing potentials. For one
reaction coordinate ξ, the WHAM equations are given by:
ρ(ξ) =
Nw∑
i=1
niρ
(b)
i (ξ)
Nw∑
j=1
nje−β(Vj(ξ)−Fj)
(2.28)
e−βFi =
∫
e−βVi(ξ)ρ(ξ)dξ, (2.29)
where β = 1/kBT , Nw is the number of windows, Vi(ξ) is the biasing potential of the
ith window, ρ
(b)
i (ξ) is the biased probability of finding the system at ξ at simulation
i, ni is the number of samples used to construct ρ
(b)
i (ξ) at simulation i, Fi is the free
energy constant of window i, and ρ(ξ) is the unbiased probability distribution. The
last two terms are unknown, and WHAM solves these two equations self-consistently
to obtain them. The potential of mean force is directly related to ρ(ξ), by the
equation:
PMF (ξ) = −kBT ln(ρ(ξ)) + C (2.30)
The constant C is obtained by setting a ξ value for which PMF (ξ) = 0, usually the
value of the PMF minimum. In Figure 2.6B we show the unbiased PMF calculated
from the distributions of Fig. 2.6A, after we have applied the WHAM method.
Integrating this curve as a function of the chosen distance gives the free energy in
this region of the phase space, that can be used to calculate the free energy of ligand
binding or local conformational changes. The way we integrate the PMF, and how
that applies to the systems in question, is further explained in Chapters 8 and 9.
2.5.3 Convergence
In both FEP and umbrella sampling, it is essential that the simulations are properly
converged for the obtention of reliable results. This means that the majority of
states involved in a given tranformation or translocation have to be appropriately
sampled, which is harder to accomplish when dealing with large systems. In the
case of FEP simulations, large conformational changes in the binding protein or the
ligand, caused by the binding/unbinding of the substrate, can cause great problems
when performing the transformation from λ = 0 to λ = 1 (or vice-versa). This issue
can be identified by a large histeresis between the forward and backward calcula-
tions, or by significant differences between results using different simulation times.
The use of TI is helpful in these situations since it allows for greater sampling of
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Figure 2.6: (A) Biased probability distribution for each of the 14 windows we simulate,
when calculating the PMF of the distance between the α-amino group of glutamate and
the E705 side chain carboxyl group of the GluA2 receptor. (B) The final PMF after we
use WHAM and the biased probability of the previous item.
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a smaller number of windows. Another way to solve convergence problems is to
treat a given conformational change on the protein, like a dihedral rotation, sepa-
rately and perform the FEP calculations in a confined state. Restraining the ligand
conformation, translation and rotation during the FEP simulations, and calculating
the free energy of applying these restraints separately, also allows for accurate FEP
calculations with less computational effort. This is explained further in Chaper 8.
In the case of PMF calculations of toxin binding to ion channels, the toxin might
experience intermediate conformational changes when it is pulled from the bind-
ing site during the steered molecular dynamics and umbrella sampling simulations.
These transient states between the bound and unbound states of the toxin can cause
convergence problems and therefore influence the results. Similarly to the case of
FEP, we can perform restrained simulations and calculate the effect of these re-
straints on the toxin separately, in the binding site and in bulk. This method also
greatly increases convergence at a relatively low computational cost84.
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Position of the Third Na+ Site in
the Aspartate Transporter GltPh
and the Human Glutamate
Transporter, EAAT1
ABSTRACT
Glutamate transport via the human excitatory amino acid transporters is
coupled to the co-transport of three Na+ ions, one H+ and the counter-
transport of one K+ ion. Transport by an archaeal homologue of the
human glutamate transporters, GltPh, whose three dimensional struc-
ture is known, is also coupled to three Na+ ions but only two Na+ ion
binding sites have been observed in the crystal structure of GltPh. In
order to fully utilize the GltPh structure in functional studies of the hu-
man glutamate transporters, it is essential to understand the transport
mechanism of GltPh and accurately determine the number and location
of Na+ ions coupled to transport. Several sites have been proposed for
the binding of a third Na+ ion from electrostatic calculations and molec-
ular dynamics simulations. In this study, we have performed detailed
free energy simulations for GltPh and reveal a new site for the third Na
+
ion involving the side chains of Threonine 92, Serine 93, Asparagine 310,
Aspartate 312, and the backbone of Tyrosine 89. We have also studied
the transport properties of alanine mutants of the coordinating residues
Threonine 92 and Serine 93 in GltPh, and the corresponding residues
in a human glutamate transporter, EAAT1. The mutant transporters
have reduced affinity for Na+ compared to their wild type counterparts.
These results confirm that Threonine 92 and Serine 93 are involved in
the coordination of the third Na+ ion in GltPh.
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3.1 Introduction
Glutamate is the major excitatory neurotransmitter in the mammalian central ner-
vous system. The extracellular concentration of glutamate is predicted to be as
low as 25 nM86 and is maintained by specific transport proteins called excitatory
amino acid transporters (EAATs). Excessive extracellular glutamate is toxic for
neurons, and therefore its concentration needs to be strictly controlled. Loss of this
control due to dysfunction of EAATs has been implicated in several neurological
diseases such as Alzheimer’s disease, motor neuron disease and amyotrophic lateral
sclerosis12.
Glutamate transport via the EAATs is coupled to the co-transport of three Na+
ions and one H+ ion followed by the counter-transport of one K+ ion13,87. Binding of
Na+ and glutamate to the EAATs also activates an uncoupled Cl− conductance88–90.
A considerable amount of data has been gathered on the functional properties of
the EAATs, but in the absence of any molecular structures it has been difficult to
interpret this data and arrive at a molecular-level understanding of the transport
mechanism of the EAATs. Determination of the crystal structure of a glutamate
transporter homologue from Pyrococcus horikoshii (GltPh)
14 has therefore caused
much excitement in the field. GltPh is a Na
+-dependent aspartate transporter that
also has an uncoupled Cl− conductance and the binding sites for the substrate
aspartate and two Na+ ions have been identified15,91 (Figure 3.1A). Whether two or
three Na+ ions are co-transported with each substrate molecule was not clear from
the initial functional studies of GltPh, where a Hill coefficient >2 was observed
15,35,91.
This issue has recently been resolved in an experiment using 22Na and 3H-aspartate,
where it has clearly been shown that three Na+ ions are co-transported with each
substrate as in the EAATs37. In this study, we follow the nomenclature already
established and call the Na+ ion binding sites observed in the crystal structure Na1
and Na215 and the third Na+ binding site Na3.
GltPh shares about 36% amino acid sequence identity with the EAATs, which
increases to above 60% for the residues forming the binding pocket15. Furthermore,
many of the residues that have been implicated in substrate and ion binding, and
also Cl− permeation, in the EAATs are conserved in GltPh 28,32,90,92–94. Thus, the
GltPh structure offers a good starting point for constructing homology models of the
EAATs which can be used to perform simulations to gain a detailed understand-
ing of the transport mechanism. All three Na+ ions need to be included in such
studies, and this requires an accurate determination of the location of the Na3 site.
Even a relatively small inaccuracy in the binding position of the ion could affect
its coordination shell and lead to sizable inaccuracies in the calculated binding free
energy. Several Na3 sites have been proposed from electrostatic calculations31,95 and
molecular dynamics (MD) simulations96,97, which are compared with the available
experimental data below.
The most important clue for the location of the Na3 site comes from the crystal
structure of GltPh
15, where the side chains of residues T92 and D312 are not in-
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Figure 3.1: Structure of GltPh with bound aspartate, Na1 and Na2 (PDB 2NWX).
(A) One protomer in cartoon representation; transmembrane domain (TM)1, TM2, TM4
and TM5 (coloured in grey), TM3 (blue), TM6 (green), TM7 (orange), TM8 (magenta),
hairpin (HP)1 (yellow) and HP2 (red). Bound aspartate is in stick representation and
Na1(1) and Na2(2) are indicated as green spheres. (B) Close-up of the substrate binding
site that has been rotated 90o around the vertical axis (coloured as in A). Aspartate 312
(D312) and threonine 92 (T92) are shown in stick representation. Figures were made using
Pymol98.
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volved in coordination of Na1 or Na2 (Figure 3.1B). This is in contrast to evidence
from mutagenesis experiments on EAAT3 where both of these residues have been
proposed to coordinate one of the coupled Na+ ions during glutamate transport30,31.
This suggests that the vicinity of the T92 and D312 side chain oxygens is the most
likely place for the Na3 site and MD simulations of the GltPh structure provide fur-
ther clues in this regard. In MD simulations lasting 50 ns we have observed that, in
the absence of a Na+ ion nearby, the D312 side chain swings ∼5 A˚ and coordinates
Na1. Similar D312–Na1 coordination has been observed in other MD simulations of
GltPh
96. The resulting coordination shell for Na1 is in substantial disagreement with
that observed in the crystal structure, indicating that D312 should not be involved
in the coordination of Na1. The only way the D312 side chain can be prevented
from swinging towards Na1 in MD simulations is by allowing it to coordinate the
third Na+ ion. Such a Na3 binding site was first proposed from electrostatic calcu-
lations, where four other oxygens besides the two oxygens from D312 were identified
as possible ligands, namely, the side chains of Y88, T92 and N310, and the back-
bone of G40431. This Na3 site was refined in subsequent MD simulations, where it
was proposed to be formed by the side chains of T92, N310 and D312, and a water
molecule97.
The aim of this study was to carefully examine the proposed Na3 binding sites
and find the best site that is consistent with all of the available data. Because
the D312–Na3 coordination is fairly well established from both experiments30 and
simulations97, we impose this condition which considerably simplifies the search.
Our simulation results indicate that there is an alternate Na3 binding site near the
one proposed in97, which involves the side chains of T92, S93, N310, D312, and the
backbone of Y89. This site provides a better coordination for the third Na+ ion and
hence a lower binding free energy. We have used site-directed mutagenesis to change
the proposed ligand residues T92, S93, N310 and D312 to alanine in GltPh. The
N310A and D312A mutant transporters are non-functional, but functional analysis
of T92A and S93A, and the equivalent residues in EAAT1, confirm their involvement
in the coordination of Na3.
3.2 Results
3.2.1 MD simulations of GltPh reveal a novel Na3 site
To date, all MD simulations of GltPh and predictions for the Na3 site have used the
aspartate–bound closed structure. In this study, we employ two simulation systems
derived from the aspartate–bound ‘closed’ (PDB: 2NWX) and the TBOA–bound
‘open’ (PDB: 2NWW) structures. In the closed structure the helical hairpin 2 (HP2)
gate is closed and aspartate and two Na+ ions (Na1 and Na2) are bound (2NWX).
While in the open structure the non-transportable inhibitor TBOA is bound in place
of aspartate which prevents closing of the HP2 gate and only one Na+ ion (Na1)
is bound (2NWW). We have created an open structure from 2NWX by removing
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the ligands and observing the opening of the HP2 gate in MD simulations36,99.
A similar apo structure has been created from 2NWW by removing TBOA. To
distinguish between these two structures, we will refer to them as “closed” and
“open” following their origin, although in both structures the HP2 gate is open.
As T92 and D312 have been proposed to bind a Na+ ion in EAAT330,31 and
they are unlikely to interact with Na1 or Na2, we placed a Na+ ion in the vicinity
of the T92 and D312 side chains in the system obtained from the closed structure,
and equilibrated this system in MD simulations. The resulting coordination shell
is consistent with that found previously97 and consists of the oxygens from the
sidechains of T92, N310 and D312 (two), and a water molecule (this site will be
called Na3’ henceforth, see Figure 3.2A). We next considered the system obtained
from the open structure of GltPh. Surprisingly, when this system is equilibrated in
MD simulations with a Na+ ion placed near the T92 and D312 side chains, a rather
different coordination shell emerges, consisting of the oxygens from the side chains
of T92, S93, N310, D312 (one oxygen), and the backbone of Y89 (Figure 3.2B).
In the new site (to be called Na3), water and one of the D312 carboxyl oxygens
in the Na3’ site are replaced with two new ligands, which leads to a tighter Na+
coordination shell due to shorter Na–O distances.
An immediate question is why there are two different Na3 sites if the two struc-
tures are so similar. The answer becomes obvious when the open and closed crystal
structures are superimposed – the O and N atoms in the N310 side chain are inter-
changed in the two structures (Figure 3.2A,B). This different position of the N310
side chain leads to a difference of about 2 A˚ between the position of Na3 and Na3’.
Na3 is closer to transmembrane domain 3 (TM3), where the extra coordinating lig-
ands reside. The aspartate and TBOA bound crystal structures were solved at ∼3 A˚
and ∼3.5 A˚ respectively. At this resolution it is difficult to assign the positions of
side chains with accuracy so we have performed several tests to see which of the
two positions of the N310 side chain is more realistic. To check the stability of the
respective binding sites, we have equilibrated the open and closed structures without
Na+ ions and Asp. In 5 ns MD simulations, the N310 side chain has retained its
original configuration in both the open and closed structures, indicating that there
is no intrinsic preference for one of the configurations in the ‘apo’ state. Next, we
have equilibrated the two structures in the presence of a Na+ ion in the respective
Na3 binding sites. Snapshots obtained from the MD simulations are compared to
the respective crystal structures (Figure 3.3). Introduction of the Na+ ion at Na3’
is seen to cause a relatively large perturbation of the N310 side chain in the closed
structure, e.g., the Cα atom is displaced by about 2 A˚ from its crystal structure po-
sition (Figure 3.3A). In contrast, placement of a Na+ ion at Na3 induces very little
change in the N310 side chain configuration in the open structure (Figure 3.3B). If
there is an unobserved third Na+ ion in these crystal structures, its introduction in
the correct location in the MD simulations should cause minimal disruption to the
coordinating ligands, which is the case for the Na3 site but not for Na3’.
To ensure that the N310 side chain conformation is the only difference between
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Figure 3.2: Comparison of the Na3 and Na3’ sites. Snapshots of the Na3’ (A) and Na3
(B) sites showing the oxygens (red) involved in the coordination of a Na+ ion (yellow).
Note the flipping of the N310 side chain between (A) and (B). Distances between the Na+
ion and coordinating ligands are shown in angstroms.
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Figure 3.3: The N310 configurations in the closed and open structures contrasted with
the MD results. Comparison of the N310 configuration from the crystal structure (green
backbone) with that obtained from MD simulations (cyan backbone). Na+ ions are shown
as yellow spheres. (A) Closed structure (PDB 2NWX) vs. Na3’ site, (B) Open structure
(PDB 2NWW) vs. Na3 site.
the 2NWX and 2NWW structures with regard to the Na3 binding site, we have
repeated the MD simulations with these two structures, but with the O and N
atoms in the N310 side chain flipped in each case. The average Na+–O distances
listed in Table 3.1 essentially reveal an identical coordination shell structure in both
cases, as long as the N310 side chains have the same conformation. Finally, we have
calculated the free energy of binding of a Na+ ion to the Na3 and Na3’ sites in the
absence of other ions and substrate. An example of the thermodynamic integration
(TI) calculations illustrating the convergence of the binding free energy for the Na3
site is shown in Figure 3A.1. The binding free energy is found to be 4 kcal/mol lower
for the Na3 site compared to that of Na3’ (Table 3.2), which again supports Na3 as
the correct binding site. Using the coordination for the Na3 and Na3’ ions shown in
Table 3.1 and the valence mapping algorithm used by Nayal et al.100, we can also
compare the valences of the Na3 and Na3’ sites from the equation v = (R/R1)
−N .
In this expression, R1 and N are empirical constants, and R is the distance of each
coordinating atom from the sodium ion. To obtain the final value of v, we sum over
all the coordinating oxygens for each case. We find a value of 1.18 for the valence
of Na3’ and 1.23 for the valence of Na3, making it difficult to assert which one is
more likely based on valence calculations. On the other hand, both are similar to
the values obtained for the valence of the Na1 site95, which further indicates the
validity of the D312 region on harbouring a sodium ion. To summarize the evidence
presented, the Na3 site is more consistent with the crystal structure compared to the
Na3’ site and leads to a lower binding free energy. Therefore, the Na3 site identified
in this study is the most likely binding site for the third Na+ ion in GltPh.
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Table 3.1: Coordination of the third Na+ ion showing the Na-O distances (in A˚) for
the closed (2NWX), and open (2NWW) structures, which give rise to the Na3’ and Na3
binding sites, respectively. When the N310 side chain is flipped in the closed structure
(2NWX*), the same coordination shell is observed as in the open structure (2NWW).
Similarly, when the N310 side chain is flipped in the open structure (2NWW*), an identical
Na+ coordination to that of 2NWX is observed.
Na3’ Na3
2NWX 2NWW* 2NWW 2NWX*
Y89 (O) 3.8 ± 0.3 3.9 ± 0.3 2.3 ± 0.1 2.3 ± 0.1
T92 (OH) 2.4 ± 0.1 2.4 ± 0.1 2.4 ± 0.1 2.4 ± 0.1
S93 (OH) 4.3 ± 0.2 4.1 ± 0.3 2.3 ± 0.1 2.4 ± 0.1
N310 (OD) 2.2 ± 0.1 2.2 ± 0.1 2.2 ± 0.1 2.2 ± 0.1
D312 (O1) 2.2 ± 0.1 2.2 ± 0.1 2.1 ± 0.1 2.1 ± 0.1
D312 (O2) 2.2 ± 0.1 2.2 ± 0.1 3.5 ± 0.3 3.6 ± 0.2
H20 (O) 2.4 ± 0.2 2.4 ± 0.2
3.2.2 Order of binding of Na+ and aspartate to GltPh
The binding order of Na+ ions and aspartate provides more evidence in this regard.
It has been argued that, because access to the Na3 site is through the Na1 site
and the path is very narrow, the Na3 site must be occupied first otherwise a Na+
ion would not be able to access the Na3 site97. Here we provide evidence from the
binding free energy calculations in favour of this proposal. As indicated in Table 3.2,
the free energy of binding of a Na+ ion is 7 kcal/mol lower for the Na3 site compared
to the Na1 site. The large free energy difference between these two sites suggests
that once a Na+ ion binds to Na3 there is a higher probability it will remain bound
than if it were to bind to Na3’ where the free energy difference compared to Na1
is smaller (3 kcal/mol). The higher free energy of binding of Na+ to Na3 suggests
that this site is a more stable one compared to Na3’.
A related question is whether aspartate binds before or after Na1. As shown in
Table 3.2, the second Na+ ion binds to the Na1 site with a fairly large free energy
(-7.1 kcal/mol) in the absence of aspartate. When aspartate is included in the
MD simulations following the binding of two Na+ ions at the Na3 and Na1 sites, the
resulting system is extremely stable – all three aspartate molecules in the trimer have
been observed to remain in their binding pockets for more than 50 ns. However,
once the Na+ ion is removed from the Na1 site, aspartate becomes unstable and
dissociates – all three aspartate molecules in the trimer have been observed to move
away from their binding pockets within 5 ns of MD simulations. These observations
provide strong evidence that aspartate binds only after the binding of two Na+ ions.
Thus the proposed binding order of the ligands to the transporter is Na3, Na1,
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Table 3.2: Binding free energies for Na+ ions in various locations (in kcal/mol). The
interaction energy (∆Gint), entropic contributions (∆Gtr) and the total binding energy
(∆Gb) are listed separately. The interaction free energy differences are obtained from the
average of the forward and backward transitions. Presence of a second Na+ ion is indicated
in parentheses. Errors are estimated from block data analysis using 50 ps windows. The
Na2 site is not considered because it is formed only after the HP2 gate shuts.
Ligand ∆Gint ∆Gtr ∆Gb
Na3 -23.3 ± 1.2 4.6 -18.7 ± 1.2
Na3’ -19.3 ± 0.9 4.6 -14.7 ± 0.9
Na1 -16.2 ± 1.3 4.9 -11.3 ± 1.3
Na1 (Na3) -11.9 ± 1.3 4.8 -7.1 ± 1.3
aspartate and Na2.
3.2.3 The Na3 site in the archaeal aspartate transporter
GltPh
To confirm the alternate Na3 binding site described above, site-directed mutagenesis
was performed on the Na3 coordinating residues T92, S93, N310 and D312. Y89
contributes a backbone carbonyl oxygen to the Na3 site and therefore was not inves-
tigated by mutagenesis. All mutations were well tolerated by GltPh; similar protein
yields were obtained and all mutant transporters eluted as symmetrical peaks fol-
lowing size exclusion chromatography at the same point as wild type GltPh (Figure
3.4A). Purified protein was reconstituted into liposomes and function was assayed
by examining 3H-L-aspartate uptake.
The N310A and D312A transporters did not exhibit 3H-L-aspartate uptake over
background levels and were not investigated further (Figure 3.4B). This is not sur-
prising as mutation of either of these residues in EAAT2 results in a non-functional
transporter101. In addition, these two residues are in the highly conserved NMDGT
motif that contains residues important for substrate binding15. Both T92A and
S93A are functional aspartate transporters (Figure 3.4B) but display altered aspar-
tate affinity and changes in the Na+ dependence of transport. T92A transports
aspartate with a slightly higher affinity than wild type GltPh; K0.5 of 61 ± 10 nM
compared to 100 ± 10 nM for wild type GltPh. In contrast, S93A exhibits a re-
duction in aspartate affinity with K0.5 of 370 ± 60 nM (Figure 3.4C). The Na+
dependence of aspartate transport was measured by monitoring the uptake of 3H-
L-aspartate under a range of Na+ concentrations, from 0.1 mM to 300 mM. Both
T92A and S93A showed a reduction in Na+ affinity compared to wild type GltPh;
T92A K0.5 of 19 ± 1 mM and S93A K0.5 of 44 ± 2 mM compared to GltPh K0.5 of
3.9 ± 0.4 mM (Figure 3.4D) but there was no change in the Hill coefficient (GltPh,
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Table 3.3: Effect of the T92A and S93A mutations on the binding free energies of Na+
ions at the Na3 and Na1 sites (in kcal/mol). Mutations significantly reduce the binding free
energies of Na3 but not of Na1. Presence of a second Na+ ion is indicated in parentheses.
Ligand GltPh T92A S93A
Na3 -18.7 ± 1.2 -11.2 ± 1.4 -12.8 ± 1.2
Na1 (Na3) -7.1 ± 1.3 -6.7 ± 1.2 -6.4 ± 1.4
2.3 ± 0.5; T92A, 2.1 ± 0.2; S93A, 1.9 ± 0.2). As T92 and S93 are not close enough
to coordinate Na1 or Na2, we propose that these mutations are affecting the Na3
site. Indeed, when the binding free energy of Na3 is calculated in the presence
of the T92A and S93A mutations, it is reduced by 7.5 kcal/mol and 5.9 kcal/mol
respectively, while the binding free energy of Na1 is unaltered (Table 3.3). Interest-
ingly, the maximal velocity of 3H-L-aspartate transport measured in the presence of
100 mM Na+ and saturating substrate concentrations by T92A is 42 ± 1 nmol/mg
protein/min and S93A is 58 ± 3 nmol/mg protein/min. These rates are increased
compared to the maximal velocity of 3H-L-aspartate transport by GltPh (7.5 ± 0.5
nmol/mg protein/min) (Figure 3A.2). The increased rate of transport observed for
the mutant transporters could be due to the reduced affinity of Na3 for its binding
site. Na3 may unbind more easily from T92A and S93A than wild type GltPh and
thus facilitate the turnover of the transporter. Taken together, the simulation and
experimental results strongly support a role for T92 and S93 in coordinating Na3 in
GltPh.
3.2.4 The Na3 site in the human glutamate transporter
EAAT1
GltPh shares ∼36% amino acid identity with the EAATs and this conservation is
even higher in the transport domain consisting of hairpin (HP)1, transmembrane
domain (TM) 7, HP2 and TM8 where amino acid identity increases to ∼ 60%. The
recent crystal structure of the inward facing Na+ and aspartate bound GltPh revealed
that TM3 and TM6 are also part of the transport domain core that is proposed to
move over 18 A˚ during the transport cycle16. TM3 is not as highly conserved
as the rest of the transport domain, GltPh shares 40% amino acid identity with
EAAT1 in this region, but there are several residues that are conserved throughout
the Na+ dependent transporters of this family including GltPh, EAAT1-5 and the
neutral amino acid transporter, ASCT1. T92 is highly conserved, while S93 is
a threonine residue in the rest of the family (Figure 3.5A). Interestingly, T92 is
replaced with an isoleucine residue in the H+ dependent glutamate transporters from
Bacillus stearothermophilus (GltTBs) and Esherichia coli (GltPEc). To investigate
if the third Na+ site predicted by simulation and experimental studies on GltPh is
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Figure 3.4: T92A and S93A mutations in GltPh have reduced Na
+ affinity. (A) Size
exclusion column profile for wild type GltPh (dark blue), T92A (red), S93A (green), N310A
(pink) and D312A (cyan). (B) Uptake of 100 nM 3H-L-aspartate in the presence of 100
mM NaCl for GltPh (black squares), T92A (white squares), S93A (grey squares), N310A
(white triangles) and D312A (black triangles). Control levels are from uptake performed
in the presence of internal buffer (100 mM KCl, 20 mM HEPES/Tris pH 7.5) (C) 3H-L-
aspartate concentration-dependent transport in the presence of 100 mM NaCl by GltPh
(black squares), T92A (white squares) and S93A (grey squares). (D) Na+ concentration-
dependent transport of 100 nM 3H-L-aspartate for GltPh (black squares), T92A (white
squares) and 500 nM 3H-L-aspartate for S93A (grey squares). Data in (C) and (D) are
normalised to the maximal velocity of transport and all data are from the mean of at least
3 separate experiments ± s.e.m.
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conserved in the human glutamate transporters the T130A (equivalent to T92) and
T131A (equivalent to S93) mutations were introduced into EAAT1. The residues
equivalent to N310 and D312 were not investigated as these transporters have been
shown to be non-functional in EAAT2101.
Application of 100 µM L-glutamate to oocytes expressing EAAT1 elicits a current
of 395 ± 20 nA when the oocytes are clamped at -60 mV (Figure 3.5B). Application
of 100 µM L-glutamate to oocytes expressing the mutant transporters T130A and
T131A also activates a conductance at -60 mV but it is reduced in amplitude to 21
± 2 nA and 25 ± 2 nA for T130A and T131A respectively (Figure 3.5B). To further
investigate the impact of the T130A and T131A mutations in EAAT1 the K0.5 for L-
glutamate transport and the K0.5 for the Na
+-dependence of L-glutamate transport
were determined. Oocytes expressing EAAT1, T130A or T131A were clamped at
-60 mV and increasing doses of L-glutamate were applied. For wild type EAAT1 the
K0.5 value for L-glutamate is 15 ± 1 M (Figure 3.5C). In contrast, the L-glutamate
affinity for T130A and T131A is reduced with K0.5 values of 87 ± 3 µM and 124 ±
11 µM, respectively (Figure 3.5C).
To investigate the Na+-dependence of transport the current elicited by saturating
L-glutamate concentrations (300 µM for EAAT1 and 1 mM for T130A and T131A) in
the presence of increasing amounts of Na+ was determined. For wild type EAAT1 the
K0.5 for Na
+ is 28 ± 4 mM and the Hill coefficient is 2.8 ± 0.4. The Na+ dependence
of L-glutamate transport for T130A and T131A was significantly altered compared
to wild type EAAT1 (Figure 3.5D). For both mutant transporters, the highest Na+
concentration tolerated by Xenopus laevis oocytes (150 mM) was not saturating and
the data could not be fit to the Hill equation to determine a K0.5 for Na
+ or a Hill
coefficient. Nevertheless, it is evident that both of these mutations have significantly
reduced the ability of Na+ to support glutamate transport.
3.3 Discussion
Molecular dynamics is a powerful tool that can simulate movements and binding
events from static snapshots of proteins obtained from X-ray crystallography, but
functional studies are vital to confirm these predictions and maximise the informa-
tion obtained from MD simulations. In this study, we have combined these tech-
niques to explore the third Na+ binding site in the glutamate transporter family
using GltPh and EAAT1 as representative transporters.
The crystal structure of the aspartate transporter GltPh with bound substrate
and two Na+ ions was an important advance in our understanding of the trans-
port mechanism of the glutamate transporter family15. Substrate transport by the
human glutamate transporters EAAT287 and EAAT313, and also by GltPh
37, is cou-
pled to the co-transport of 3 Na+ ions, yet only 2 Na+ binding sites were identified
in the GltPh structure
15 leaving the location of the third Na+ ion unknown. Previ-
ous studies using electrostatic calculations, MD simulations and mutagenesis studies
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Figure 3.5: T130A and T131A mutations in EAAT1 have reduced Na+ affinity. (A)
Amino acid alignment of TM3 and TM7. Alignment was made using ClustalW2102 and
adjusted manually. T130A and T131A mutations in EAAT1 have reduced Na+ affinity.
(A) Amino acid alignment of TM3 and TM7. Alignment was made using ClustalW2102
and adjusted manually. Amino acid sequences are; human (h)EAAT1 (NP 004163.3),
hEAAT2 (NP 004162.2), hEAAT3 (NP 004161.4); hEAAT4 (NP 005062.1); hEAAT5
(NP 006662.3); hASCT1 (NP 003029.2); Pyrococcus horikoshii GltPh (NP 143181); Es-
cherichia coli GltPEc (EGT70436.1); Bacillus stearothermophilus GltTBs (P24943.1). Red
shading indicates the residues that form the Na3 site, grey shading indicates conserved
residues and black shading indicates residues absolutely conserved. (B) Average current
activated by the application of 100 µM L-glutamate to oocytes clamped at -60 mV express-
ing EAAT1 (black), T130A (white) and T131A (grey). Red shading indicates the residues
that form the Na3 site, grey shading indicates conserved residues and black shading in-
dicates residues absolutely conserved. (B) Average current activated by the application
of 100 µM L-glutamate to oocytes clamped at -60 mV expressing EAAT1 (black), T130A
(white) and T131A (grey). (C) L-glutamate concentration-dependent currents for EAAT1
(black), T130A (white) and T131A (grey). (D) Na+ concentration-dependent currents in
the presence of 300 µM L-glutamate for EAAT1 (black circles), and 1 mM L-glutamate
for T130A (white circles) and T131A (grey circles). Data in (C) are normalised to the
current at saturating glutamate concentrations and all data are from the mean of at least
3 separate experiments ± s.e.m.
3.3 Discussion 51
have proposed several different sites for Na330,31,95–97. Here, we present a new loca-
tion of the Na3 site as determined by MD simulations of both the open and closed
GltPh structures. The veracity of this site has been further tested by calculating the
binding free energy of substrate and ions and site-directed mutagenesis experiments,
which corroborate our proposed Na3 location.
The binding site for Na3 is made up of residues from TM3 and TM7 which are
both in the transport domain that is proposed to undergo a large conformational
change during substrate translocation16. T92 (TM3), S93 (TM3), N310 (TM7) and
D312 (TM7) all donate side chain oxygens to the binding site while Y89 (TM3)
contributes a backbone carbonyl oxygen (Figure 3.6A). To verify the contribution
of the side chains of T92, S93, N310 and D312 to the Na3 site predicted by MD
simulations we used site-directed mutagenesis to change these residues in GltPh to
alanine. The N310A and D312A transporters were non-functional. These residues
reside in the highly conserved NMDGT motif that contains residues important for
substrate binding15 and mutations of the equivalent residues in EAAT2 leads to
non-functional transporters101. In contrast, the T92A and S93A transporters were
functional aspartate transporters but these mutations result in a reduced affinity
for Na+ compared to wild type GltPh, while the Hill coefficient is unaltered. This
data suggests that the ability of Na+ to support aspartate transport is diminished
but the number of Na+ ions coupled to transport is unchanged. There is also some
variation in the affinity of aspartate for these mutant transporters. T92A has a
slightly higher aspartate affinity, while S93A displays a reduced aspartate affinity
compared to wild type GltPh. As aspartate binding and transport is coupled to Na
+,
it is not surprising that disruption of the Na3 site also affects the K0.5 for aspartate
transport. Further evidence to support the location of Na3 comes from the binding
free energies calculated when the T92A and S93A mutations were introduced into
GltPh. Both of these mutations reduced the binding free energy calculated for Na3,
but did not affect the binding free energy calculated for Na+ binding to the Na1 site
(Table 3.3). To translate the information gained about the location of the Na3 site in
GltPh to the human glutamate transporters, parallel mutagenesis experiments were
performed in EAAT1. The residues corresponding to T92 and S93 in EAAT1 were
also changed to alanine and these mutant transporters displayed a similar phenotype
to the mutant transporters in GltPh in that the ability of Na
+ to support glutamate
transport was substantially reduced.
Why hasn’t Na3 been observed in any of the crystal structures of GltPh? The
resolution of the available GltPh structures is not good enough to visualise Na
+ ions
directly and the heavy atom thallium (Tl+) was used to probe cation binding sites
on GltPh. Two Tl
+ sites were identified and ion competition studies confirmed that
Na1 and Na2 were genuine Na+ sites, but Tl+ binding was not observed at the Na3
site under these conditions15. The Na+ affinity for Na3 is considerably higher than
for Na1 and Na2 as suggested by the binding free energies (Table 3.2) and as Tl+ has
a larger ionic radius than Na+ (1.40 vs. 0.95 A˚), it simply may not be able to bind
to the Na3 site. In addition, the pathway between Na1 and Na3 is narrow97 and as
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Figure 3.6: The third Na+ binding site in GltPh. (A) The coordination of the Na3
binding site identified in this study. TM3 (blue) and TM7 (orange) are shown in cartoon
and the coordinating residues are shown in stick representation and labelled. Na3 is shown
as a yellow sphere. (B) The area of the Na3 site in the inward occluded structure of GltPh
(PDB 3KBC); colouring as in A. (C) Na+ binding site on the rotor ring (c ring) of the
F-Type Na+ ATPase from Ilyobacter tartaricus (PDB 1YCE). V63, S66 are from the A
subunit and Q32, E65 are from the B subunit of the c ring. Na+ ion is shown as a
yellow sphere. (D) One protomer of GltPh with bound aspartate, Na1, Na2 and Na3.
The transport domain is shown in colour; TM3 (blue), TM6 (green), HP1 (yellow), TM7
(orange), HP2 (red) and TM8 (purple) and the 3 Na+ ions are shown as green spheres
and numbered. (E) The proposed order of binding for substrate and ions to GltPh. All
distances are in angstroms and structure figures were made using Pymol.98
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Tl+ was soaked into GltPh crystals that already contained Na
+, exchange between
Na+ and Tl+ may not have been possible at the Na3 site. We have compared the
Na3 site of GltPh identified in this study (Figure 3.6A) with the Na
+ binding site
on an unrelated protein, the F-type Na+-ATPase from Ilyobacter tartaricus103. The
F-type Na+-ATPase is a molecular motor that utilises a Na+ gradient to synthesise
ATP. The Na+ binding sites (11 identical sites) are located on the rotor ring (or c
ring) and investigation of these Na+ sites (Figure 3.6C) reveals that they share a
number of similarities with Na3 site in GltPh (Figure 3.6A). Both sites are formed
by the side chain oxygen of an acidic amino acid (D312 in GltPh; E65 in c ring),
a polar amino acid (N310 in GltPh; Gln32 in c ring), a backbone carbonyl oxygen
(Y89 in GltPh; Val63 in c ring) and the hydroxyl oxygen of a serine residue (S93 in
GltPh; S66 in c ring). The Na3 binding site in GltPh has an additional coordinating
ligand from T92. The striking similarities between these two Na+ binding sites on
proteins unrelated in sequence or function further supports the correct identification
of the third Na+ binding site of GltPh in this study.
Two different orders for Na+ and aspartate binding to GltPh have been proposed
where aspartate binds either before or after Na197. The binding free energy cal-
culations for Na+ and MD simulations of aspartate binding to GltPh presented in
this study suggest an order of binding where Na3 binds first, followed by Na1. The
binding of these two Na+ ions creates a favourable site for aspartate to bind. Finally,
Na+ binding to the Na2 site secures HP2 down over the substrate and results in the
‘occluded’ state observed in previous crystal structures (Figure 3.6D,E)14,15. The
transport domain with aspartate and Na1-3 bound is then predicted to undergo a
conformational change and move to the intracellular side of the membrane where it
is ready to release its cargo into the cell16. Interestingly, examination of the Na3
site in the ‘inward occluded’ structure16 reveals that two of the coordinating ligands
for Na3 (the side chains of N310 and D312) appear to be facing away from this site
(Figure 3.6B). The resolution of this structure is moderate ( 3.8 A˚) and side chain
placement may not be accurate, but if these movements do occur, the affinity of
Na+ at the Na3 site in the intracellular occluded state would be reduced and may
facilitate unbinding of Na+. Further molecular dynamics simulations of the ‘inward
occluded’ structure and/or a structure of an inward facing ‘apo’ state of GltPh are
required to confirm these side chain movements and will shed light on the process
of Na+ and substrate unbinding.
Three dimensional crystal structures of prokaryotic homologues of membrane
proteins have resulted in a major advance in our understanding of the structure and
mechanism of their human counterparts. Here, we present the precise location of
the third Na+ site in GltPh and show that this site is conserved in EAAT1. This
information is required to develop accurate homology models of the EAATs which
will provide useful starting points to investigate the transport mechanism of the
human glutamate transporters. Such studies may help to explain the differences
between GltPh and the EAATs including differences in transport rates, substrate
selectivity and K+ dependence of transport.
54
Chapter 3 Position of the Third Na+ Site in the Aspartate Transporter GltPh and
the Human Glutamate Transporter, EAAT1
3.4 Materials and Methods
3.4.1 Ethics statement
Frogs used in this study were anaesthetised to minimize suffering and all surgical
procedures followed a protocol approved by The University of Sydney Animal Ethics
Committee (protocol # K21/2-2010/3/5269) under the Australian Code of Practice
for the Care and Use of Animals for Scientific Purposes.
3.4.2 Model system and MD simulations
The simulation systems are prepared using the software VMD104. The crystal struc-
ture of the GltPh trimer is embedded in a 1-palmitoyl-2-oleoyl-phosphatidylethanolamine
(POPE) phospholipid bilayer and solvated in a box of water molecules with phys-
iological concentration of NaCl. The final system consists of the trimer, 239 lipid
molecules, 15688 water molecules and 35 Na+ and 35 Cl− ions. GltPh has a net
charge of +6e, so to keep the system neutral 6 Cl− ions are added in the apo sys-
tem (more Cl− ions are added when the bound Na+ ions are included to preserve
neutrality). After the system is built, it is equilibrated in two stages: first, the
coordinates of the protein atoms are fixed and the system is equilibrated with 1 atm
pressure coupling until the correct water and lipid densities are obtained. The x and
y-dimensions of the simulation box are then fixed (at 115 and 113 A˚, respectively),
and pressure coupling is applied in the z-direction (the average z length is 71 A˚).
In the second stage, the protein is gradually relaxed in 2.4 ns MD simulations by
reducing the restraints on the protein atoms in several steps. The system is further
equilibrated for 5 ns with only a small (0.1 kcal/mol/A˚2) restraint left on the back-
bone atoms of the protein. This helps to preserve the structural integrity of the
protein during long MD simulations. This procedure is repeated for both the closed
and open structures, and the final states obtained have been used in all subsequent
MD simulations and free energy perturbation (FEP) calculations.
MD simulations are performed using the NAMD package, version 2.7b259 with
the CHARMM22 force field55 including the CMAP corrections105. The temperature
is kept at 300 K using the Langevin damping method, and the pressure is kept
at 1atm using the Langevin piston method. The Lennard-Jones interactions are
switched off for distances over 12 A˚ with a switching distance of 10 A˚. Periodic
boundary conditions with the particle-mesh Ewald method are employed to calculate
the electrostatic interactions without truncation. A time step of 2 fs is used in all
MD simulations.
3.4.3 Free energy calculations
The binding free energies of Na+ ions are calculated using the expression, ∆Gb =
∆Gint + ∆Gtr , where the first term gives the free energy difference for the interac-
tions of the ion in the binding site and bulk (i.e. translocation energy) and the second
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term measures the free energy loss due to reduction in translational entropy upon
binding106. The latter can be estimated from the rms fluctuations of the ion in the
binding site (σx,σy,σz) as ∆Gtr = −kBT ln[(2pie)3/2σxσyσx/V0], where V0 = 1660A˚3
which is the reference volume for the standard concentration107. The interaction
energy is calculated using both the free energy perturbation (FEP) and the ther-
modynamic integration (TI) methods52,108. Because the two methods have yielded
essentially the same results, here we report only the TI calculations. Initially, the
Na+ ion is placed at the appropriate binding position in the protein and the sys-
tem is equilibrated. In the forward calculation, the bound Na+ ion is alchemically
transformed to a water molecule while a water molecule in the bulk is transformed
to a Na+ ion simultaneously. After equilibrating the last window in the forward cal-
culation, a backward calculation is performed, where the opposite transformations
are performed bringing the system back to the initial state with a bound Na+ ion.
Any significant difference between the forward and backward calculations points to
hysteresis effects in the TI calculations. Otherwise the binding free energy of the
ion is determined from the average of the forward and backward calculations.
Integrals in the TI calculations are evaluated using a seven-point Gaussian quadra-
ture, which has been shown to be sufficiently accurate for calculation of the binding
free energies of ions108. The simulation systems for the seven windows are adapted
from the parallel FEP calculations because the windows are more closely spaced in
FEP and hence equilibrate faster. Each window is equilibrated for 0.5 ns followed
by a 1 ns production run. Convergence of the free energy results are checked from
the running averages which become flat once sufficient sampling is obtained.
The same procedure is used to calculate the binding free energy of the Na+ ions
at the Na1 and Na3 sites in the T92A and S93A mutations of the transporter. The
mutations are implemented using the MUTATOR plug-in from the VMD software,
where the side chain of the chosen residue is mutated while the backbone coordinates
remain the same. To make sure that the mutated residue is in a stable conforma-
tion, the resulting structure is energy minimized and equilibrated for 3 ns in MD
simulations before starting the free energy calculations.
3.4.4 Site-directed mutagenesis
Site-directed mutagenesis was performed using a polymerase chain reaction (PCR)
based method109 and Velocity DNA polymerase (Bioline). All mutations were
sequenced on both strands by Dye Terminator Cycle Sequencing (ABI PRISM,
PerkinElmer Life Sciences). The wild type EAAT1 and mutant transporter cD-
NAs were linearized with SpeI and cRNA transcribed with T7 RNA polymerase
using the mMessage mMachine T7 kit (Ambion Inc.).
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3.4.5 Protein purification and reconstitution
GltPh protein was purified as described previously
91. Briefly, membranes were iso-
lated, solubilized with (40 mM) n-dodecyl-β-D-maltopyranoside (C12M, Anatrace),
and protein was purified using Ni-NTA resin (Qiagen). The C12M concentration in
the buffer was reduced to 2 mM before addition to Ni-NTA beads. The histidine
tag was subsequently removed by digestion with thrombin (10 U/mg protein) and
the protein further purified on a size exclusion column where the detergent was
exchanged to 7 mM n-decyl-β-D-maltopyranoside (C10M, Anatrace).
Pure protein was reconstituted into liposomes using a method modified from
Gaillard et al., 1996110. Escherichia coli polar lipids and 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (Avanti Polar Lipids), at a ratio of 3:1, were mixed, dried
under nitrogen, and resuspended in internal buffer (100 mM KCl, 20 mM HEPES
pH 7.5 or the appropriate internal buffer as indicated below). The lipid mixture was
briefly sonicated using a cylindrical sonicator (Labatory Supplies Co.) and the lipid
suspension was frozen in liquid nitrogen and thawed at 45oC several times. Lipo-
somes were formed by extrusion through 400 nm polycarbonate membranes (Avanti
Polar Lipids) and were treated with Triton X-100 at a 0.5:1 (w/w) detergent to
lipid ratio prior to the addition of protein at 0.25 µg protein/mg lipid35. The pro-
tein/lipid mixture was left at room temperature for 30 minutes before detergent was
removed using SM2 Biobeads (Biorad). The protein/lipid mixture was incubated,
with gentle agitation, with three consecutive batches of the Biobeads (80 mg/ml).
Proteoliposomes were concentrated by centrifugation at 150,000g for 30 minutes in
a Beckman Optima TLX centrifuge, resuspended at 100 mg lipid/mL and either
used immediately or flash frozen in liquid nitrogen and stored at -80oC.
3.4.6 Proteoliposome transport assay
3H-L-aspartate transport by wild type GltPh and mutant GltPh transporters was
assayed using a protocol modified from Gaillard et al., 1996110. Proteoliposomes
were loaded with internal buffer (100 mM KCl, 20 mM HEPES pH 7.5) by several
freeze/thaw cycles followed by extrusion as described above. The uptake reaction
was initiated by diluting the proteoliposomes (100 mg lipid/mL) 133 fold into reac-
tion buffer pre-warmed to 30oC. The reaction buffer contained: 100 mM NaCl, 20
mM HEPES pH 7.5, 1 µM valinomycin and the indicated concentrations of 3H-L-
aspartate. At each time point, a 200 µL aliquot was removed and diluted 10 fold into
ice cold quench buffer (100 mM LiCl, 20 mM HEPES pH 7.5), followed by imme-
diate filtration over nitrocellulose filters (0.22 µm pore size, Millipore). The filters
were washed once with 2 mL of ice cold quench buffer and assayed for radioactivity
using a Trilux beta counter (Perkin Elmer). The Na+ dependence of 3H-L-aspartate
transport was measured by varying extraliposomal Na+ from 0.1 to 300 mM Na+.
Choline (Ch+) was used to balance osmolarity and the intraliposomal K+ concen-
tration was adjusted to 300 mM. 3H-L-aspartate concentrations used for the Na+
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titrations were 100 nM for GltPh and T92A and 500 nM for S93A; concentrations
close to the aspartate K0.5 value for each transporter. Background levels of uptake
were measured by diluting proteoliposomes into internal buffer (100 mM KCl, 20
mM HEPES pH 7.5) containing 1 µM valinomycin and the indicated concentrations
of 3H-L-aspartate.
3.4.7 Electrophysiology
All chemicals were obtained from Sigma unless otherwise stated. Stage V oocytes
were harvested from Xenopus laevis as described previously111. 4 ng of cRNA was
injected into oocytes and incubated in standard frog Ringers solution (ND96: 96
mM NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2, 5 mM HEPES, pH 7.5) supple-
mented with 50 µg/mL gentamycin, 2.5 mM sodium pyruvate, 0.5 mM theophylline
at 16-18oC.
Current recordings were made using the two-electrode voltage clamp technique
with a Geneclamp 500 amplifier (Axon Instruments, Foster City, CA) interfaced
with a PowerLab 2/20 chart recorder (ADI Instruments, Sydney, Australia) using
the chart software and a Digidata 1322A (Axon Instruments) controlled by an IBM-
compatible computer using the pClamp software (version 10, Molecular Devices,
Union City, California). When measuring Na+ dependence of substrate induced
currents, saturating concentrations of L-glutamate were used (300 µM for EAAT1
and 1 mM for T130A and T131A) and the concentration of Na+ varied from 1 to
150 mM. NMDG+ was used as a Na+ substitute to maintain ionic strength of the
buffers.
3.4.8 Analysis of kinetic data
Substrate responses were fitted by least squares as a function of substrate concentra-
tion to I/Imax = [S]/([S] + K0.5), where I is the current, Imax is the maximal current,
K0.5 is the concentration of substrate that generates half-maximal response, and
[S] is the substrate concentration. Na+ concentration responses were fit to the Hill
equation I/Imax = [S]
n/([S]n + (K0.5)
n) where n is the Hill coefficient and all other
terms are as described above. For 3H-L-aspartate uptake by GltPh, initial rates were
calculated from the linear portion of the curve and all data represent the mean ±
s.e.m. of at least 3 experiments.
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3.A Appendix for Chapter 3
Figure 3A.1: TI calculations for Na+. Convergence of the binding free energy of a
Na+ ion to the Na3 site is demonstrated using the running averages of the free energies,
which flatten out as the data are accumulated. Binding free energies for the negative
of the forward (binding site → bulk) and the backward transitions are shown with solid
and dashed lines, respectively. The final results read from the end points of the curves,
are -22.3 kcal/mol (forward) and -24.2 kcal/mol (backward), whose average gives the
interaction energy value (∆Gint) quoted in Table 3.2.
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Figure 3A.2: Maximal velocity of 3H-L-aspartate transport. The maximal rate of trans-
port in the presence of saturating aspartate concentrations and 100 mM NaCl for GltPh
(black), T92A (white) and S93A (grey).
Chapter 4
Free Energy Simulations of Ligand
Binding to the Aspartate
Transporter GltPh
ABSTRACT
Glutamate/Aspartate transporters cotransport three Na+ and one H+
ions with the substrate and countertransport one K+ ion. The binding
sites for the substrate and two Na+ ions have been observed in the crystal
structure of the archaeal homologue GltPh, while the binding site for the
third Na+ ion has been proposed from computational studies and con-
firmed by experiments. Here we perform detailed free energy simulations
of GltPh, giving a comprehensive characterization of the substrate and
ion binding sites, and calculating their binding free energies in various
configurations. Our results show unequivocally that the substrate binds
after the binding of two Na+ ions. They also shed light into Asp/Glu
selectivity of GltPh, which is not observed in eukaryotic glutamate trans-
porters.
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4.1 Introduction
Glutamate transporters (GlTs) remove the excess extracellular glutamate using the
electrochemical gradient of Na+ ions12. In mammalian GlTs (called excitatory
amino acid transporters, or EAATs for short), the transport mechanism involves
cotransport of three Na+ and one H+ ions, and countertransport of one K+ ion13,85.
A large amount of functional data has been accumulated on GlTs in the last two
decades12 but their interpretation has proved difficult in the absence of any struc-
tures. As in ion channels, the first crystal structure of a GlT was determined in
prokaryotes, namely that of GltPh from Pyrococcus horikoshii
14. The binding sites
for the substrate and two ions were identified in a subsequent crystal structure of
GltPh
15. Initial functional studies of GltPh revealed that the transport mechanism
was independent of H+ and K+, but they were inconclusive on whether two or three
Na+ ions were cotransported in each cycle15,35. This issue was settled in a recent ex-
periment with radioactive 22Na+ ions and [14C] aspartate, which showed conclusively
that three Na+ ions are cotransported with the substrate as in EAATs37.
GltPh has about 36% amino acid sequence identity with the EAATs, which is
somewhat low. However, the sequence identity is much higher for the residues
forming the binding pocket (∼ 65%), and most of the residues implicated in substrate
and ion binding in EAATs are conserved28,32,90,94. Thus, in the absence of any
EAAT structures, one may use the GltPh structure to interpret the functional data
from EAATs and thereby gain insights for the transport mechanism in GlTs112,113.
This can be achieved by performing detailed molecular dynamics (MD) simulations
of GltPh, where one characterizes the binding sites for the substrate and the ions
and calculates their binding free energies in various configurations to determine the
binding order. But before one can proceed with such a program, the binding site
for the third Na+ ion (to be called Na3) needs to be located accurately. Otherwise
a reliable prediction of the binding free energies would not be possible.
So far several MD simulations of the GltPh structure have been carried out fo-
cusing on the opening of the extracellular gate and substrate binding36,99, location
of the Na3 site96,97, and substrate translocation and release39,114. The Na3 site was
also searched via electrostatic calculations and valence mapping31,95. Of the pre-
dicted Na3 sites, only those involving D31231,97 are completely consistent with the
functional30,31 and structural15 data. Our initial free energy calculations indicated
that even those Na3 sites did not yield binding energies that were consistent with the
transport mechanism, which prompted us to further refine the Na3 site proposed in
Ref.97. The proposed new site for Na3 involves, besides the already identified T92,
N310 and D312 side chains31,97, two other residues, Y89 backbone and S93 side
chain. The presence of the S93 side chain in the coordination shell of the third Na+
ion has been confirmed by S93A mutation experiments both in GltPh and EAAT1,
where a large reduction in Na+ affinity has been observed38.
It appears that all the binding sites in GltPh have been well identified so the
system is ripe for a detailed MD study. Our aim here is first to show that the MD
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results for the binding sites and coordination of the substrate and ions are in good
agreement with the experimental data. This is important to build confidence in
the model and dispel any doubts about the ion binding sites in the crystal struc-
ture where Tl+ ions were employed instead of Na+. We then perform free energy
calculations for the substrate and ions in various configurations to determine their
binding free energies, which are used in predicting their binding order. In particular,
a strong dependence of Asp binding to Na1 binding is found, which is explained by a
H-bond network linking the two ligands. Finally we examine the Asp/Glu selectivity
in GltPh and discuss its implications for constructing homology models for EAATs,
where such an Asp/Glu selectivity is not observed.
4.2 Model system and simulation details
Several crystal structures of the GltPh protein are available from the Protein Data
Bank. The most revealing structure is the closed structure (PDB ID: 2NWX),
where an Asp and two Na+ ions are bound and the helical hairpin 2 (HP2) gate
is closed15. Following previous MD studies36,99, we have created an open structure
from 2NWX by removing the bound Asp and Na+ ions and observing opening of
the HP2 gate in MD simulations. In a second crystal structure (PDB ID: 2NWW),
the transporter inhibitor DL-threo-β-Benzyloxyaspartate (TBOA) is bound in place
of Asp, which keeps the HP2 gate open. We have created a similar apo structure
of GltPh from 2NWW by removing the bound TBOA and equilibrating the system
in MD simulations. The two open structures are very similar in all respects except
for the orientation of the N310 side chain, which is flipped 180◦ between the two
structures. Because the N310 side chain is directly involved in the coordination of
the Na3 site, it is important to choose the correct conformation for this side chain.
The Na3 site predicted using the 2NWW structure has been shown to be more
consistent with experiments38. Therefore we have adopted the conformation of the
N310 side chain from the 2NWW structure in the 2NWX structure as well. With
this change, the two open structures yield essentially identical results in free energy
simulations.
The simulation systems are prepared using the software VMD104. The crystal
structure of the GltPh trimer is embedded in a 1-palmitoyl-2-oleoyl-phosphatidylethanolamine
(POPE) phospholipid bilayer and then solvated in a box of water molecules with
125 mM of NaCl. The system contains the trimer, 239 lipid molecules, 15688 water
molecules and 35 NaCl ions. The GltPh trimer has a net charge of +6e in the apo
state. Therefore, 6 extra Cl− ions are included in the apo system to maintain charge
neutrality. When the bound ligands are included in simulations, neutrality of the
system is preserved by adding more counter ions. After the initial preparation, the
system is equilibrated in two stages.
In the first stage, the coordinates of the protein atoms are fixed and the system is
equilibrated with 1 atm pressure coupling in all directions until the correct water and
4.3 Free Energy calculations 63
lipid densities are obtained. At this point, the x and y-dimensions of the simulation
box are fixed, and pressure coupling is applied only in the z direction henceforth
(typical dimensions of the simulation box are 115 × 111 × 71 A˚3). In the second
stage, the protein is gradually relaxed in 2.4 ns MD simulations by reducing the
restraints on the protein atoms in several steps. The system is further equilibrated
for 5 ns with only a small (0.1 kcal/mol/A˚2) restraint left on the backbone atoms
of the protein. This helps to preserve the structural integrity of the protein during
long MD simulations. The above procedure is repeated for all structures employed
in MD simulations.
MD simulation are performed using the NAMD package (version 2.7b2)59 with
the CHARMM22 force field55 including the CMAP dihedral corrections105. The
temperature is maintained at 300 K using Langevin damping with a coefficient of
5 ps−1, and the pressure is kept at 1 atm using the Langevin piston method with
a damping coefficient of 20 ps−1 64. Periodic boundary conditions with the particle-
mesh Ewald method are employed to calculate the electrostatic interactions without
truncation. The Lennard-Jones (LJ) interactions are switched off between 10 and
12 A˚ using a smooth switching function. A time step of 2 fs is used in all MD
simulations.
4.3 Free Energy calculations
The standard binding free energy of a ligand can be expressed as106,115,116
∆Gb = ∆Gtr + ∆Grot + ∆Gcon + ∆Gint, (4.1)
where the first two terms represent the translational and rotational free energy dif-
ferences of the ligand between the binding site and the bulk, the third term measures
the free energy cost of applying conformational restraints on the ligand in the bind-
ing site relative to bulk, and the last term represents the free energy of translocating
the restrained ligand from the bulk to the binding site. The translational and rota-
tional free energy differences can be evaluated assuming Gaussian distributions for
the ligand configurations in the binding site, which yields107,117–119
∆Gtr = −kBT ln
[
(2pie)3/2σxσyσz
V0
]
,∆Grot = −kBT ln
[
(2pie)3/2σφ1σφ2σφ3
8pi2
]
, (4.2)
where V0 = 1660 A˚
3 is the reference volume for the standard concentration, σx, σy,
and σz, are the principal rms fluctuations of the center of mass of the ligand in the
binding site, and σφ1, σφ2, and σφ3, are the rotational rms fluctuations of the ligand
calculated using the quaternion representation119. The various σ’s are estimated
from MD simulations of the bound ligands without using any restraints because
they are stably bound.
The free energy difference for applying conformational restraints can be written
as
∆Gcon = ∆G
bulk
con −∆Gsitecon, (4.3)
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where ∆Gbulkcon and ∆G
site
con are the free energies of restraining the ligand in the bulk
and the binding site, respectively. To calculate ∆Gsitecon, the equilibrium position
of the ligand is determined as accurately as possible, and the heavy atoms on the
ligand are restrained using kf = 4.5 kcal/mol/A˚
2. Following Cecchini et al.120, these
restraints are gradually relaxed and the free energy change is calculated from
∆Gsitecon =
1
2
∫ kf
0
〈|X−X0|2〉 dk, (4.4)
where |X − X0| represents the difference of the restrained coordinates from the
reference values at a given k. The integral is evaluated using 10 windows with
k = 4.5, 2.0, 1.0, 0.5, 0.2, 0.1, 0.05, 0.02, 0.01 and 0 kcal/mol/A˚2. Each window
is simulated for 600 ps, and the ensemble average of the coordinate difference is
calculated from the last 300 ps. A similar calculation is performed in the bulk for
∆Gbulkcon using a box containing the ligand and 1193 water molecules (plus counterions
to keep the system neutral).
The free energy of translocation, ∆Gint, is calculated using the free energy per-
turbation (FEP) and thermodynamic integration (TI) methods52. In both methods,
one introduces a hybrid Hamiltonian H(λ) = (1−λ)H0 +λH1, where H0 represents
the Hamiltonian for the initial (apo) state with the ligand in the bulk and H1 for
the final (ligand-bound) state. In the FEP method, the interval between λ = 0 and
1 is divided into n subintervals with {λi, i = 1, . . . , n− 1}, and for each subinterval
the free energy difference is calculated from the ensemble average
∆Gi = −kBT ln〈exp[−(H(λi+1)−H(λi))/kBT ]〉λi . (4.5)
The free energy of translocation is obtained from the sum, ∆Gint =
∑
i ∆Gi. A cri-
terion for successful application of FEP is that ∆Gi . 2 kcal/mol for each window.
Because charges are involved in the FEP calculations, satisfaction of this criterion
would require over 130 windows if uniform subintervals are used. We have used
instead exponentially spaced subintervals, which halves the required number of win-
dows to 66. In a typical FEP calculation, each window is equilibrated for 40 ps
followed by a 40-ps production run. We have used shorter and longer simulation
times to check the convergence of the results in sample calculations and found that
40 + 40 ps sampling is adequate.
In the TI method, the ensemble average of the derivative, ∂H(λ)/∂λ, is obtained
at several λ values, and the free energy of translocation is calculated from the integral
∆Gint =
∫ 1
0
〈
∂H(λ)
∂λ
〉
λ
dλ. (4.6)
Again because charges are involved, Gaussian quadrature provides a better method
for the evaluation of this integral. In previous applications of the TI method to ion
binding free energies108, a seven-point quadrature was found to be adequate, which
is also adapted here. Each window is typically equilibrated for 0.5 ns and sampled
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for 1 ns. Convergence of the results are checked from the running averages of the
free energy differences, and the sampling runs are extended if necessary.
For Na+ ions, application of these methods is straightforward. It is observed that
the Na1 and Na3 sites in the apo structure are occupied by water molecules within
a few ns of MD simulations. A similar thing happens when the Na+ ion is removed
from the Na2 site in the closed structure. This justifies alchemical transformation of
a Na+ ion in one of the binding sites to a water molecule while a water molecule in
the bulk is simultaneously transformed to a Na+ ion. To check against the hysteresis
effects, we also perform the backward calculation, where a Na+ ion in the bulk is
translocated to the binding site. Thus TI calculations for each Na+ ion took 11.5
x 2 = 23 ns. Convergence of the TI results are checked from the running averages
(see Fig. 4A.1 in the Appendix). Denoting the free energy differences obtained from
the forward and backward calculations as ∆Gforint and ∆G
back
int , the free energy of
translocation is obtained from their average as
∆Gint =
1
2
[−∆Gforint + ∆Gbackint ], (4.7)
and the absolute binding free energy follows upon adding the translational free
energy difference
∆Gb = ∆Gint + ∆Gtr. (4.8)
When Asp is removed from the open structure, the binding site is similarly
flooded with water molecules in a few ps. However, a direct application of the FEP
method runs into convergence issues for molecules, which necessitates adoption of a
staged approach to free energy calculations116. Accordingly, Asp is restrained in the
binding site and the electrostatic and LJ interactions are switched off in turn, which
results in annihilation of Asp in the binding site. A reverse process is performed in
the bulk simultaneously, resulting in creation of a restrained Asp in the bulk, which
is then unrestrained. The reference positions for the restrained atoms are chosen so
that there is a maximal overlap between the restrained and unrestrained Asp. This
is demonstrated in Table 4.2, where the restrained Asp (last column) is seen to have
an almost identical coordination geometry as the unrestrained Asp (fifth column).
To improve convergence and prevent instabilities in the FEP calculations, we use
a soft-core LJ potential with a shift coefficient of 5.082. This avoids the necessity of
splitting the LJ interaction into short-range and dispersion parts. We have discov-
ered that during the backward calculation—while an uncharged Asp is created in
the binding site—a water molecule gets trapped under Asp, leading to a final state
inconsistent with the crystal structure. To prevent this from happening, we have
inserted Asp to the binding site in two stages, first the backbone and then the side
chain. A similar splitting is employed in the forward calculation—the side chain of
Asp is destroyed first, followed by the backbone.
The free energy difference at each stage is calculated separately, and the forward
free energy of translocation is obtained from the sum
∆Gforint = ∆Gelec + ∆GLJ−bb + ∆GLJ−sc, (4.9)
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where the three terms represent the contributions from the electrostatic interac-
tions, LJ-backbone, and LJ-side chain. To calculate ∆Gelec, Asp in the binding
site is discharged while an uncharged Asp in the bulk (30 A˚ away from the binding
site) is charged simultaneously. We have used both FEP and TI methods for this
purpose employing the window parameters specified above. In total four FEP and
two TI simulations are performed. Evidence for convergence of the FEP results are
presented in the Appendix (see Fig. 4A.2). In the second and third stages, the LJ
interactions for the side chain and backbone of the uncharged Asp in the binding
site are switched off while they are switched on for an uncharged Asp in the bulk.
The FEP method is employed in these calculations with 52 windows for ∆GLJ−sc
and 44 windows for ∆GLJ−bb. In both cases, a shorter spacing (∆λ = 0.01) is used
closer to the end points to facilitate convergence. For each of the forward calcu-
lations mentioned above, a complementary backward calculation is performed to
check against hysteresis. Because of the larger relative fluctuations observed, ten
independent FEP calculations are run for the LJ interactions.
We have also investigated the selectivity of GltPh for Asp over Glu. Since all
the residues that coordinate Asp in the open GltPh are conserved in the EAATs
(R276 is an exception but it coordinates with the backbone oxygen), it is assumed
that Glu binds to the transporter in the same position as Asp. The free energy of
mutating Asp to Glu in the binding site and bulk are determined via TI calculations
as described above (except using 1 ns equilibration time for each window). The
selectivity free energy is determined from the difference
∆∆G(Asp→ Glu) = ∆GsiteAsp→Glu −∆GbulkAsp→Glu. (4.10)
Note that no restraints are needed in this case as both Asp and Glu are bound to
GltPh.
We have further simulated the Glu-bound system for 10 ns starting from the last
window of the Asp → Glu transformation. Differences in the coordination of Asp
and Glu in the binding pocket are examined to find out which changes are required
in EAATs in order to accommodate Glu as well as Asp and transport it with equal
efficiency.
4.4 Results and discussion
4.4.1 Characterization of the binding sites
We start with a comparison of the binding sites for the three Na+ ions and Asp
obtained from the MD simulations of GltPh with those observed in the crystal struc-
ture 2NWX. The residues involved in the coordination of the Na+ ions are listed
in Table 4.1 together with the average Na+–O distances obtained from 2-ns MD
simulations of the closed and open structures. The main difference between the two
is that the HP2 gate is open in the latter which abolishes the Na2 site. From Table
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4.1 it is seen that the Na3 site is tightly coordinated by one backbone and four side
chain oxygens. Note that only one of the D312 oxygens is in the first hydration shell
and there are no water molecules. A similarly tight binding site is found for the
Na1 site. There is a one-to-one correspondence between the coordinating residues
observed in the crystal structure and those found from the MD simulations. The
larger ion-oxygen distances in the crystal structure is presumably due to the larger
size of the Tl+ ion employed in the experiments. Almost identical coordinations
are obtained in the closed and open structures for the Na3 and Na1 sites, which
indicates that the opening of the HP2 gate, while abolishing the Na2 site, has a
minimal effect on the Na3 and Na1 sites.
Table 4.1: The GltPh residues coordinating the three Na
+ ions, listed according to their
binding order. The average Na+–O distances obtained from 2-ns MD simulations of the
closed and open structures are compared to those of the crystal structure (2NWX). Nature
of the coordinating oxygens are indicated in parenthesis, i.e., bare O denotes backbone
and the others are side chain. The Na3 site is not seen in the crystal structure. The open
state has Asp and two Na+ ions bound because the Na2 site is not formed. All distances
are in A˚.
Ion Helix - Residue Cry. str. Closed st. Open st.
Na3 TM3 - Y89 (O) 2.3± 0.1 2.3± 0.1
TM3 - T92 (OH) 2.4± 0.1 2.4± 0.1
TM3 - S93 (OH) 2.4± 0.1 2.3± 0.1
TM7 - N310 (OD) 2.2± 0.1 2.2± 0.1
TM7 - D312 (O1) 2.1± 0.1 2.1± 0.1
TM7 - D312 (O2) 3.6± 0.2 3.5± 0.3
Na1 TM7 - G306 (O) 2.8 2.4± 0.2 2.4± 0.2
TM7 - N310 (O) 2.7 2.3± 0.1 2.4± 0.2
TM8 - N401 (O) 2.7 2.4± 0.2 2.5± 0.2
TM8 - D405 (O1) 3.0 2.2± 0.1 2.2± 0.1
TM8 - D405 (O2) 2.8 2.2± 0.1 2.3± 0.1
H2O - 2.3± 0.1 2.3± 0.1
Na2 TM7 - T308 (O) 2.6 2.3± 0.1
TM7 - T308 (OH) 5.5 2.4± 0.1
HP2 - S349 (O) 2.1 4.5± 0.3
HP2 - I350 (O) 3.2 2.3± 0.1
HP2 - T352 (O) 2.2 2.3± 0.1
H2O - 2.3± 0.1
Inspection of the Na2 coordination in Table 4.1 shows that there are some dif-
ferences between the MD results and the crystal structure, which we again attribute
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Figure 4.1: The coordination of Na2 (a) in the closed crystal structure of GltPh and
(b) in our MD simulations. See Table 4.1 for a list of the coordinating residues and the
Na+–O distances.
to differences between the Tl+ and Na+ ions. When a Na+ ion is placed in the ex-
perimentally observed position (to be called Na2′), it immediately shifts 2-3 A˚ away
from the coordinating S349 backbone oxygen. With further equilibration, the side
chain of T308 enters the coordination shell of Na+, forming a very stable binding site
to be called Na2 (see Fig. 4.1). This is observed in all three monomers suggesting
that the Na2 site is more likely to be the binding site for a Na+ ion. The function
of the Na2 site is to lock the HP2 gate in the closed conformation by binding to
the residues in HP2 and TM7. In the crystal structure, this lock (the Na2′ site) has
three hinges on HP2 and only one on TM7, whereas the Na2 site has two hinges
on each, which provides a more reliable lock. More quantitative evidence for the
proposed Na2 site will presented below from the binding free energies.
A similar comparison is presented for the Asp binding site in Table 4.2. Again
there is a one-to-one correspondence between the coordinating residues seen in the
crystal structure and those found from the MD simulation of the closed state. Most
of the contact distances match very well except the side chain of S278 which is
found to coordinate the α-carboxyl of Asp. This has been observed in other MD
simulations of GltPh as well
99,114. Below we will show that S278 side chain plays
a key role in binding of Asp following Na1. A water molecule coordinating Na1
also makes a H-bond with the S278 side chain. We speculate that absence of this
water molecule in the crystal structure may have caused the shift in the position
of the S278 side chain. Opening of the HP2 gate leads to the removal of the V355
and G359 residues from the coordination shell of Asp, which is partly compensated
by the entry of the N1 atom of the R397 side chain. The remaining eight contacts
are preserved between the closed and open states and continue to provide a stable
binding site for Asp.
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Table 4.2: List of the GltPh residues (first column) coordinating Asp atoms (second
column). The average N–O and O–O distances obtained from the MD simulations are
compared to those of the crystal structure 2NWX (third column). Again bare N and O
in parenthesis refer to the backbone atoms and the others refer to the side chain atoms.
The last column shows the effect of the conformational restraints on the coordination of
Asp. All distances are in A˚.
Helix - Residue Asp Cry. str. Closed st. Open st. Open st.res
HP1 - R276 (O) α-N 2.4 3.0± 0.2 3.0± 0.2 3.0± 0.2
HP1 - S278 (N) α-O1 2.8 2.8± 0.1 2.8± 0.1 2.8± 0.1
HP1 - S278 (OH) α-O2 3.8 2.7± 0.1 2.8± 0.2 2.8± 0.1
TM7 - T314 (OH) β-O2 2.7 2.7± 0.1 2.8± 0.1 2.8± 0.1
HP2 - V355 (O) α-N 2.9 2.9± 0.2 11.9± 0.4 11.9± 0.3
HP2 - G359 (N) β-O2 2.8 3.1± 0.2 6.1± 0.4 6.3± 0.3
TM8 - D394 (O1) α-N 2.6 2.7± 0.1 2.7± 0.1 2.7± 0.1
TM8 - R397 (N1) β-O2 4.6 4.2± 0.2 2.7± 0.1 2.7± 0.1
TM8 - R397 (N2) β-O1 2.5 2.9± 0.2 2.9± 0.2 2.9± 0.2
TM8 - T398 (OH) α-N 3.2 3.2± 0.2 3.0± 0.2 3.0± 0.2
TM8 - N401 (ND) α-O2 2.8 2.8± 0.1 3.0± 0.2 2.9± 0.2
4.4.2 Binding free energies
We first consider the binding free energies of the Na+ ions to the sites Na1, Na2
and Na3 (Table 4.3). Test calculations with the FEP and TI methods have yielded
essentially identical results, therefore only the TI method is used in the calculations
for convenience. The forward and backward results are seen mostly to agree within 1
kcal/mol indicating minimal hysteresis effects. The free energy difference due to loss
of translational entropy remains around 4.5–5 kcal/mol for all sites. The absolute
binding free energies listed in the last column reveal that the Na3 site provides by
far the largest affinity for Na+ ions and hence it will be occupied first, followed by
Na1 and Na2. It has been shown that the path to the Na3 site goes through the Na1
site97. The 7 kcal/mol energy gradient found between the Na3 and Na1 sites here
provides sufficient incentive for a Na+ ion bound to the Na1 site to move quickly
to the empty Na3 site. As shown below, the Na1 site is occupied before Asp. We
have therefore calculated the binding free energy for the Na1 ion in the presence of
Na3. Coulomb repulsion due to the Na3 ion results in about 4 kcal/mol increase in
the binding free energy for Na1 compared to the apo state. Nevertheless this is still
sufficient to provide a µM affinity for Na1.
The Na2 site is occupied last after Na3, Na1 and Asp bind, and the HP2 gate
is closed. The calculated binding free energy for Na2 is higher than all the other
ligands, consistent with its binding last. Because Na2 binds last, its binding free
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Table 4.3: Binding free energies for Na+ ions in the open state (for Na3 and Na1) and
closed state (for Na2) of GltPh (in kcal/mol). Various contributions to the binding free
energy as described in Eqs. 4.7 and 4.8 are listed separately. Other ligands present in the
transporter are indicated in parenthesis. Errors are estimated from block data analysis
using 100 ps windows.
Ion −∆Gforint ∆Gbackint ∆Gint ∆Gtr ∆Gb
Na3 −22.3± 1.2 −24.2± 0.9 −23.3± 1.1 4.6 −18.7± 1.1
Na1 −15.9± 0.9 −16.5± 1.6 −16.2± 1.3 4.9 −11.3± 1.3
Na1 (3) −11.8± 1.6 −11.9± 0.9 −11.9± 1.3 4.8 −7.1± 1.3
Na2 (1, 3, Asp) −6.6± 1.3 −7.7± 1.3 −7.1± 1.3 4.4 −2.7± 1.3
Na2′ (1, 3, Asp) −1.4± 0.9 −2.1± 0.8 −1.7± 0.8 4.4 +2.7± 0.8
energy can be estimated from the observed Michaelis–Menten constant, Km = 3.9
mM as−3.3 kcal/mol35, which is in good agreement with the calculated value of−2.7
kcal/mol. As argued above, the Na2 binding site found from the MD simulations
is slightly different from the Na2′ site observed in the crystal structure, and the
former provides a better site for binding of a Na+ ion. Indeed the binding free
energy calculated for the Na2′ site is about 5 kcal/mol higher than that of Na2, and
it is positive. This provides quantitative evidence that the Na2 site is more likely
to be the actual binding site. We note that the T308 side chain—proposed to be
involved in coordination of the Na2 site here—is highly conserved in the EAATs and
may not have been resolved in the crystal structure due to the replacement of Na+
by the larger Tl+ ion. This hypothesis could be confirmed in future experiments by
mutating T308 to a non-polar residue and observing how the Na+ affinity and the
Asp transport rate are affected by this mutation.
The results of the binding free energy calculations for Asp are presented in Table
4.4. As discussed below, Asp binds only in the presence of Na1 and Na3, therefore
the calculations are performed only for this configuration. To ensure the reliability
of the electrostatic calculations, we have determined it using both the FEP and
TI methods. As seen from Table 4.4, the two methods yield consistent results.
Electrostatic interactions dominate the binding of Asp resulting in a tightly bound
ligand. This happens at the expense of the LJ interactions, which, therefore make
a positive contribution (4.6 kcal/mol) to the binding energy. The translational and
rotational free energy losses are even more significant, reducing the binding free
energy by a further 7.2 kcal/mol. Comparable results have been obtained for the
entropic free energy losses for similar-sized ligands116. Finally, the conformational
restraints make a relatively small contribution to the binding free energy, reflecting
the fact that Asp is slightly more restrained in the binding site compared to the
bulk. We note that the measured binding free energy of Asp, −12 kcal/mol15,
refers to the closed state of GltPh, which includes the free energies of gate-closure
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Table 4.4: Binding free energy of aspartate in the open state of GltPh with the Na1 and
Na3 sites occupied (in kcal/mol). The forward and backward calculations differed less than
1 kcal/mol in all cases, therefore only their average is listed. The electrostatic contribution
is taken as the average of the FEP and TI results given in the first two columns. The
absolute binding free energy of Asp is given in the last column.
∆Gelec (FEP) ∆Gelec (TI) ∆GLJ−bb ∆GLJ−sc ∆Gtr ∆Grot ∆Gcon ∆Gb
−15.8± 0.6 −16.4± 0.9 3.8± 0.5 0.8± 0.5 3.3 3.9 0.5 −3.8± 1.0
and Na2 binding. The calculated free energy is for the binding of Asp to the open
state of GltPh. Therefore, a direct comparison with experiment is not possible at this
stage. Binding free energy calculations that include the gating free energy have been
performed for a glutamate receptor recently41. We are planning similar calculations
for the HP2 gate in GltPh, which will enable comparison with experiments.
4.4.3 Role of Na1 in facilitating Asp binding
We have also attempted to calculate the binding free energy of Asp in the presence
of Na3 only, but failed to stabilize Asp in the binding site in the absence of Na1.
Na1 is not directly involved in the coordination of Asp so the cause of this instability
is not immediately clear. A careful study of this phenomenon has revealed a close
relationship between the binding of Asp and the occupation of the Na1 site, namely,
a network of hydrogen bonds that pin down Asp in the binding site is only stable in
the presence of Na1. This H-bond network is indicated by a dashed line in Fig. 4.2,
which shows the binding site of Asp obtained from the equilibrium simulations of
the open structure with Asp, Na1 and Na3 bound. It is seen from Fig. 4.2 that the
water molecule that coordinates the Na1 ion also makes a H-bond with the side-chain
oxygen of S278, which, in turn, initiates the following chain of H-bonds: S278 (HG)
– Asp (α-O2) – N401 (HD2); N401 (HD1) – T314 (OG); T314 (HG) – Asp (β-O2) –
R397 (HN). The net effect of the H-bond network is to firmly anchor the backbone
and side chain oxygens of Asp to the protein via four H-bonds. This network of
H-bonds remains very stable throughout the simulations of the open structure as
indicated by the average O–H distances (see Table 4A.1 in the Appendix).
To see how removal of the Na1 ion destabilizes and unzips the H-bond network,
we have performed MD simulations of the system after removing the Na1 ion with
only Na3 and Asp present. Initially 4 kcal/mol/A˚2 restraints are applied to all the
C and N atoms of Asp, which are gradually relaxed during 2 ns of MD simulations.
The system is then run for a further 3 ns with no restraints applied, during which
time Asp is observed to unbind in all three monomers. The sequence of events
leading to the collapse of the H-bond network and release of Asp are as follows (see
Fig. 4A.3 in the Appendix for the snapshots).
1. After 1 ns of simulations when the restraints on Asp are 1 kcal/mol/A˚2
72
Chapter 4 Free Energy Simulations of Ligand Binding to the Aspartate
Transporter GltPh
Figure 4.2: The binding site of GltPh in the open state, with aspartate (dark-shaded)
bound. The hydrogen bonds are denoted by dotted lines, with the purple ones showing
the chain of H-bonds that stabilizes Asp in the binding site in the presence of Na1. The
three contacts to the substrate α-amino group are not shown. This structure is stable
throughout the simulations performed in the open state, as shown in Table 4A.1 in the
Appendix.
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(Fig. 4A.3a): a water molecule is near the Na1 site now with its hydrogens facing
the Na1 site and its oxygen directed towards the S278 side chain. This causes the
S278 side chain break the H-bond with Asp (α-O2) and make a H-bond with the
water oxygen instead.
2. At 2 ns with no restraints (Fig. 4A.3b): Sideway motion of S278 allows entry
of a water molecule to the binding site. This water molecule breaks the Asp (α-O2)
– N401 (HD2) H-bond, and starts making H-bonds with these two atoms and S278
(OG). Freeing of the N401 side chain disrupts the N401 (HD1) – T314 (OG) H-bond,
which, in turn, destabilizes the T314 side chain. Entry of another water molecule
(not shown) helps to break the T314 (HG) – Asp (β-O2) H-bond, with T314 side
chain now making a H-bond with this water molecule. At this stage, α-O2 of Asp
is free, and mobility of Asp has increased considerably.
3. At 2.5 ns (Fig. 4A.3c): The two contacts from the β-carboxyl group of Asp
to the R397 side chain are lost, leaving it completely free. Only four out of the nine
contacts are still intact, namely, S278 (N) that coordinates α-O1, and R276 (O),
D394 (O1) and T398 (OH) that coordinate α-N. More water molecules enter the
binding site, further destabilizing Asp.
4. At 3.6 ns (Fig. 4A.3d): The remaining contacts are also lost. The binding
site is now full of water molecules, and Asp is released to the solvent.
The above mechanism could play a role in the binding/unbinding of Asp. To
appreciate its potential significance, we note that none of the Na+ ions in GltPh
is in direct contact with Asp, which makes it difficult to understand the physical
basis of the Asp–Na+ coupling in glutamate transporters. For example, in LeuT
transporters a Na+ ion is in direct contact with the substrate, which makes their
coupling obvious121. Here the Na1 ion is separated from Asp by a water molecule
and a hydroxyl side chain but they are nevertheless coupled through the H-bond
network depicted in Fig. 4.2. Removal of the Na1 ion triggers the unzipping of
the H-bond network and simultaneous entry of water molecules to the binding site,
which facilitate the unbinding of Asp. A likely scenario for binding of Asp is to
follow this script in reverse, that is, Asp binds to GltPh after Na1 following the steps
1–4 in the reverse direction. Experimental evidence for the key role played by the
S278 side chain in the binding of Asp comes from cysteine scanning experiments
in EAAT226. Mutation of the residue corresponding to S278 in EAAT2 (S363) to
cysteine results in 100-fold reduction in the transport activity. Due to the strong
electronegative potential in the D405 region in the presence of the substrate and in
the absence of Na1, it is also possible that this residue becomes protonated at some
point during the transport cycle. Since there is no proton transport in GltPh
35 and,
as we shown in Chapter 7, the protonation of D405 is not favourable in the fully
bound state, the presence of the proton could only be possible as a transient state
in either the outward or inward conformation of GltPh.
In a recent crystal structure of GltPh, the transporter was captured in the inward-
facing conformation. This structure has indicated that HP1 is most likely to be the
intracellular gate, functioning in a similar fashion to the extracellular HP2 gate16.
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A similar conclusion has also been reached from modeling studies39,122. Inspection
of Table 4.2 shows that three residues in HP1 coordinate Asp, including the S278
side chain that plays a key role in the H-bond network. Thus opening of HP1 will
not only remove these three contacts from Asp but will also lead to the unzipping of
the H-bond network, further destabilizing Asp. In the light of the above discussions,
we suggest that Asp should unbind quite fast and may even be the first ligand to
vacate the binding pocket.
4.4.4 Aspartate/Glutamate selectivity
The bacterial transporter GltPh does not transport Glu, which is the main substrate
for the mammalian GlTs (EAATs). In order to build a homology model of EAATs
based on GltPh, one needs to understand why Glu is not transported by GltPh, and
find the differences in structures that enable EAATs to transport both substrates.
Fig. 4.3 shows the results obtained from 10 ns MD simulations with Glu bound
to the open and closed states of GltPh. In the open state, the three contacts that
coordinate the Asp side chain, two from R397 and one from T314, do not coordinate
Glu, even though Glu stays bound to the transporter. The longer side chain of Glu
does not quite fit in the binding pocket, resulting in the loss of these contacts.
Mutagenesis experiments on the R447 residue in EAAT3 (equivalent to R397 in
GltPh) have shown that interaction of this residue with the side-chain carboxyl of
Glu is of critical importance for transport32, which is prevented in the open state
of GltPh due to space constraints. Closing of the HP2 gate (Fig. 4.3b) induces a
conformational change in the Glu side chain such that the contacts with the R397
and T314 side chains are restored.
When this conformation of Glu is placed in the open state and equilibrated,
it goes back to the original open-state conformation (Fig. 4.3a) within few ps of
releasing the restraints. This indicates that Glu is in a higher energy conformation
in the closed state. However, even in this conformation, the Glu side chain does not
fit in the binding pocket as well as Asp, resulting in displacement of the HP2 gate by
about 1.5 A˚ relative to the Asp-bound case (Fig. 4.3b). These observations suggest
that the binding pocket in EAATs must be larger or more flexible to accommodate
Glu. Sequence alignment indicates that majority of the residues forming the binding
pocket are conserved, and the only residue that may have an effect on the volume
is R276 in GltPh, which is replaced by A or S in EAATs. The R276 side chain is
located between HP1 and TM8 and its replacement by a smaller side chain may
help to increase the volume of the binding pocket.
For a quantitative assessment of the perturbations caused by the binding of Glu,
we have calculated the free-energy required to mutate Asp to Glu in the open and
closed structures of GltPh (listed in Table 4.5). In the open state, the binding free
energy difference between Asp and Glu is ∆GopAsp→Glu = 5.2 kcal/mol. Using the
binding free energy of Asp (−3.8 kcal/mol), we can estimate the binding free energy
of Glu as +1.4 kcal/mol. However, for the reasons stated above for Asp, this result
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Figure 4.3: The binding site of GltPh with a bound Glu in the open and closed states. (a)
Open state: residues R397 and T314, which coordinate the β-carboxyl group of Asp, do
not coordinate Glu (dark shade), resulting in a lower binding affinity for Glu. (b) Closed
state: The side chain of Glu (dark shade) sticks out further relative to Asp (transparent
light shade), resulting in displacement of the HP2 residues (dark shade) with respect to
the Asp-bound case (transparent light shade).
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Table 4.5: Asp → Glu selectivity in the binding site for the open state of GltPh with
Na1 and Na3 bound, and the closed state with all the ions bound to the transporter. The
second column gives the free energy of mutating Asp to Glu in the binding site, minus
the free energy of doing the same in the bulk. The third column gives the same for the
backward transition. The average of the two is listed in the fourth column. The next
two columns give the translational and rotational free energy differences between Asp and
Glu, and the last column gives the total selectivity free energy. Errors are estimated from
block data analysis using 100 ps windows.
GltPh state ∆G
for
int -∆G
back
int ∆G
av
int ∆Gtr ∆Grot ∆GAsp→Glu
open 5.3± 1.1 5.3± 1.6 5.3± 1.3 0.0 −0.1 5.2± 1.3
closed 6.3± 1.4 5.7± 1.7 6.0± 1.5 −0.1 −0.5 5.4± 1.5
cannot be directly compared to the experimental value for Glu binding. In the closed
state, the binding free energy difference is given by ∆GclAsp→Glu = 5.4 kcal/mol. The
experimental value obtained from the ratio of the dissociation constants of Asp and
Glu is 6.6 kcal/mol15, which is close to the calculated binding free energy difference.
Since we know the free-energy of mutating Asp to Glu in the closed and open
states, we can estimate the difference in free energy of gating between the Asp and
Glu-bound configurations. Using the thermodynamic cycle, this quantity can be
written as
∆Gop→clGlu −∆Gop→clAsp = ∆GclAsp→Glu −∆GopAsp→Glu (4.11)
From the values given in Table 4.5, it is seen that the gating energy remains about
the same when Glu is bound compared to the Asp-bound case. It will be interesting
to calculate the individual gating energies for the Asp-bound and Glu-bound cases
from umbrella sampling MD simulations41 and compare the substrate binding free
energies directly to the experimental results.
4.5 Conclusions
We have performed free energy simulations for the Asp transporter GltPh, a homolog
of the mammalian glutamate transporters (EAATs). We have investigated in detail
the coordination of all the ligands and calculated their binding free energies. The
coordination shells found for Asp and Na1 in the closed state are in good agreement
with the crystal structure. A small displacement of the experimental Na2 site is
observed, which results in replacement of the S349 carbonyl in the coordination
shell with the T308 hydroxyl. The new Na2 site is shown to be more stable and also
more consistent with the gate-locking function of Na2.
Our simulations show that Asp is firmly bound to the open structure in the
presence of Na3 and Na1 but becomes unstable when Na1 is removed, unbinding in
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less that 5 ns in all three monomers. A close scrutiny of the unbinding process has
revealed that Na1 and Asp are coupled via a hydrogen-bond network, and removal of
Na1 leads to the unzipping of this network destabilizing Asp. The binding sequence
of the ligands is determined from their binding free energies as: Na3, Na1, Asp
(HP2 gate closes), Na2. The binding order of the second Na+ ion and Asp has not
been resolved from experimental observations and previous MD simulations97. Our
results clearly show that Asp binding is contingent upon the presence of Na1 and
thus happens after the binding of the second Na+ ion. Finally our MD simulations
with bound Glu and FEP calculations for transforming Asp→ Glu in the open and
closed states provide a simple mechanistic explanation for why GltPh transports Asp
but not Glu—the binding pocket is too small to accommodate the larger Glu, which
remains in a higher energy state compared to Asp both in the open and closed states.
The insights provided for Asp/Glu selectivity here will provide valuable guidance in
constructing homology models for EAATs based on the GltPh structure.
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4.A Appendix for Chapter 4
Table 4A.1: List of the residues involved in the H-bond network that stabilizes Asp in
the binding site when the Na1 site is occupied, and the average distances between the
contact atoms (indicated in parentheses). Oxygens are defined as in Tables 4.1 and 4.2.
HG refers to the hydroxyl hydrogen, HD1 and HD2 refer to the two hydrogens of the
β-amide group of N401, and HN refers to the closest hydrogen in the guanidium group of
R397.
Residue Residue Distance
Na1 H2O (O) 2.3± 0.1
H2O (H) S278 (OG) 2.1± 0.3
S278 (HG) Asp (α-O2) 1.9± 0.2
Asp (α-O2) N401 (HD2) 2.1± 0.3
N401 (HD1) T314 (OG) 2.0± 0.1
T314 (HG) Asp (β-O2) 1.8± 0.2
Asp (β-O2) R397 (HN) 1.8± 0.2
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Figure 4A.1: Convergence of the TI results for the translocation free energy of the Na3
(top) and Na1 (middle) and Na2 (bottom) ions from running averages. The Na3 ion is
present in the Na1 calculation, and the Na2 calculation is for the closed state with all
the ligands present. The negative of the forward (binding site → bulk) and the backward
transitions of Na+ are shown with solid and dashed lines, respectively.
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Figure 4A.2: Convergence of the FEP simulations for the binding free energy of Asp. a)
The variation on the free energy during the FEP simulations of the discharging of aspartate
inside the binding pocket and charging it in the bulk. The graph shows the free energies
for the windows located at λ = 0.0 (black), λ = 0.2 (red), λ = 0.4 (green), λ = 0.6 (blue),
λ = 0.8 (yellow) and λ = 0.99 (purple). b, c) The same for the destruction/creation in the
binding pocket/bulk of the side chain (b) and backbone (c) of the discharged substrate.
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Figure 4A.3: The sequence of events that leads to the unbinding of Asp after the removal
of the Na1 ion are summarized in the the snapshots a-d (see the main chapter for further
explanations). The H-bonds forming the network are indicated by dotted lines.
Chapter 5
Mechanism and Energetics of
Ligand Release in the Aspartate
Transporter GltPh
ABSTRACT
The bacterial aspartate transporter GltPh cotransports three Na
+ ions
with the substrate. Mechanism and energetics of ligand binding have
previously been studied using molecular dynamics simulations on the
crystal structure of GltPh captured in the outward-facing state. Here
we use the recent crystal structure of the inward-facing state of GltPh
to study the reverse process of unbinding of ligands. Gating behavior is
studied in the presence of different ligands. A detailed characterization
of the intracellular gate is given, pointing out the differences from the
extracellular gate. We then perform free energy simulations to calculate
the binding affinities of all the ligands in different combinations, from
which the unbinding order is determined as Na2, (gate opens), Asp, Na1
and Na3. The strong coupling between Asp and Na1 is quantified from
several free energy calculations. Na3 has the largest affinity to GltPh,
and therefore its unbinding is proposed as the rate-limiting step in the
transport cycle. The release time of Na3, estimated from Kramers’ rate
theory, is shown to be consistent with the experimental turnover rate of
the transporter.
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5.1 Introduction
Mammalian glutamate transporters, known as excitatory amino acid transporters
(EAATs), are membrane proteins responsible for clearing the excess glutamate re-
leased at the nerve synapses. Malfunctioning of glutamate transporters has been
implicated in many pathological conditions including cerebral ischemia, amyotrophic
lateral sclerosis and Alzheimer’s disease.12 The transport mechanism of EAATs in-
volves the cotransport of three Na+ and one H+ ions with the substrate, and the
countertransport of one K+ ion.13,85 Glutamate transporters function by cycling be-
tween two states: one facing the extracellular (EC) medium where the ligands bind
to the transporter, and the other facing the intracellular (IC) medium where the
ligands are released to the cytoplasm. The first crystal structure of an archaeal
homolog of EAATs—the aspartate transporter GltPh from Pyrococcus horikoshii—
was determined in the outward-facing state.14 In subsequent crystal structures of
this state, GltPh was captured both in the open and closed conformations, and the
binding sites for the substrate and two ions were identified.15 Recently, the crystal
structure of GltPh was reported in the inward-facing closed state, also complexed
with the substrate and two ions.16 So far, there is no crystal structure available for
the inward-facing open state of GltPh.
GltPh shares about 37% sequence identity with the EAATs, but the homology
is much larger for the residues involved in the binding of the ligands, with almost
of all of them being conserved.28,32,90,94 Experiments have shown that, while the
transport mechanism in GltPh is independent of H
+ and K+ ions,35 it is still coupled
to the cotransport of three Na+ ions as in EAATs.37 The third Na+ site could not
be identified in the crystal structures of GltPh, but a binding site determined from
molecular dynamics (MD) simulations was confirmed from mutagenesis experiments
and shown to be conserved in GltPh and the EAAT family.
38 Due to the structural
and functional similarities between these proteins, and in the absence of any crystal
structures for the EAATs, GltPh provides a good model to interpret functional data
on EAATs and gain new insights into the transport mechanism.112,113
Several MD simulations have been performed on the outward-facing state of
GltPh, to study the opening of the HP2 segment which works as the EC-gate,
36,99
to find the location of the Na3 site,38,96,97 and to calculate the binding free energies
of the ligands.96,123 MD simulations and elastic network models have also been used
to study substrate translocation,114,122,124,125 and release.39 In an interesting appli-
cation of metadynamics simulations, Grazioso et al.126 investigated the mechanism
of substrate uptake and release, and calculated the free energy surfaces for opening
of the EC and IC-gates with different combinations of bound ligands. This study
revealed that, i) contrary to the outward-facing state where only the HP2 segment
works as the EC-gate, opening of the IC-gate involves the movement of both HP1
and HP2, and ii) there is an energy barrier between the open and closed conforma-
tions of the IC-gate, which is not seen in the case of the EC-gate. We note that
the metadynamics simulations were carried out using a single monomer in solution
84
Chapter 5 Mechanism and Energetics of Ligand Release in the Aspartate
Transporter GltPh
instead of a trimer embedded in membrane and in the absence of the Na3 ion. It
is important to confirm that the gating results obtained in Ref.126 are retained in a
more realistic environment and in the presence of the Na3 ion.
In a previous paper,123 we performed detailed free energy simulations in the
outward-facing state of GltPh with an Asp and three Na
+ ions as ligands. From
the binding free energies of ligands in different configurations, we determined their
binding order as, Na3, Na1, Asp, (EC-gate closes), and Na2. A key finding of this
work is that Asp and Na1 are coupled through a hydrogen-bond network despite
being separated by about 7 A˚. Here we perform a similar study for the inward-
facing state of GltPh. We first investigate the opening of the IC-gate by performing
unbiased MD simulations with different combinations of the bound ligands. This is
followed by free energy calculations of the binding affinities for Na2 in the closed
configuration, and for other ligands in the open configuration. As in the outward-
open case, we find a close link between binding of Asp and Na1, namely, Asp can
only bind in the presence of Na1 and it is released to the cytoplasm when Na1 is
removed from the binding site. The binding free energy results indicate that the
ligands are released in a reverse order compared to their binding, that is, Na2, (IC-
gate opens), Asp, Na1, and Na3. The Na3 ion is released last with a binding affinity
much higher than the other ligands, which suggests that this step is the rate-limiting
step of the transport cycle.
5.2 Model system and simulation details
. There are several crystal structures of GltPh available from the Protein Data
Bank, most of them in the outward-facing state.14,15 In this study we use the crystal
structure of GltPh K55C–A364C mutant crosslinked with divalent mercury, which
is in the inward-facing, closed conformation with two Na+ ions (Na1 and Na2) and
Asp bound (PDB ID: 3KBC).16 We choose this structure here because our goal is
to study the mechanism and energetics of release of the ligands to the cytoplasm.
As in the other crystal structures of GltPh, the Na3 site was not resolved in 3KBC.
Therefore, we add a third Na+ ion at the Na3 site identified in Ref.38, where it
is coordinated by the side chains of D312, N310, T92 and S93, and the backbone
carbonyl of Y89. Justification for this site comes from mutagenesis experiments,38
which show that the T92A and S93A mutations significantly reduce Na+ affinity to
the transporter. Also when an alternative Na3 site is used in MD simulations, the
D312 side chain swings away from the crystal structure position by about 6 A˚ and
starts coordinating Na1, which is in conflict with the Na1 coordination shell found
in the crystal structure.38
The simulation system is prepared using the software VMD.104 We first embed
the crystal structure of the GltPh trimer in a 1-palmitoyl-2-oleoyl-phosphatidylethanolamine
(POPE) phospholipid bilayer containing 251 POPE molecules. Each subunit of
GltPh has four ligands bound: three Na
+ ions, namely Na1, Na2 and Na3, and Asp
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as the substrate. We then solvate the protein-membrane complex in a box of 16204
water molecules with 34 Na+ ions and 43 Cl− ions. The extra Cl− ions are required
to keep the simulation box neutral, and their number changes depending on the
ligands bound to the transporter. The system is then equilibrated in two stages. In
the first stage, the coordinates of the ligands and protein atoms are fixed and the
system is equilibrated with 1 atm pressure coupling in all directions until the correct
water and lipid densities are obtained. At this point, the x and y-dimensions of the
simulation box are fixed, and pressure coupling is applied only in the z direction
thereafter (typical dimensions of the simulation box are 114 × 112 × 75 A˚3). In
the second stage, the protein is gradually relaxed by reducing the restraints on the
protein atoms in several steps during MD simulation lasting 2.4 ns. The system is
then further equilibrated for 10 ns without restraints before we start collecting data.
All of our MD simulations are performed using the NAMD package (version 2.8)59
with the CHARMM22 force field55 including the CMAP dihedral corrections.105 We
note that the latest version (CHARMM36) has an updated force field for lipids but
not for proteins. We have checked that using CHARMM36 instead of CHARMM22
yields essentially the same results for the binding free energies of ligands. The
temperature is maintained at 300 K using Langevin damping with a coefficient of
5 ps−1, and the pressure is kept at 1 atm using the Langevin piston method with
a damping coefficient of 20 ps−1.64 Periodic boundary conditions with the particle-
mesh Ewald method are employed to calculate the electrostatic interactions without
truncation. The Lennard-Jones (LJ) interactions are switched off between 10 and
12 A˚ using a smooth switching function. A time step of 2 fs is used in all MD
simulations.
5.3 Free energy calculations
. We use essentially the same methods as in our previous work123 in calculation
of the binding free energies of ligands. Therefore, we briefly review the free energy
methods here and refer to Ref.123 for details. The standard binding free energy of a
ligand can be expressed as106,115,116
∆Gb = ∆Gtr + ∆Grot + ∆Gcon + ∆Gint. (5.1)
Here the first two terms give the free energy change due to translational and ro-
tational entropy loss upon binding, the third term measures the free energy cost
of applying conformational restraints on the ligand in the binding site relative to
bulk, and the last term represents the free energy of translocating the restrained lig-
and from the bulk to the binding site. The translational and rotational free energy
differences are determined using107,117–119
∆Gtr = −kBT ln
[
(2pie)3/2σxσyσz
V0
]
, ∆Grot = −kBT ln
[
(2pie)3/2σφ1σφ2σφ3
8pi2
]
, (5.2)
86
Chapter 5 Mechanism and Energetics of Ligand Release in the Aspartate
Transporter GltPh
where V0 = 1660 A˚
3, σx, σy, and σz, are the principle rms fluctuations of the center
of mass of the ligand in the binding site, and σφ1, σφ2, and σφ3, are the rotational
rms fluctuations of the ligand calculated using the quaternion representation.119 The
various σ values are estimated from 8 ns of MD simulations of the bound ligands
with no restraints applied.
The free energy cost of applying conformational restraints is determined using120
∆Gcon =
1
2
∫ kf
0
〈|X−X0|2〉 dk, (5.3)
where |X − X0| represents the difference of the restrained coordinates from the
reference values at a given k. The integral is evaluated using 10 windows with
k = 4.0, 2.0, 1.0, 0.5, 0.2, 0.1, 0.05, 0.02, 0.01 and 0 kcal/mol/A˚2. Each window
is simulated for 600 ps, and the ensemble average of the coordinate difference is
calculated from the last 300 ps. For the bulk simulations, we use a box containing
the ligand and 1193 water molecules (plus counterions to keep the system neutral).
The value of ∆Gcon is then obtained from ∆Gcon = ∆G
bulk
con −∆Gsitecon.
The free energy of translocation, ∆Gint, is calculated using the free energy
perturbation (FEP) and thermodynamic integration (TI) methods,52 In the FEP
method, the interval between λ = 0 and 1 is divided into n subintervals with
{λi, i = 1, . . . , n − 1}, and for each subinterval the free energy difference is cal-
culated from the ensemble average
∆Gi = −kBT ln〈exp[−(H(λi+1)−H(λi))/kBT ]〉λi , (5.4)
where H(λ) = (1 − λ)H0 + λH1, with H0 and H1 representing the free-ligand and
bound-ligand states. The free energy of translocation is obtained from the sum
∆Gint =
∑
i ∆Gi. For electrostatic interactions, we use exponentially spaced subin-
tervals which are smaller near the end points, with a total of 66 windows.123 In a
typical FEP calculation, each window is equilibrated for 40 ps followed by 40 ps of
production. In the TI method, the ensemble average of the derivative, ∂H(λ)/∂λ, is
obtained at several λ values, and the free energy of translocation is calculated from
the integral
∆Gint =
∫ 1
0
〈
∂H(λ)
∂λ
〉
λ
dλ. (5.5)
Provided the integrand can be fitted well with a polynomial, Gaussian quadrature
provides an efficient and accurate method for evaluation of such integrals because it
allows for longer sampling of a smaller number of windows. This is the case for all
of our calculations, therefore we use a seven-point quadrature for the TI simulations
that involve electrostatic interactions.108 Seven windows are found to be insufficient
for the LJ interactions so a nine or twelve-point quadrature has been used in this
case. All the TI windows are created from the previous FEP runs, which have
already been equilibrated. Each window is sampled for 0.8 ns, of which the last
0.7 ns is used for production. Adequacy of this protocol is demonstrated from the
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running averages of the free energy differences which converge to a flat line, and
from lack of hysteresis effects between the forward and backward calculations. In
addition, the free energies calculated using the FEP and TI methods agree within
statistical fluctuations. To prevent duplication, we report here only the TI results,
which are expected to be slightly more accurate due to longer sampling of each
window.
For the Na+ ions, only two of the terms in Eq. 5.1 contribute to the binding
free energy, ∆Gtr and ∆Gint. All the Na sites are observed to be occupied by a
water molecule in the absence of the ion. Thus ∆Gint is calculated by alchemically
transforming a Na+ ion in one of the binding sites to a water molecule while a water
molecule in the bulk is simultaneously transformed to a Na+ ion. The backward
calculation for the reverse process is also performed, and ∆Gint is determined from
their average as, ∆Gint = (−∆Gforint + ∆Gbackint )/2.
Due to its more complex nature, we adopt a staged approach for free energy
calculations of Asp.116 Accordingly, Asp is restrained in the binding site and the
electrostatic and LJ interactions are switched off one at a time, which results in
annihilation of Asp in the binding site. A reverse process is performed in the bulk
simultaneously, resulting in creation of a restrained Asp in the bulk, which is then
unrestrained. The reference positions for the restrained atoms are chosen so that
there is a maximal overlap between the restrained and unrestrained Asp. The LJ
interactions are switched off using a soft-core LJ potential with a shift coefficient
of 5.0.82 To avoid trapping of water molecules under the substrate during the back-
ward LJ calculation, it is performed in two stages: first the neutral backbone is cre-
ated/destroyed and then the neutral side chain is created/destroyed. This approach
is also used in the forward LJ calculation to preserve symmetry. Thus the forward
free energy of translocation is given by, ∆Gforint = ∆Gelec+∆GLJ−bb+∆GLJ−sc, where
the three terms represent the contributions from the electrostatic interactions, LJ-
backbone, and LJ-side chain. ∆Gelec is calculated by discharging Asp in the binding
site while an uncharged Asp in the bulk (30 A˚ away from the binding site) is charged
simultaneously. In the second and third stages, the LJ interactions for the side chain
and backbone of the uncharged Asp in the binding site are switched off while they
are switched on for an uncharged Asp in the bulk (see Ref.123 for details).
5.4 Kramers’ rate theory
. The binding free energies of ions, especially that of Na3, are quite large which
may delay their release to bulk considerably. Therefore, it is important to show that
the estimated release times are consistent with the observed turnover rates in GltPh.
For this purpose, we use Kramers’ rate theory,127,128 which provides an estimate for
the rate of escape of a particle from a binding pocket over a barrier described by a
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1-dimensional external potential energy function U(x)
k =
ωa
2pi

[
1 +
(
ζ
2ωb
)2]1/2
− ζ
2ωb
 exp(−Ub/kBT ). (5.6)
Here Ub is the barrier height, ωa and ωb are the frequencies of the harmonic poten-
tials at the bottom of the well and top of the barrier, and ζ is the friction coefficient
which is related to the diffusion coefficient via the Einstein relation, ζ = kBT/mD.
We assume an inverse harmonic potential for the barrier with height Ub and range
xb. Because U(x) is an external potential energy, Ub is taken from the enthalpic
contribution to the binding free energy of the ion. The frequency, ωb, can be de-
termined from Ub = mω
2
bx
2
b/2. The frequency in the binding pocket follows from
the equipartition theorem, mω2aσ
2
x = kBT , where σx is the RMS fluctuations of the
particle along the reaction coordinate which is calculated from the MD simulations.
We note that, in a low friction environment (ζ  ωb), the rate coefficient has the
maximum value of
kmax = (ωa/2pi) exp(−Ub/kBT ). (5.7)
With increasing friction, the rate coefficient steadily decreases, and in the high
friction limit (ζ  ωb), it takes the form, k = kmaxωb/ζ.
5.5 Results and discussion
5.5.1 Opening of the IC-gate
. In the 3KBC crystal structure of GltPh, the IC-gate is closed, and only the Na2 ion
has access to the solvent. Thus using this structure, only the binding free energy
of the Na2 ion can be calculated. In order to calculate the binding free energies
of the other ligands, we need the open conformation of GltPh where the IC-gate is
open and the ligands are exposed to the solvent. To find the open conformation, we
have performed several 30-ns MD simulations of the 3KBC structure with different
ligand configurations. The opening of the IC-gate is monitored using the S277(Cα)–
V355(Cα) distance, which has been used in studies of the opening of the EC-gate
previously.36 The S277 and V355 residues are located at the tips of the HP1 and
HP2 hairpins, respectively, and hence provide a good measure for the gate opening.
The results of these simulations are summarized below.
i) All the ligands bound: No perceptible changes are observed in the transporter
structure with regard to the opening of the IC-gate. Na2 ion remains bound in all
subunits for the entire 30 ns of simulations. Note that the Na2 site is different from
the Na2′ site obtained from the crystal structure, which is found to be unstable.123
ii) Asp, Na1 and Na3 bound: Na2 ions are removed from all subunits in the last
frame of (i) before running the simulations. In Fig. 5.1A, we show the time evolution
of the S277–V355 distance for the three subunits. The subunits A and B remain
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in the same state as in (i) and do not show any sign of gate opening. In contrast,
subunit C displays a spontaneous opening of the IC-gate at 5 ns with a temporary
intermediate state between the open and closed configurations as can be seen from
the histogram of distance distributions (Fig. 5.1B). We note that the EC-gate has
not been observed to open in the presence of Asp in MD simulations of the outward
structure. The rare event observed in subunit C here is traced to entry of water
molecules to the binding pocket through the HP2 segment, which facilitate breaking
of the H-bonds that hold the IC-gate. Inspection of the H-bonds during the gate
opening shows that the gate is stabilized by two H-bonds HP2 makes with Asp and
HP1, namely, Asp(N)–V355(O) and S279(N)–G354(O) (see Table 5.1). Breaking
of the first H-bond results in the half-open intermediate state and breaking of the
second H-bond leads to the fully open state. In the open state, Asp and Na1 are
exposed to the solvent, so, in principle, both ligands could unbind at this point.
iii) Asp and Na3 bound: Simulations are run after removing Na1 ions from all
subunits in the last frame of (ii). As shown in Fig. 5.2A, the S277–V355 distances
do not show any gating transitions, with subunits A and B remaining in the closed
state and C in the open state. Interestingly, Asp in subunit C remains in the binding
site for the whole 30 ns, indicating a semi-stable binding of Asp in the absence of
Na1 (see Fig. 5.3A). In contrast, in similar simulations of the outward structure, Asp
is released within 5 ns in all subunits. We have, therefore, extended this simulation
for a further 20 ns. Asp is eventually observed to lose most of its contacts at 45 ns
(Fig. 5.3B).
iv) Na1 and Na3 bound: Removing Asp instead of Na1 in the last frame of (ii)
leads to a very different result. The IC-gates in subunits A and B also open but
the gates are extremely unstable, fluctuating freely between the open and closed
conformations in all subunits (Fig. 5.2B). This further confirms the role of Asp in
stabilizing the IC-gate.
v) Na3 bound: Removing Na1 from the last frame of (iv) yields very similar
results to that observed in (iv) (not shown).
vi) No ligands: Simulations are run after removing all the ligands from the last
frame of (i). All the IC-gates open within 6 ns (Fig. 5.2C). Although the gates still
exhibit large fluctuations, they don’t visit the fully closed state anymore, indicating
that it is less favored in the apo state.
The above results demonstrate that the bound Asp plays an important role
in stabilizing the IC-gate via the V355(O)–Asp(N) H-bond. The H-bonds noted
in simulation (ii) result in a sizable energy barrier between the open and closed
conformations, which suppresses random gating transitions. To confirm the role of
these H-bonds in gating and also to create open-states in all subunits, we attempt to
break them in simulation (ii) where Asp, Na1 and Na3 are bound. For this purpose,
we introduce a repulsive half-harmonic potential defined by U = 0.5k(r − r0)2 for
r < r0 and U = 0 for r > r0, with parameters k = 25 kcal/mol/A˚
2 and r0 = 4.5
A˚. This potential acts on the H-bond partners only when the distance between the
atoms (r) is less than 4.5 A˚. It speeds up breaking of the specified H-bonds and
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Figure 5.1: (A) Time evolution of the S277(Cα)–V355(Cα) distance in subunits A
(black), B (red), and C (green) when all the ligands are bound except Na2. There is
a spontaneous opening of the IC-gate in subunit C starting at 5 ns. (B) The histogram
analysis of the same graph, showing the unstable intermediate state in subunit C during
the opening of the IC-gate.
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Figure 5.2: Similar to Fig. 5.1A but for different combinations of bound ligands. (A)
Only Asp and Na3 are bound. (B) Only Na1 and Na3 are bound. (C) No ligands are
bound. The gate distances are stable in case A but exhibit large fluctuations in B and
C. This indicates that presence of Asp results in an energy barrier between the open and
closed conformations.
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Figure 5.3: (A) Position of Asp in the binding site in the absence of Na1 after 10 ns
of MD simulations. Contacts are indicated with purple dashed lines. (B) The same after
45 ns of simulations, where Asp has lost most of the contacts indicated in A.
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Table 5.1: List of the GltPh residues (first column) coordinating Asp atoms (second
column). The average N–O and O–O distances (in A˚) obtained from the MD simulations
in the closed and open states are compared to those of the crystal structure 3KBC (third
column). Bare O and N atoms in parenthesis refer to the backbone atoms and the others
refer to the side chain atoms. The first row shows the S279(N)–G354(O) H-bond distance
involved in the IC-gate.
Crystal Closed Open
GltPh residue Asp residue structure state state
HP1 - S279 (N) HP2 - G354 (O) 3.3 3.0± 0.2 6.0± 0.8
HP1 - R276 (O) Asp (α-N) 3.1 2.9± 0.1 3.0± 0.2
HP1 - S278 (N) Asp (α-O1) 2.5 2.8± 0.1 2.9± 0.1
HP1 - S278 (OH) Asp (α-O2) 3.7 2.7± 0.1 2.8± 0.1
TM7 - T314 (OH) Asp (β-O2) 2.6 2.7± 0.1 2.7± 0.1
HP2 - V355 (O) Asp (α-N) 2.1 3.0± 0.2 5.5± 0.3
HP2 - G359 (N) Asp (β-O2) 2.7 3.0± 0.2 3.2± 0.4
TM8 - D394 (O1) Asp (α-N) 3.4 2.7± 0.1 2.7± 0.1
TM8 - R397 (N1) Asp (β-O2) 3.9 4.3± 0.2 2.7± 0.1
TM8 - R397 (N2) Asp (β-O1) 2.5 2.9± 0.2 2.7± 0.1
TM8 - T398 (OH) Asp (α-N) 3.6 3.2± 0.2 3.0± 0.2
TM8 - N401 (Nδ) Asp (α-O2) 2.9 2.9± 0.1 2.9± 0.2
thereby facilitates the gate opening process observed in subunit C. Applying this
potential to the Asp(N)–V355(O) and S279(N)–G354(O) distances in subunits A
and B, we observe that the IC-gate in subunit B quickly opens and remains in
this state for almost 10 ns with no bias forces acting as they are outside the range
(Fig. 5.4, red line). In subunit A, upon breaking of the S279(N)–G354(O) H-bond,
G354(O) forms two intermediate H-bonds with the hydroxyl groups of S277 and
S279, keeping the IC-gate closed. These H-bonds are also broken by applying the
half-harmonic potentials at 5 ns, after which the IC-gate in subunit A also opens
and remains in this state with no bias forces acting (Fig. 5.4, black line). Despite
the differences in the opening mechanisms, all three states have very similar final
conformations as demonstrated in the alignment diagram in Fig. 5.5. We stress,
in particular, the similarity between the open states obtained using the bias forces
(subunits A and B) and the one obtained from MD simulations (subunit C). This
is further quantified by calculating the RSMDs between the subunits A-C and B-C
after aligning the segments HP1, HP2, TM7 and TM8, which yield 0.9 A˚ in both
cases.
The conformational changes occurring during the opening of the IC-gate is
demonstrated in Fig. 5.6A, where the open apo state obtained from the MD sim-
ulations is superposed with the closed state obtained from the crystal structure.
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Figure 5.4: Time evolution of the distance in Fig. 5.1A in a 10 ns simulation with Asp,
Na1 and Na3 bound. Here a bias force is introduced in subunits A (black) and B (red) to
observe the opening of the IC-gate in these subunits. Even though the bias force does not
act after the IC-gate opens, the transporter is seen to remain in the open state, indicating
presence of an energy barrier between the two states when there is a bound Asp.
Figure 5.5: Comparison of the open states obtained using bias forces in subunits A
(black) and B (red) with the one obtained from MD simulations in subunit C (green).
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Opening of the IC-gate involves a partial movement of HP2 towards TM2 and a
similarly small movement of HP1 away from HP2, e.g., the S277–V355 distance in-
creases by about 4 A˚ after the IC-gate opens while the same distance increases by
10 A˚ in the EC-gate. As shown in Fig. 5.6B, essentially the same open conformation
is obtained from the MD simulations with bound Asp, Na1 and Na3, which is used
in the free energy calculations. To show the effect of gate opening on the bound Asp,
we present in Table 5.1 the residues involved in the coordination of Asp, and how the
contact distances change when the IC-gate opens. The S279(N)–G354(O) distance
is also given in Table 5.1 because it is involved in the gating. Comparing the results
in Table 5.1 with those obtained for the outward-facing conformation (Table 4.2123),
we find a rather different mechanism. Opening of the EC-gate involves breaking of
the V355(O)–Asp(N) and G359(N)–Asp(βO2) bonds, which allows HP2 to move
away from a stationary HP1. In opening of the IC-gate, only the first of these HP2–
Asp bonds is broken while the second remains intact and performs a hinge function
(Table 5.1). More importantly, none of the HP1–Asp bonds are broken.
In order to quantify and contrast the changes occurring in the IC and EC-gates
further, we show the RMSD of the Cα atoms at the tip of HP1 and HP2 using
the closed crystal structures as reference (Fig. 5.7). Here it is clearly seen that
HP2 is the only moving part in the EC-gate whereas both HP1 and HP2 move
in the IC-gate but to a much lesser degree. The movement is also less uniform
across the tip with the maximum occurring in the residues S279 in HP1 and A353
in HP2 (indicated in Fig. 5.6B). As noted above, the movement of the HP2 tip is
restricted by the unbroken G359–Asp H-bond, which results in partial opening of
HP2 around the G359 hinge. We also see that the HP1–Asp bonds are maintained
during gating because HP1 moves only a small distance. Thus the IC-gate involves
a smaller opening and preserves the Asp contacts better relative to the EC-gate.
As a result we expect Asp to have a higher affinity on the IC side compared to
the EC side, which will affect its release to the cytoplasm. This has already been
noted in case (iii) above where Asp is observed to remain in the binding site much
longer in the absence of Na1. In order to make sure that the smaller opening of
the IC-gate does not prevent the release of Asp, we have facilitated its release by
applying repulsive harmonic potentials to the N–O contacts between the R397 side
chain and Asp(β-carboxyl), and between D394 side chain and Asp(α-amino). The
same values of potential parameters are employed as in breaking of the H-bonds
in the IC-gate. The key events leading to the release of Asp are captured in four
snapshots in Fig. 5.8:
Frame A: This is the same snapshot as in Fig. 5.3A (MD simulations with only
Asp and Na3 bound after 45 ns). Most of the contacts with the GltPh residues have
already been lost, and Asp is relatively free to move and rotate within the binding
pocket. The half-harmonic potentials are applied at this point and the system is
simulated until Asp is released.
Frame B: In this position, the α-carboxyl group of Asp still makes contacts with
S278(N) and S279(N), and the β-carboxyl group of Asp with G357(N). There are
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Figure 5.6: (A) Comparison of the closed state taken from the crystal structure (green)
and the open state obtained from the MD simulations with no bound ligands (orange).
The black dotted line indicates the S277(Cα)–V355(Cα) distance used in measuring the
opening of the IC-gate. (B) The open state obtained from the simulations with Na1,
Na3 and Asp bound. In this conformation both Na1 and Asp have access to the solvent.
The Cα atoms used in RMSD measurements in Fig. 5.7 (R276–S279 and A353–G357) are
indicated with black spheres.
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Figure 5.7: Comparison of the IC-gate opening (black) with the EC-gate opening (red).
The RMSD of the open-state Cα atoms at the tips of HP1 and HP2 are measured with
respect to the closed crystal structure after aligning the segments HP1, HP2, TM7 and
TM8.
no other contacts made by Asp.
Frame C: At this point the G357(N) contact is lost, and the Asp side-chain moves
up towards the solution and away from the binding site. The S278(N) and S279(N)
contacts are still maintained.
Frame D: Finally the S278(N) and S279(N) contacts are also lost, and Asp is
released to the cytoplasm.
A similar picture is obtained for the opening of the IC-gate from metadynamics
simulations, e.g., the IC-gate remains closed in the presence of Na2, opening of the
IC-gate involves movement of both HP1 and HP2, and there is an energy barrier
between the open and closed conformations.126 The metadynamics simulations were
performed for a monomer in solution with two bound Na+ ions. Our results confirm
that the basic features of the gating dynamics are not influenced by embedding the
GltPh trimer in membrane and including the third Na
+ ion. This indicates that
Na3 is not involved in gating or coupling to Asp, rather it provides the electrostatic
energy needed to move the binding pocket from the EC to IC side. This energy
comes from the membrane associated voltage of around -80 mV, which produces an
inward-directed potential for positive charges.
5.5.2 Binding free energies
. The binding free energies of Na+ ions are calculated using the formalism described
in methods and the results are presented in Table 5.2. Convergence of the translo-
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Figure 5.8: Four snapshots depicting the release of Asp. Explanations are given in the
text.
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Table 5.2: Binding free energies for Na+ ions in the closed state (for Na2 and Na2′) and
in the open state (for Na1 and Na3) of GltPh. The forward and backward calculations
of the interaction energy are listed in the second and third columns, and their average
in the fourth column. The total binding free energy that includes the translational free
energy difference (fifth column) is given in the last column. Other ligands present in the
transporter are indicated in parenthesis. Errors are estimated from block data analysis
using 100 ps windows. All energies are in kcal/mol.
Ion −∆Gforint ∆Gbackint ∆Gint ∆Gtr ∆Gb
Na2 (1, 3, Asp) −6.8± 1.2 −6.7± 1.1 −6.8± 1.2 4.4 −2.4± 1.2
Na2′ (1, 3, Asp) −2.1± 0.8 −2.1± 1.0 −2.1± 0.9 4.3 +2.2± 0.9
Na1 (3, Asp) −19.3± 1.2 −20.0± 1.3 −19.6± 1.3 4.7 −14.9± 1.3
Na1 (3) −12.3± 1.6 −11.8± 1.8 −12.1± 1.3 4.8 −7.3± 1.3
Na3 −21.5± 1.5 −19.9± 1.2 −20.7± 1.1 4.4 −16.3± 1.1
cation free energies and lack of hysteresis effects are demonstrated in Fig. 5.9. We
first discuss binding of Na2, which is bound to the closed state and already exposed
to the solvent, so it should be the first ligand to be released. The free energy calcu-
lation is performed using the closed crystal structure 3KBC. In the outward crystal
structure, Na2 is coordinated by the backbone oxygens of T308, S349, I350 and
T352. But in MD simulations, Na2 is observed to shift away from the S349 back-
bone oxygen immediately, which we call the Na2′ site.123 With further equilibration,
the S349 oxygen is replaced by the side chain oxygen of T308 in all subunits and
Na2 remains stably bound in this position.123 The same thing is observed to hap-
pen in the inward structure simulations albeit more slowly, resulting in an identical
coordination shell for Na2 as in the inward structure. The calculated Na2 binding
free energy is −2.4 kcal/mol, which is also similar to the value obtained for the
outward structure, −2.7 kcal/mol.123 The binding free energy for the Na2′ site is
+2.2 kcal/mol, indicating its instability. We note that the Na2 site is not as well
located as the Na1 and Na3 sites due to Tl+ substitution and intrinsic flexibility of
the binding site, so there is still some uncertainty about its exact location.
Once the IC-gate is open, the binding pocket is exposed to the solvent, and
either Asp or Na1 can unbind. To cover both possibilities, we calculate the Na1
binding free energy in two cases: with only Na3 bound, and with Na3 and Asp
bound. These and the remaining free energy calculations are performed using the
open structure obtained from the MD simulations (subunit C in Fig. 5.1). The Na1
binding free energy in the presence of Na3 is found to be −7.3 kcal/mol, which is
very close to the value obtained for the outward structure under the same conditions
(−7.1 kcal/mol).123 This is expected because the same residues coordinate Na1 in
the inward and outward structures. From Table 5.2, presence of Asp is seen to
have a big influence on the binding affinity of Na1, boosting its binding free energy
100
Chapter 5 Mechanism and Energetics of Ligand Release in the Aspartate
Transporter GltPh
Figure 5.9: Convergence of the TI results for the translocation free energy of the (A)
Na1, (B) Na2 and (C) Na3 ions from running averages. For the Na1 ion we show the case
with only Na3 bound, and the Na2 calculation is for the closed state with all the ligands
present. The negative of the forward (binding site → bulk) and the backward transitions
of Na+ are shown with black and red lines, respectively.
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by −7.6 kcal/mol to −14.9 kcal/mol. In the outward structure calculations,123 we
provided a qualitative demonstration of the Asp–Na1 coupling via a hydrogen-bond
network, which linked the α-carboxyl group of Asp with Na1. Because Asp(α-
carboxyl) and Na1 are separated by 7 A˚ with a water molecule and the S278-OH
group in between them (see Fig. 5.10), the strength of this coupling is not clear.
In the outward structure, Asp is not stable in the absence of Na1, and therefore
the Na1 binding free energy could not be calculated in the presence of Asp. In the
inward structure, Asp remains stable in the absence of Na1 long enough to allow
such a calculation. The above estimate of 7.6 kcal/mol difference in Na1 binding
free energies with and without Asp indicates that the Asp–Na1 coupling is fairly
strong despite their sizable separation. We emphasize this point because, unlike in
LeuT transporters where a Na+ ion is in direct contact with the substrate,121 the
nature and strength of the substrate-ion coupling is not obvious in GltPh.
In order to investigate the nature of the Asp–Na1 coupling and examine the
role of the electrostatic interactions between Asp and Na1 in this coupling, we
repeat the Na1 binding free energy calculation in the presence of Na3 and Asp but
with a neutralized α-carboxyl group. This is expected to abolish the electrostatic
interaction between Asp and Na1 because the β-carboxyl and α-amino groups of Asp
are at similar distances from Na1 (10 A˚) so their effects should mostly cancel each
other (Fig. 5.10). The calculated binding free energy (−4.2 kcal/mol) is about 3.1
kcal/mol larger than the value obtained in the absence of Asp (−7.3 kcal/mol). Thus
other factors also contribute to the Asp–Na1 coupling besides the direct electrostatic
interactions. For example, the α-carboxyl group of Asp is involved in the H-bond
network responsible for binding of Asp,123 and its neutralization will affect this
H-bond network.
Na3 is buried in the protein and can only be released after Na1 and Asp. We
calculate the binding free energy of Na3 using the last frame from the 20 ns MD
simulations with only Na3 bound. The calculated value (−16.3 kcal/mol) is again
comparable to the value obtained for the outward-facing state (−18.7 kcal/mol),
reflecting the fact that Na3 coordination is also similar in the inward and outward
structures. The Na3 ion has by far the largest affinity of all the ligands, with a
high enthalpic barrier (20.7 kcal/mol) that has to be crossed for this ion to be
released. We use Kramers’ rate theory discussed in Methods to provide a rough
estimate for the release time of Na3. The barrier potential is specified with height
Ub = 20.7 kcal/mol and range xb ∼ 4 A˚ (half of the distance from the Na3 site to
solvent which is 8 A˚), from which we obtain ωb = 7× 1012 s−1. Similarly, from the
RMSD fluctuations of the Na3 ion in the binding pocket (σx = 0.2 A˚), we obtain
ωa = 16 × 1012 s−1. From Eq. 5.7, these values correspond to a maximum rate of
kmax = 2.9 × 10−3 s−1 at T = 30 ◦C, or average release time of 6 min. Including
friction in the rate equation (Eq. 5.6) will lower the rate and increase the release
time. The friction coefficient of Na+ ions in bulk water is ζ = 8× 1013 s−1, which is
larger than ωb. However, there are no water molecules in the Na3 binding pocket,
and hence we expect ζ to be much smaller than the bulk value. As an example, for
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Figure 5.10: Picture depicting the strong coupling between Asp and Na1. The distances
between the charges on Asp and Na1 are indicated with dashed lines. Asp α-carboxyl is
closer to Na1 which is the source of strong coupling while the other positive and negative
charges on Asp are at equal distance to Na1 and hence cancel each other.
ζ ∼ ωb, the rate would be k = 0.6kmax = 1.7× 10−3 s−1 corresponding to an average
release time of 10 min.
The experimental turnover time of GltPh is 3.5 min at T = 30
◦C.35 There is
strong support from mutagenesis experiments that unbinding of Na3 is the rate-
limiting step in the transport cycle. Mutation of the residues coordinating Na3,
which reduce its binding affinity and facilitate its release, result in almost 20-fold
increase in the transport rate.38 Experiments also indicate that the outward-inward
transition is relatively rapid (seconds) and does not limit the rate of transport.16
Thus, assuming that the rate-limiting step in the transport cycle is the release of
Na3, the calculated release time is consistent with the experimental turnover time
(note that the computational accuracy of free energies is about 1 kcal/mol which
translates to a factor of five in the rate coefficients or release times).
While the release time of the Na+ ions is quite long, their electrostatic poten-
tial energy provides sufficient incentive for keeping the transporter in the inward
conformation until they are released. For a membrane potential of −80 mV, trans-
port of each Na+ ion against this potential gradient costs 80/25 = 3.2 kT. For two
Na+ ions, the cost is 6.4 kT. Thus compared to the apo state, transition of the
Na1-Na3 bound transporter to the outward-facing state is suppressed by a factor of
exp(−6.4) ∼ 1/600.
Temperature dependence of Asp uptake provides another test for the proposed
model. The Q10 value estimated from the Na3 release rates at T = 25 and 35
◦C is
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Table 5.3: Various terms contributing to the binding free energy of Asp in the open
state of GltPh. The forward and backward calculations differed by less than 1 kcal/mol in
all cases, therefore only their average is listed. Other ligands present in the transporter
are indicated in parenthesis. The absolute binding free energy of Asp is given in the last
column. Errors are estimated from block data analysis using 100 ps windows. All energies
are in kcal/mol.
Substrate ∆Gelec ∆GLJ−bb ∆GLJ−sc ∆Gtr ∆Grot ∆Gcon ∆Gb
Asp (1,3) −17.0± 1.0 2.6± 0.6 0.3± 0.6 3.9 4.6 0.7 −4.9± 1.1
Asp (3) −9.3± 1.2 1.8± 0.7 0.4± 0.5 3.9 4.4 0.6 +1.8± 1.3
3.1, which is in reasonable agreement with the measured Q10 value of 3.7.
35
We next consider the binding free energy of Asp in the presence of Na1 and Na3,
which is calculated using the open subunit from the last frame of the MD simulations
in Fig. 5.1A (Table 5.3). Convergence of the Asp translocation free energies for
various contributions and lack of hysteresis effects are demonstrated in Fig. 5.11.
The calculated value (−4.9 kcal/mol) is 10 kcal/mol higher than the binding free
energy of Na1 in the presence of Asp and Na3 (−14.9 kcal/mol), which assures that
Na1 is released only after Asp. Thus the ligands are released into the cytoplasm in
the order of Na2, Asp, Na1 and Na3, which is the reverse of their binding order in
the outward-facing state.123 As noted in the discussion of the IC-gate, Asp is better
coordinated in the inward structure compared to the outward structure, and this is
corroborated by its binding free energy which is 1.1 kcal/mol lower in the inward
state relative to the outward state. In fact, the enthalpic contribution to the binding
free energy is 2.6 kcal/mol lower in the inward state but this is partly offset by the
entropic contributions which are also higher. All of these point to a tighter binding
of Asp in the inward state.
As pointed out above, Asp remains stable in the absence of Na1 long enough
(> 30 ns) to allow free energy calculations. This means that we can also calculate the
binding free energy of Asp in the presence of only Na3 (Table 5.3). The calculation is
performed using the open subunit of the MD simulations in Fig. 5.2A. The calculated
value is 1.8 kcal/mol, showing that Asp is indeed unstable in this configuration, but
the relatively large enthalpic contribution to the binding free energy (−7.1 kcal/mol)
delays its release. Comparing the Asp binding free energies with and without Na1
(Table 5.3) gives another estimate for the Asp–Na1 coupling. The binding free
energy difference is 6.7 kcal/mol, which is consistent with the value obtained from
the Na1 binding free energies with and without Asp (7.6 kcal/mol).
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Figure 5.11: Convergence of the TI results for the three different components of the
translocation free energy of aspartate from running averages: (A) the creation/destruction
of the neutral backbone, (B) the same for the side-chain, and (C) the charging/discharging
of the whole aspartate molecule. Here we show the case in which we have both Na1 and
Na3 bound to the transporter. The negative of the forward (binding site → bulk) and the
backward transitions of Na+ are shown with black and red lines, respectively.
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5.6 Conclusions
We have performed MD simulations and free energy calculations in the inward-facing
state of the Asp transporter GltPh. The gating mechanism is studied in equilibrium
simulations with different ligands bound to the transporter. Spontaneous opening
of the IC-gate with Na1, Na3 and Asp bound is observed in one of the MD simula-
tions, which happens through the breaking of two hydrogen bonds. The IC-gate is
found to be quite different from the EC-gate as it involves movement of both HP1
and HP2 but in much smaller amounts. Our results indicate that presence of Asp
leads to an energy barrier between the open and closed states, consistent with the
metadynamics simulations.126 This mechanism presumably facilitates the unbinding
of Asp by keeping the transporter in an open state until it is released.
The unbinding order predicted from the binding free energies is, Na2, (IC-gate
opens), Asp, Na1 and Na3, which is the reverse of the order of binding found in
the outward structure.123 Another difference between the inward and and outward
structure calculations is the semi-stable binding of Asp in the inward case when only
Na3 is present. This has allowed us to give a quantitative estimate for the strength
of the coupling between Asp and Na1, which was only qualitatively described in the
previous work.123 The binding free energy of Na3 is found to be substantially lower
than the other ligands, suggesting that its unbinding is the the rate-limiting step in
the transport process. Estimates of the release time obtained from Kramers’ rate
theory is consistent with the experimental turnover rate of GltPh, which provides
further support for this proposal.
The free energy calculations show that the binding free energies of Na+ ions
and Asp in the inward structure are very similar to those obtained from the out-
ward structure. This is expected from the similarity of the binding sites in the
inward and outward open state structures. The faster turnover rates observed in
mammalian glutamate transporters could result from the extra proton transported
and/or changes in the binding sites during the transition, which could facilitate the
release of ligands. It will be interesting to see if the homology models of mammalian
glutamate transporters could provide such mechanistic explanations for the differ-
ences observed between them and GltPh. Although the results showed in this work
and our previous study of GltPh
123 focus mainly on thermodynamic properties of
ligand binding, the kinetics of transport also plays an important role in the under-
standing of GltPh and the EAATs. These properties are harder to obtain due to the
different time scales of laboratory experiments and MD simulations. Simulations
that can reproduce the unbinding of the substrate as shown in Ref.123, or the cal-
culation of transitions rates using Kramers’ theory and equilibrium properties, are
an effort in that direction. Unfortunately, we are still limited to the calculation of
the free energies between bound or unbound states using FEP, which usually do not
bring insights into the further kinetic properties of our systems.
Chapter 6
Molecular Dynamics Simulations
of the Mammalian Glutamate
Transporter EAAT3
ABSTRACT
Excitatory amino acid transporters (EAATs) are membrane proteins
that enable sodium-coupled uptake of glutamate and other amino acids
into neurons. Crystal structures of the archaeal homolog GltPh have been
recently determined both in the inward- and outward-facing conforma-
tions. Here we construct homology models for the mammalian gluta-
mate transporter EAAT3 in both conformations and perform molecular
dynamics simulations to investigate its similarities and differences from
GltPh. In particular, we study the coordination of the different ligands,
the gating mechanism and the location of the proton and potassium
binding sites in EAAT3. We show that the protonation of the E374
residue is essential for binding of glutamate to EAAT3, otherwise glu-
tamate becomes unstable in the binding site. The gating mechanism
in the inward-facing state of EAAT3 is found to be different from that
of GltPh, which is traced to the relocation of an arginine residue from
the HP1 segment in GltPh to the TM8 segment in EAAT3. Finally, we
perform free energy calculations to locate the potassium binding site in
EAAT3, and find a high-affinity site that overlaps with the Na1 and Na3
sites in GltPh.
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Figure 6.1: Cartoon showing the functional mechanism of the EAAT transporters. Steps
3-4 denote the translocation of the binding site across the membrane with 3 Na+, H+, and
glutamate bound to EAAT3, while steps 7-8 denote the same with only K+ bound. Step
2 shows the binding of the Na2 ion, which binds after the substrate and the closure of the
HP2 gate. Step 5 shows the opposite happening in the intracellular media, assuming that
the binding and unbinding of ligands are symmetrical.
6.1 Introduction
Excitatory Amino Acid Transporters (EAATs) are responsible for clearing the ex-
cess glutamate released at the nerve synapses. There are five subtypes identified in
humans, called EAAT1 to EAAT5. Malfunctioning of these proteins has been im-
plicated in many pathological conditions including cerebral ischemia, amyotrophic
lateral sclerosis and Alzheimer’s disease12. The transport mechanism of EAATs
involves two half cycles, which enables transport of Glu or Asp against their con-
centration gradients. The first part involves the binding and translocation of three
Na+ and one H+ ions with the substrate across the membrane while the second
half cycle brings the transporter back to its initial conformation by binding and
counter-transporting one K+ ion13,85 (Figure 6.1). Many mutagenesis and functional
experiments have been performed on EAATs in the past, especially in the rodent
homologs of EAAT2 and EAAT3, also known as GLT-1 and EAAC1, respectively.
We have summarized the results of several studies concerning the residues close
to the binding site in Table 6.1, pointing out the effects of different mutations on
the main functional properties of the EAATs. These include transporter/exchanger
functionality, the cation and substrate affinities, the Na+/Li+ selectivity, and the
ability to interact with K+ ions28,30–34,38,92,96,129–142. We will refer to this table to
motivate the choices made in modeling of EAAT3 and justify the simulation results.
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A recent breakthrough in our understanding of the EAATs came with the crystal
structure of the archaeal homolog GltPh
14, and the identification of the Asp sub-
strate and two of the Na+ binding sites (Na1 and Na2)15. These initial structures
captured GltPh in the outward-facing state. The inward-facing state was similarly
characterized in a subsequent crystal structure16. GltPh shares about 37% sequence
identity with the EAATs, but the homology is much higher for residues near the
binding pocket, reaching around 60% in this region. Furthermore, almost all of the
residues shown to be involved in the binding of the ions and aspartate in GltPh are
conserved in the EAATs14–16,32,90,94. Experiments have shown that, while the trans-
port mechanism in GltPh is independent of H
+ and K+ ions35, it is still coupled to
the co-transport of three Na+ ions as in EAATs37. The third Na+ site (Na3) could
not be identified in the crystal structures of GltPh, but a binding site determined
from molecular dynamics (MD) simulations was confirmed from mutagenesis exper-
iments and shown to be conserved in GltPh and the EAAT family
38. Because of
its structural and functional similarity to EAATs, GltPh provides a good model for
studying the transport mechanism in EAATs112,113. This has prompted several MD
simulations of GltPh, investigating the gating mechanism in the outward
36,99,126 and
inward-facing states126,143,144, location of the Na3 site38,96,97, binding free energies of
the ligands96,123,144, and substrate translocation114,124,125.
In order to facilitate homology modeling of EAATs from GltPh, we list in Ta-
ble 6.2 all the functionally important residues close to the binding site, which are
identified from the crystal structures and the mutation experiments in Table 6.1.
Considering the conserved residues first, there seems to be good agreement between
the crystal structure data and mutagenesis experiments, e.g., identification of D444
and R447 in EAAT3 as being involved in the coordination of glutamate α-amino
and side-chain carboxyl groups, respectively32,33. There is, however a discrepancy
related to D455 in EAAT3, which corresponds to D405 in GltPh. In GltPh, D405
coordinates the Na1 ion with both side-chain carboxyl oxygens. But the D455N
mutation in EAAT3 has shown little effect on the Na+ affinity both in the pres-
ence and absence of the substrate (Table 6.1). To resolve this issue, it has been
proposed that D455 might be protonated during the whole transport cycle, which
would explain why neutralizing this residue does not affect the Na+ affinity141. An-
other important difference between EAATs and GltPh is the K
+ binding site in the
inward-facing state of EAATs, which is not present in GltPh. Different sites have
been suggested for K+ binding, overlapping with either the proposed protonation
site28, or the substrate α-amino group95, or the Na1 site140,141.
There are only six non-conserved mutations between GltPh and EAATs in Ta-
ble 6.2. Of these, R276 and T352 contribute backbone carbonyls to the coordination
of the Glu substrate and the Na2 ion, respectively, while the others are not directly
involved in ligand coordination. Mutation of R276 and M395 in GltPh to S331 and
R445 in EAAT3 switches the position of the arginine residue from the HP1 segment
in GltPh to the TM8 segment in EAATs, which will be discussed later in the paper.
The Q242 residue in GltPh is a histidine in EAATs, which has been proposed as the
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protonation site in EAATs. But this was contradicted by the H296Q mutation in
EAAT3, which had no effect on the transport mechanism (Table 6.1). The Q318
residue in GltPh is a glutamate in EAATs, suggesting that this might be the protona-
tion site. There is strong experimental evidence for this hypothesis, e.g., the E374Q
mutation does not affect the Glu affinity of EAAT3 (Table 6.1), but it abolishes the
pH dependence of Glu translocation seen in the wild-type transporter137,145. An-
other piece of evidence comes from the neutral amino acid transporters, where the
corresponding residue is also a glutamine like in GltPh, and the pH sensitivity can
be engineered into these transporters by mutating this glutamine to glutamate137.
The G354 residue in GltPh is conserved in EAAT1 and EAAT3, but it is a serine in
EAAT2. Among EAATs, EAAT2 is the only one where Li+ cannot replace Na+ in
the transport cycle. Either the S440G or Y403F mutation enables Li+ to support
transport in EAAT2, indicating that the S440 and Y403 residues are involved in the
Na+/Li+ selectivity of EAAT234.
Here we attempt to address the issues raised above by performing MD sim-
ulations on two homology models for EAAT3 based on the GltPh transporter in
the inward- and outward-facing states. We analyze several properties of EAAT3
such as the coordination of the ligands and the stability of the substrate with a
protonated/deprotonated E374 side chain, the effect of the D455N mutation (or
protonation of D455) on Na+ affinity, and the extracellular (EC) and intracellular
(IC) gating mechanisms. We also discuss binding of a K+ ion in the inward-facing
state and propose a binding site based on free energy calculations.
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Table 6.1: Effect of different mutations on the properties of EAAT1, EAAT2 (GLT-1) and EAAT3
(EAAC1) transporters. Transporter/Exchanger functionality is given in the third and fourth columns.
Columns 5 and 6 gives the Na+ affinity in the presence and absence of glutamate, respectively. Columns
7 and 8 specify K+ and Li+ interactions with the transporter. Glu and Asp affinities are given in
the last two columns. For the affinities, N/S means no saturation of the binding site in the range
considered, and nRed/nInc means reduction/increase in the ligand affinity by n orders of magnitude
(0, same order). Human sequences are used for EAAT3 which have one extra residue than the rat
sequences employed in some experiments.
Transporter Trans. Exch. Na+ aff.(s) Na+ aff. K+ int. Li+ int. Glu aff.∗ Asp aff.∗
EAAT1
Wild-Type129,130 Yes Yes 20 mM Yes Yes 24 µM 16 µM
T131A38 Yes N/S 1Red
S363R/R477M129 No Yes 0Inc No 2Inc 2Inc
EAAT2
Wild-Type28,34,131,132 Yes Yes 24 mM Yes No 5.3 µM 2.8 µM†
Y403F132 No Yes 1Inc No Yes WT WT†
E404D28 No Yes WT No
S440G34 Yes Yes Yes Yes WT WT†
EAAT3
Wild-Type30,133,134 Yes Yes 8 mM 120 mM Yes Yes 14 µM 14 µM
T101A31 Yes Yes 0Red N/S Yes 2Red
H296Q135 Yes Yes WT Yes WT
N366Q92 Yes Yes N/S Yes No 3Red 2Red
D368E92 Yes Yes WT Yes No None 1Red
D368N30 No Yes 0Red N/S No 2Red
N366D/D368N92 No Yes No No 1Red 0Red
T370S96,134,136 Yes Yes N/S 0Red Yes No 2Red WT
E374Q133,137 Yes Yes WT WT Yes WT
D440N133 No No 1Red WT 2Red 1Red
D440E138 Yes Yes 1Inc Yes Yes 1Inc 1Inc
D444C33 No Yes‡ WT WT
D444E33 No Yes 0Inc WT WT
R445E33 Yes Yes
R445S139 Yes Yes WT Yes 1Inc 1Inc†
R447C32 No No Becomes a Na+ dependent serine/cysteine exchanger
N451S136 Yes Yes N/S Yes No 2Red 1Red
D455N30,133,140,141 No Yes WT WT Yes Yes 0Inc 0Inc
D455S140 No Yes 0Red No Yes WT 0Inc
D455E140 No No
D455A140–142 No No WT
∗All glutamate affinities measured at [Na+] between 100–150 mM.
†Result for D-aspartate.
‡Enables succinate exchange, unlike wild-type.
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Table 6.2: GltPh residues involved in the coordination of the ligands and their equivalents
in EAAT1, EAAT2 and EAAT3. Residues from the mutagenesis experiments in Table 6.1
are also included in the table. Those residues that are not conserved between GltPh and
EAATs are indicated with boldface. Human sequences are used for EAAT3.
GltPh Y89 T92 S93 Q242 R276 S277 S278 G306 T308
EAAT1 Y127 T130 T131 H328 S363 S364 S365 G394 T396
EAAT2 Y124 T127 T128 H326 A361 S362 S363 G392 T394
EAAT3 Y98 T101 T102 H296 S331 S332 S333 G362 T364
GltPh N310 D312 T314 Y317 Q318 S349 I350 T352 G354
EAAT1 N398 D400 T402 Y405 E406 S437 I438 A440 G442
EAAT2 N396 D398 T400 Y403 E404 S435 I436 A438 S440
EAAT3 N366 D368 T370 Y373 E374 S405 I406 A408 G410
GltPh V355 G359 D390 D394 M395 R397 T398 N401 D405
EAAT1 I443 G447 D472 D476 R477 R479 T480 N483 D487
EAAT2 I441 G445 D470 D474 R475 R477 T478 N481 D485
EAAT3 V411 G415 D440 D444 R445 R447 T448 N451 D455
Table 6.3: QMEAN scores and DFIRE energy values for the GltPh crystal structures,
and the EAAT3 models constructed in this work. The QMEAN score goes from 0 to
1, 1 being the best possible model. Lower DFIRE energy values indicate better quality
structures.
Structure QMEAN score DFIRE Energy
GltPh (2NWX) 0.524 −629.6
EAAT3 (outward) 0.489 −605.0
GltPh (3KBC) 0.557 −628.3
EAAT3 (inward) 0.540 −605.6
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6.2 Results and Discussion
6.2.1 Model Description
We have used the crystal structures of GltPh in the outward- (PDB ID 2NWX) and
inward-facing states (PDB ID 3KBC) to construct two homology models for the
EAAT3 transporter. Both conformations have the substrate binding site occluded
from the solvent, and have an Asp and two Na+ ions bound (Na1 and Na2). To build
the models, we have used the program MODELLER74 and the alignment from Ref.14
(Figure 6A.1 in the Appendix). The templates had Asp, Na1, Na2 and Na3 bound,
with this last Na+ added at the site as described in Ref.38. We have created the
models including the ligands in the alignment in order to obtain EAAT3 structures
in the fully-bound states. We have created 20 models for each conformation and
assessed the quality of the structures by using the Swiss Model Server79,80. After
choosing the best models, we have constructed a trimer for each conformation by
superposing the EAAT3 monomer to chains A, B and C of GltPh. These two models
have been employed in the MD simulations.
EAAT3 has a sequence of around 50 residues close to the trimerization domain,
called 4B-4C loop, which is not present in GltPh. In order to ensure robustness of
EAAT3 trimers, we had to exclude this region from the models. Experiments have
shown that cysteine substitution in the residues from this loop has little effect on the
transporter properties146. However, studies of the LacY transporter indicate that
this does not necessarily mean that this segment is not important for transport,
as it can be involved in conformational changes happening during the transport
cycle147. To make sure that the truncation of this segment has little effect on our
results, we have also built outward and inward models with the inclusion of the
4B-4C loop. This is achieved by placing the 4B-4C loop in the position suggested
from FRET studies146, and adding restraints in MODELLER (see Figure 6A.2 in
the Appendix). It can be seen from Figure 6A.2 that this loop is not close to the
conformational changes we investigate in this study or to the bound ligands, which
corroborates our approach. While this full model of EAAT3 is sufficient to give an
idea about the distance between the 4B-4C loop and the binding pocket, there are
large uncertainties in the secondary structure of the 4B-4C loop, which may cause
simulation artifacts. Therefore, we prefer to use the truncated model without the 4B-
4C loop in the MD simulations. Regarding the other segments of EAAT3, a previous
FRET study has shown that their relative positions have a strong correlation with
the GltPh crystal structure, which indicates that the structures are well conserved
between the two transporters.148
6.2.2 Evaluation of the Models
We have assessed the quality of our EAAT3 homology models using three different
methods. QMEAN (Qualitative Model Energy ANalysis) is a composite scoring
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function ranging from 0 to 1, which describes the major geometrical aspects of pro-
tein structures79. DFIRE (Distance-scaled, Finite Ideal-gas REference) is a potential
based on a database of non-homologous proteins80. DOPE (Discrete Optimized Pro-
tein Energy) is an atomic distance-dependent statistical potential calculated from
a sample of native structures74. The first two are available on the Swiss Model
Server, and the last one is built into the program MODELLER. In Table 6.3 we
show the QMEAN scores and DFIRE energies for the original GltPh crystal struc-
tures, as well as our EAAT3 models in the outward and inward-facing states. It
is seen that the QMEAN and DFIRE values are comparable between the crystal
structures and the EAAT3 models, which shows that the EAAT3 models are re-
liable, and in principle provide a good option to investigate EAATs. The DOPE
energy profile for the outward-facing EAAT3 model is compared with that of the
2NWX crystal structure in Figure 6A.3A in the Appendix, and the same is done for
the inward-facing EAAT3 model and the 3KBC crystal structure in Figure 6A.3B
in the Appendix. The profiles are very similar, especially in the regions that form
the glutamate binding site, which range from residues 260 to 410. We have also
compared the Ramachandran plots for the templates and the models, which agree
very well with few residues in the forbidden regions in all cases (Figure 6A.4 in the
Appendix). These results confirm that, even though the homology between EAAT3
and GltPh is not very high, we can still build good models and hopefully gain insights
into the mammalian glutamate transporters using the structural information from
the archaeal homolog.
6.2.3 Fully Bound EAAT3
We first discuss the stability of the ligands in the outward and inward fully-bound
models of EAAT3 with the EC-gate and IC-gates closed. To check the hypothesis
that E374 is the proton carrier in EAAT3, we have prepared two systems for the
outward-facing state of EAAT3: one with the side chain of E374 protonated and the
other with a deprotonated E374 side chain in all three monomers. All of these sys-
tems have been equilibrated for 20 ns initially. In order to show that our models are
stable for longer periods, we have performed an additional 40 ns of MD simulations
for the outward and inward fully bound states with protonated E374. The RMSDs
of the protein backbone for these models, obtained from the 60 ns MD data, are
shown in Figure 6A.5 in the Appendix. Both RMSDs show no major changes after
the first 10 ns. More importantly, the coordination of the ligands remain intact,
exhibiting no perceptible changes between 10–20 ns and 20–60 ns of data collection.
These results indicate that our systems are stable in the vicinity of the outward and
inward states, and 20 ns appears to be sufficient for their equilibration.
Our simulations with the protonated E374 residue show that Glu is stable, re-
maining bound to the transporter with the EC-gate closed and the coordination
shown in Table 6.4 throughout the 60 ns of MD simulations (Figure 6.2A). We
have applied the same procedure in the inward-facing state of EAAT3, and ob-
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Table 6.4: List of the EAAT3 residues coordinating the Glu substrate atoms. The
average N–O and O–O distances (in A˚) are obtained from 5 ns of MD simulations in the
closed conformation of the outward and inward-facing states of the transporter. Bare O
and N atoms in parenthesis refer to the backbone atoms and the others with subscripts
refer to the side chain atoms.
Glu- Outward Inward
Helix-Residue atom EAAT3 EAAT3
HP1 - S331 (O) α-N 2.8± 0.2 3.0± 0.2
HP1 - S333 (N) α-O1 2.7± 0.1 2.7± 0.1
HP1 - S333 (OH) α-O2 2.8± 0.1 2.7± 0.1
TM7 - T370 (OH) β-O2 2.7± 0.1 2.7± 0.1
HP2 - V411 (O) α-N 2.9± 0.2 3.0± 0.3
HP2 - G415 (N) β-O1 2.7± 0.1 2.8± 0.1
TM8 - D444 (O1) α-N 2.7± 0.1 2.7± 0.1
TM8 - R447 (N1) β-O1 2.7± 0.1 2.7± 0.1
TM8 - R447 (N2) β-O2 2.8± 0.2 2.7± 0.1
TM8 - T448 (OH) α-N 3.0± 0.2 3.1± 0.2
TM8 - N451 (Nδ) α-O2 2.8± 0.1 2.8± 0.1
tained very similar results for the coordination of Glu when the E374 side-chain
is protonated (Table 6.4). In contrast, if we have a deprotonated E374 side-chain,
the substrate shows instability and loses most of its contacts with the transporter
(Figure 6.2B). In the closed state, the substrate and the E374 side-chain carboxyl
groups are separated by around 7 A˚, and there are no water molecules between
them so the dielectric screening is expected to be small in this region. Thus the
electrostatic repulsion between these two groups is likely to destabilize Glu in the
binding site, making the protonation of E374 necessary for Glu binding. This is
consistent with the experimental observations indicating that protonation of E374
precedes Glu binding137,145. We have further tested this possibility by performing
20 ns of simulations of the GltPh Q318E mutant in two systems previously equili-
brated in a recent study123. One of them had Asp, Na1, Na2 and Na3 bound in the
outward-facing closed state, and the other one had Asp, Na1 and Na3 bound in the
outward-facing open state. In the first case we don’t see any changes, except for the
partial hydration of the E318 residue that takes place in one of the chains after a
few nanoseconds. In the second, however, we see that the Asp substrate becomes
unstable and loses most of its contacts with the protein, and Asp is released back to
the solvent in two of the three chains of GltPh. A movie is included in the Supporting
Info of Ref.161, showing the release of the Asp substrate in one of the chains that
occurs between 5 and 15 ns.
Regarding the ions in our EAAT3 models, Na1 and Na3 are very stable and
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Figure 6.2: Binding of glutamate to EAAT3 with a protonated vs deprotonated E374
side chain. (A) Glutamate substrate (in green) bound to EAAT3 in the closed outward
state with a protonated E374 side chain. (B) The same but with a deprotonated E374
side chain. Glutamate is stable in A for 20 ns, but becomes unstable in B, losing most of
the contacts after 10 ns of simulations.
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have very similar coordinations compared to those in GltPh
123,144 (Table 6.5). This
is expected because all of the residues in the coordination shell of both ligands are
conserved between EAAT3 and GltPh, except for T102 which is a serine (S93) in
GltPh. The Na2 ion, on the the other hand, is unstable and spontaneously un-
binds in two of the chains in the outward-facing state and one of the chains in the
inward-facing state. The ones that remain bound are coordinated by the residues
shown in Table 6.5. Because the Na2 site in the crystal structure has contacts with
the backbone carbonyl oxygens, it is difficult to assess it through mutagenesis ex-
periments. Previous MD studies of GltPh have shown that this site is unstable
149,
which is consistent with our observations. It is possible that the Na2 site is not con-
served in EAATs. Mutagenesis experiments have shown that the T370S96,136 and
the N451S136 mutations seem to affect the Na+ affinity and selectivity in EAAT3
(Table 6.1), and a site having the coordination of these residues and the substrate
has been suggested96. Since Na2 is likely to be the only Na+ ion to bind to EAAT3
after the substrate, this site would make a good candidate for the Na2 site if the
original site from the GltPh crystal structure is shown not to be conserved in EAATs.
More experiments and simulations are needed to clarify this issue.
6.2.4 Opening of the EC- and IC-Gates
In order to observe the gating mechanism in EAAT3, we have performed two 60 ns
simulations for each model: one of them had no ligands bound, and the other had
only the Na1 and Na3 ions bound (Figure 6.3). The opening of the EC- and IC-
gates is monitored using the S332(Cα)–V411(Cα) distance, which has been used in
previous studies of the GltPh transporter
36,144. These two residues are located at the
tips of the HP1 and HP2 hairpins, respectively, and hence provide a good measure
for the opening of the EC-gate. In the simulations of the fully-bound state this
distance remains around 5 A˚, meaning that the gates are closed in this configuration.
Once the Glu substrate is removed, both the EC- and the IC-gates show opening
in all of the chains regardless of whether the Na1 and Na3 ions are present or not
(Figure 6.3). Presence of the Na+ ions appears to reduce the fluctuations in the
gate motions but does not have much effect on the opening of the gates. In both
Figures 6.3B and 6.3D, the Na1 and Na3 ions are not affected by the gate opening
despite the flooding of the binding site by water molecules, and remain bound with
the coordination shown in Table 6.5. This shows that these sites are very stable in
EAAT3 even after 60 ns of simulations in the absence of the substrate, so they are
likely to be the two Na+ ions that are proposed to bind to EAATs before glutamate
binds31.
To assess in more detail the conformational changes brought by the gate opening
in the outward and inward-facing states, we choose the chains that show the largest
opening in the absence of ligands in both cases, which are chain A and chain B,
respectively, in Figures 6.3A and 6.3C. In Figures 6.4A and 6.4B, we show the
overlap of these two structures with their respective closed states, and in Figure 6.4C
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Table 6.5: List of the EAAT3 residues coordinating the three Na+ ions. The average
Na+–O distances (in A˚) are obtained from 5 ns MD simulations of the closed state in the
outward and inward-facing conformations of EAAT3. Nature of the coordinating oxygens
are indicated in parenthesis.
Outward Inward
Helix-Residue EAAT3 EAAT3
Na1 TM7 - G362 (O) 2.4± 0.1 2.7± 0.3
TM7 - N366 (O) 2.3± 0.1 2.3± 0.1
TM8 - N451 (O) 3.4± 0.5 2.5± 0.2
TM8 - D455 (O1) 2.2± 0.1 2.2± 0.1
TM8 - D455 (O2) 2.2± 0.1 2.2± 0.1
H2O 2.3± 0.1 2.3± 0.1
Na3 TM3 - Y98 (O) 2.3± 0.1 2.3± 0.1
TM3 - T101 (OH) 2.4± 0.1 2.4± 0.1
TM3 - T102 (OH) 2.4± 0.2 2.4± 0.2
TM7 - N366 (Oδ) 2.2± 0.1 2.2± 0.1
TM7 - D368 (O1) 2.1± 0.1 2.2± 0.1
TM7 - D368 (O2) 2.7± 0.4 2.6± 0.3
Na2 TM7 - T364 (OH) 2.3± 0.1 2.6± 0.4
HP2 - I406 (O) 4.2± 0.4 2.4± 0.3
HP2 - A408 (O) 2.3± 0.1 2.4± 0.3
H2O 2.4± 0.2 2.3± 0.2
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Figure 6.3: Gating motions in the outward- and inward-facing conformations of EAAT3.
Time evolution of the S332(Cα)–V411(Cα) distance in the outward-facing conformation
with (A) no ligands bound to the transporter, and (B) only the Na1 and Na3 ions bound to
the transporter. The same for the inward-facing conformation with (C) no ligands bound
to the transporter, and (D) only the Na1 and Na3 ions bound to the transporter. The
color code for the subunits are A (black), B (red), and C (green).
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Figure 6.4: Comparison of gate opening in the outward- and inward-facing conformations
of EAAT3. (A) Overlap between the closed (grey) and the open (purple) states in the
outward EAAT3. Glutamate and three Na+ ions bound to the transporter, as well as the
S331, D444 and R445 residues are indicated. (B) The same for the inward-facing state,
showing a large movement of HP1, HP2 and TM8. The contacts made by the insertion
of the R445 side-chain between HP1 and TM8 are also shown. The dark shade of grey in
the closed state indicates the position of the residues from part C below. (C) Comparison
of the IC-gate opening (black) with the EC-gate opening (red). The RMSD of the Cα
atoms at the tips of HP1 and HP2 is obtained by aligning the open and closed states and
calculating the RMSD from 2 ns of MD simulations.
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we show the average RMSD displacement of the Cα atoms of six residues located
at the tips of each of the two hairpins. These are calculated by aligning each frame
and calculating the RMSD of each atom between the closed and open states during
2 ns of MD simulations. The opening observed in the outward facing EAAT3 looks
very similar to GltPh, with a large movement of HP2 and a small displacement of
the HP1, TM7 and TM8 segments. The inward state, on the other hand, shows
movements of HP1, HP2 and TM8, with a much larger opening of HP1 compared
to our previous study of GltPh
144. From Figure 6.4B, we see that this is caused by
the insertion of the R445 side-chain in between the residues S331 and D444, making
contacts with them. This shifts the HP1 and TM8 segments apart, causing a larger
exposure of the binding site. This event is observed at around 40 ns in the simulation
of Figure 6.3C, but the contacts are kept and the transporter maintains the large
opening in the remainder of that simulation. Interestingly, GltPh has a methionine
in the position equivalent to R445, and an arginine replaces the serine in position
331.
It is instructive to compare our results to those obtained from metadynamics
simulations on GltPh by Grazioso et al.
126. In both cases, opening of the gate in the
outward-facing state shows a large movement of HP2, and a small displacement of
the neighbouring segments. Similarly, during the opening of the gate in the inward-
facing state, both studies show a movement of not only HP1 and HP2, but also
of the nearby segments TM7 and TM8. A salt bridge between R276 and D394
is observed in the inward open state of GltPh, which is similar to the R445–D444
salt bridge we see in our simulations. We also compare our results for EAAT3
to the microsecond MD simulations of Zomot and Bahar143 in the inward-facing
state of GltPh. In GltPh, a salt bridge between D394 and R276 prevents HP1 from
opening further, but it also attracts the Glu substrate away from the binding site,
facilitating its release. In EAAT3 there is still a salt bridge in this position, but
it has the opposite effect on the gating; it allows the transporter to open further
and stabilizes an open conformation through the contact between R445 and D444.
Therefore, the switching of this arginine from position 331 to 445 in EAAT3—which
is conserved in all EAATs—has a two-fold effect: first, it creates a more stable
and open conformation of the transporter in the inward state, which facilitates the
release of the larger Glu substrate; and second, it conserves the salt bridge (R445–
D444) in the vicinity of the binding site that has been shown to help the release
of the substrate. Even though this is an intermediate state followed by further
conformational changes in the transporter, these are significant features of inward
gating that are worth emphasizing.
6.2.5 The D455N Mutation
As mentioned in the Introduction, there is an apparent disagreement between the
crystal structure and the mutagenesis experiments concerning the Na1 binding site,
raising the possibility that the D455 residue is protonated throughout the trans-
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port cycle. To address this issue, we have prepared four simulation systems in the
outward-facing state of EAAT3: two systems with the D455N mutation and with
either Na1 and Na3 bound or with only Na1 bound, and another two with a proto-
nated D455 residue and the same Na1/Na3 occupancy as above. For the Na1 and
Na3 bound systems, we use the last frame of the simulation in Figure 6.3B. The
Na1 bound system is prepared by removing Na3 from this system and equilibrating
it for a further 10 ns. We perform a 2 ns alchemical transformation in the D455
side-chain to an asparagine or to a protonated aspartate, and at the same time
gradually release restraints applied to the Na1 ion. After the mutation/protonation
step, we equilibrate the system for a further 8 ns, monitoring the distance between
the side-chain carboxyl/carboxamide carbon atom and the Na1 ion.
The results for the D455N mutation and the D455 protonation in the presence
of Na3 are displayed in Figure 6.5A. It is seen that Na1 is released to the solvent
in all of the chains after the protonation of D455, and in two out of three chains
after the D455N mutation. Therefore, it is unlikely that EAAT3 can support the
binding of both Na1 and Na3 if the D455 side-chain is protonated. When we perform
the same simulations in the absence of the Na3 ion, Na1 is found to be stable in
all the chains for the whole 10 ns (not shown). In this case, we observe that the
Na1 ion finds a new coordination shell involving the carboxyl oxygens of D368, one
carboxamide/carboxyl oxygen of N455/D455 and the carbonyl oxygens of residues
N366 and N451 (Figure 6.5B). This site involves some of the residues that coordinate
the original Na1 ion (Table 6.5), and is located about 3 A˚ from the Na1 site. In the
absence of the Glu substrate, the Na+ affinity is measured via the [Na+]-dependent
anion leak current, which is unaffected by the D455N mutation in EAAT3. This
may be explained by assuming that this current is coupled to the binding of two
Na+ ions in the wild-type transporter, but only to one Na+ ion after the D455N
mutation. It is important to mention that, even though the D455N mutation does
not affect the Na+ or Glu affinity in EAAT3, it does lock this transporter in the
exchange mode (Table 6.1), meaning that one of the steps in the transport cycle is
impaired by this mutation.
6.2.6 The Potassium Binding Site
In contrast to GltPh, EAATs counter-transport one K
+ ion back to the extracellu-
lar medium at each cycle. Binding of K+ is essential for the reorientation of the
transporter back to the outward-facing state after the release of all the ligands into
the intracellular medium. It has been suggested that mutants that are locked in the
exchange mode cannot interact with K+, and therefore are not able to carry out the
second half of the transport cycle. This is the case for a few mutations close to the
Na1 and Na3 binding sites, such as the D368N, D455A, D455S mutations and the
N366D/D368N double mutation in EAAT3 (Table 6.1). The D455N mutation is an
exception where the transporter is still locked in the exchange mode, but it could
interact with K+ albeit with a reduced affinity compared to wild type141. Therefore,
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Figure 6.5: Effect of the D455N mutation on sodium binding. (A) The distance between
the Na1 ion and the side-chain carboxyl/carboxamide carbon atom of the residue D455
during its mutation from aspartate to an asparagine (black, red and green), and to a
protonated aspartate (blue, yellow and brown) in the presence of the Na3 ion. In the first
case, Na1 leaves the binding site in 2 out of 3 chains, and in the second case, Na1 leaves
the binding site in all chains. (B) The new coordination of Na1 when the D455N mutation
is performed in the absence of the Na3 ion. This site has the coordination of the carbonyl
oxygens of N366 and N451, as well as the side chain oxygens of D368 and N455.
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Figure 6.6: Three potential sites for binding of a K+ ion. (A) Site 1 is obtained by
replacing Na1 by a K+ ion and equilibrating the system for 10 ns in the absence of other
ligands (B) Site 2 is obtained by restraining K+ close to the E374 carboxyl group and
equilibrating the system for 10 ns with no other ligands bound. (C) Site 3 is obtained by
placing a K+ ion near glutamate α-N atom and equilibrating the system for 10 ns in the
absence of other ligands.
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this region is a good candidate for the K+ binding site in EAAT3, which we call site
1. To obtain this site, we remove the Na3 ion from the last state of the simulation in
Figure 6.3D—where EAAT3 is in the Na1-Na3 bound inward-facing state—replace
the Na+ ion at Na1 to K+ in all of the three chains and equilibrate the system for a
further 50 ns. The final coordination of K+ is shown in Figure 6.6A, which is similar
in all of the three subunits. Site 1 makes contacts with both side-chain oxygens of
residue D455, the backbone atoms of residues G362, I365, and N366, and two water
molecules (see Table 6.6 for the contact distances). The two water molecules are
very stable as they are kept in place by the D368 side-chain, which is also close to
the K+ ion. This region has a strong negative potential due to the presence of two
negatively-charged side chains, and therefore is likely to harbour a cation binding
site.
Table 6.6: EAAT3 residues coordinating the K+ ion at sites 1, 2, and 3. Notation is the
same as in Table 6.5.
Helix-Residue Distance
site 1 TM7 - G362 (O) 2.8± 0.2
TM7 - I365 (O) 2.9± 0.2
TM7 - N366 (O) 2.7± 0.1
TM8 - D455 (O1) 2.6± 0.1
TM8 - D455 (O2) 2.7± 0.2
H2O (1) 2.7± 0.1
H2O (2) 2.9± 0.3
site 2 TM7 - T370 (OH) 3.0± 0.3
TM7 - T370 (O) 2.7± 0.2
TM7 - E374 (O1) 2.8± 0.2
TM7 - E374 (O2) 2.7± 0.2
H2O (1) 2.8± 0.2
H2O (2) 2.9± 0.3
site 3 HP1 - S331 (O) 2.7± 0.2
HP1 - S331 (OH) 3.1± 0.4
TM8 - D444 (O) 3.2± 0.4
TM8 - D444 (O1) 2.8± 0.3
TM8 - D444 (O2) 3.4± 0.4
TM8 - T448 (OH) 2.8± 0.1
H2O 2.9± 0.3
In EAAT2, the Y403F and E404D mutations also lock this transporter in the
exchange mode (Table 6.1). The same happens for the E374Q mutation in EAAT3,
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even though in this case the transporter is still able to interact with K+ in the
homoexchange mode137. This raises the possibility that the K+ binding site might
overlap with the proton binding site, which we call site 2. To obtain this site, we
restrain a K+ ion close to the deprotonated E374 side-chain and equilibrate the
system in the absence of other ligands for 50 ns, gradually releasing the restraints
applied to the K+ ion. The K+ ion remained in a similar position in two of the three
chains and was unstable . The one that has the tightest coordination is chosen for
site 2 (Figure 6.6B), and will be used in free energy calculations. The contacts in
site 2 are the two side-chain oxygens of E374, and both the backbone oxygen and
the side-chain hydroxyl group of T370 (Table 6.6). While the T418 residue does not
directly interact with K+, it remains close to this ion and might have an indirect
effect on the stability of K+ in site 2.
The last site we consider (to be called site 3) overlaps with the positively-charged
substrate α-amino group and was proposed from electrostatic mapping calculations
of a homology model of EAAT395. This site has also been suggested in a recent study
of the novel mosquito dicarboxylate transporter CuqDCT, which has an asparagine
at the position equivalent to the D444 residue in EAAT3150. Mutations of this
residue or its equivalent affect K+ counter-transport in both EAAT3 and CuqDCT,
so this site is also a good candidate for binding of a K+ ion. Here we obtain this site
by removing the substrate and placing a K+ ion in the same position as its α-amino N
atom. The system is then equilibrated for 50 ns in the absence of other ligands. The
same coordination is obtained for site 3 in all chains of EAAT3 (Figure 6.6C), which
is also very similar to the one suggested in Ref.95. Site 3 has contacts with an oxygen
of the D444 side-chain, the hydroxyl groups of S331 and T448, and the backbone
atoms of D444 and S331 (Table 6.6). Even though site 3 has many coordinating
residues, it is also close to the positively-charged R445 and R447 residues, which
will reduce its affinity for a K+ ion.
To find out which site is more likely to be the binding site for K+, we calculate the
affinity and the selectivity of the three sites for K+, using FEP and TI calculations
as described in Methods. The FEP values show up to 3 kcal/mol difference between
the forward and backward calculations whereas hysteresis in the TI values remains
within 1 kcal/mol. This is because TI allows for longer simulations of fewer windows,
which increases sampling and reduces the observed hysteresis. Therefore, we report
only the TI results here but stress that very similar results are obtained from the
averages of the forward and backward FEP values. The results are summarized
in Table 6.7 and evidence for the convergence of the TI calculations is provided
in Figure 6A.6 in the Appendix. Site 1 has by far the highest affinity of all sites
(−20.5 kcal/mol), with a low selectivity margin for Na+; the binding free energy
decreases by only 0.5 kcal/mol when we go from K+ to Na+. Site 2 has an affinity
of −9.5 kcal/mol and is highly selective for Na+ with a selectivity free energy of
3.9 kcal/mol. Site 3 has the lowest affinity (−6.5 kcal/mol) but this site is highly
selective for K+, having −3.1 kcal/mol lower binding free energy compared to Na+
in agreement with previous valence studies in an EAAT3 model95.
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Table 6.7: Binding free energies for K+ and K+/Na+ selectivity free energies at the three
sites proposed for the inward-facing EAAT3. The forward and the backward calculations
of the interaction energy are listed in the second and third columns, respectively, and their
average in the fourth column. The total binding free energy that includes the translational
free energy difference (fifth column) is given in the last column. Errors are estimated from
block data analysis using 100 ps windows. All energies are in kcal/mol.
Ion −∆Gforint ∆Gbackint ∆Gint ∆Gtr ∆Gb
K+-site 1 −25.6± 1.2 −24.2± 1.0 −24.9± 1.1 4.4 −20.5± 1.1
K+-site 2 −13.7± 1.1 −14.0± 1.3 −13.8± 1.2 4.3 −9.5± 1.2
K+-site 3 −10.6± 0.8 −11.0± 0.8 −10.8± 0.8 4.3 −6.5± 0.8
K+/Na+-site 1 0.4± 0.3 0.3± 0.5 0.3± 0.4 0.2 0.5± 0.4
K+/Na+-site 2 3.7± 0.5 4.0± 0.4 3.8± 0.4 0.1 3.9± 0.4
K+/Na+-site 3 −3.1± 0.7 −3.5± 0.5 −3.3± 0.6 0.2 −3.1± 0.4
The three K+ sites tested here are all based on a model which was initially built
from the GltPh structure with all the ligands bound. In a recent study, the crystal
structure of GltTk—a close homolog of GltPh—was resolved in a substrate-free state
and in the absence of Na+ ions151. This structure shows a few conformational
changes compared to the holo state of GltPh, in particular, the region around TM7
and TM8 which is close to our K+ site 1. Comparison of this region in GltTk and our
apo state of EAAT3 shows that such conformational changes are well reproduced
in our model (Figure 6A.7 in the Appendix). We stress that GltTk, like GltPh, does
not interact with K+ ions, so its crystal structure cannot be used directly in search
of K+ binding sites. For example, the K+ binding site 2 is not formed because GltTk
has a glutamine at the position equivalent to E374 in EAAT3. Similarly, formation
of the K+ site 3 is compromised in GltTk because D398 (D444 in EAAT3) interacts
with R401.
The turnover rate of GltPh is 0.29 min
−1 at 30◦ C35, and we have suggested in
a previous study of GltPh that the release of the Na3 ion is the rate-limiting step in
the transport cycle due to its high affinity144. The speed of transport in EAATs is
much higher, with turnover rates of EAAT2 and EAAT3 at room temperature being
15 s−1 and 90 s−1, respectively. In this case, experimental evidence from EAAT2 and
EAAT3 points to the K+-dependent relocation step as rate-limiting in the transport
cycle131,152. A K+ ion at site 1, which is the site with the highest affinity, would
be consistent with a model in which this ion would replace the Na+ ions during
the release of the ligands, therefore making this process faster than in GltPh. This
K+ ion could again be replaced by Na+ ions once the transporter goes back to the
outward facing state, restarting the cycle. This last step is consistent with the MD
simulations of GltPh, which show that the first Na
+ ion to bind to the transporter
occupies a transient state, equivalent to the K+-site 1, before moving to the Na3
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site97. It is important to note that this model is based only on the thermodynamics
and ion binding, and does not take into account conformational changes of the
transporter, which may indicate a different picture. Such conformational changes
happen in time scales that are not accessible by all-atom MD simulations, and
therefore, are difficult to analyze.
After the completion of this work, two FRET studies were published on the
outward to inward transitions of GltPh and the time scales involved in them. In one
of them, the translocation of the binding pocket from the outward state to the inward
state is observed in the order of minutes, suggesting that this transition is the rate-
limiting step in the transport cycle153. The second study asserts that the transporter
is always in a very dynamic state with the transitions between the outward and
inward states occurring in the order of seconds regardless of which ligands are bound
to it, and furthermore no long dwell times are observed154. Interestingly, this last
study also shows that GltPh cannot perform the full outward to inward translocation
(or vice-versa) in the presence of the bound Na+ ions—it can only alternate between
an intermediate and an inward/outward conformation. The results of Ref.154 are
more consistent with our model, but further experiments and simulations are needed
to clarify this issue.
6.3 Conclusions
In this work we have performed MD simulations on two homology models of the
mammalian glutamate transporter EAAT3—one in the outward- and the other in
the inward-facing conformation—based on the crystal structures of the archaeal
homolog GltPh. We have evaluated the quality of the EAAT3 models using three
different methods and shown the reliability of the structures especially in the region
of the substrate binding. We have examined the coordination of the ligands in
EAAT3, and observed that Glu is stable in the binding site only if the residue E374
is protonated. This is in good agreement with numerous experiments that point to
this residue as the proton carrier in EAATs. Regarding the opening of the EC- and
IC-gates, our simulations show that the EC-gating in EAAT3 is very similar to that
in GltPh whereas the IC-gate in EAAT3 exhibits a larger opening compared to GltPh.
This difference can be traced to the change in the position of an arginine residue
from the HP1 segment in GltPh to the TM8 segment in EAATs, which creates a salt
bridge that stabilizes the open state and also helps the release of the Glu substrate
to the intracellular media. We have also investigated an apparent disagreement
between the crystal structure and the mutagenesis experiments regarding the role
of the D455 residue in Na+ binding and the possible protonation of this residue.
According to our simulations, when D455 is protonated or mutated to an asparagine,
the substrate-free EAAT3 cannot support the binding of two Na+ ions at the Na1
and Na3 positions. This disagreement can be explained if we assume that only one
Na+ ion binds to the D455N mutant before the substrate in contrast to two in the
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wild-type transporter.
We have considered three potential sites for the counter-transported K+ ion. Free
energy calculations of K+ binding at these sites reveal that a site which overlaps with
the Na1 and Na3 binding sites has by far the highest affinity of the three. We suggest
that binding of K+ to this site, which does not happen in GltPh, could be responsible
for the much faster turnover rate in EAAT3 compared to the archaeal transporter.
By looking at these results, we can speculate that the proton co-transport and the K+
counter-transport might have evolved together and are closely related. As pointed
out above, to speed up the transport rate, one needs to exchange the last Na+ ion
with K+ in the inward-facing EAAT3 and counter-transport this K+ ion. This extra
positive charge in EAAT3 relative to GltPh is neutralized by the residue E374 which
is a glutamine in GltPh. In the fully bound, outward-facing EAAT3, protonation
of E374 results in the same charge content as in the fully bound, outward-facing
GltPh. Thus the charge content in the binding pocket of GltPh is preserved in the
EAAT3 transport cycle despite the co- and counter-transport of extra ions. To
summarize, proton co-transport via E374 and its subsequent deprotonation enables
K+ counter-transport. This mechanism might also explain why mutations in the
vicinity of the proposed protonation site, like E404D and Y403F in EAAT2 and
E374Q in EAAT3, either lock the transporter in the exchange mode by not allowing
the counter-transport of K+ or significantly reduce this step in the transport cycle
(Table 6.1).
6.4 Methods
6.4.1 Simulation Details
The simulation system is prepared using the software VMD104. We embed the
EAAT3 trimer in a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) phos-
pholipid bilayer. Each monomer has four ligands bound: three Na+ ions, namely
Na1, Na2 and Na3, and Asp as the substrate. We then solvate the protein-membrane
complex in a box of water molecules with 48 Na+ ions and 45 Cl− ions. The extra
Na+ ions are required to keep the system neutral, and their number changes de-
pending on the ligands bound to the transporter. For the outward state there are
a total of 244 lipid molecules and 15,953 water molecules, and for the inward state
239 lipid molecules and 15,871 water molecules, with a total of ∼ 100, 000 atoms in
each simulation box. The two systems are equilibrated in three stages. In the first
stage, the coordinates of the ligands and protein atoms are fixed and the system is
equilibrated with 1 atm pressure coupling in all directions until the correct water
and lipid densities are obtained. At this point, the x and y-dimensions of the simula-
tion box are fixed, and pressure coupling is applied only in the z direction thereafter
(typical dimensions of the simulation box for both cases are 112 × 113 × 76 A˚3).
In the second stage, the protein is gradually relaxed by reducing the restraints on
the protein and ligand atoms in several steps during MD simulations lasting 2.4 ns.
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At the end of this stage we are left only with a restraint of 0.1 kcal/mol/A˚2 in all
the backbone atoms of the trimer. Following this, we perform a 2.5 ns alchemical
transformation from the Asp substrate to Glu in the three chains, and equilibrate
the system with Glu for another 5 ns by gradually releasing the backbone restraints.
All the MD simulations are performed using the NAMD package (version 2.9)59
with the CHARMM36 force field155. The temperature is maintained at 300 K using
Langevin damping with a coefficient of 5 ps−1, and the pressure is kept at 1 atm
using the Langevin piston method with a damping coefficient of 20 ps−1 64. Peri-
odic boundary conditions with the particle-mesh Ewald method are employed to
calculate the electrostatic interactions without truncation. The Lennard-Jones (LJ)
interactions are switched off between 10 and 12 A˚ using a smooth switching function.
A time step of 2 fs is used in all MD simulations. Details of all the MD simulations
we have performed in the outward and inward models of EAAT3 are summarized
in Tables 6A.1 and 6A.2, respectively, giving the conditions and the total running
time for each simulation.
6.4.2 Free Energy Calculations
We perform free energy calculations to determine the standard binding free energy
of a K+ ion at different sites in the protein, as well as the K+/Na+ selectivity.
For this purpose, we use the free energy perturbation (FEP) and thermodynamic
integration (TI) methods52, as in our previous studies of Na+ binding to GltPh
123,144.
We note that the binding free energies calculated using the crystal structures cannot
be compared directly to the experimental values due to the large conformational
changes occurring in GltPh following the binding/unbinding of the Na
+ ions156.
Nevertheless they are still a useful tool for finding relative affinities of different sites,
as we have done in locating the Na3 site GltPh
38.
In the FEP method, the interval between λ = 0 and 1 is divided into n subinter-
vals with {λi, i = 1, . . . , n − 1}, and for each subinterval the free energy difference
is calculated from the ensemble average
∆Gi = −kBT ln〈exp[−(H(λi+1)−H(λi))/kBT ]〉λi . (6.1)
where H(λ) = (1 − λ)H0 + λH1, with H0 and H1 representing the free-ligand and
bound-ligand states. The free energy difference is obtained from the sum, ∆Gint =∑
i ∆Gi. In the TI method, the ensemble average of the derivative, ∂H(λ)/∂λ, is
obtained at several λ values, and the free energy difference is calculated from the
integral:
∆Gint =
∫ 1
0
〈
∂H(λ)
∂λ
〉
λ
dλ. (6.2)
Provided the integrand can be fitted well with a polynomial, Gaussian quadrature
provides an efficient and accurate method for evaluation of such integrals because
it allows for longer sampling of a smaller number of windows. The binding free
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energy of a K+ ion is calculated by alchemically transforming a a K+ ion to a water
molecule in the binding site, while at the same time the opposite transformation
is performed in bulk. This approach is justified by the observation that, in the
absence of a K+ ion, a water molecule always occupies the binding site. For the
Na+/K+ selectivity, we replace a K+ ion with a Na+ ion in the binding site, and
vice-versa in bulk. In the FEP simulations we use 66 exponentially spaced windows
with 20 ps of equilibration plus 40 ps of production for each window. In the TI
method, we use seven windows starting from the FEP runs, and run 0.4 ns of
equilibration plus 0.8 ns of data collection for each window. These parameters
have been found to be optimal in previous studies of GltPh
123,144. We report here
only the TI results because they show better convergence, but we always check for
consistency between the two methods, as well as performing both the forward and
backward transformations in each case. When calculating the standard binding free
energies, we also have to account for the loss of translational entropy of the ligand
upon binding. The translational free energy difference is determined using118,119
∆Gtr = −kBT ln
[
(2pie)3/2σxσyσz
V0
]
, (6.3)
where V0 = 1660 A˚
3, σx, σy, and σz, are the principal rms fluctuations of the center
of mass of the ligand in the binding site, estimated from 5 ns of MD simulations of
the bound ion with no restraints applied. The standard binding free energy of the
ion can then be expressed as106,115:
∆Gb = ∆Gtr + ∆Gint. (6.4)
In this approach, the force field contribution to the free energy difference between
the bound and unbound states (∆Gint) is calculated using the alchemical FEP and
TI methods, with a restrained ion/water molecule in the binding site/bulk solvent.
To make sure that these restraints have little effect on ∆Gint, values of the spring
constant are determined from the expression ktr ∼ 3kBT 〈r2〉, where 〈r2〉 is the
mean-square fluctuations of the unrestrained ion in the binding site, which gives
ktr = 6 kcal/mol/A˚
2. The same goes for the replacement of a water molecule, which
also samples a small volume in the ion binding site. In the bulk solvent, the restraints
have no effect in the force field contribution to the free energy because bulk water
is an isotropic medium. The free energy change due to loss of the translational
entropy upon binding of the ion (∆Gtr) is calculated separately using Eq. 6.3, where
no restraints are employed. A more detailed validation of the method is given in
a recent study of ligand binding to the ionotropic glutamate receptor GluA2157.
We note that the alchemical transformation approach adapted here is independent
of path, and differs from the path-dependent methods that use a physical reaction
coordinate. In the latter case, the ligand needs to be restrained within a cylinder or a
cone while moving along the reaction coordinate, and this restriction has to be taken
into account in calculating the binding affinity at the standard concentration158,159.
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Table 6A.1: Equilibrium simulations performed in this study for the outward-facing
model of EAAT3.
Mut. Time Glu Na1 Na2 Na3 Comments
E374p 60ns + + + +
Transporter remained stable with gate closed,
Na2 was released in two of the chains.
None 20ns + + + +
Instability in the substrate and in the HP2
gate, Na2 was released in all of the chains.
None 60ns - + - +
Opening and large fluctuations of the HP2 gate
in all of the chains, Na+ ions remained bound.
None 60ns - - - -
Opening and large fluctuations of the HP2
gate observed in all of the chains.
D455N 10ns - + - +
Na1 is released back to the solvent in two of
the chains of the transporter.
D455N 10ns - + - -
Na1 remains bound coordinated by D368 in all
of the chains of the transporter.
D455p 10ns - + - +
Na1 is released back to the solvent in all of the
chains of the transporter.
D455p 10ns - + - -
Na1 remains bound coordinated by D368 in all
of the chains of the transporter.
132
Chapter 6 Molecular Dynamics Simulations of the Mammalian Glutamate
Transporter EAAT3
Table 6A.2: Equilibrium and FEP simulations performed in this study for the inward-
facing model of EAAT3.
Mut. Time Glu Na1 Na2 Na3 K+ Comments
E374p 60ns + + + + -
Transporter remained stable with gate
closed, Na2 was released in one of the
chains.
None 20ns + + + + -
Instability in the substrate and in the
HP1-HP2 gate, Na2 was released in all
chains.
None 60ns - + - + -
Opening of the HP1-HP2 gates in all of
the chains, Na+ ions remained bound.
None 60ns - - - - -
Opening of the HP1-HP2 gates in all of
the chains, with a large displacement of
HP1.
None 50ns - - - - s-1
K+ remains bound at site 1 during the
whole simulation.
None 50ns - - - - s-2
K+ remains bound at site 2 in two of the
chains during the whole simulation.
None 50ns - - - - s-3
K+ remains bound at site 3 during the
whole simulation.
FEP simulations
None 16.8ns - - - - s-1
K+ binding affinity of −20.5 kcal/mol at
site 1.
None 16.8ns - - - - s-1 K+ selectivity of 0.5 kcal/mol at site 1.
None 16.8ns - - - - s-2
K+ binding affinity of −9.5 kcal/mol at
site 2.
None 16.8ns - - - - s-2 K+ selectivity of 3.9 kcal/mol at site 2.
None 16.8ns - - - - s-3
K+ binding affinity of −6.5 kcal/mol at
site 3.
None 16.8ns - - - - s-3 K+ selectivity of −3.1 kcal/mol at site 3.
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Figure 6A.1: The aligment used to build our models, from Ref.14, showing the se-
quences of archaeal aspartate transporters, and human glutamate and neutral amino acid
transporters.
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Figure 6A.2: (A) The model for the outward-facing state of EAAT3 including the 4B-
4C loop 50-residue segment—which is not present in our model–placed at the position
proposed in Ref.146 (shown in red). The position of the HP2 segment in the open state,
which is the segment that goes through conformational changes during the opening, is
shown in blue. The substrate and sodium ions in the binding site are also shown. (B)
The same for the inward-facing model of EAAT3, showing the segments that undergo
conformational changes during the inward opening in blue, namely, HP1, HP2 and TM8.
In both cases, the bound ligands and the conformational changes that happen during the
opening of EAAT3 are not in proximity to the 4B-4C loop.
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Figure 6A.3: (A) DOPE per-residue score for the 2NWX crystal structure (red) and the
EAAT3 model in the outward-facing state (black). The residues are numbered according
to the GltPh sequence. (B) The same for the 3KBC crystal structure (red) and the EAAT3
model in the inward-facing state (black).
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Figure 6A.4: Ramachandran plots for the templates and models used in this study.(A)
2NWX crystal structure.(B) EAAT3 model in the outward-facing conformation.(C) 3KBC
crystal structure.(D) EAAT3 model in the inward-facing conformation.
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Figure 6A.5: RMSD of the protein backbone during 60 ns of simulations with all ligands
bound and the protonated E374 side-chain, in the outward (black) and inward (red) states
of EAAT3. The system shows no large conformational changes after 10 ns, which indicates
that the models are stable.
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Figure 6A.6: Convergence of the TI results in the calculation of the binding free energies
of K+, and also the K+/Na+ selectivity. In all graphs the negative of the forward and the
backward transformations results are shown with black and red lines, respectively. (A)
Interaction free energy and (B) selectivity of the K+ ion at site 1. (C,D) The same for the
site 2. (E,F) The same for site 3.
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Figure 6A.7: Comparison of the conformations around the TM7–TM8 region in the
GltTk crystal structure (A) and in our simulations of the apo state of EAAT3 (B). Con-
formational changes that are observed between the loaded and apo states of the crystal
structures are captured in our apo state model of EAAT3. Only the functionally important
residues in this region are indicated explicitly.
Chapter 7
Molecular Dynamics Simulations
Elucidate the Mechanism of
Proton Transport in the
Glutamate Transporter EAAT3
ABSTRACT
The uptake of glutamate in nerve synapses is carried out by the exci-
tatory amino acid transporters (EAATs), involving the cotransport of a
proton and three Na+ ions and the countertransport of a K+ ion. In this
study we use an EAAT3 homology model to calculate the pKa of several
titratable residues around the glutamate binding site to locate the proton
carrier site involved in the translocation of the substrate. After identi-
fying E374 as the main candidate for carrying the proton, we calculate
the protonation state of this residue in different conformations of EAAT3
and with different ligands bound. We find that E374 is protonated in the
fully bound state, but removing the Na2 ion and the substrate reduces
the pKa of this residue and favors the release of the proton to solution.
Removing the remaining Na+ ions again favors the protonation of E374
in both the outward and inward-facing states, hence the proton is not
released in the empty transporter. By calculating the pKa of E374 with
a K+ ion bound in three possible sites, we show that binding of the K+
ion is necessary for the release of the proton in the inward-facing state.
This suggests a mechanism in which a K+ ion replaces one of the ligands
bound to the transporter, which may explain the faster transport rates
of the EAATs compared to its archaeal homologs.
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7.1 Introduction
Excitatory amino acid transporters (EAATs) are essential for proper functioning of
the nervous system because they clear the excess glutamate released at the nerve
synapses. Glutamate can be toxic to neurons in large concentrations, so prob-
lems in these transporters have been implicated in many pathological conditions
including cerebral ischemia, amyotrophic lateral sclerosis and Alzheimer’s disease12.
EAATs transport the substrate across the membrane by coupling to three Na+
ions and a proton, and a K+ ion is countertransported at every cycle. There is
a great amount of experimental data on EAATs, mostly through mutagenesis ex-
periments28,30–34,38,92,96,129–142, but also via structural information146,160 and the pH
dependence of transport137,145. A significant step in our understanding of the EAATs
came with the solution of the crystal structures of the archaeal homolog GltPh both
in the outward- and inward-facing conformations14–16. GltPh has aspartate as the
main substrate and the transport mechanism is not coupled to a proton or K+,
but it still involves the cotransport of three Na+ ions. Only two of them could be
resolved in the crystal structure, but radio-labeled Na+ experiments showed that
three Na+ ions were coupled to the substrate transport37. The third Na+ site (Na3)
was determined from molecular dynamics (MD) simulations, and mutagenesis ex-
periments confirmed that this site was present in GltPh and conserved in the EAAT
family38. In GltPh two Na
+ ions bind before the substrate, called Na1 and Na3,
and the last Na+ ion (Na2) binds after the substrate and the closure of the HP2
gate that forms the binding site123. Experimental studies show that this binding
sequence is probably conserved in EAAT3, with the binding of two Na+ ions in the
absence of glutamate and the third Na+ ion after the substrate31,133.
Recently, we have created homology models for the outward- and inward-facing
states of EAAT3 based on the GltPh structures in the same conformations. GltPh
shares about 37% sequence identity with the EAATs, but the homology is much
higher for residues near the binding pocket, reaching around 60% in this region. Fur-
thermore, almost all of the residues shown to be involved in the binding of Na+ ions
and the substrate in GltPh are conserved in the EAATs
14–16,32,90,94. We have shown
that the model is stable with glutamate as a ligand, and that the coordination of the
ligands can be reproduced in good agreement with mutagenesis experiments161. A
major result from this work is that the substrate is not stably bound unless the E374
side chain of EAAT3 is protonated, making this residue a natural candidate for the
proton carrier, which also agrees well with experiments137. Using the inward-facing
state of EAAT3 from our model, we have also investigated three possible binding
sites for the K+ ion, and found a high-affinity site that overlaps with the Na1 and
Na3 binding sites.
Even though there is strong theoretical and experimental evidence pointing to
the residue E374 as the proton carrier, the mechanism of proton association and
dissociation from this residue in the outward and inward states of EAAT3 remains
unknown. Also the protonation states of other titratable residues close to the bind-
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ing site has not been thoroughly investigated, and in MD simulations, it is usually
assumed that they retain the same protonation states as in solution. Here we use
homology models of EAAT3 to address these issues. We perform free energy per-
turbation (FEP) calculations to obtain the pKa values of different residues close to
the substrate binding site in the fully bound outward conformation. After identify-
ing the residue E374 as the only one being protonated under these conditions, we
calculate the pKa value of this residue in different states of the transporter and with
different ligands bound. We show that the protonation/deprotonation of E374 is
coupled to the binding/unbinding of the substrate, as well as the closure/opening of
the HP1 and HP2 gates that give the substrate access to the solution. We also show
that the binding of a K+ ion in the inward state of EAAT3 is necessary for the de-
protonation of E374, so that only the K+ ion is transported back to the extracellular
media in the second half of the transport cycle.
7.2 Model system and simulation details
For the outward and inward-facing conformations of EAAT3 we use the same models
created in our previous work161, built from their respective GltPh templates and
equilibrated in the presence and absence of the various ligands in both states. In
addition to these two, we have also created a new model for the outward-apo state of
EAAT3 from a recent crystal structure of GltTk (PDB ID: 4KY0), another archaeal
homolog of the EAATs and a close homolog of GltPh
151. This GltTk structure is
in the outward-apo state with the HP2 gate open, for which there were no crystal
structures of EAAT3 homologs available until now. To build this model we have
used the program MODELLER74, following the same protocol as described in161.
We have produced 20 initial structures and choose the one with the best scores from
the Swiss Model Structure Assessment Tool79,80. We then construct a trimer by
superposing the EAAT3 monomer to chains A, B and C of GltTk.
The simulation systems for the models built from the GltPh templates are pre-
pared and equilibrated as described in161. The EAAT3 system built from the
GltTk template is prepared in the same way, using the software VMD
104. First the
EAAT3 trimer in the apo-state is embedded in a 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) phospholipid bilayer. We then solvate the protein-membrane
complex in a box of water molecules with 54 Na+ ions and 45 Cl− ions. The extra
Na+ ions are included to keep the system neutral. The simulation box has 237 lipid
molecules and 15,851 water molecules, with a total of 98,124 atoms. The system
is then equilibrated in two stages. First, the coordinates of the ligand and protein
atoms are fixed and the system is equilibrated with 1 atm pressure coupling in all
directions until the correct water and lipid densities are obtained. At this point, the
x and y-dimensions of the simulation box are fixed, and pressure coupling is applied
only in the z direction (typical dimensions of the simulation are 113× 113× 74 A˚3).
In the second stage, the protein is gradually relaxed by reducing the restraints in
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Figure 7.1: The thermodynamic cycle used in the FEP/TI calculations: A represents
the side-chain of interest, H is the proton, the indices p and d refer to the protonated and
deprotonated states, and the subscripts m and pr indicate that A is in the bulk solvent
(model compound) and in the protein, respectively.
several steps during MD simulations lasting 2.4 ns. We then perform a further 15 ns
of simulations with no restraints applied.
MD simulations are performed using the NAMD program59 with the CHARMM36
force field155. The temperature is maintained at 300 K using Langevin damping with
a coefficient of 5 ps−1, and the pressure is kept at 1 atm using the Langevin piston
method with a damping coefficient of 20 ps−1 64. Periodic boundary conditions with
the particle-mesh Ewald method are employed to calculate the electrostatic inter-
actions without truncation. The Lennard-Jones (LJ) interactions are switched off
between 10 and 12 A˚ using a smooth switching function. A time step of 2 fs is used
in all MD simulations.
7.3 Free energy calculations
To calculate the pKa values of the aspartate and glutamate side-chains in the vicinity
of the glutamate binding site, we use the alchemical free energy perturbation (FEP)
and thermodynamic integration (TI) methods in molecular dynamics (MD) simula-
tions52. These methods use an explicit solvent and have advantages over continuum
electrostatic models. Continuum models are very sensitive to the dielectric constant
assigned to the protein interior, and the value used is usually an empirical parame-
ter with a value ranging from 8 to 20 to account for different effects such as water
penetration, protein flexibility, and conformational rearrangements in response to
the ionization state162–164. These models are also influenced by the method used
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in constructing the dielectric boundary between the protein and the surrounding
environment165. All these effects can be taken into account rigorously by computing
the free energy difference between the protonated and deprotonated forms using the
MD/FEP method with an explicit solvent166. This is carried out by alchemically
transforming a deprotonated carboxyl group to a protonated one in the protein while
simultaneously performing the opposite transformation in a reference residue located
in bulk solvent, according to the thermodynamic cycle shown in Fig. 7.1. The ref-
erence residues, or model compounds, that we use are N-acetyl-L-isoasparagine for
the aspartate calculations and the N-acetyl-L-isoglutamine for the glutamate calcu-
lations (Fig. 7.2). These two compounds reproduce the side-chains of aspartate and
glutamate and also the backbone atoms, but do not have the zwitterion charges that
could affect the electrostatic component of the results. The experimental pKa val-
ues of N-acetyl-L-isoasparagine and N-acetyl-L-isoglutamine are 4.0 and 4.3, which
compare well with the pKa values of aspartate (3.7) and glutamate (4.3).
167. The
CHARMM parameters are readily available for these compounds55, which further
facilitate their use in FEP calculations. The pKa value of a residue in a protein is
given by168:
pKa = pKa(model) − ∆∆Gpr
2.3kBT
(7.1)
where ∆∆Gpr can be calculated from the thermodynamic cycle in Fig. 7.1
∆∆Gpr = ∆Gpr→m(d)−∆Gpr→m(p) = ∆Gpr(d→ p)−∆Gm(d→ p) (7.2)
MD/FEP calculations are performed to determine the free energy difference on the
right hand side of Eq. 7.2, corresponding to the horizontal legs in Fig. 7.1.
We use both the MD/FEP and MD/TI methods to calculate ∆∆Gpr by alchem-
ically transforming a deprotonated glutamate residue to a protonated one in the
protein while doing the opposite transformation in the model compound in bulk.
This process is carried out as a function of the reaction coordinate λ, in which the
end points are at λ = 0 and λ = 1. In the FEP method, the interval between
λ = 0 and 1 is divided into n subintervals with {λi, i = 1, . . . , n − 1}, and for each
subinterval the free energy difference is calculated from the ensemble average
∆Gi = −kBT ln〈exp[−(H(λi+1)−H(λi))/kBT ]〉λi . (7.3)
where H(λ) = (1 − λ)H0 + λH1, with H0 and H1 representing the states with the
proton in the model compound and in the protein residue, respectively. The free
energy difference is obtained from the sum, ∆∆Gpr =
∑
i ∆Gi. In the TI method,
the ensemble average of the derivative, ∂H(λ)/∂λ, is obtained at several λ values,
and the free energy difference is calculated from the integral:
∆∆Gpr =
∫ 1
0
〈
∂H(λ)
∂λ
〉
λ
dλ. (7.4)
Provided the integrand can be fitted well with a polynomial, Gaussian quadrature
provides an efficient and accurate method for evaluation of such integrals because it
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Figure 7.2: The model compounds used in our free energy calculations in bulk. (A)
N-acetyl-L-isoasparagine is used for aspartate, (B) N-acetyl-L-isoglutamine is used for
glutamate. The colors are cyan for carbon atoms, blue for nitrogen atoms, red for oxygen
and white for hydrogens.
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allows for longer sampling of a smaller number of windows. In the FEP simulations
we use 66 exponentially spaced windows with 40 ps of equilibration plus 40 ps of
production for each window. In the TI method, we use seven windows starting
from the nearest FEP windows, and run 0.4 ns of equilibration plus 0.8 ns of data
collection for each window. These parameters have been found to be optimal in
previous studies of GltPh
123,144. We report here only the TI results because they show
better convergence, but we always check for consistency between the two methods,
as well as performing both the forward and backward transformations in each case
to check against any hysteresis effects.
7.4 Results and discussion
7.4.1 Evaluating the model
We have assessed the quality the open-state EAAT3 model obtained from GltTk
using three different methods, similar to the case of the EAAT3 models obtained
from the closed states of GltPh
161. QMEAN (Qualitative Model Energy ANalysis)
is a composite scoring function ranging from 0 to 1, which describes the major ge-
ometrical aspects of protein structures79. DFIRE (Distance-scaled, Finite Ideal-gas
REference) is a potential based on a database of non-homologous proteins80. DOPE
(Discrete Optimized Protein Energy) is an atomic distance-dependent statistical po-
tential calculated from a sample of native structures74. The first two are available
on the Swiss Model Server, and the last one is built into the program MODELLER.
In Table 7.1 we show the QMEAN scores and DFIRE energies for the original GltTk
crystal structure, as well as our EAAT3 model in the outward apo state. As in the
case of GltPh
161, the QMEAN scores and DFIRE energies are very similar, as well
as the energy profiles obtained using DOPE (Fig. 7.3). This indicates that, even
though the homology is not high between the archaeal and the human transporters,
we can still built high quality models using the former as a template. Furthermore,
we are looking at ligand binding and small conformational changes instead of large
conformational transitions. Therefore, the models built for the EAATs in the vicin-
ity of the outward- and inward-facing states are likely to retain the same features of
the archaeal transporters in the same states.
7.4.2 pKa values in the glutamate-bound outward EAAT3
The first step in identifying the proton carrier is to calculate the pKa values of all
titratable residues in the vicinity of the binding pocket. The fully-bound outward
closed state precedes the transition to the inward-facing transporter, and therefore
should have a proton bound. We choose this equilibrated model to look for the pro-
ton carrier in the EAATs, by performing pKa calculations as described in methods.
We have shown previously that the substrate is not stable unless the E374 residue,
which is a glutamine in GltPh and GltTk, is protonated
161. We cannot discard the
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Table 7.1: Comparison of the QMEAN scores and DFIRE energies between the GltTk
crystal structure and the EAAT3 homology model. The QMEAN score goes from 0 to
1, 1 being the best possible model. Lower DFIRE energy values indicate better quality
structures.
Structure QMEAN score DFIRE Energy
GltTk (4KY0) 0.515 −679.6
EAAT3 (outward apo) 0.484 −608.3
Figure 7.3: DOPE per-residue score for the 4KY0 crystal structure (black) and our
EAAT3 model in the apo outward-facing state (red). The residues are numbered according
to the GltTk sequence.
possibility that other residues in the binding pocket could also be protonated, so, in
addition to E374, we have also calculated the pKa values of the residues D368, D440,
D444 and D455. The side chains of D455 and D368 are involved in Na+ binding at
sites Na1 and Na3, the side chain of D444 coordinates the substrate α-amino group,
and the side chain of D440 makes a salt bridge with the R447 residue (Fig. 7.4).
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This arginine also coordinates the glutamate substrate side-chain carboxyl group.
In order to test the suitability of our reference residues in bulk, we have also cal-
culated the pKa values of an aspartate (D83) and a glutamate (E135) residue in
the protein that are fully exposed to the solvent and are not close to any charged
groups. These residues are expected to retain the same pKa values as in bulk. To
avoid the unbinding of ligands during the protonation process, all the ligands are
restrained during the pKa calculations at the binding sites found in Ref.
161. This
procedure allows us to calculate the pKa values in a given state, so we can deter-
mine which residues are protonated under these conditions. The Na1 and Na2 ions
share the same binding sites as the GltPh 2NWX crystal structure, and the Na3 site
binding site was determined from MD simulations and mutagenesis experiments38.
The coordination of the glutamate substrate is very similar to that of aspartate in
GltPh, which is stable with a protonated E374, and is in good agreement with the
mutagenesis experiments32,33,161.
Table 7.2: Calculated pKa values of various aspartate and glutamate residues in EAAT3.
The forward and the backward calculations of the protonation free energies are listed in
the second and third columns, respectively, and their average in the fourth column. The
shift ∆pKa is given in the fifth column, and the final value of the pKa is given in the last
column. Errors are estimated from block data analysis using 100 ps windows. All free
energies are in kcal/mol.
Residue ∆∆Gforpr −∆∆Gbackpr ∆∆Gpr ∆pKa pKa
D83 0.4± 0.8 1.1± 0.9 0.7± 0.8 −0.5± 0.6 3.5± 0.6
E135 0.2± 0.9 0.2± 0.8 0.2± 0.8 −0.1± 0.6 4.2± 0.6
E374 −20.1± 0.7 −20.3± 1.1 −20.2± 0.9 14.7± 0.7 19.1± 0.7
D368 18.8± 0.9 17.0± 0.9 17.9± 0.9 −13.1± 0.7 −9.1± 0.7
D440 6.8± 1.7 6.0± 1.1 6.4± 1.4 −4.7± 1.0 −0.7± 1.0
D444 −0.4± 0.9 0.8± 1.1 0.2± 1.0 -0.1± 0.7 3.9± 0.7
D455 16.3± 2.3 14.9± 1.5 15.6± 1.9 −11.4± 1.4 −7.4± 1.4
In Table 7.2, we present the calculated pKa values of the glutamate and aspar-
tate residues mentioned above. The pKa values for the test residues D83 and E135
are 3.5 and 4.2, respectively, which are in good agreement with the experimentally
determined pKa values for the side chains of aspartate and glutamate (3.7 and 4.3).
Thus our models can accurately reproduce the properties of the aspartate and glu-
tamate side chains in bulk water. Returning to the EAAT3 residues, we find a
pKa value of 19.1 for E374 (Table 7.2), indicating that this residue is undoubtedly
protonated in the fully-bound outward state of EAAT3. We believe that this large
pKa value is related to both the presence of the glutamate substrate and the closure
of the HP2 gate after this ligand binds. We have shown previously that glutamate
substrate is not stable in the binding site if E374 is deprotonated due to the repul-
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Figure 7.4: (A) The substrate binding site in the outward-facing fully-bound state,
showing the bound glutamate (in green) and the titratable residues in this region. (B)
The binding sites of the Na1 and Na3 ions in the same state of EAAT3, coordinated by
the D455 and D368 side chains, respectively.
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sion between the negatively charged carboxyl groups161. Therefore, protonation of
E374 would be energetically favourable in the presence of the substrate. Further-
more, E374 is isolated from the solvent by a nonpolar region formed by a series of
hydrophobic residues at the TM7 (M367 and T370) and HP2 (A404, A408, A414,
T418 and V422) segments (Fig. 7.5A). All of them are strictly conserved throughout
the EAAT family except for V422, which is an isoleucine in EAAT2. Conservation
of this hydrophobic motif in all EAATs is indicative of its functional importance in
stabilizing the protonated state of E374.
The experimental pKa value of the proton carrier in EAAT3 is about 8
145. This
value is determined from the pH-dependence of the uncoupled and coupled cur-
rents associated with glutamate transport, thus reflecting the free energy difference
between the fully bound protonated state and the ensemble of deprotonated con-
formations where the substrate translocation cannot happen. We believe that the
deprotonated state of E374 is likely to be solvent exposed and without a bound
substrate, given that the substrate is unstable under these conditions. Because ac-
counting for the conformational changes and the unbinding of the substrate is not
feasible in our FEP calculations, we have calculated the pKa for the fully-bound
closed state, where the E374 side-chain is isolated from the solvent and glutamate is
bound. Hence the calculated pKa value of 19.1 cannot be directly compared to the
experimental value, but it is sufficient to ascertain that E374 is protonated in the
fully-bound transporter. After 60 ns of MD simulations of EAAT3 in the absence
of the substrate and the Na2 ion161, we have observed the opening of the HP2 gate
and the hydration of E374 (Fig. 7.5B). This will result in a change in the pKa value
of E374, which may trigger release of the proton in the inward state. This scenario
will be explored further in the next section.
We next consider the pKa values of other titratable residues. The side chains of
D368 and D455, which coordinate Na3 and Na1, respectively, give very large values
of ∆∆Gpr, and consequently very low pKa values. This is a direct consequence
of the proximity of these two side-chains to Na1 and Na3 and the absence of water
molecules in this region— there is only one water molecule in the binding sites of Na1,
Na3 and the substrate (Fig. 7.4). Protonating a negatively charged aspartate side-
chain that coordinates a positively charged Na+ ion results in a very high energetic
penalty, which is reflected in the calculated pKa values. This indicates that the
residues D368 and D455 have to be deprotonated in order to coordinate the Na1
and Na3 ions. We have shown previously that Na1 leaves the binding site shortly
after D455 is protonated161, which is consistent with the results obtained here. The
D440 and D444 residues also give low pKa values, most likely because they are also
involved in charge interactions with the R447 side-chain and the substrate α-amino
group, respectively (Fig. 7.4A).
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Figure 7.5: (A) The region around E374 (purple) in the fully bound state, where this
residue is buried under a series of hydrophobic residues from the HP2 and TM7 segments.
(B) After the removal of the substrate and the Na2 ion, the HP2 gate opens and the E374
side-chain is hydrated.
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7.4.3 pKa values of E374 in different states of EAAT3
In our previous study of EAAT3161, we obtained a series of states by running simu-
lations with different combinations of bound ligands. Besides the fully bound states
in the outward- and inward-facing conformations, we also simulated these two con-
formations in the apo state and with only Na1 and Na3 bound to the transporter.
Further, we investigated the binding sites of the K+ ion in the inward model of
EAAT3 and calculated the binding free energies of the K+ ion in three sites sug-
gested by the mutagenesis experiments161. Here we calculate the pKa value of E374
in all these states, as well as in the EAAT3 model built from the apo GltTk (Ta-
ble 7.3). Our aim is to gain insights into the mechanism of proton binding and
release and how that relates to the binding/unbinding of the other ligands. Be-
cause all our results are obtained using the EAAT3 model created from the fully
bound GltPh, it is important to check its consistency by comparing the apo state
result with that obtained from the EAAT3 model based on the apo GltTk template.
As seen from the top two rows in Table 7.3, there is excellent agreement between
the two results, confirming the relevance of the apo-state EAAT3 model used in
the calculations. Comparison of the pKa values between the outward and inward
states for the apo, Na1-Na3 bound, and fully bound states (Table 7.3) shows that
they are very similar. Even though this symmetry demonstrates the consistency of
our results, experiments based on the pH dependence of the forward and reverse
transport modes reveal an asymmetry of 1.5 pKa units between the outward- and
inward-facing states of EAAT3 in the presence of the substrate145. This discrepancy
might arise from the free energies involved in the gating process of the substrate-
bound EAAT3, which we do not consider in this study. This step isolates E374 from
the solvent, directly affecting its pKa, and is likely to be different in the inward and
outward states, as shown in the metadynamics studies of gate opening in GltPh
126.
We see from Table 7.3 that absence of the substrate and the Na2 ion (Na1, Na3
rows) has a great effect on the pKa of this residue, which can be traced to hydration
of E374 and the absence of the negatively charged substrate (Fig. 7.5). The pKa
value is reduced to 6.6 and 6.7 for the outward- and inward-states, meaning that
around 85% of the E374 side-chains are deprotonated when only Na1 and Na3 are
bound. This shows that the binding of the substrate and the closure of the HP2 gate
in the presence of the these two Na+ ions strongly favour proton binding to E374.
To determine the relative contribution of these two processes, we have removed
the Na2 ion from the fully bound outward state and simulated the system with a
deprotonated E374 and a restrained substrate for 50 ns. In one of the chains of the
transporter, we obtain a state in which Na1, Na3 and glutamate are bound, but
the HP2 gate is fully open and E374 is hydrated. The pKa value of E374 under
these conditions is 10.4 (Table 7.3), which indicates that binding of glutamate is
sufficient for the protonation of E374, and the closure of the gate further stabilizes
it. As in GltPh, Na1 and Na3 are necessary for substrate binding to EAAT3, but
these ions also favor the deprotonation of E374 and the consequent instability of the
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Table 7.3: Calculated pKa values of E374 with different ligands bound to the outward and
inward states of EAAT3. The forward and the backward calculations of the protonation
free energies are listed in the second and third columns, respectively, and their average in
the fourth column. The shift ∆pKa is given in the fifth column, and the final value of the
pKa is given in the last column. Errors are estimated from block data analysis using 100
ps windows.All free energies are in kcal/mol.
Outward EAAT3
Ligands ∆∆Gforpr -∆∆G
back
pr ∆∆Gpr ∆pKa pKa
apo −10.4± 1.0 −10.1± 0.9 −10.2± 1.0 7.4± 0.7 11.7± 0.7
apo (GltTk) −9.2± 1.5 −11.5± 1.2 −10.3± 1.4 7.5± 1.0 11.8± 1.0
Na1, Na3 −4.0± 0.9 −2.1± 1.1 −3.0± 1.0 2.2± 0.7 6.6± 0.7
Na1, Na3, Glua −8.9± 0.9 −7.7± 1.4 −8.3± 1.2 6.1± 0.9 10.4± 0.9
fully bound −20.1± 0.7 −20.3± 1.1 −20.2± 0.9 14.7± 0.7 19.1± 0.7
Inward EAAT3
Ligands ∆∆Gforpr -∆∆G
back
pr ∆∆Gpr ∆pKa pKa
apo −10.2± 1.6 −10.1± 1.2 −10.2± 1.4 7.4± 1.0 11.7± 1.0
Na1, Na3 −3.3± 1.5 −3.4± 1.2 −3.3± 1.4 2.4± 1.0 6.7± 1.0
fully bound −22.7± 1.1 −22.2± 0.9 −22.4± 1.0 16.3± 0.7 20.6± 0.7
K-site 1 −0.6± 1.0 −0.5± 1.1 −0.5± 1.0 0.4± 0.7 4.7± 0.7
K-site 3 −4.0± 1.0 −3.3± 1.4 −3.6± 1.2 2.6± 0.9 6.9± 0.9
a With the HP2 gate open and the hydrated E374 side-chain.
substrate in the binding site. On the other hand, the system with glutamate bound
and a protonated E374 is very stable, and also produces a high value for the pKa of
this residue. Therefore, we propose that proton and substrate binding are mutually
coupled, that is, substrate binding brings about the protonation of E374 and vice-
versa. This mechanism is corroborated by experiments, which show that in the
pH range from 6 to 10, saturation of glutamate binding can be achieved by either
increasing the glutamate concentration or decreasing the pH in the extracellular
media145.
An interesting observation is that the pKa value is 11.7 for both apo states,
indicating a protonated E374 residue. We attribute this to the negative potential
induced by the negative charges of the D368 and the D455 residues, which are 10
and 15 A˚ away from E374, respectively. Even though there are water molecules
between these residues and E374, they are mostly limited to the surface of the
protein, and hence provide a limited dielectric screening compared to bulk water
(Fig. 7.6A). Presence of the Na1 and Na3 ions neutralizes these negative charges,
thereby explaining the reduction in the pKa value of E374 when the Na1 and Na3
ions are bound.
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We next look at the release of the proton into the intracellular media, and how
this is related to K+ binding. Similar to the outward state, this proton is released
when we remove the substrate and the Na2 ion, but it is bound if the transporter
is empty because the pKa of E374 is 11.7 in the inward-apo state (Table 7.3). To
investigate the influence of K+ binding on the proton release, we have also calcu-
lated the protonation state of E374 in the presence of K+ in each of the three sites
considered in our previous study161. For K+ site number 2, which is coordinated by
the same E374 side-chain, K+ is not stable in the binding site and leaves it shortly
after the protonation of this residue (not shown). Therefore, the deprotonation of
E374 is absolutely necessary for K+ binding at this site. In the case of K+ sites 1
and 3, we obtain pKa = 4.7 when K
+ is bound in site 1 and pKa = 6.9 when K
+
is bound in site 3 (Table 7.3). This is a direct consequence of introduction of a K+
ion in the apo state, which either replaces the Na1 and Na3 sodium ions (site 1)
or the substrate α-amino group (site 3). Interestingly, introduction of one K+ ion
at site 1 causes a larger shift in the pKa value compared to the apo state than the
presence of both Na1 and Na3 (4.7 vs. 6.7). This can be explained by the fact that
the binding of K+ at site 1 not only reduces the negative potential in that region,
but it also helps to hydrate the D368 side-chain, which does not happen in the apo
transporter (Fig. 7.6A and 7.6B). In the case of site 3, the D444 side-chain is part
of the substrate binding site (coordinates its α-amino group), and is separated from
E374 by the salt bridge between R447 and D440 (Fig. 7.6C). The presence of a pos-
itive charge in this region, instead of the negatively charged substrate or an empty
binding site, is responsible for reducing the pKa value of E374, deprotonating this
residue when K+ is bound at site 3. These results show that binding of a K+ ion
is necessary for the deprotonation of the E374 side-chain and the completion of the
transport cycle.
7.5 Conclusions
In conclusion, we have performed rigorous pKa calculations using the MD/FEP
method to identify protonated residues in the human glutamate transporter EAAT3,
and also to elucidate the mechanism of proton transport. Our calculations show that
E374 is the only protonated residue in the fully bound outward-facing state, which
agrees with experiments that point to this residue as the proton carrier in EAATs.
We find that both the presence of the substrate and the closure of the HP2 gate
contribute to the high pKa value obtained in our calculations. A hydrophobic region
formed by conserved residues in the TM7 and HP2 segments isolates E374 from the
solvent, favoring the presence of a neutral side-chain as opposed to a negatively
charged one. When we remove the substrate and the Na2 ion, we see the opening
of the HP2 gate and the hydration of the E374 side-chain, which now has a pKa
value below the physiological pH and therefore should be mostly deprotonated. If
we remove the remaining Na+ ions, the negative charges from the D368 and D455
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Figure 7.6: (A) The region between E374 (purple) and the D368 and D455 side-chains,
which has water molecules located mostly on the surface of the protein, resulting in reduced
dielectric screening. (B) The same area but now in the presence of the bound K+ at site
1. We see that, in addition to the presence of the positively charged K+ ion, the side chain
of D368 is also hydrated. (C) The substrate binding site with a K+ ion bound at site 3,
which now has a positive charge instead of the negatively charged substrate, reducing the
pKa of E374.
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side-chains induce the protonation of E374, which now has a pKa of ∼12. There
is good agreement between the results from the apo states created from the fully
bound GltPh and the apo GltTk templates, confirming the relevance of the former
in apo state calculations.
To understand the mechanism of proton release, we perform the pKa calcula-
tions in the inward-facing state of EAAT3 in the fully-bound state, with only Na1
and Na3 bound, in the apo state, and also with K+ bound in three possible sites
previously determined. There is good symmetry between the values in the inward
and the outward conformations of EAAT3, with the inward apo state also having a
protonated E374 carboxyl group. This result shows that the release of all the ligands
and the hydration of E374 is not enough to deprotonate this residue, and therefore
the proton release should depend on K+ binding to the inward transporter. Indeed,
the binding of the K+ ion in any of the sites tested induces the deprotonation of
E374, by either reducing its pKa or directly coordinating this ion. This is consistent
with a mechanism in which the K+ ion replaces either the Na1 and Na3 ions, the
substrate, or the proton itself, so the transporter never needs to reach the inward
apo state. This is in contrast to GltPh, in which all the ligands have to unbind for
the relocation of the transporter to the outward state. This difference might explain
the much faster transport rates of the human transporters compared to the archaeal
ones, and also the need for the countertransport of a K+ ion in the EAATs.
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Chapter 8
Computation of Standard Binding
Free Energies of Polar and
Charged Ligands to the
Glutamate Receptor GluA2
ABSTRACT
Accurate calculation of the binding affinity of small molecules to proteins
has the potential to become an important tool in rational drug design.
In this study, we use the free energy perturbation (FEP) method with
restraints to calculate the standard binding free energy of five ligands
(ACPA, AMPA, CNQX, DNQX and glutamate) to the glutamate recep-
tor GluA2, which plays an essential role in synaptic transmission. To
deal with the convergence problem in FEP calculations with charged lig-
ands, we use a protocol where the ligand is coupled in the binding site
while it is decoupled in bulk solution simultaneously. The contributions
from the conformational, rotational and translational entropies to the
standard binding free energy are determined by applying/releasing re-
spective restraints to the ligand in bulk/binding site. We also employ the
confine-and-release approach, which helps to resolve convergence prob-
lems in FEP calculations. Our results are in good agreement with the
experimental values for all five ligands, including the charged ones which
are often problematic in FEP calculations. We also analyze the different
contributions to the binding free energy of each ligand to GluA2 and
discuss the nature of these interactions.
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8.1 Introduction
The mechanism of action of many pharmaceutical drugs rely on binding of small
molecules to receptor sites with high affinity and specificity.169,170 If we can find
efficient ways to calculate the protein-ligand binding affinities accurately, computa-
tional methods could become a powerful tool in the discovery and optimization of
lead molecules.171 To achieve that goal, one needs both a well-parametrized force
field and a suitable method for calculating binding free energies. Software packages
such as Antechamber in AMBER172 and CGenFF in CHARMM173,174 provide miss-
ing force-field parameters for drug-like molecules so that they can be incorporated
in simulations of biomolecules. These parameters can be further optimized by per-
forming quantum mechanical calculations using programs such as Gaussian 09.72
Binding free energies of ligands can be calculated in a number of ways, and gener-
ally, greater accuracy of the results comes at a larger computational cost. Simple
empirical scoring functions can sieve through millions of compounds, which may be
desirable in an industrial environment.175 However, these simplifications often com-
promise the accuracy of the predictions made.176 At the other end of the spectrum,
we have the free energy perturbation (FEP) and potential of mean force (PMF)
methods that use all-atom molecular dynamics (MD) simulations.106,115,177–182 They
provide the most accurate approach for the prediction of ligand binding affinities,
but they are also very time consuming and computationally costly. Nevertheless,
thanks to the consistent, rapid increase in computing power and improvements in
computational methods, these MD methods are fast becoming viable alternatives
for lead selection.
Depending on the ligand-receptor system, the FEP or the PMF method may be
more appropriate for the calculation of binding affinities. An important consider-
ation in this regard is the size and charge state of the ligand, which determine its
hydration energy. For small, neutral molecules, the hydration energy can be calcu-
lated accurately using the FEP method.183,184 Hence FEP has become the standard
method for such molecules.116,185–191 Here the ligand interactions are decoupled from
the rest of the system in both the binding site and bulk solvent, and the free energy
of binding is obtained from the difference of these transformations. The standard
binding free energies—needed for comparison of the results to experimental binding
constants—are obtained by including entropy terms that take into account the loss
of translational, rotational and conformational freedoms of the ligand upon bind-
ing.107,117–119,192–194
For large and especially charged molecules, the FEP method has rarely been
used due to convergence problems, and therefore, the PMF method has been the
method of choice.43,47,84,195–200 The PMF is determined along one or more reaction
coordinates of the ligand with respect to the receptor, and the free energy of binding
is obtained by integrating the PMF along these coordinates. Even though in PMF
calculations the ligand does not need a clear pathway to the binding site,194 these
calculations become very difficult for ligands that are buried inside proteins. Such
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a situation occurs in the closed state of ionotropic glutamate receptors, where the
ligand is partially isolated from the solvent. One way to deal with this problem is to
create an open state so as to establish a clear pathway for the ligand. This method
was recently applied to binding of neurotransmitters to the ionotropic glutamate
receptor GluA241. While good results were obtained for the binding free energies of
several ligands, in general, it would be desirable to perform the free energy calcula-
tions using directly the crystal structures. This is feasible using the FEP method,
where only the end points are needed in the calculations. Therefore, it is worth-
while to examine the convergence problem in FEP, and see if it can be resolved using
a different protocol than the one commonly used. In most FEP calculations, the
decoupling of the ligand from the binding site and bulk solution are performed in
separate simulations. By increasing the system size slightly, it is possible to perform
both transformations simultaneously, that is, coupling the ligand in the binding site
while decoupling it in bulk at the same time. For charged ligands, this approach also
solves the neutrality problem so that one does not need to annihilate ions together
with the ligand in order to keep the system neutral during the FEP calculations,201
or include correction terms for the inserted charges.202 This method was recently
used in FEP calculations of aspartate binding to the transporter protein GltPh,
123,144
and free energy change due to a charge mutation in a bound toxin,203 and was shown
to yield consistent results with experiments.
The aim of this work is to perform extensive FEP calculations using the above
protocol to determine the binding free energies of five ligands (ACPA, AMPA,
CNQX, DNQX and glutamate) to the S1S2 ligand binding domain (LBD) of GluA2.
Glutamate is the predominant excitatory neurotransmitter in the brain, and ionotropic
glutamate receptors are essential for the fast synaptic transmission between nerve
cells.3 They work by coupling the binding of a ligand to the opening of an ion chan-
nel, which allows flow of cations through the membrane and transmission of a nerve
impulse. This coupling is related to the closure of the clamshell-shaped LBD in
the presence of agonists such as glutamate and AMPA. Antagonists such as CNQX
and DNQX, on the other hand, bind to GluA2 but do not allow the closure of the
LBD, thereby blocking receptor activation. From a biomedical point of view, it has
been shown that malfunctioning of the GluA2 receptors is implicated in a range of
diseases, including stroke, depression and Parkinson’s disease.204,205 Accurate calcu-
lation of the free energies involved in ligand binding and the closure of the LBD will
help to understand the mechanism of synaptic transmission,41 which will facilitate
finding treatments for such diseases.
There are several other reasons for choosing GluA2 in this study. First, there are
high-resolution crystal structures of GluA2 in the apo state and in complex with all
the ligands tested,206–209 so that any conformational changes in GluA2 due to their
presence can be easily identified. Next, the experimental binding free energies of
these ligands are available in the literature,206–209 so we can test the accuracy of our
calculations. Finally, there are computational studies that use umbrella sampling41
and metadynamics42 to obtain the ligand affinities, which can be directly compared
160
Chapter 8 Computation of Standard Binding Free Energies of Polar and Charged
Ligands to the Glutamate Receptor GluA2
to our FEP results. In umbrella sampling simulations,41 ∼13 ns was used to calcu-
late the binding affinity of each ligand from a 1-dimensional PMF, plus ∼40 ns to
calculate the conformational PMF of the receptor in each case. Much longer sim-
ulation times were used in Ref.42 with 0.5 µs of metadynamics simulations for the
opening of the receptor LBD and 13.5 µs for calculating the binding affinity each
ligand to the open state.
In the following sections, we first discuss the theoretical background and the
methodology used in our calculations. We then present the results and compare the
binding free energies obtained using the FEP method to the experimental/computational
values available in the literature. For all five ligands considered, the FEP results are
found to be in good agreement with the ones obtained experimentally and through
umbrella sampling simulations.
8.2 Standard Binding Free Energy
The standard binding free energy for binding of a ligand to a receptor is defined
from the equilibrium constant Kb as
∆G0b = −kBT ln(C0Kb), (8.1)
where C0 is the standard concentration of 1 mol/L = 1/(1661 A˚3). For computa-
tional convenience, ∆G0b can be decomposed as follows
106,177,178
∆G0b = ∆∆Gcf + ∆∆Grot + ∆∆G
0
tr + ∆∆Gint + ∆Gclose, (8.2)
where the first three terms represent the free energy contributions due to the changes
in the conformational, rotational and translational entropies of the ligand upon bind-
ing and the fourth term gives the interaction free energy difference for translocating
the ligand from the bulk to the binding site. The last term in Eq. 8.2 represents
the free energy change due to conformational rearrangements in the receptor upon
ligand binding such as the closure of the glutamate receptor. Straightforward calcu-
lation of the interaction energy term without any restraints on the ligand runs into
convergence problem because it is difficult to sample all possible states of the ligand
in both the binding site and bulk solvent. This problem is resolved in the double de-
coupling method (DDM),106,177,178 where restraints are imposed on the ligand while
its interactions with the solvent/receptor are decoupled/coupled. The contributions
from these restraints are taken into account separately by means of simulations or
analytical methods.
The thermodynamic cycle we use in the FEP calculations is illustrated in Fig-
ure 8.1, which describes the binding of a ligand to the receptor site. The ligand is
restrained in bulk using conformational, rotational and translational potentials de-
noted by uc, ur and ut, respectively. The restrained ligand is then translocated from
bulk to the binding site, followed by removal of the restraints in reverse order. Below
we first describe the free energy changes associated with the application/release of
the restraints followed by the interaction energy.
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Figure 8.1: The thermodynamic cycle used in the FEP calculations, where the restraints
are applied on the ligand in bulk solution and released while it is at the binding site.
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8.2.1 Conformational Free Energy.
Conformational restraining of a ligand in bulk/binding site is achieved using the
harmonic potential
uc =
kc
2n
n∑
i=1
(xi − x0i)2, (8.3)
with kc = 50 kcal/mol/A˚
2. Here {xi, i = 1, ..., n} give the current positions of the
ligand atoms after its position and orientation have been aligned with the reference
state described by {x0i, i = 1, ..., n}. The reference state is chosen as the aver-
age conformation of the fully-interacting ligand in the bulk/binding site when no
restraints are applied. The conformational free energy difference for applying the
restraint in bulk and releasing it in the binding site is given by (see Figure 8.1)
∆∆Gcf = ∆G
bulk
cf −∆Gsitecf (8.4)
The bulk/site contributions to ∆Gcf are determined in separate FEP calculations
where kc is relaxed from 50 kcal/mol/A˚
2 to 0 in ten steps given by {50, 30, 15, 8,
4, 2, 1, 0.5, 0.2, 0.1, 0}. Each FEP window is equilibrated for 300 ps followed by
800 ps of production data collection, and the free energy is obtained via numerical
integration of the window values.
8.2.2 Rotational and Translational Free Energies.
In recent calculations of the standard free energy of ligands, the translational and
rotational freedom of the ligand are restrained relative to the protein using anchoring
atoms in the ligand and the protein.116,188–191 This can be done in a number of ways,
but it is essential that these anchors are chosen properly.210 Here we use instead the
Body Restraint Algorithm,192 where the absolute coordinates are employed for both
the position and orientation of the ligand, even though these quantities must be
determined relative to the protein in order to obtain accurate results. We circumvent
this problem by strongly restraining the orientation and the position of the center
of mass (COM) of our receptor, such that these restraints are much larger than the
restraints applied on the ligand. We stress that the strong restraints applied on
the receptor affect only its position of the COM and overall orientation but not its
internal degrees of freedom.
The orientational restraints are applied using the quaternion formalism: for a
given ligand orientation q and its average orientation q0, the restraining potential
is given by ur = (kr/2)Ω
2, where Ω = cos−1(q · q0) and kr = 300 kcal/mol/rad2 is
employed. Similarly, a harmonic potential of the form ut = (kt/2)(r−r0)2 is used to
restrain the COM of the ligand in the binding site with kt = 10 kcal/mol/A˚
2. The
average orientation q0 and the average position r0 are determined from restraint-
free MD simulations of the ligand in the binding site. The magnitude of the spring
constants kr and kt are chosen according to the fluctuations of the associated coor-
dinates, namely, kt ∼ 3kBT/〈(r − r0)2〉 and kr ∼ 3kBT/〈Ω2〉. The force constants
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applied to the position and orientation of the protein are about a hundred times
larger than the ones applied on the ligand. This ensures that the protein can be
considered fixed in space compared to the fluctuations of the ligand, and hence we
can safely use the absolute coordinates of the ligand in the calculations.
The free energy differences associated with the application/release of the rota-
tional and translational restraints in bulk/binding site are given by
∆∆Grot = ∆G
bulk
rot −∆Gsiterot , (8.5)
∆∆G0tr = ∆G
bulk
tr −∆Gsitetr (8.6)
The binding site contributions to both terms are determined by performing FEP
calculations similar to those of the conformational case. For ∆Gsiterot , kr is relaxed
from 300 kcal/mol/rad2 to 0 in eleven steps given by {300, 200, 150, 80, 50, 30,
15, 8, 4, 2, 1, 0}. Similarly for ∆Gsitetr , kt is relaxed from 10 kcal/mol/A˚2 to 0 in
eight steps given by {10, 8, 5, 2, 1, 0.5, 0.2, 0.1, 0}. In both FEP calculations, each
window is equilibrated for 300 ps followed by 800 ps of data collection. The bulk
contributions can be determined analytically using the rigid-rotor approximation,
which works well for conformationally restrained ligands116
∆Gbulkrot = −kBT ln
[
1
8pi2
∫
e−ur(φ1,φ2,φ3)/kBTdφ1dφ2dφ3
]
= −kBT ln
[
1
8pi2
(
2pikBT
k′r
)3/2]
, (8.7)
∆Gbulktr = −kBT ln
[
1
V0
∫
e−ut(r)/kBTd3r
]
= −kBT ln
[
1
V0
(
2pikBT
kt
)3/2]
, (8.8)
where V0 = 1661 A˚
3 is the reference volume for the standard concentration. In
obtaining Eq. 8.7, we have converted the quaternion representation to the three axes
of rotation assuming that they are not coupled, which is valid for small rotations.
Therefore k′r in Eq. 8.7 represents the spring constant applied to the three rotation
axes.
It is of interest to compare the rotational and translational free energy differences
obtained from the application of restraints with the corresponding ones obtained
directly from the rotational and translational entropy differences for binding of a
free ligand to a receptor site107,117–119,192
∆∆Grot-ent = −kBT ln
[
(2pie)3/2σφ1σφ2σφ3
8pi2
]
, (8.9)
∆∆G0tr-ent = −kBT ln
[
(2pie)3/2σxσyσz
V0
]
. (8.10)
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Here σx, σy, and σz, are the principal rms fluctuations of the COM of the ligand in
the binding site, and σφ1, σφ2, and σφ3, are the principal rotational rms fluctuations
of the ligand calculated using the quaternion representation.119 The various σ values
are calculated by performing 6 ns of MD simulations of the unrestrained ligand in the
binding site and diagonalizing the translational and rotational covariance matrices
obtained from the trajectory data.118,119 The MD simulations show that the six
degrees of freedom associated with the positions and orientations of the ligands
in the binding site are well-described by normal distributions so that the entropic
contributions to the binding free energy can be determined accurately using Eqs. 8.9
and 8.10. Although Eqs. 8.5 and 8.6 are formally different from Eqs. 8.9 and 8.10, we
will show in the Results that they lead to very similar results when the restraining
potentials are chosen appropriately.
8.2.3 Interaction Free Energy.
The free energy of translocation, that is, decoupling the restrained ligand in bulk
and coupling it in the binding site, is given by
∆∆Gint = ∆G
site
int −∆Gbulkint . (8.11)
Here we perform the binding site and bulk calculations simultaneously and in the
same system, which helps to maintain neutrality of the system for charged lig-
ands.123,144 Performing these calculations separately could lead to substantial errors
due to the large solvation free energies associated with charged ligands.43 In the
present approach, the electrostatic part of the alchemical transformation can be
seen as a transfer of charge between two regions of the same system. This reduces
the errors arising from the large solvation energies of charged ligands as well as
potential artifacts from use of the periodic boundary conditions.
The free energy of translocation in Eq. 8.11 is calculated using the FEP and
thermodynamic integration (TI) methods.180 In both methods, one introduces a
hybrid Hamiltonian H(λ) = (1−λ)H0 +λH1, where H0 represents the Hamiltonian
for the initial state and H1 for the final state of the system. In the FEP method, the
interval between λ = 0 and 1 is divided into n subintervals with {λi, i = 1, . . . , n−1},
and for each subinterval the free energy difference is calculated from the ensemble
average
∆Gi = −kBT ln〈exp[−(H(λi+1)−H(λi))/kBT ]〉λi . (8.12)
The free energy of translocation is then obtained from the sum, ∆Gint =
∑
i ∆Gi.
In the TI method, the ensemble average of the derivative, ∂H(λ)/∂λ, is obtained at
several λ values, and the free energy of translocation is calculated from the integral
∆Gint =
∫ 1
0
〈
∂H(λ)
∂λ
〉
λ
dλ. (8.13)
This integral is evaluated using a seven-point or nine-point Gaussian quadrature,
which has been shown to provide a good method for free energy calculations involving
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translocation of charged ligands.123,144 In order to improve convergence and prevent
instabilities in the FEP and TI calculations, decoupling/coupling of the ligand in
bulk/site is performed in two stages by separating the Coulomb and Lennard-Jones
(LJ) interactions
∆∆Gint = ∆∆Gelec + ∆∆GLJ. (8.14)
In the calculations, first the electrostatic interactions of the ligand are switched
off/on in bulk/site followed by decoupling/coupling of the LJ interactions in bulk/site.
We also use a soft-core potential for the LJ interactions to avoid problems at the
end-points of the simulations.82
In the FEP calculations, it is important to choose the number of windows such
that the ∆Gi value in each window is not much larger than 1.5 kT.
180 For the
electrostatic terms in CNQX and DNQX, 66 windows are found to be sufficient
while for ACPA, AMPA and glutamate—which carry charged groups—100 windows
are required in order to obtain good convergence. Each window is equilibrated for
80 ps followed by a 120 ps of production run. In the case of the LJ interactions, 60
λ values are used for all ligands with smaller intervals close to the end-points. Each
window is equilibrated for 80 ps followed by 80 ps of data collection. The windows
for the TI calculations are adapted from those created during the FEP simulations.
For the electrostatic terms, seven windows are used with 300 ps of equilibration
and either 1 ns (CNQX and DNQX) or 1.5 ns (ACPA, AMPA and glutamate) of
data collection. For the LJ terms, seven windows are used for CNQX and DNQX
and nine windows for ACPA, AMPA and glutamate. In this case each window is
equilibrated for 200 ps followed by 1 ns of production. The statistical errors in
the TI calculations are estimated by performing block data analysis, using blocks
of 100 ps. This does not take into account any systematic errors arising from the
force field used or the asymmetry between the insertion and deletion of particles.211
An estimate for the latter can be obtained from hysteresis between the forward and
backward calculations.
To assess the convergence of the FEP and TI calculations, it is important to
perform both the forward and the backward transformations, and check for consis-
tency between the two results. A large hysteresis may be an indication of an energy
barrier that cannot be crossed within the time scales of individual windows, and
the results will not be reliable. In such situations, TI may provide a better option
than FEP due to longer sampling of a smaller number of windows. Here we look
for agreement between the forward and backward transformations in both FEP and
TI calculations, and use it as evidence that our calculations are properly converged.
The interaction binding free energy is determined from the average of the forward
and the negative of the backward transformation results. In many studies, the Ben-
nett acceptance ratio method212,213 is used to obtain the optimal value of ∆Gi. This
method uses an ensemble of forward and backward transformations at each window,
in order to get the maximum likelihood estimator for the free energy difference.
Here we perform the whole transformation in both directions, and the sigma values
are based only on the TI calculations. Nevertheless, we can still obtain an estimate
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of the boundary values for the FEP calculations from the forward and backward
results. According to the Gibbs-Bogoliubov inequality,212 the optimal value of the
free energy difference lies between the values of the forward and the backward cal-
culations. The values we obtain using TI are mostly within the range specified by
FEP, which indicates consistency between the FEP and TI methods.
8.2.4 Confine-and-Release
Conformational changes in a protein that take place upon binding/unbinding of
a ligand can sometimes affect convergence and prevent obtaining accurate results
using FEP. This has been the case in the FEP calculations of the electrostatic
terms for AMPA and glutamate, where a large hysteresis is observed between the
forward and backward transformations. The problem is traced to the formation
of a salt bridge between the ligand’s α-amino group and the E705 side chain in
GluA2. To resolve this problem we use the confine-and-release method,214 which is
a FEP/PMF hybrid—FEP is used to calculate the binding free energy of the ligand
to the confined protein, and the free energy of confinement is obtained from the
PMF of the confining coordinate. The interaction free energy can be written as
∆∆Gint = ∆∆Gint,C + ∆Gcon + ∆Grel. (8.15)
where ∆∆Gint,C represents the free energy of translocation of the restrained ligand
to the confined protein, and ∆Gcon and ∆Grel are, respectively, the free energies of
confining the protein in the apo state and removing these restraints in the bound
state. These are calculated from
∆Gcon = −∆Grel = −kBT ln
( ∑
i∈Sα
e−Fi/kBT∑
all
e−Fi/kBT
)
, (8.16)
where Sα are the bins in the confined region, and Fi are the free energies for each bin
in the apo states for ∆Gcon and the bound states for ∆Grel. These are computed
by performing umbrella sampling simulations for the chosen confinement coordi-
nate(s) and constructing the associated PMF using the weighted histogram analysis
method.81
The confine-and-release approach can be related to the method used in Refs.43,194,
where the conformation of the ligand is confined and then released in the unbound
and bound states. Here we are interested only in the conformational changes in
the receptor that are related to the salt bridge in question. Using an overall con-
formational ensemble as in Refs.43,194 would take much longer to converge, which
rationalizes our choice for a simpler reaction coordinate that is sufficient to resolve
the large hysteresis observed in the FEP calculations. The simplest choice for this
confinement coordinate is the distance between the COM of the α-amino group of
the ligand and the COM of the two oxygens in the E705 side chain. This requires
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construction of a 1-D PMF, and therefore computationally less costly than restrain-
ing the two dihedrals of E705, which would require construction of a 2-D PMF. For
both the apo and the bound states, we use 14 windows between the distances 2.5 A˚
and 9.0 A˚ spaced 0.5 A˚ apart. Note that the restrained, non-interacting ligand is
still present in the apo state though it has no effect on the protein. The chosen
range is sufficient to cover all the possible distances between these two groups as
values outside this range are forbidden due to the limited flexibility of the E705
side-chain or steric clashes with the neighbouring groups. The initial windows for
umbrella sampling simulations are created from 2 ns of steered MD. A spring con-
stant of 8 kcal/mol/A˚2 is employed, and each umbrella window is equilibrated for
2 ns followed by 3 ns of data production.
8.3 Model System and Simulation Details.
The simulation systems are prepared using the crystal structures of GluA2 S1S2 lig-
and binding domain in complex with five ligands, namely, glutamate (PDB ID:1FTJ),
AMPA (1FTM), ACPA (1M5E), CNQX (3B7D), DNQX (1FTL), and the apo state
of GluA2 (1FTO). The structures of the five ligands are shown in Figure 8.2. In
all cases only one monomer (chain A) is used. All simulation boxes are created
using the software VMD.104 The apo protein or complex are solvated in a box of
dimensions 80× 80× 70 A˚3 with about 12,000 water molecules. This size is chosen
to ensure that during the decoupling of the ligands in bulk, they do not interact
with the protein (the ligands are more than 25 A˚ away from the binding site). To
create a 0.15 M NaCl solution and maintain the charge neutrality, we add to the
solution 34 Na+ and 38 or 39 Cl− ions, depending on the ligand bound. The total
number of atoms in each system is about 40,000.
After energy minimization of each system, the restraints on the non-hydrogen
atoms of the protein and ligand are gradually released during 5 ns of MD simulations.
Each system is further simulated for 4 ns with no restraints applied. In order to
compare our results to experimental values and to the PMF results,41 we perform
the FEP simulations in the same open state of the receptor as employed in Ref.41.
This state is defined by introducing two distance restraints between groups of atoms
in lobes S1 and S2, namely, ξ1 which measures the distance between the COM of
residues the 479–481 in S1 and the COM of the residues 654–655 in S2, and ξ2
which measures the distance between the COM of the residues 401–403 in S1 and
the COM of the residues 686–687 in S2. These distances are restrained at (ξ1, ξ2) =
(14.4 A˚, 13.7 A˚). We perform 2 ns steered MD to achieve this state from the initial
equilibrated complex, while keeping the ligands bound to the R485 residue on S1
and restraining the protein RMSD separately on the S1 and S2 lobes, as described
in Ref.41. After the steered MD is completed, we release the ligand and the RMSD
restraints and simulate the resulting system for a further 5 ns. Throughout the
following MD simulations and in all the FEP calculations, restraints are applied
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Figure 8.2: Structures of the five ligands considered in this study.
to the ξ1 and ξ2 distances keeping them at (ξ1, ξ2) = (14.4 A˚, 13.7 A˚). In order
to compare the values obtained for the ligand affinities in the open state to the
experimental values, we add the free energy of LBD closure obtained from Ref.41 to
the final value of the binding free energy of each ligand.
All of our MD simulations are performed using the NAMD package (version 2.9)59
with the CHARMM36 force field.70 Initial Parameters for ACPA, AMPA, CNQX
and DNQX were obtained from the ParamChem server,173,174 and parameters with
penalties higher than 10 were optimized using Gaussian 0972. The parameters files
for ACPA, AMPA, CNQX and DNQX are shown in the Appendix as Figures 8A.1,
8A.2, 8A.3 and 8A.4, respectively. The temperature of the simulation is maintained
at 300 K using Langevin damping with a coefficient of 5 ps−1, and the pressure is kept
at 1 atm using the Langevin piston method with a damping coefficient of 20 ps−1.64
Periodic boundary conditions with the particle-mesh Ewald method are employed
to calculate the electrostatic interactions without truncation. The Lennard-Jones
(LJ) interactions are switched off between 10 and 12 A˚ using a smooth switching
function. A time step of 2 fs is used in all MD simulations.
8.4 Results and discussion
The results of the FEP/TI calculations are summarized in Table 8.1, and the stan-
dard binding free energies obtained are compared to those determined from umbrella
sampling41 and experiments.206–208 The electrostatic and LJ contributions to the in-
teraction free energy have been calculated using both the FEP and TI methods, and
also in both the forward and backward directions to check for any hysteresis effects.
The two methods yield very similar results, therefore only the TI results are shown
8.4 Results and discussion 169
in Table 8.1 as they allow for longer sampling and also estimation of the errors by
block data analysis. As mentioned in the Methods section, all the calculations are
performed in the same open state of the receptor as in Ref.41. This enables a direct
comparison of the computational results obtained using the FEP/TI methods here
with those determined from the PMF method. Also using the free energy of recep-
tor closure from Ref.41 allows us to determine the final standard binding free energy
of the ligands, which can be compared with experiments. We first discuss CNQX
and DNQX, which have similar structures and give very similar results, followed by
discussions of the more challenging cases of ACPA, glutamate and AMPA.
8.4.1 CNQX and DNQX
CNQX and DNQX are antagonists whose binding to the receptor prevents closure
of the LBD. Consistent with these properties, both ligands have substantially larger
Table 8.1: The Standard Binding Free Energies of the Five Ligands Considered in This
Study. The free energy changes due to conformational, rotational and translational re-
straints are given in rows 1,2 and 3, respectively. The confine-and-release results (Eq. 8.16)
for glutamate and AMPA are given in rows 4-5. The electrostatic and LJ contributions to
the interaction free energy differences obtained from TI calculations are listed in rows 6-7.
The binding free energies of the ligands to the open state of the receptor (sum of the rows
1–7) are given in row 8. The standard binding free energies in row 10 are obtained by
adding the free energies of closure from Ref.41 (row 9) to the open state results in row 8.
The standard binding free energies obtained in this work (row 10) are compared to those
determined from umbrella sampling (row 11) and experiments (row 12). The rotational
free energies of DNQX (marked with a *) include a factor of −kBT ln(2) = −0.41, due to
the two-fold symmetry of this ligand. All energies are in kcal/mol.
CNQX DNQX ACPA Glu AMPA
∆∆Gcf 0.2 0.6 0.9 0.3 0.7
∆∆Grot 4.4 3.2* 4.5 3.9 4.6
∆∆G0tr 3.8 3.6 4.1 3.8 4.0
∆Gcon - - - 0.5 1.1
∆Grel - - - −2.3 −7.9
∆∆Gelec −7.3± 0.6 −6.9± 0.6 −10.6± 1.1 −5.5± 1.6 −4.8± 1.1
∆∆GLJ −7.0± 1.3 −7.8± 1.4 −0.8± 0.7 0.9± 0.9 −1.0± 1.3
∆G0b −∆Gclose −5.9± 1.4 −7.3± 1.5 −1.9± 1.3 1.6± 1.8 −3.3± 1.7
∆Gclose
41 −1.7 −1.6 −10.4 −10.1 −8.3
∆G0b −7.6± 1.4 −8.9± 1.5 −12.3± 1.3 −8.5± 1.8 −11.6± 1.7
∆G0b (US)
41 −7.7 −7.9 −11.2 −9.1 −10.1
∆G0b (exp) −8.5206 −8.2207 −10.6208 −8.4207 −10.8208
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affinities for the open state of the receptor compared to the agonists ACPA, glu-
tamate and AMPA (row 8 in Table 8.1), and much smaller free energies of closure
(row 9). The main aim of this work is to demonstrate the feasibility of using the
FEP/TI methods in calculation of the translocation free energies in ligand binding.
To this end, we study the quality and convergence of the free energy calculations
for the electrostatic and LJ terms. In Figure 8.3, we present the results of the FEP
calculations as a function of the parameter λ, and the results of the TI calculations
as running averages plotted as a function of the production time. In both cases,
the free energy difference ∆∆G is given by the end points in the plots. Comparison
of the forward and backward transformation results shows that there is a minimal
hysteresis effect in all cases. For example, in TI calculations the difference between
the two sets is seen to be less than 1 kcal/mol in all cases except for ∆∆GLJ in
CNQX where it is 1.5 kcal/mol. Also the FEP and TI results obtained from the
average of the forward and backward transformations are consistent with each other.
Comparison of the standard binding free energies with those obtained from umbrella
sampling and experiments (Table 8.1) provides further support for the feasibility of
the FEP/TI approach—for both CNQX and DNQX, the calculated values are within
1 kcal/mol of the umbrella sampling and experimental results.
Table 8.2: Comparison of the Entropic Contributions to the Free Energy Obtained With
and Without Restraints. The free energy changes due to rotational and translational re-
straints from Table 8.1 are reproduced in rows 1 and 3. The free energy changes calculated
from the rotational and translational entropies (Eqs. 8.9 and 8.10) are listed in rows 2
and 4 for comparison. All energies are in kcal/mol.
CNQX DNQX ACPA Glu AMPA
∆∆Grot 4.4 3.2* 4.5 3.9 4.6
∆∆Grot-ent 4.0 3.6* 4.6 3.4 4.3
∆∆G0tr 3.8 3.6 4.1 3.8 4.0
∆∆G0tr-ent 3.4 3.4 3.9 3.6 4.0
In Table 8.2, we compare the results of free energy changes calculated from the
rotational and translational entropies of an unrestrained ligand using Eqs. 8.9 and
8.10 with those obtained from application of the rotational and translational re-
straints as presented in Table 8.1. The two methods are seen to yield very close
results. In fact, using the values obtained from Eqs. 8.9 and 8.10 in Table 8.1, one
would get very similar results for the binding free energies. The entropy calculations
for an unrestrained ligand using Eqs. 8.9 and 8.10 are much easier and computa-
tionally less demanding than the free energy calculations involving application of
rotational and translational restraints to a ligand. Therefore, it is worthwhile to
check whether this alternative approach can be justified. Because restraints have
to be used in calculation of the translocation free energy of a ligand in Eq. 8.2, we
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Figure 8.3: Plots of the FEP (first column) and TI (second column) calculations for the
electrostatic (A, B) and LJ (C, D) interactions in CNQX, respectively. The graphs E-H
show the same for DNQX. The black lines indicate the forward transformations and the
red lines, the negative of the backward transformations.
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need to show that the force-field interactions of the ligand in the binding site/bulk
are not affected by restraining its position and orientation. We test this conjecture
by performing FEP calculations for the electrostatic and LJ parts of DNQX using
different sets of restraints. The results shown in Table 8.3 are all very similar in-
dicating that for reasonable choices, these restraints have indeed little effect on the
force field contributions to the binding free energy.
A distinguishing feature of the CNQX and DNQX results in Table 8.1 is the
relatively large contribution of the LJ term to the binding free energy compared
to the other ligands. This is directly responsible for the much higher affinities of
CNQX and DNQX for the open state of the receptor, and therefore warrants a better
understanding. The LJ term arises mostly from the hydrophobic interactions of the
ligands with the receptor. Inspection of the binding modes of CNQX and DNQX
shows that such an interaction occurs between the double-ring of CNQX/DNQX
and the ring of the Y450 residue of the receptor as shown in Figure 8.4. These two
structures are observed to be stacked stably on top of each other during the entire
MD simulations, suggesting that this interaction is a major contributor to the high
affinity of these two antagonists in the open state of the receptor.
8.4.2 ACPA
ACPA differs from CNQX and DNQX in that it has a net charge −e but lacks the
double ring structure. These differences help to explain the stronger electrostatic
and weaker LJ interactions in ACPA relative to CNQX and DNQX (Table 8.1).
Quality and convergence of the FEP and TI calculations for the electrostatic and
LJ terms are studied in Figure 8.5. In all cases, the forward and backward results
differ by less than 1 kcal/mol, indicating a minimal hysteresis effect. Also there is
an almost perfect agreement between the FEP and TI results. Yet the calculated
standard binding free energy deviates from the experimental value by 1.7 kcal/mol—
the only case among the five ligands where this deviation is larger than 1 kcal/mol.
Table 8.3: Restraint Dependence of the Translocation Free Energy. Results of the FEP
calculations for the electrostatic and LJ terms and their sum for DNQX using different
translational and orientational restraints for the ligand. The free energy is in kcal/mol, kt
is in kcal/mol/A˚2 and kr is in kcal/mol/rad
2.
Restraints ∆∆Gelec ∆∆GLJ ∆∆Gint
kt = 5, kr = 300 −7.2 −7.2 −14.4
kt = 10, kr = 100 −6.6 −7.6 −14.2
kt = 10, kr = 300 −7.1 −7.3 −14.4
kt = 10, kr = 500 −6.7 −8.0 −14.7
kt = 25, kr = 300 −6.4 −7.0 −13.4
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Figure 8.4: A snapshot of the DNQX complex in the open state of the receptor showing
the hydrophobic interaction between the double ring of DNQX and the ring of the Y450
residue. The same pattern is also observed in the CNQX complex.
To see if this is due to some fluctuation, we have repeated the TI calculations but
obtained essentially the same results. Another possibility is that the free energy of
the receptor closure ∆Gclose might be slightly overestimated, leading to the lower
free energy value.
8.4.3 Glutamate and AMPA
As mentioned in Theory and Methods, large hysteresis effects have been observed in
the FEP calculations of the electrostatic terms for glutamate and AMPA. Despite its
similarity with AMPA, this does not happen for ACPA. To explain why the hysteresis
effect occurs for glutamate and AMPA and not for ACPA, we show snapshots of
these ligands in complex with the open state of the receptor (Figure 8.6). It is seen
that, in the case of glutamate and AMPA, there is a salt bridge between the ligand’s
α-amino group and the E705 side chain of the receptor, but this does not occur in
ACPA. Thus the problem is caused by this salt bridge and to circumvent it, we use
the confine-and-release method as outlined in Theory and Methods.
For glutamate, we confine the distance between the ligand α-amino and the
receptor E705 side-chain carboxyl groups to the range 4.5–6.5 A˚ by adding high
energy barriers at these two points, which keeps the distance unbiased but confined
within the specified range. This procedure breaks the salt bridge during the FEP
simulations, and the contribution of this interaction is added later through the PMF
term. The results of the FEP and TI calculations for the electrostatic and LJ terms,
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Figure 8.5: Same as Fig. 8.3 but for ACPA. Plots of the FEP (first column) and TI
(second column) calculations for the electrostatic (A, B) and LJ (C, D) interactions.
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Figure 8.6: Snapshots of the ACPA, glutamate and AMPA complexes in the open state
of the receptor. The critical E705 side chain has no interactions with ACPA but makes
salt bridges with the α-amino group of glutamate and AMPA (indicated by dotted lines).
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Figure 8.7: Plots of the FEP (first column) and TI (second column) calculations for the
electrostatic (A, B) and LJ (C, D) interactions in glutamate. We also show the PMF as
a function of the distance between the ligand α-amino and the receptor E705 side-chain
carboxyl group in the apo (E) and bound (F) states of the receptor. The range of the
confinement potential is indicated by the vertical dotted lines.
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as well as the PMFs for the apo and bound states, are shown in Figure 8.7. Apart
from the FEP result for the LJ term, there is minimal hysteresis between the forward
and backward results. Because there is good agreement between the average FEP
and TI results for the LJ term, we have not pursued this issue further. Convergence
of the PMF results are demonstrated via block data analysis of the trajectory data
(Figure 8.7E-F). The four PMF’s constructed using 0.75 ns of data for each exhibit
small fluctuations around the full PMF, which is taken as a sign of convergence.
The standard binding free energy is in good agreement with the umbrella sampling
and experimental results (Table 8.1), which shows that hysteresis problems in the
FEP calculations can be overcome using the confine-and-release approach (Table
8.1). This is especially useful for calculations involving charged ligands because
they often produce the largest conformational changes upon binding to a protein,
and these changes can compromise the reliability of FEP calculations. By identifying
the interactions causing problems and analyzing them separately, we can avoid such
problems at the cost of some additional computations.
In the case of AMPA, using the same confinement range as in glutamate have still
resulted in a large hysteresis in the FEP calculations. Therefore we have reduced
the confinement range from 4.5–6.5 A˚ to 5.5–6.5 A˚, further hindering the interaction
between these two charged groups. As shown in Figure 8.8, this smaller range solved
the hysteresis problem in the FEP calculations, yielding well-converged results in
all FEP, TI, and PMF calculations. The standard binding free energy is within
1 kcal/mol of the experimental value but 1.5 kcal/mol smaller than the umbrella
sampling result (Table 8.1). We note that this is the case among the five ligands
where the difference between the FEP/TI and umbrella sampling results is largest.
Another point to note is the relatively large contribution of the confine-and-release
terms to the binding free energy of AMPA (rows 4-5 in Table 8.1). This is partly
caused by the confinement potential which keeps the charged groups in the salt
bridge further apart in AMPA compared to glutamate. Another reason can be
gleaned from Figure 8.6. In the case of glutamate, there is some repulsive interaction
between the β-carboxyl group and the E705 side-chain carboxyl, which reduces the
effectiveness of the salt bridge. In AMPA, the carboxyl group is replaced by hydroxyl
attached to the isoxazole ring, which does not hinder the formation of the salt bridge,
rather it makes a hydrogen bond with E705. We can also see why the salt bridge
does not form in ACPA—it is prevented by attachment of a carboxyl group instead
of hydroxyl to the isoxazole ring. Thus the carboxyl group of E705 plays a critical
role in binding of agonist ligands to the open state of GluA2.
8.5 Conclusions
In this study we have performed FEP/TI calculations of five polar and charged lig-
ands using different techniques to obtain their standard binding free energies to the
glutamate receptor GluA2. The FEP/TI calculations are performed by restraining
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Figure 8.8: Same as Figure 8.7 but for AMPA. In this case, the range of the confinement
potential is 5.5–6.5A˚.
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the position and orientation of ligands using the absolute coordinates, which do not
require anchoring atoms in the protein and ligand, and therefore are easier to imple-
ment. It also allows a direct calculation of the entropy differences between the free
and bound states of the ligand. We have shown that this approach produces very
similar results to the double decoupling method, and considering its simplicity, may
offer an alternative method for the calculation of the standard binding free energies.
For glutamate and AMPA, for which the straightforward FEP calculations lacked
good convergence, we have used the confine-and-release method, and obtained very
good agreement with the experimental values. The results obtained in this study
show that it is possible to calculate the binding free energies accurately using the
FEP/TI methods even for ligands with net charges as long as the bulk and binding
site transformations are performed in the same system. The FEP/TI methods, even
though not suitable for protein-protein binding, are advantageous over the PMF
method for binding sites that are deeply buried inside proteins. The techniques
used here can be applied to many protein-ligand systems. The accuracy of the re-
sults means that they could, in particular, become very useful tools in rational drug
design.
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Figure 8A.1: CHARMM parameters for ACPA.
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Figure 8A.2: CHARMM parameters for AMPA.
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Figure 8A.3: CHARMM parameters for CNQX.
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Figure 8A.4: CHARMM parameters for DNQX.
Chapter 9
A Potent and Selective Peptide
Blocker of the Kv1.3 Channel:
Prediction from Free-Energy
Simulations and Experimental
Confirmation
ABSTRACT
The voltage-gated potassium channel Kv1.3 is a well-established target
for treatment of autoimmune diseases. ShK peptide from a sea anemone
is one of the most potent blockers of Kv1.3 but its application as a
therapeutic agent for autoimmune diseases is limited by its lack of selec-
tivity against other Kv channels, in particular Kv1.1. Accurate models
of Kv1.x-ShK complexes suggest that specific charge mutations on ShK
could considerably enhance its specificity for Kv1.3. Here we evaluate
the K18A mutation on ShK, and calculate the change in binding free
energy associated with this mutation using the path-independent free
energy perturbation and thermodynamic integration methods, with a
novel implementation that avoids convergence problems. To check the
accuracy of the results, the binding free energy differences were also de-
termined from path-dependent potential of mean force calculations. The
two methods yield consistent results for the K18A mutation in ShK and
predict a 2 kcal/mol gain in Kv1.3/Kv1.1 selectivity free energy relative
to wild-type peptide. Functional assays confirm the predicted selectivity
gain for ShK[K18A] and suggest that it will be a valuable lead in the
development of therapeutics for autoimmune diseases.
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9.1 Introduction
High-affinity binding to the target protein is a key criterion in the search for drug
leads, and several methods, from high-throughput screening to computational dock-
ing, have been used for this purpose. The selectivity of a drug lead for a given target
is also important as high affinity for an unintended target could lead to unaccept-
able side effects. In principle, experimental or computational screening methods
developed for lead searching can be used to address the selectivity problem, al-
though the complexity of proteins compared to lead ligands makes such brute force
methods less likely to be successful. Methods based on structure-based drug design
provide a promising alternative for solving selectivity problems, as we illustrate in
this study, which also identifies a potent analog of ShK peptide that is selective for
the voltage-gated potassium channel Kv1.3.
Kv1.3 is a well-established target for the treatment of autoimmune diseases
mediated by effector memory TEM lymphocytes, such as multiple sclerosis and
rheumatoid arthritis18,215. ShK peptide, from the sea anemone Stichodactyla he-
lianthus45,46,216, is a potent blocker of the Kv1.3 channel with an IC50 of around 10
pM217, and thus an excellent lead for development of an immunomodulatory drug218.
However, ShK also blocks other Kv channels with high affinity, in particular Kv1.1
(IC50 = 16 pM)
217. This lack of specificity for Kv1.3 is an impediment for the use
of ShK as a therapeutic agent, and considerable effort has gone into developing
ShK analogs with improved selectivity for Kv1.3 over Kv1.1 and other potassium
channels46,218. Several analogs with the desired selectivity have been developed, e.g.
ShK-Dap22217, ShK-F6CA219, ShK-186220, and ShK-192221, but all of them contain
non-natural amino acids and/or adducts, and, in the case of ShK-186, the phospho-
rylated Tyr residue is susceptible to hydrolysis. For this reason, it is desirable to
develop selective ShK analogs for Kv1.3 containing only natural amino acids.
An essential first step in searching for selective analogs using structure-based
drug design methods is to construct accurate models of the relevant protein-ligand
complexes. This has been achieved recently for Kv1.x-ShK complexes using docking
and molecular dynamics (MD) simulations47,222. The validity of the complex models
was established by comparing the predicted binding modes with alanine scanning
mutagenesis data223,224, and showing that the binding free energies of ShK obtained
from the potential of mean force (PMF) calculations reproduce the experimental
values within chemical accuracy47. Comparison of the binding modes in the Kv1.1-
ShK and Kv1.3-ShK complexes reveals that the side chain of K18 in ShK is strongly
coupled to a glutamate side chain in Kv1.1 via electrostatic interactions but it does
not exhibit any interactions with the Kv1.3 residues47. Thus, mutation of this
residue in ShK to alanine could lead to a substantial selectivity gain for Kv1.3 over
Kv1.1.
Here we perform free energy simulations to calculate the change in the binding
free energy of the Kv1.1-ShK and Kv1.3-ShK complexes associated with the K18A
mutation. Two independent methods are used to check the veracity of the calcula-
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tions. First we perform free energy perturbation (FEP) and thermodynamic integra-
tion (TI) calculations where ShK in the binding site is transformed to ShK[K18A]
while the reverse transformation is carried out in the bulk for ShK[K18A], which
gives directly the change in the binding free energy due to the mutation. We
avoid convergence problems by using uncharged side chains as intermediate states.
Convergence of the results was checked using the TI method, which also demon-
strates the robustness of the calculations. Secondly, the PMFs for the dissociation
of ShK[K18A] from Kv1.x are constructed from umbrella sampling MD simulations,
from which the relative and absolute binding free energies of ShK[K18A] are deter-
mined. The change in the binding free energy is obtained by subtracting the relative
binding free energy of the mutant from that of wild-type peptide47. The FEP and
TI methods are computationally much cheaper but their reliability is not very well
established for charge mutations. Thus, one of our aims was to demonstrate that
the free energy change due to a charge mutation can be calculated accurately using
the FEP and TI methods. The predictions of the free energy calculations were con-
firmed by measuring the binding constants of ShK[K18A] for Kv1.1 and Kv1.3 by
patch-clamp electrophysiology.
9.2 Materials and methods
9.2.1 Ethics statement
All procedures involving vertebrate animals were conducted after approval by the
Institutional Animal Care and Use Committee at Baylor College of Medicine. Bay-
lor College of Medicine follows the requirements of the Guide for the Care and Use
of Laboratory Animals (National Research Council, 8th edition). Female Lewis rats
were purchased from Taconic (Germantown, NY, USA) and housed in autoclaved
setup with food and water ad libitum in an Association for Assessment and Ac-
creditation of Laboratory Animal Care International (ALAAAC)-approved facility.
Every effort was made to minimize animal discomfort and to keep the number of
animals used to a minimum. Rats were euthanized by deep isoflurane anesthesia
(slow breathing and lack of reactivity to toe pinching), followed by cardiac puncture.
Death was ensured by decapitation.
9.2.2 Peptide synthesis
The synthesis of the peptide has been described before224. Briefly, Fmoc-amino acid
derivatives were obtained from Bachem A.G. (CH-4416 Bubendorf, Switzerland).
Solid-phase assembly was initiated with an Fmoc-Cys(Trt)-2-chlorotrityl resin to
minimize potential racemization of the C-terminal Cys residue. Automated step-
wise assembly was carried out entirely on an ABI-431A peptide synthesizer (Applied
Biosystems, Foster City, CA). ShK[K18A] was solubilized, oxidized, and purified by
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reverse phase-high pressure liquid chromatography using the method described pre-
viously217,223, and high pressure liquid chromatography-pure fractions were pooled
and lyophilized. The structure and purity of the peptides were confirmed by reverse
phase-high pressure liquid chromatography, amino acid analysis, and electrospray
ionization-mass spectroscopy analysis. Samples were weighed and adjusted to ac-
count for peptide content before bioassay. The purity and mass were determined
using LC and ESI-MS analyses (Figures 9A.1 and 9A.2 in the Appendix).
9.2.3 NMR spectroscopy and data analysis
Samples were prepared by dissolving freeze-dried ShK[K18A] in 90% H2O/10%
2H2O, pH 4.8, to a concentration of 870 µM. One-dimensional 1H spectra and two
dimensional homonuclear TOCSY spectra with a spin lock time of 80 ms were ac-
quired at 20oC on a Bruker Avance 600 MHz spectrometer. A NOESY spectrum
(mixing times 200 ms) was also acquired at 20oC, pH 4.8. All spectra were processed
in TOPSPIN (version 3.0, Bruker Biospin) and analysed using CcpNmr-Analysis
(version 2.1.5). 1H chemical shifts were referenced to the 1,4-dioxane signal at 3.75
ppm. Chemical shift assignments for backbone and side chain protons of ShK[K18A]
were made by conventional analysis of TOCSY and NOESY spectra. A complete
assignment of the proton NMR signals of ShK[K18A] was obtained.
The one-dimensional 1H NMR spectrum (Figures 9A.3 and 9A.4 in the Ap-
pendix) of ShK[K18A] showed sharp and well-dispersed resonances similar to that
of wild-type ShK, indicating that the K18A mutation did not cause any significant
perturbation of the native structure. To further compare the structures of wild-
type ShK and the K18A mutant, chemical shift differences from random coil values
for amide, Hα and Hβ resonances were plotted (Figure 9A.5 in the Appendix). This
shows that the patterns of chemical shift deviations from random coil for ShK[K18A]
closely resemble those for wild-type ShK, and confirms that the three-dimensional
structures are basically the same. Small differences in chemical shifts between wild-
type and mutant were observed only for resonances around the mutated residue K18
(Figure 9A.5 in the Appendix).
9.2.4 Cells
Mouse L929 fibroblasts stably expressing mKv1.1, mKv1.3, hKv1.5 channels225 were
gifts from Dr. K. George Chandy (University of California, Irvine). Human em-
bryonic kidney 293 cells stably expressing hKv11.1 (hERG) were a gift from Dr.
Craig January (University of Wisconsin, Madison). CCR7− Ova-GFP TEM cells
(gift from Dr. Flgel, Munich, Germany) were derived from Lewis rats and react
to ovalbumin226; they were maintained in culture through alternating rounds of
antigen-dependent stimulation and of expansion in a cytokine-rich medium227,228.
As antigen-presenting cells for TEM cell stimulation, we used irradiated (30 Gy)
thymocytes harvested from humanely euthanized Lewis rats227. Histopaque-1077
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gradients (Sigma-Aldrich) were used to isolate splenocytes from the same Lewis
rats220,229.
9.2.5 Electrophysiology
Electrophysiology experiments were conducted in the whole-cell configuration of the
patch-clamp technique on a Port-a-Patch (Nanion Technologies, North Brunswick,
NJ) connected to an EPC10-USB amplifier (HEKA Instruments, Bellmore, NY)228,230.
A holding potential of -80 mV was used for all recordings. Pipette resistances aver-
aged 2.0 MΩ and series resistance compensation of 80% was employed when currents
exceeded 2 nA. Kv1.3 currents were elicited by repeated 200-ms pulses from -80 mV
to 40 mV, applied at intervals of 30 or 60 s. Kv1.3 currents were recorded in normal
Ringer solution with a Ca2+-free pipette solution containing (in mM): 145 KF, 10
HEPES, 10 EGTA, 2 MgCl2, pH 7.2, 300 mOsm. IC50-values were determined by
fitting the Hill equation to the reduction of area under the current curve measured
at 40 mV. Kv1.1 and Kv1.5 currents were recorded with 200-ms depolarizing pulses
to 40 mV applied every 10 sec. HERG (Kv11.1) currents were recorded with a 2-step
pulse from -80 mV first to 20 mV for 2 sec and then to -50 mV for 2 sec and the
reduction of both peak and tail current by the drug was determined.
9.2.6 T Lymphocyte proliferation assays
The TEM cells were used after 4 days of IL-2-dependent expansion. The splenic
T cells were used immediately after collection from Lewis rats. Cells were seeded
in flat-bottom 96-well plates in 200 µL of culture medium supplemented with 1%
homologous rat serum. ShK or ShK[K18A] were added to the cells 30 min before
the antigen or mitogen. TEM cells were stimulated with 10 µg/ml ovalbumin in
the presence of irradiated thymocytes as antigen-presenting cells and splenocytes
were stimulated with 1 µg/mL concanavalin A. The cells were cultured for 3 days
and were pulsed with [3H] thymidine (1 4µCi/well) 16-18 h before harvest. The
proliferative response of T cells was assessed in a β scintillation counter measuring
the [3H] thymidine incorporated into their DNA228,230.
9.2.7 Delayed type hypersensitivity
Lewis rats were immunized against ovalbumin227 and a week later challenged in the
pinna of one ear with ovalbumin or saline227,231. They received a subcutaneous injec-
tion of 100 µg/kg ShK[K18A] at time of challenge and ear thickness was determined
24 h later as a measure of inflammation220,227,228.
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9.2.8 Modeling of Kv1.x-ShK[K18A] complexes
The solution structure of ShK was obtained from the Protein Data Bank (PDB
ID, 1ROO)232. Homology models of Kv1.1 and Kv1.3 were taken from previous
work47. The structure of ShK[K18A] was generated from that of ShK using the
VMD plugin, Mutator104. Two-dimensional homonuclear NMR spectroscopy was
used to confirm that the solution structure of this analog was essentially identical
with that of ShK232,233 (Figures 9A.3-5 in the Appendix). The Kv1.x-ShK[K18A]
complex models were generated via docking and refinement with MD following the
same protocols used for Kv1.x-ShK complexes47. Briefly, the structure ShK[K18A]
was equilibrated in bulk MD simulations for 5 ns, and ten frames were chosen for
use in docking calculations. The initial Kv1.x-ShK[K18A] complexes were obtained
using HADDOCK69. For both Kv1.1 and Kv1.3, the top ten poses with the highest
scores were found to be very similar, and the one with the highest score was chosen
for refinement with MD. Each complex structure was embedded in a lipid bilayer
consisting of 125 POPC molecules and solvated with 10,525 water molecules and 0.1
M KCl. After the correct water and lipid densities were obtained with pressure cou-
pling, the protein-toxin complex was gradually relaxed in 5 ns MD simulations. The
equilibrated system was run for another 5 ns for analysis of the complex structure,
where convergence of the channel protein and toxin peptide was monitored using the
RMSD of the backbone atoms. MD simulations were performed using the NAMD
program59 with the CHARMM27 force field55, which includes the CMAP correc-
tion105. An NpT ensemble was used with the temperature and pressure maintained
at 300 K and 1 atm, respectively, via Langevin coupling with damping coefficients
of 5 ps−1 and 10 ps−1. Periodic boundary conditions were employed together with
particle-mesh Ewald algorithm to compute the long-range electrostatic interactions.
Lennard-Jones (LJ) interactions were switched off within a distance of 10–12 A˚, and
the list of non-bonded interactions was truncated at 13.5 A˚. A time step of 2 fs was
used, and the trajectory data were written at 1 ps intervals.
9.2.9 FEP and TI calculations
The free energy change due to a mutation is most efficiently calculated using the
alchemical transformation methods such as FEP and TI52, where the side chain of
an amino acid is gradually transformed into another side chain and the free energy
change is determined from the free energies of the end-points. This also applies to a
protein-ligand complex, provided the binding mode is not altered by the mutation,
which is the case for the K18A mutation in the Kv1.x-ShK complexes considered
here. To avoid the problems posed by the change in the charge state, we implement
the thermodynamic cycle in Figure 9.1. Accordingly, while the K18A mutation
was applied to ShK in the binding site, the reverse transformation was applied to
the toxin in the bulk simultaneously and in the same system, which ensures that
the net charge in the system did not change during the calculations. To deal with
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Figure 9.1: The thermodynamic cycle used in the free energy calculations. The super-
script 0 denotes amino acids with no charges on the side chain atoms.
convergence issues, we separated the Coulomb and LJ interactions and performed
the K18A mutation in three stages as depicted in Figure 9.1. First, the K18 side
chain on the bound ShK was discharged, while the reverse process was performed
on ShK in the bulk with an uncharged K18 side chain. Secondly, the uncharged
K18 side chain on the bound ShK was transformed to an uncharged A18 side chain,
while the reverse was performed on the bulk ShK. Finally, the A18 side chain in
the binding site was charged, while the corresponding side chain in the bulk was
discharged (note that the Ala side chain is neutral overall but has small partial
charges on C and H atoms). The change in the binding free energy due to the K18A
mutation can, thus, be expressed as:
∆∆Gb = ∆Gb(ShK[K18A])−∆Gb(ShK) = ∆∆G(K → K0) + ∆∆G(K0 → A0) + ∆∆G(A0 → A)
(9.1)
The first and last terms on the right hand side give the Coulomb contributions
to the free energy change and the middle term gives the LJ contribution. Each
term is calculated using the FEP and/or TI methods. In both methods, one in-
troduces a hybrid Hamiltonian H(λ) = (1 − λ)H0 + λH1, where H0 represents the
Hamiltonian for the initial state and H1 for the final state. In the FEP method,
the interval [0,1] is divided into n subintervals with {λi, i = 1, . . . , n − 1}, and for
each subinterval the free energy difference is calculated from the ensemble average,
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∆Gi = −kBT ln〈exp[−(H(λi+1) − H(λi))/kBT ]〉λi . The free energy difference be-
tween the initial and final states is obtained from the sum, ∆G =
∑
i ∆Gi. Provided
∆Gi ≤ 2kT for each window52, the FEP sum should converge with reasonable sam-
pling. For charge mutations, satisfaction of this condition would require over 130
windows if uniform subintervals were used. Using exponentially spaced subintervals
instead halves the required number of windows to 66 (the λ values are provided
in the Appendix). Each window was equilibrated for 80 ps followed by a 120 ps
production run. These were found to be optimal times after several tests with dif-
ferent times. We also performed the backward calculation to check for hysteresis
effects. The system was equilibrated for 5 ns after the forward transformation before
starting the backward transformation. For the LJ part, we used 30 equally-spaced
windows at the end points, i.e., for λ between 0–0.3 and 0.7–1, and 20 equally-spaced
windows in between. Using 20 ps equilibration and 30 ps production run for each
window was found to be adequate. In order to improve convergence and prevent
instabilities, we used a soft-core LJ potential with a shift coefficient of 7.082.
In the TI method, the ensemble average of the derivative, ∂H(λ)/∂λ, was ob-
tained at several values, and the free energy difference was calculated from the
integral, ∆G =
∫ 1
0
〈∂H(λ)/∂λ〉λ dλ . The TI method was especially advantageous
for charge interactions because Gaussian quadrature allows evaluation of the integral
using a small number of windows, which can be sampled for longer times to check
convergence of the results. A seven-point quadrature was found to be adequate
in previous applications of the TI method123, which was also adopted here (the λ
values are provided in the Appendix). The initial TI windows were taken from the
nearest FEP window. Each window was typically equilibrated for 1 ns and sampled
for 1 ns. The TI method has not been used in the calculation of the LJ interactions
because it offers no advantages over FEP (it requires as many windows due to the
unsuitability of Gaussian quadrature and takes longer time), and good results have
already been obtained using FEP.
9.2.10 PMF Calculations
PMF provides the most reliable method for calculation of the absolute binding free
energies of charged peptides, which can be directly compared to the experimental
values. Unlike the FEP and TI methods, which give the free energy difference
between two states, PMF provides a continuous free energy profile between the initial
and final states. This makes PMF computationally more expensive than the FEP
and TI methods. Nevertheless, it is very useful for testing of alternative methods.
The PMFs for unbinding of ShK from Kv1.x are available from earlier work47,
and those for ShK[K18A] were constructed here using the umbrella sampling MD
simulations employing the protocols developed in earlier work47,84. Briefly, umbrella
windows are generated at 0.5 A˚ intervals along the channel axis using steered MD
simulations with k = 30 kcal/mol/A˚2 and v = 5 A˚/ns. After each pulling step, the
toxin was equilibrated for 0.4 ns with the same restraining force to relax the effect of
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steering on the environment. The reaction coordinate was measured from the center
of mass of the channel protein to the center of mass of the toxin along the z axis,
which was aligned with the channel axis. A minimum of 5% overlap between the
sampling of neighboring windows was required for an accurate construction of the
PMF84. When the overlap was below this limit, e.g. due to a sharp rise in the PMF,
an extra window was included between the two windows. The same umbrella force
constant (30 kcal/mol/A˚2) was used in all windows, which was found to be optimal
for this size toxin84. The PMF was constructed from the reaction coordinates of
ShK[K18A] collected during the umbrella sampling simulations via the weighted
histogram analysis method81. Simulations were continued until the convergence of
each PMF is assured. The binding constant was determined from the integral of the
PMF, W (z), along the reaction coordinate, and the absolute binding energy from
the log of the binding constant:
Keq = piR
2
∫ z2
z1
e−W (z)/kBTdz (9.2)
Gb = −kBT ln(KeqC0) (9.3)
Here z1 is in the binding pocket and z2 is in the bulk where W vanishes. The factor
piR2 measures the average cross-sectional area of the binding pocket as explored by
the center of mass (COM) of the toxin. The values of R were determined from the
widths of the transverse fluctuations of the toxin COM. They were obtained from
restraint-free MD simulations of the complexes as 0.71 and 0.70 A˚, respectively, for
Kv1.1-ShK[K18A] and Kv1.3-ShK[K18A]. C0 is the standard concentration of 1 M.
9.3 Results and discussion
9.3.1 ShK[K18A] complexes with Kv1.1 and Kv1.3
Equilibrated structures of the Kv1.1-ShK[K18A] and Kv1.3-ShK[K18A] complexes
were obtained as described in Methods. To visualize the effect of the K18A muta-
tion on the binding modes, we superimpose the snapshots of the Kv1.x-ShK[K18A]
complexes with those of ShK (Figure 9.2). In both complex structures, there is a
very good overlap between the backbones of the mutant and wild-type ShK, indi-
cating that the K18A mutation causes minimal perturbation of the binding mode.
This observation is made more quantitative in Table 9.1, which compares the aver-
age interatomic distances between the strongly interacting residues in the mutant
and wild-type complexes. All the contact pairs are seen to be preserved after the
mutation in both complexes, and the changes in the pair distances are well within
the fluctuations for all the strongly coupled pairs (distance < 4 A˚).
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Table 9.1: Comparison of the strongly interacting pair distances in the ShK-Kv1.x com-
plexes with those in the ShK[K18A]-Kv1.x complexes. The average atom-atom distances
obtained from 5 ns MD simulations are listed in column 3 for the wild-type complexes and
in column 6 for the mutant complexes (in units of A˚). Subscripts refer to the side chain
atoms and the monomer identity in K+ channels is given in parentheses.
ShK Kv1.1 MD average ShK[K18A] Kv1.1 MD average
R11-N2 D361-O2(B) 5.5 ± 0.5 R11-N2 D361-O1(B) 4.5 ± 0.3
K18-N1 E353-O2(C) 2.7 ± 0.2
S20-OH Y379-OH(B) 3.0 ± 0.3 S20-OH Y379-OH(B) 3.0 ± 0.3
K22-N1 Y375-O(ABC) 2.7 ± 0.2 K22-N1 Y375-O(BCD) 2.7 ± 0.5
F27-Cε2 Y379-Cε1(A) 3.6 ± 0.2 F27-Cε2 Y379Cε1(A) 4.0 ± 0.4
R29-N2 E353-O2(D) 2.5 ± 0.3 R29-N2 E353-O2(D) 2.8 ± 0.4
ShK Kv1.3 MD average ShK[K18A] Kv1.3 MD average
R1-N1 D376-O1(C) 4.5 ± 0.4 R1-N1 D376-O1(C) 3.5 ± 0.3
R11-N2 D402-O1(A) 3.5 ± 0.3 R11-N2 D402-O1(A) 4.0 ± 0.3
H19-NH S378-O(B) 3.0 ± 0.5 H19-NH S378-O(B) 3.5 ± 0.5
S20-OH G401-O(B) 2.7 ± 0.2 S20-OH G401-O(B) 2.7 ± 0.2
K22-N1 Y400-O(ABD) 2.7 ± 0.2 K22-N1 Y400-O(ABD) 2.7 ± 0.2
Y23-OH G401-O(A) 3.5 ± 0.3 Y23-OH G401-O(A) 3.5 ± 0.3
F27-Cε1 H404-Cγ(C) 3.6 ± 0.2 F27-Cε1 H404-Cγ(C) 3.7 ± 0.4
9.3.2 Free energy changes from FEP and TI calculations
Provided the binding mode is preserved, the most straightforward way to calculate
the binding free energy change due to a mutation on a ligand is to use the FEP
and/or TI methods. To facilitate convergence, we adopted a staged approach, as
described in Figure 9.1. We used both methods for the charging/discharging steps
where convergence issues are critical for the long-range Coulomb interactions. Evi-
dence for the convergence of the FEP and TI calculations for charging/discharging
of Lys side chain is provided in Figure 9.3. Mutation of the uncharged Lys to Ala
involves short-range LJ interactions, where convergence is not an issue provided the
windows at the end points are chosen at small intervals. Because the TI method
offers no advantages, we have performed three independent FEP calculations for the
LJ step. Convergence of the FEP calculations for the LJ step is demonstrated in
Figure 9.3B. Detailed results of the FEP and TI calculations showing the individual
contributions from the three steps in both forward and backward directions for the
Kv1.1 and Kv1.3 channels are presented in Table 9.2. We note that there is neg-
ligible hysteresis between the forward and backward calculations in all cases, and
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Figure 9.2: The K18A mutation does not change the binding modes of ShK to Kv1.1
and Kv1.3 channels. Snapshots of ShK[K18A] (yellow with colored side chains) and ShK
(transparent orange) in complex with Kv1.1 and Kv1.3 are superposed to show that there
is a good overlap between the toxin backbones, and all the important interactions identified
in the ShK complexes are preserved in the ShK[K18A] complexes. To give the full picture,
two views of the cross sections of the complex, depicting the monomers C and A (left
panel) and D and B (right panel) are presented. Only the residues involved in binding are
indicated explicitly.
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the FEP and TI calculations yield consistent results for the charging/discharging
steps. As expected, the main contribution to the free energy difference comes from
the charging/discharging of the Lys side chain, while the charging/discharging of
the Ala side chain makes a negligible contribution.
Table 9.2: Differences in the binding free energy of ShK to Kv1.1 and Kv1.3 due to the
K18A mutation, calculated with the FEP and TI methods. The three contributions to the
binding free energy difference and their sum (Eq. 9.1) are listed in columns 2-4 (in units
of kcal/mol). In each case, the results of the forward and backward calculations are given
separately, followed by their average. The TI calculations are performed for the Coulomb
parts only; the LJ contribution is taken from the FEP calculations. The uncertainties are
calculated from block data analysis of the data.
Kv1.1/FEP ∆∆G(K → K0) ∆∆G(K0 → A0) ∆∆G(A0 → A) ∆∆Gb
FORWARD 2.4 ± 0.4 -0.3 ± 0.1 -0.1 ± 0.1 2.0 ± 0.4
BACKWARD -2.5 ± 0.5 0.3 ± 0.1 0.1 ± 0.1 -2.1 ± 0.5
AVERAGE 2.5 ± 0.5 -0.3 ± 0.1 -0.1 ± 0.1 2.1 ± 0.5
Kv1.3/FEP
FORWARD 0.9 ± 0.3 -0.2 ± 0.1 0.0 ± 0.1 0.7 ± 0.2
BACKWARD -0.4 ± 0.3 0.2 ± 0.1 0.0 ± 0.1 -0.2 ± 0.2
AVERAGE 0.7 ± 0.3 -0.2 ± 0.1 0.0 ± 0.1 0.5 ± 0.2
Kv1.1/TI
FORWARD 2.7 ± 0.5 -0.3 ± 0.1 -0.1 ± 0.1 2.3 ± 0.5
BACKWARD -3.0 ± 0.6 0.3 ± 0.1 0.1 ± 0.1 -2.6 ± 0.6
AVERAGE 2.8 ± 0.6 -0.3 ± 0.1 -0.1 ± 0.1 2.4 ± 0.6
Kv1.3/TI
FORWARD 0.6 ± 0.5 -0.2 ± 0.1 0.0 ± 0.1 0.4 ± 0.5
BACKWARD -0.1 ± 0.5 0.2 ± 0.1 -0.1 ± 0.1 0.0 ± 0.5
AVERAGE 0.4 ± 0.5 -0.2 ± 0.1 0.0 ± 0.1 0.2 ± 0.5
9.3.3 Free energy changes from PMF calculations
PMF calculations were then performed to check the accuracy of the FEP and TI
calculations. The binding constants and absolute binding free energies obtained
from PMFs also allow a direct comparison with the experimental values. The PMFs
for the unbinding of ShK from Kv1.1 and Kv1.3 were constructed in our earlier
work47. Here we repeat these PMF calculations for ShK[K18A] using the same
protocols. Convergence studies of the PMFs from block data analysis (Figures 9A.6
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Figure 9.3: Convergence of the FEP and TI calculations. (A) Convergence of the FEP
calculations for discharging/charging of the K18 in ShK in the binding site/bulk. Running
averages of ∆Gi for windows at λ = 0 (black), λ = 0.2 (red), λ = 0.4 (green), λ = 0.6
(blue), λ= 0.8 (yellow) and λ= 0.999 (magenta) are plotted as a function of the production
time for Kv1.1 (left) and Kv1.3 (right). (B) Similar to A but showing the convergence of
the FEP calculations for transformation of the uncharged Lys side chain to that of Ala.
(C) Convergence of the TI calculations for discharging/charging of K18 in ShK in the
binding site/bulk. Running averages of the ∆G values obtained from the TI calculations
are plotted as a function of the production time for Kv1.1 (left) and Kv1.3 (right). Both
the forward (black) and the negative of the backward (red) results are shown to check for
hysteresis effects, which remain well below 1 kcal/mol for both channels.
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and 9A.7 in the Appendix) show that the PMF in the Kv1.3-ShK[K18A] system
converges relatively quickly, just as in the case of the Kv1.3-ShK system47, and the
final PMFs for ShK and ShK[K18A] are very similar (Figure 9.4). Convergence of
the PMF in the Kv1.1-ShK[K18A] system is delayed somewhat (Figures 9A.6 and
9A.7 in the Appendix), which can be traced to the slow equilibration of the E353-R29
side chain interactions. As expected, abolishing a charge interaction in the Kv1.1-
ShK[K18A] system leads to a shallower PMF compared with that for Kv1.1-ShK.
An interesting feature of the ShK[K18A] PMF is the absence of the shoulder region
observed in the ShK PMF, which is caused by the long-range Coulomb interactions,
in particular by the E353-R29 pair47. To understand this feature, we compare the
E353(O2)-R29(N2) pair distances in ShK and ShK[K18A] PMFs as a function of
the channel-toxin distance, z (Figure 9A.8 in the Appendix). The pair distance
remains around 7-8 A˚ for z > 35A˚ in the ShK PMF but becomes double that in
the ShK[K18A] PMF. Thus, there are no discernible charge interactions left after
z = 35A˚ in the ShK[K18A] PMF, which explains its earlier flattening compared to
the ShK PMF. Similarly the bump in the Kv1.1-ShK PMF around z = 43A˚ can be
explained by the re-engagement of the E353-R29 pair due to rotation of the toxin and
its subsequent dissociation (Figure 9A.8 in the Appendix). Absolute binding free
energies obtained from the integration of the PMFs (Eq. 9.2) are compared to the
experimental values in Table 9.3. In all cases, the calculated binding free energies
agree with the experimental values within the chemical accuracy of 1 kcal/mol,
which provides strong support for the accuracy of the complex models.
Table 9.3: The relative and absolute binding free energies obtained from the PMF calcu-
lations for the Kv1.x-ShK and Kv1.x-ShK[K18A] complexes. The relative binding energy,
∆Wwell, is given by the well depth in the PMF and the absolute binding free energy, Gb, is
obtained from the integration of the PMF via Eq. 9.2 (in units of kcal/mol). Experimental
Gb is determined from the binding constants using Eq. 9.3.
Complex ∆Wwell Gb (PMF) Gb (exp)
Kv1.1-ShK -18.0 ± 0.7 -14.3 ± 0.6 -14.4 ± 0.1
Kv1.1-ShK[K18A] -15.3 ± 0.7 -11.7 ± 0.7 -11.3 ± 0.1
Kv1.3-ShK -17.8 ± 0.8 -14.2 ± 0.7 -15.0 ± 0.1
Kv1.3-ShK[K18A] -17.4 ± 0.7 -13.9 ± 0.6 -14.2 ± 0.1
9.3.4 Selectivity free energies
The results of the binding free energy differences obtained using various approaches
are summarized in Table 9.4 together with the experimental values. The FEP and
TI results are in good agreement with those of the PMF, which indicates that the
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Figure 9.4: Comparison of the PMFs for the unbinding of ShK and ShK[K18A] from
the Kv1.1 and Kv1.3 channels.
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former methods can be used reliably in calculation of the free energy differences
associated with mutation of amino acids. The TI method gives slightly better results
compared with FEP for charge interactions, presumably because of longer sampling
of windows. The crucial question of the selectivity free energy gain for Kv1.3/Kv1.1
associated with the K18A mutation is addressed in the last column of Table 9.4.
All methods predict a gain in selectivity free energy of about 2 kcal/mol, which is
confirmed with the binding constant measurements of ShK[K18A] for Kv1.1 and
Kv1.3.
Table 9.4: Comparison of the binding free energy differences for Kv1.1 and Kv1.3, and
the selectivity free energy for Kv1.3/Kv1.1, obtained using the FEP, TI and PMF methods,
with the experimental results. The FEP and TI results are taken from Table 9.2, and the
PMF results are obtained from Table 9.3 using ∆∆Gb = Gb (ShK[K18A]) - Gb (ShK) (a
similar result is obtained if ∆Wwell is used instead of Gb). The change in selectivity free
energy due to the mutation in column 4 follows from ∆∆Gsel = ∆∆Gb (Kv1.1) - ∆∆Gb
(Kv1.3). All energies are in units of kcal/mol.
∆∆Gb (Kv1.1) ∆∆Gb (Kv1.3) ∆∆Gsel
FEP 2.1 ± 0.5 0.5 ± 0.2 1.6 ± 0.6
TI 2.4 ± 0.6 0.2 ± 0.5 2.2 ± 0.8
PMF 2.6 ± 1.0 0.3 ± 1.0 2.3 ± 1.4
Exp. 3.1 ± 0.1 0.8 ± 0.2 2.3 ± 0.2
9.3.5 Experimental validation of modeling results
In order to validate the modeling results by experimentation, we used the well-
established technique of whole-cell patch-clamp. Using this technique, mouse fi-
broblasts stably expressing either Kv1.1 or Kv1.3 channels were patch-clamped to
measure total potassium currents through these channels. The perfusion of various
dilutions of ShK or ShK[K18A] induced Kv1.1 or Kv1.3 channel block, measured
by a steady-state reduction in potassium currents through the Kv1 channels, allow-
ing for the determination of the half-inhibitory concentration (IC50) for ShK and
its analog. ShK[K18A] inhibited Kv1.3 channels with an IC50 of 39.6 ± 3.8 pM,
displaying a modest decrease in potency compared to ShK (IC50 on Kv1.3 = 9.3 ±
2.0 pM) (Figure 9.5A)230. ShK also inhibited Kv1.1 channels with a high affinity
(IC50 = 25.6 ± 2.8 pM) (Figure 9.5B). In contrast, ShK[K18A] exhibited a 124-fold
selectivity for Kv1.3 over Kv1.1 channels (IC50 on Kv1.1 = 4,900 ± 200 pM).
A potential concern when developing potassium channel blockers is off-target
toxic effects on cardiac channels. We therefore used the whole-cell patch-clamp
assay to determine the effects of ShK[K18A] on the two cardiac potassium channels
Kv1.5 and Kv11.1 (hERG). ShK[K18A] had no effects on either cardiac potassium
channels when tested at concentrations of up to 100 nM (results not shown).
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Since selective Kv1.3 channel blockers are known to preferentially inhibit the
proliferation of CCR7− TEM lymphocyte with little to no effect on the prolifera-
tion of CCR7+ na¨ıve and TCM lymphocytes, we next tested the effects of ShK and
ShK[K18A] on the proliferation of rat T lymphocytes. Both peptides displayed
a marked preferential inhibition of the proliferation of TEM lymphocytes (Figure
9.5C) with little effect on na¨ıve/TCM cells (Figure 9.5D). These results suggest that
ShK[K18A] is selective for Kv1.3 over KCa3.1 channels as na¨ıve/TCM cells rely on
KCa3.1 channels for their proliferation215.
Finally, we used an active DTH reaction to ovalbumin to determine the in vivo
ability of ShK[K18A] to inhibit a TEM lymphocyte-mediated inflammatory reaction.
ShK[K18A] reduced this active DTH reaction by ca 52% (Figure 9.5E), exhibiting
similar activity to ShK-186 and ShK-192 in this model221.
These results demonstrate that ShK[K18A] is bioavailable and can inhibit TEM
cells both in vitro and in vivo, making it a compound of considerable interest for
immunomodulation and treatment of TEM-mediated diseases.
9.4 Conclusions
Increasing the selectivity of a drug lead for a specified target is a design problem
that in principle could be greatly facilitated using computational methods. Here we
have described the case of ShK peptide, which binds with high affinity to the Kv1.3
channel and is a potential drug lead for the treatment of autoimmune diseases. We
have analyzed the K18A mutation in ShK, which was suggested by accurate models
of Kv1.x-ShK complexes, and shown via free energy calculations, to produce a 2
kcal/mol gain in selectivity free energy for Kv1.3/Kv1.1. Experimental confirma-
tion of this result increases confidence in the ability of the free energy methods,
in particular computationally cheaper FEP and TI methods, to predict the effects
of mutations accurately. Moreover, the potency of ShK[K18A] against Kv1.3, its
selectivity for this channel over Kv1.1, its preferential inhibition of TEM cells over
na¨ıve and TCM cells, its ability to significantly reduce a DTH reaction, and the fact
that it is composed entirely of protein amino acids, make it an attractive candidate
for further evaluation as a therapeutic for autoimmune diseases.
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Figure 9.5: ShK[K18A] is selective for Kv1.3 over Kv1.1 channels and preferentially
targets TEM lymphocytes in vitro and in vivo. (A) Effects of ShK (black squares) and
ShK[K18A] (open circles) on Kv1.3 currents measured by whole-cell patch-clamp on L929
fibroblasts stably transfected with mKv1.3. The two left panels show whole-cell Kv1.3
currents before (control) and after perfusion of ShK[K18A] (left panel) or ShK (middle
panel). The panel on the right shows the Kv1.3 currents remaining after steady-state block
is reached with the different concentrations of ShK and its analog, fitted to a Hill equation
(N = 5-6 cells per concentration).(B) Effects of ShK (black squares) and ShK[K18A]
(open circles) on Kv1.1 currents measured by whole-cell patch-clamp on L929 fibroblasts
stably transfected with mKv1.1. The two left panels show whole-cell Kv1.1 currents before
(control) and after perfusion of ShK[K18A] (left panel) or ShK (middle panel). The panel
on the right shows the Kv1.1 currents remaining after steady-state block is reached with
the different concentrations of ShK and its analog, fitted to a Hill equation (N = 6-7 cells
per concentration).(C) Effects of ShK (black squares) and ShK[K18A] (open circles and
dashed line) on the proliferation of rat TEM cells measured in vitro by the incorporation of
[3H] thymidine into the DNA of dividing cells (N = 3). (D) Effects of ShK (black squares)
and ShK[K18A] (open circles and dashed line) on the proliferation of rat splenocytes
(mainly na¨ıve/TCM cells; N = 3).(E) Effects of the subcutaneous administration of 100
µg/kg ShK[K18A] on an active DTH reaction elicited against ovalbumin. Data show
the difference in challenged and non-challenged ear thickness in vehicle-treated rats and
ShK[K18A]-treated rats (N = 6/group).
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Lambda values used in charge/discharge FEP calculations. 67 exponen-
tially spaced lambda values were used:
0.000000000 1.0000004e-03 5.9452732e-03 1.1209489e-02 1.6813217e-02 2.2778355e-
02 2.9128211e-02 3.5887597e-02 4.3082927e-02 5.0742315e-02 5.8895691e-02 6.7574915e-
02 7.6813901e-02 8.6648751e-02 9.7117893e-02 1.0826224e-01 1.2012533e-01 1.3275353e-
01 1.4619617e-01 1.6050579e-01 1.7573831e-01 1.9195323e-01 2.0921393e-01 2.2758785e-
01 2.4714678e-01 2.6796716e-01 2.9013033e-01 3.1372291e-01 3.3883708e-01 3.6557097e-
01 3.9402905e-01 4.2432252e-01 4.5656975e-01 0.5000000000 5.4343025e-01 5.7567748e-
01 6.0597095e-01 6.3442903e-01 6.6116292e-01 6.8627709e-01 7.0986967e-01 7.3203284e-
01 7.5285322e-01 7.7241215e-01 7.9078607e-01 8.0804677e-01 8.2426169e-01 8.3949421e-
01 8.5380383e-01 8.6724647e-01 8.7987467e-01 8.9173776e-01 9.0288211e-01 9.1335125e-
01 9.2318610e-01 9.3242508e-01 9.4110431e-01 9.4925769e-01 9.5691707e-01 9.6411240e-
01 9.7087179e-01 9.7722165e-01 9.8318678e-01 9.8879051e-01 9.9405473e-01 9.9900000e-
01 1.0000000000
Lambda values used in charge/discharge TI calculations (seven point
Gaussian quadrature):
0.02544 0.12923 0.29707 0.50000 0.70292 0.87076 0.97455
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Figure 9A.1: The LC profile of ShK[K18A].
Figure 9A.2: ESI-MS analysis of ShK[K18A]. The mass of the peptide calculated from
the predicted amino acid sequence (3998 Da), compared well to the electrospray mass
spectrometry (ESI-MS, 3998 Da).
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Figure 9A.3: The 1D 1H NMR spectrum of wild-type ShK and ShK[K18A] at pH 4.8,
acquired on a Bruker Avance 600 MHz spectrometer at 20oC.
Figure 9A.4: The amide and aromatic region of 1H NMR spectra of wild-type ShK and
ShK[K18A] at pH 4.8, acquired on a Bruker Avance 600 MHz spectrometer at 20oC.
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Figure 9A.5: Deviation from random coil chemical shifts (4) of the HN (A), Hα (B), and
Hβ (C) resonances of wild-type ShK and ShK[K18A] at 20oC and pH 4.8.
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Figure 9A.6: Convergence of the Kv1.x-ShK[K18A] PMFs from 2 ns block data analysis.
To reduce fluctuations, we use a large sampling size (2 ns), which is slid in 0.5 ns steps
over the range of the data. In Kv1.1, the PMFs drop monotonically until 3.5-5.5 ns, after
which they fluctuate around a base line. In Kv1.3, equilibration occurs earlier, presumably
due to the stronger binding. To decide more precisely which part of the data should be
discarded for equilibration, we have constructed PMFs from 0.5 ns blocks in Figure 9A.7.
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Figure 9A.7: Convergence of the Kv1.x-ShK[K18A] PMFs from 0.5 ns block data anal-
ysis. In Kv1.1, the first 4.5 ns of data are discarded as equilibration, and the final PMF is
determined from the last 2.5 ns of data. In Kv1.3, the first 1.5 ns of data are discarded,
and the final PMF is determined from the last 5 ns of data.
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Figure 9A.8: The E353(O2)R29(N2) pair distances in ShK and ShK[K18A] PMFs as
a function of the channel-toxin distance in Kv1.1. In the case of ShK[K18A], the pair
decouple for z > 35 A˚, which explains the earlier flattening of the corresponding PMF
in Figure 9.4. The bump in the Kv1.1-ShK PMF around z = 43 A˚ (Figure 9.4) can be
traced back to the temporary re-engagement of R29 with E353 facilitated by rotation of
the toxin.
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Conclusions and future work
In this thesis we have performed all-atom molecular dynamics simulations on differ-
ent proteins related to the process of neurotransmission in the brain. We focus on
glutamate transporters and receptors, as well as potassium channels. These struc-
tures are related to a number of neurodegenerative conditions and auto-immune
diseases, and therefore serve as potential drug targets. In order to investigate these
proteins, we combine classical molecular dynamics with a variety of methods in com-
putational biology. We parameterize drug-like molecules for use with the CHARMM
force-field using ab initio calculations, and use archaeal homologs to build protein
models that do not have crystal structures available. We also dock ligands to proteins
to find the correct binding modes, which are used in binding free energy calculations.
In order to calculate the ligand binding free energies and the protein conformational
changes, we perform free energy perturbation calculations with restraints, as well as
potential of mean force calculations.
The first structure we investigate is an archaeal homolog of the human glutamate
transporters, called GltPh, which is mainly an aspartate transporter. GltPh displays
many similarities with the EAATs, and therefore can provide important insights into
the mechanism of the human transporters. Like the EAATs, GltPh co-transports the
substrate with three sodium ions, even though only two of them could be identified
in the GltPh crystal structure. We locate the binding site of the missing sodium
ion (Na3), providing experimental evidence that this binding site is present in both
GltPh and the EAATs. We then perform MD simulations in the outward-facing
GltPh including the Na3 ion, showing the coordination of all the ligands, their order
of binding, the nature of the sodium-aspartate coupling, and the reasons behind
the aspartate/glutamate selectivity. We follow by performing simulations in the
inward-facing structure of GltPh, searching for an understanding of the mechanism
of ions and substrate release. Our results demonstrate that the binding affinity of
the ligands is symmetrical between the inward and outward states, as well as the
order of binding/unbinding, with the ligands that bind last being released first. In
the absence of any crystal structures of GltPh in the inward open state, we obtain
this conformation by simulating the inward GltPh with different combinations of
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ligands bound. The simulations show the inward gating involving both the HP1
and HP2 segments, as opposed to the large HP2 movement observed in the outward
state. Free energy calculations also show that the sodium-aspartate coupling is
mostly electrostatic, and that the large affinity of the Na3 ion might be behind the
long turnover rates of GltPh. Our thorough investigation of the GltPh properties
enabled us to build homology models for the human transporter EAAT3 based on
this archaeal homolog, which we studied next.
The EAATs and GltPh, although having similar binding sites for the sodium ions
and the substrate, as well as tertiary structures, have a few important differences.
One of them is that, in addition to the co-transport of three sodium ions, the EAATs
also transport one proton with glutamate and counter-transport one potassium ion
at each cycle. The EAATs also have a much faster turnover rate compared to GltPh,
which might be related to these two additional ligands. This has prompted us to
create models for the EAAT3 transporter based on GltPh, and study the properties
of the former by using MD simulations and FEP/TI calculations. The fully-bound
EAAT3 models we produce are very stable, and so is the coordination of the ligands,
even after several nanoseconds of simulations. By removing the substrate, we find
that the gating motions of EAAT3 and GltPh in the outward-facing states are very
similar, but there is a larger opening in the HP1 segment in the inward state of
EAAT3 compared to GltPh. We trace that to the relocation of an arginine residue
from the HP1 segment in GltPh to the TM8 segment in the EAATs. To locate the
potassium binding site in the EAATs, we test three potential sites for this ion as
suggested by experiments; either overlapping with the substrate, the proton, or two
sodium ions. We find that this last site has the lowest binding free energy, and
that sodium/potassium exchange could explain the faster transport of the EAATs
compared to GltPh.
In our EAAT3 model glutamate is not stably bound with a deprotonated E374
side-chain, making this residue a good candidate for the proton carrier, which is also
corroborated by experiments. We perform rigorous pKa calculations using FEP/TI
on all the titratable residues close to the substrate binding site in the fully bound
EAAT3, and find that E374 is the only one protonated in these conditions. We then
calculate the pKa of this residue in different states of EAAT3 and with different
ligands bound, to elucidate the mechanism of proton transport. We find that the
binding and release of the proton is dependent on the presence of the substrate and
the closure of the HP1/HP2 gates, and that potassium binding in the inward facing
state is necessary for proton release.
The next protein we investigate is the GluA2 receptor, which has high-resolution
crystal structures available in complex with many ligands, and also the experimental
binding affinities for each of them. We calculate the binding free energies of five
ligands to GluA2, including two ligands with a net charge, using alchemical FEP/TI
with restraints combined with PMF calculations. Alchemical FEP/TI methods are
advantageous over PMF methods for binding sites that are deeply buried inside
proteins, but they also present problems for ligands that have charges. Here we
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show that these calculations are possible using FEP, as long as we perform the
decoupling/coupling of charges in the bulk/binding site in the same system, which
preserves the neutrality of the periodic cell. We also apply the confine-and-release
method, which is a useful tool when there are large hysteresis effects in the forward
and backward FEP calculations. We obtain results close to the experimental values
for all the ligands, and therefore our method provides an efficient and accurate way
of computing the binding free energies of small molecules. These calculations have
the potential to become a useful tool in the final stages of rational drug design,
since they can be applied to a number of different systems. In the case of the GluA2
receptor, we also gained insights into the components of the binding free energy
of each ligand, since our FEP/TI approach separates the free energies arising from
Lennard-Jones and electrostatic interactions.
In addition to the binding affinity of small molecules, alchemical FEP/TI also
provides a good solution to calculate the binding free energy differences between
wild-type and mutant toxin peptides to ion channels. In this case, to obtain good
convergence and accurate results, the toxin binding modes should not be affected by
the mutation. Here we apply alchemical FEP/TI to increase the selectivity of the
sea-anemone ShK toxin for the Kv1.3 channel over Kv1.1, which is a problem for
the wild-type toxin. We successfully create a ShK mutant that is a selective blocker
of the Kv1.3 channel over Kv1.1, and therefore may provide a good alternative in
the treatment of auto-immune diseases. The results we obtain are also in good
agreement with PMF calculations and experiments, even though FEP/TI is less
computationally costly compared to PMF methods. Therefore, this approach also
provides a good alternative for rational drug design, but for small peptides instead
of drug-like molecules.
There are still many unanswered questions related to the aspartate/glutamate
transporters. Even though there are crystal structures in the inward and outward
facing states of GltPh, with many related MD studies, the outward to inward transi-
tion mechanism remains unknown. We plan as future work to perform multidimen-
sional potential of mean force calculations on this transition, with different ligands
bound to the transporter, to understand the mechanism of substrate translocation
in GltPh and the EAATs. GltPh is also a homolog of the human neutral amino acid
transporters (ASCTs), and we have recently used a ASCT1 model created by us to
help interpret mutagenesis experiments in this transporter. We also plan on em-
ploying the FEP/TI calculations we did on the glutamate receptor to other proteins
that are potential drug targets, turning this method into an automated protocol
that could be quickly applied to any system. By combining this protocol with ho-
mology modeling, parameterization of molecules and ligand docking, we aim to have
a complete set of tools that can be used on computer-aided drug design. In the case
of peptide toxins, there is a large database of potassium channel blockers that can
be engineered to bind to a particular channel based on MD simulations, opening up
the possibility of new drugs developed from toxins found in the animal kingdom.
Chapter 11
Bibliography
1. Kolb, B., and I. Q. Whishaw. 2003. Fundamentals of Human Neuropsychology.
Worth Publishers, London, UK.
2. Purves, D, G. J. Augustine, D. Fitzpatrick, L. C. Katz, A. LaMantia, J. O. Mc-
Namara, and S. M. Williams. 2001. Neuroscience. Sinauer Associates, Sunderland,
MA, USA.
3. Hayashi, T. 1954. Effects of sodium glutamate on the nervous system Keio J.
Med. 3:183–192.
4. Curtis, D. R., J. W. Phillis, and J. C. Watkins. 1959. Chemical excitation of
spinal neurons. Nature 183:611–612.
5. Sugiyama, H., I. Ito, and M. Watanabe. 1989. Glutamate receptor subtypes may
be classified into two major categories: A study on Xenopus oocytes injected with
rat brain mRNA. Neuron 3:129–132.
6. Dingledine, R., K. Borges, D. Bowie, and S. F. Traynelis. 1999. The glutamate
receptor ion channels. Pharmacol. Rev. 51:7–61.
7. Armstrong, N., and E. Gouaux. 2000. Mechanisms for Activation and Antago-
nism of an AMPA-Sensitive Glutamate Receptor: Crystal Structures of the GluR2
Ligand Binding Core. Neuron 28:165–181.
8. Chaudhry, C., M. C. Weston, P. Schuck, C. Rosenmund, and M. L. Mayer. 2009.
Stability of ligand-binding domain dimer assembly controls kainate receptor de-
sensitization. Embo J. 28:1518–1530.
9. Jin, R., S. K. Singh, S. Gu, H. Furukawa, A. I. Sobolevsky, J. Zhou, Y. Jin,
and E. Gouaux. 2009. Crystal structure and association behaviour of the GluR2
amino-terminal domain. Embo J. 28: 1812–1823.
10. Kumar, J., and M. L. Mayer. 2010. Crystal structures of the glutamate receptor
ion channel GluK3 and GluK5 amino-terminal domains. J. Mol. Biol. 404:680–696.
213
214 Chapter 11 Bibliography
11. Sobolevsky, A. I., M. P. Rosconi, and E. Gouaux. 2009. X-ray structure, symme-
try and mechanism of an AMPA-subtype glutamate receptor. Nature 462:745–756.
12. Danbolt, N. C. 2001. Glutamate uptake. Prog. Neurobiol. 65:1–105.
13. Zerangue, N. and M. P. Kavanaugh. 1996. Flux coupling in a neuronal glutamate
transporter. Nature. 383:634–637.
14. Yernool, D., O. Boudker, Y. Jin, and E. Gouaux. 2004. Structure of a glutamate
transporter homologue from Pyrococcus horikoshii. Nature 431:811–818.
15. Boudker, O., R. M. Ryan, D. Yernool, K. Shimamoto, and E. Gouaux. 2007.
Coupling substrate and ion binding to extracellular gate of a sodium-dependent
aspartate transporter. Nature. 445:387–393.
16. Reyes, N., C. Ginter, and O. Boudker. 2009. Transport mechanism of a bacterial
homologue of glutamate transporters. Nature. 462:880–885.
17. Hille, B. 2001. Ionic Channels of Excitable Membranes. Sinauer Associates, Sun-
derland, MA, USA.
18. Beeton, C., H. Wulff, N. E. Standifer, P. Azam, K. M. Mullen, M. W. Pen-
nington, A. Kolski-Andreaco, E. Wei, A. Grino, D. R. Counts et al.. 2006. Kv1.3
channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc.
Natl. Acad. Sci. USA. 103:17414–17419.
19. Rossi, D.J., T. Oshima, and D. Attwell. 2000. Glutamate release in severe brain
ischaemia is mainly by reversed uptake. Nature 403:316–321.
20. Rothstein, J.D., M. Van Kammen, A. I. Levey, L. J. Martin, and R. W. Kuncl.
1995. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral
sclerosis. Ann. Neurol. 38:73–84.
21. Li, S., M. Mallory, M. Alford, S. Tanaka, and E. Masliah. 1997. Glutamate
transporter alterations in Alzheimer disease are possibly associated with abnormal
APP expression. J. Neuropathol. Exp. Neurol. 56:901–911.
22. During, M.J., and D. D. Spencer. 1993. Extracellular hippocampal glutamate
and spontaneous seizure in the conscious human brain. Lancet 341:1607–1610.
23. Tanaka, K., K. Watase, T. Manabe, K. Yamada, M. Watanabe, K. Takahashi,
H. Iwama, T. Nishikawa, N. Ichihara, S. Hori, M. Takimoto, and K. Wada. 1997.
Epilepsy and exacerbation of brain injury in mice lacking the glutamate trans-
porter GLT-1. Science 276:1699–1702.
24. Kanai, Y., C. P. Smith, and M. A. Hediger. 1993. A new family of neurotransmit-
ter transporters the high-affinity glutamate transporters. FASEB J. 7:1450–1459.
215
25. Grunewald, M., A. Bendahan, and B. I. Kanner. 1998. Biotinylation of single
cysteine mutants of the glutamate transporter GLT-1 from rat brain reveals its
unusual topology. Neuron 21:623–632.
26. Grunewald, M., and B. I. Kanner. 2000. The accessibility of a novel reentrant
loop of the glutamate transporter GLT-1 is restricted by its substrate. J. Biol.
Chem. 275:9684–9689.
27. Danbolt, N. C., K. P. Lehre, Y. Dehnes, F. A. Chaudhry, L. M. Levy. 1998. Lo-
calization of transporters using transporter-specific antibodies. Methods Enzymol.
296:388–407.
28. Kavanaugh, M. P., A. Bendahan, N. Zerangue, Y. Zhang, and B. I. Kanner. 1997.
Mutation of an amino acid residue influencing potassium coupling in the glutamate
transporter GLT-1 induces obligate exchange. J. Biol. Chem. 272:1703–1708.
29. Wadiche, J. I., S. G. Amara, and M. P. Kavanaugh. 1995. Ion fluxes associated
with excitatory amino acid transport. Neuron 15:721–728.
30. Tao, Z., Z. Zhang, and C. Grewer. 2006. Neutralization of the aspartic acid
residue Asp-367, but not Asp-454, inhibits binding of Na+ to the glutamate-free
form and cycling of the glutamate transporter EAAC1. J. Biol. Chem. 281:10263–
10272.
31. Tao, Z., N. Rosental, B. I. Kanner, A. Gameiro, J. Mwaura, and C. Grewer. 2010.
Mechanism of cation binding to the glutamate transporter EAAC1 probed with
mutation of the conserved amino acid residue Thr101. J. Biol. Chem. 285:17725–
17733.
32. Bendahan, A., A. Armon, N. Madani, M. P. Kavanaugh, and B. I. Kanner. 2000.
Arginine 447 plays a pivotal role in substrate interactions in a neuronal glutamate
transporter. J. Biol. Chem. 275:37436–37442.
33. Teichman, S., and B. I. Kanner. 2007. Aspartate-444 is essential for produc-
tive substrate interactions in a neuronal glutamate transporter. J. Gen. Physiol.
129:527–539.
34. Zhang, Y. and B. I. Kanner. 1999. Two serine residues of the glutamate trans-
porter GLT-1 are crucial for coupling the fluxes of sodium and the neurotransmit-
ter. Proc. Natl. Acad. Sci. USA. 96:1710–1715.
35. Ryan, R. M., E. L. Compton, and J. A. Mindell. 2009. Functional characteri-
zation of a Na+-dependent aspartate transporter from Pyrococcus horikoshii. J.
Biol. Chem. 284:17540–17548.
36. Huang, Z., and E. Tajkhorshid. 2008. Dynamics of the extracellular gate and
ion-substrate coupling in the glutamate transporter. Biophys. J. 95:2292–2300.
216 Chapter 11 Bibliography
37. Groeneveld, M., and D. J. Slotboom. 2010. Na+:aspartate coupling stoichiome-
try in the glutamate transporter homologue Glt(Ph). Biochemistry. 49:3511–3513.
38. Bastug, T., G. Heinzelmann, S. Kuyucak, M. Salim, R. J. Vandenberg, and R.
M. Ryan. 2012. Position of the Third Na Site in the Aspartate Transporter GltPh
and the Human Glutamate Transporter, EAAT1. PLoS ONE 7:e33058.
39. DeChancie, J., I. H. Shrivastava, and I. Bahar. 2011. The mechanism of sustrate
release by the aspartate transporter GltPh: insights from simulations. Mol. BioSyst.
7:832–842.
40. Verdon, G., and O. Boudker. 2012. Crystal structure of an asymmetric trimer
of a bacterial glutamate transporter homolog. Nat.Struct.Mol.Biol. 19:355–357.
41. Lau, A. Y., and B. Roux. 2011. The Hidden Energetics of Ligand Binding and
Activation in a Glutamate Receptor. Nat. Struc. Mol. Biol. 18:283–287.
42. Wolter, T., T. Steinbrecher, and M. Elstner. 2013. Computational Study of Syn-
thetic Agonist Ligands of Ionotropic Glutamate Receptors. PLoS ONE 8:e58774.
43. Woo, H., and B. Roux. 2005. Calculation of Absolute Protein-Ligand Binding
Free Energy from Computer Simulations. Proc. Nat. Acad. Sci. U.S.A. 102:6825–
6830.
44. Felipe, A., J. Bielanska, N. Comes, A. Vallejo, S. Roig, S. Ramn Y Cajal,
E. Condom, J. Hernndez-Losa, and J. C. Ferreres. 2012. Targeting the voltage-
dependent K+ channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection
and prevention. Curr. Med. Chem. 19:661–674.
45. Norton, R.S., M. W. Pennington, and H. Wulff. 2004. Potassium channel block-
ade by the sea anemone toxin ShK for the treatment of multiple sclerosis and other
autoimmune diseases. Curr. Med. Chem. 11:3041–3052.
46. Beeton, C., M. W. Pennington, and R. S. Norton. 2011. Analogs of the sea
anemone potassium channel blocker ShK for the treatment of autoimmune dis-
eases. Inflamm. Allergy Drug Targets 10:313–321.
47. Rashid, M. H., and S. Kuyucak. 2012. Afinity and selectivity of ShK toxin
for the Kv1 potassium channels from free energy simulations. J. Phys. Chem. B
116:4812–4822.
48. Einstein, A. 1905. U¨ber die von der molekularkinetischen Theorie der Wrme
geforderte Bewegung von in ruhenden Flssigkeiten suspendierten Teilchen. An-
nalen der Physik 17:549–560.
49. Kohn, W., and L. J. Sham. 1965. Self-consistent equations including exchange
and correlation effects. Phys. Rev. A 140:1133–1138.
217
50. Car, R., and M. Parrinello. 1985. Unified approach for molecular dynamics and
density-functional theory. Phys. Rev. Lett. 55:2471–2474.
51. Karplus, M., and J. A. McCammon. 2002. Molecular dynamics simulations of
biomolecules. Nat. Struct. Biol. 9:646–652.
52. Beveridge, D. L., and F. M. DiCapua. 1989. Free energy via molecular simu-
lation: applications to chemical and biomolecular systems. Ann. Rev. Biophys.
Biophys. Chem. 18:431–492.
53. Torrie, G.M., and J. P. Valleau. 1997. Nonphysical sampling distributions in
Monte Carlo free-energy estimation: umbrella sampling. J. Comp. Phys. 23:187–
199.
54. Laio, A., and M. Parrinello. 2002. Escaping free-energy minima. Proc. Natl.
Acad. Sci. USA. 99:12562–12566.
55. MacKerell, A. D., D. Bashford, R. Bellott, R. L. Dunbrack, J. D. Evanseck,
M. J. Field, S. Fisher, J. Gao, H. Guo, S. Ha, et al. 1998. All-atom empirical
potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem.
B 102:3586–3616.
56. Wang, J., R. M. Wolf, J. W. Caldwell, P. A. Kollman, and D. A. Case. 2004.
Development and testing of a general amber force field. J. Comput. Chem. 25:1157–
1174.
57. Christen, M., P. H. Hunenberger, D. Bakowies, R. Baron, R. Bu¨rgi, D. P. Geerke,
T. N. Heinz, M. A. Kastenholz, V. Krutler, C. Oostenbrink, C. Peter, D. Trzes-
niak, and W. F. van Gunsteren. 2005. The GROMOS software for biomolecular
simulation: GROMOS05. J. Comput. Chem. 26:1719–1751.
58. Lennard-Jones, J.E. 1924. On the determination of molecular fields. II. The
equation of state of a gas. Proc. Roy. Soc. A. 106:463–477.
59. Phillips, J. C., R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid, E. Villa, C.
Chipot, R. D. Skeel, L. Kale, and K. Schulten. 2005. Scalable molecular dynamics
with NAMD. J. Comput. Chem. 26:1781–1802.
60. Ryckaert, J., G. Ciccotti, and H. Berendsen. 1977. Numerical integration of the
cartesian equations of motion of a system with constraints:molecular dynamics of
n-alkanes. J. Comput. Phys. 23:327–341.
61. Frenkel, D., and B. Smit. 2002. Understanding Molecular Simulation From Al-
gorithms to Applications. Academic Press, California, USA.
62. Kubo, R., M. Toda, and N. Hashitsume. 1991. Statistical Physics II: Nonequi-
librium Statistical Mechanics. Springer.
218 Chapter 11 Bibliography
63. Brnger, A., C. B. Brooks, and M. Karplus. 1984. Stochastic boundary conditions
for molecular dynamics simulations of ST2 water. Chem. Phys. Lett. 105:495–500.
64. Feller, S. E., Y. Zhang, R. W. Pastor, and B. R. Brooks. 1995. Constant-
pressure molecular-dynamics simulation–The Langevin piston method. J. Chem.
Phys. 103:4613–4621.
65. Martyna, G. J., D. J. Tobias, and M. L. Klein. 1994. Constant-pressure
molecular-dynamics algorithm. J. Chem.Phys. 101:4177–4189.
66. Ewald, P. 1921. Die Berechnung optischer und elektrostatischer Gitterpotentiale.
Ann. Phys. Berlin. 369:253–287.
67. Darden, T. A., D. M. York, and L. G. Pedersen. 1993. Particle mesh Ewald: an
N log (N) method for Ewald sums in large systems. J. Chem.Phys. 98:10089–10092.
68. Chen, R., and Z. Weng. 2002. Docking unbound proteins using shape comple-
mentarity, desolvation, and electrostatics. Proteins 47:281–294.
69. Dominguez, C., R. Boelens, and A. M. Bonvin. 2003. HADDOCK: a protein-
protein docking approach based on biochemical and/or biophysical information.
J. Am. Chem. Soc. 125:1731–1737.
70. Vanommeslaeghe, K., E. Hatcher, C. Acharya, S. Kundu, S. Zhong, J. Shim, E.
Darian, O. Guvench, P. Lopes, I. Vorobyov, and A. D. MacKerell. 2010. CHARMM
General Force Field: A Force Field for Drug-Like Molecules Compatible with the
CHARMM All-Atom Additive Biological Force Field. J. Comput. Chem. 31:671–
690.
71. O’Boyle, N. M., M. Banck, C. A. James, C. Morley, T. Vandermeersch, and G.
R. Hutchison. 2011. Open Babel: An open chemical toolbox. J. Cheminform. 3:33.
72. Frisch, M. J. et al. 2009. Gaussian 09, Revision D.01.
73. Pulay, P., G. Fogarasi, F. Pang, and J. E. Boggs. 1979. J. Am. Chem. Soc.
101:2550–2560.
74. Eswar, N., D. Eramian, B. Webb, M. Shen, and A. Sali. 2008. Protein structure
modeling with MODELLER. Methods Mol. Biol. 426:145–159.
75. Sali, A., and T. L. Blundell. 1990. Definition of general topological equivalence
in protein structures: A procedure involving comparison of properties and rela-
tionships through simulated annealing and dynamic programming. J. Mol. Biol.
212:403-428.
76. Notredame, C., D. G. Higgins, and J. Heringa. 2000. T-Coffee: A novel method
for fast and accurate multiple sequence alignment. J. Mol. Biol. 302:205–217.
219
77. Altschul, S. F., T. L. Madden, A. A. Schffer, J. Zhang, Z. Zhang, W. Miller,
and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of
protein database search programs. Nucleic Acids Res. 25:3389–3402.
78. Sali, A., and T. L. Blundell. 1993. Comparative Protein Modelling by Satisfac-
tion of Spatial Restraints. J. Mol. Biol. 234:779-815.
79. Benkert, P., M. Biasini, and T. Schwede. 2011. Toward the estimation of the
absolute quality of individual protein structure models. Bioinformatics 27:343–350.
80. Zhou, H., and Y. Zhou. 2002. Distance-scaled, finite ideal-gas reference state
improves structure-derived potentials of mean force for structure selection and
stability prediction. Protein Sci. 11:2714–2726.
81. Kumar, S. J., M. Rosenberg, M., D. Bouzida, R. H. Swendsen, and P. A. Koll-
man. 1992. The Weighted Histogram Analysis Method for Free-Energy Calcula-
tions on Biomolecules. I. The Method. J. Comput. Chem. 13:1011–1021.
82. Zacharias, M., T. P. Straatsma, and J. A. McCammon. 1994. Separation-Shifted
Scaling, a New Scaling Method for Lennard-Jones Interactions in Thermodynamic
Integration. J. Chem. Phys. 100:9025–9031.
83. Darve, E., D. Rodr´ıguez-Go´mez, and A. Pohorille. 2008. Adaptive biasing force
method for scalar and vector free energy calculations. J. Chem. Phys. 128:144120.
84. Chen, P.C., and S. Kuyucak. 2011. Accurate determination of the binding free
energy for KcsA-Charybdotoxin complex from the potential of mean force calcu-
lations with restraints. Biophys. J. 100:2466–2474.
85. Kanner, B. I. and A. Bendahan. 1982. Binding order of substrates to the sodium
and potassium-ion coupled L-glutamic acid transporter from rat-brain. Biochem-
istry. 21:6327–6330.
86. Herman, M. A., and C. E. Jahr. 2007. Extracellular glutamate concentration in
hippocampal slice. J. Neurosci. 27:9736–9741.
87. Levy, L. M., O. Warr, and D. Atwell. 1998. Stoichiometry of the glial glutamate
transporter GLT-1 expressed inducibly in a chinese hamster ovary cell line selected
for low endogenous Na+-dependent glutamate uptake. J. Neurosci. 18:9620–9628.
88. Fairman, W. A., R. J. Vandenberg, J. L. Arriza, M. P. Kavanaugh, and S. G.
Amara. 1995. An excitatory amino-acid transporter with properties of a ligand-
gated chloride channel. Nature 375: 599–603.
89. Wadiche, J. I., and M. P. Kavanaugh. 1998. Macroscopic and microscopic prop-
erties of a cloned glutamate transporter/chloride channel. J. of Neurosc. 18:7650–
7661.
220 Chapter 11 Bibliography
90. Vandenberg, R. J., J. L. Arriza, S. G. Amara, and M. P. Kavanaugh. 1995.
Constitutive ion fluxes and substrate binding domains of human glutamate trans-
porters. J. Biol. Chem. 270:17668–17671.
91. Ryan, R. M., and J. A. Mindell. 2007. The uncoupled chloride conductance of
a bacterial glutamate transporter homolog. Nat. Struct. Mol. Biol. 14:365–371.
92. Rosental, N., A. Bendahan, and B. I. Kanner. 2006. Multiple consequences of
mutating two conserved beta-bridge forming residues in the translocation cycle of
a neuronal glutamate transporter. J. Biol. Chem. 281:27905–27915.
93. Ryan, R. M., A. D. Mitrovic, and R. J. Vandenberg. 2004. The chloride per-
meation pathway of a glutamate transporter and its proximity to the glutamate
translocation pathway. J. Biol. Chem. 279:20742–20751.
94. Seal, R. P., B. H. Leighton, and S. G. Amara. 2000. A model for the topology
of excitatory amino acid transporters determined by the extracellular accessibility
of substituted cysteines. Neuron. 25:695–706.
95. Holley, D. C., and M. P. Kavanaugh. 2009. Interactions of alkali cations with
glutamate transporters. Philos. Trans. R. Soc. Lond. B Biol. Sci. 364:155–161.
96. Larsson, H. P., X. Y. Wang, B. Lev, I. Baconguis, D. A. Caplan, N. P. Vyleta,
H. P. Koch, A. Diez-Sampedro, and S. Y. Noskov. 2010. Evidence for a third
sodium-binding site in glutamate transporters suggests an ion/substrate coupling
model. Proc. Natl. Acad. Sci. USA. 107:13912–13917.
97. Huang, Z. and E. Tajkhorshid. 2010. Identification of the third Na+ site and the
sequence of extracellular binding events in the glutamate transporter. Biophys. J.
99:1416–1425.
98. Schrodinger, L. L. C. 2010. The PyMOL Molecular Graphics System, Version
1.3r1.
99. Shrivastava, I. H., J. Jiang, S. G. Amara, and I. Bahar. 2008. Time-resolved
mechanism of extracellular gate opening and substrate binding in a glutamate
transporter. J. Biol. Chem. 283:28680–28690.
100. Nayal, M. and E. di Cera. 1994. Predicting Ca2+-binding sites in proteins. Proc.
Natl. Acad. Sci. USA. 91:817–821.
101. Zarbiv, R., M. Grunewald, M. P. Kavanaugh, and B. I. Kanner. 1998. Cys-
teine scanning of the surroundings of an alkali-ion binding site of the glutamate
transporter GLT-1 reveals a conformationally sensitive residue. J. Biol. Chem.
273:14231–14237.
221
102. Higgins D. G., M. A. Larkin, G. Blackshields, N. P. Brown, R. Chenna, et al.
2007. Clustal W and clustal X version 2.0. Bioinformatics 23:2947–2948.
103. Meier, T., P. Polzer, K. Diederichs, W. Welte, and P. Dimroth. 2005. Struc-
ture of the rotor ring of F-Type Na+-ATPase from Ilyobacter tartaricus. Science
308:659–662.
104. Humphrey, W., A. Dalke and K. Schulten. 1996. VMD - Visual Molecular
Dynamics. J. Molec. Graphics 14:33–38.
105. MacKerell, A. D., M. Feig, and C. L. Brooks. 2004. Extending the treatment
of backbone energetics in protein force fields. J. Comput. Chem. 25:1400–1415.
106. Boresch, S., F. Tettinger, M. Leitgeb, and M. Karplus. 2003. Absolute binding
free energies: A quantitative approach for their calculation. J. Phys. Chem. B.
107:9535–9551.
107. Karplus, M., and J. N. Kushick. 1981. Methods for estimating the configura-
tonal entropy of macromolecules. Macromolecules. 14:325–332.
108. Bastug, T., and S. Kuyucak. 2006. Energetics of ion permeation, rejection,
binding and block in gramicidin A from free energy simulations. Biophys. J.
90:3941–3950.
109. McKinzie, A. A., R. M. Ryan, and R. J. Vandenberg. 2010. Site-directed mu-
tagenesis in the study of membrane transporters. Methods Mol. Biol. 637:277–293.
110. Gaillard, I., D. Slotboom, J. Knol, J. S. Lolkema, and W. N. Konings. 1996.
Purification and reconstitution of the glutamate carrier GltT of the thermophillic
bacterium Bacillus stearothermophillus. Biochemistry 35:6150–6156.
111. Vandenberg, R. J., A. D. Mitrovic, G. A. Johnston. 1998. Serine-O-sulphate
transport by the human glutamate transporter, EAAT2. Br. J. Pharmacol.
123:1593–1600.
112. Forrest, L. R., R. Kra¨mer, and C. Ziegler. 2011. The structural basis of sec-
ondary active transport mechanisms. Biochim. Biophys. Acta. 1807:167–188.
113. Jiang, J., and S. G. Amara. 2011. New views of glutamate transporter structure
and function: Advances and challenges. Neuropharmacology. 60:172–181.
114. Gu, Y., I. H. Shrivastava, S. G. Amara, and I. Bahar. 2009. Molecular simu-
lations elucidate the substrate translocation pathway in a glutamate transporter.
Proc. Natl. Acad. Sci. USA. 106:2589–2594.
115. Gilson, M. K., J. A. Given, B. L. Bush, and J. A. McCammon. 1997. The
statistical-thermodynamic basis for computation of binding affinities: A critical
review. Biophys. J. 72:1047–1069.
222 Chapter 11 Bibliography
116. Deng, Y., and B. Roux. 2006. Calculation of standard binding free energies
: Aromatic molecules in T4 lysozyme L99A mutant. J. Chem. Theory Comput.
2:1255–1273.
117. Luo, H, and K. Sharp. 2002. On the calculation of absolute macromolecular
binding energies. Proc. Natl. Acad. Sci. USA. 99:10399–10404.
118. Carlson, J., and J. Aqvist. 2005. Absolute and relative entropies from computer
simulation with applications to ligand binding. J. Phys. Chem. B. 109:6448–6456.
119. Minh, D. D. L., J. M. Bui, C. Chang, T. Jain, J. M. J. Swanson, and J. A.
McCammon. 2005. The entropic cost of protein-protein association. Biophys. J.
89:L25–L27.
120. Cecchini, M., S. V. Krivov, M. Spichty, and M. Karplus. 2009. Calculation
of free-energy differences by confinement simulations. Application to peptide con-
formers. J. Phys. Chem. B. 113: 9728–9740.
121. Yamashita, A., S. K. Singh, T. Kawate, Y. Jin, and E. Gouaux. 2005. Crystal
Structure of LEUTAA, a bacterial homolog of Na+/Cl− dependent neurotransmit-
ter transporters. Nature. 437: 215–223
122. Crisman, T. J., S. Qu, B. I. Kanner, and L. R. Forrest. 2009. Inward-facing con-
formation of glutamate transporters as revealed by their inverted-topology struc-
tural repeats. Proc. Natl. Acad. Sci. USA. 106:20752–20757.
123. Heinzelmann, G., T. Bastug, and S. Kuyucak. 2011. Free Energy Simulations
of Ligand Binding to the Aspartate Transporter GltPh. Biophys. J. 101:2380–2388.
124. Jiang, J., I. H. Shrivastava, S. D. Watts, I. Bahar, and S. G. Amara. 2011.
Large collective motions regulate the functional properties of glutamate trans-
porter trimers. Proc. Natl. Acad. Sci. USA 108:15141–15146.
125. Stolzenberg, S., G. Khelashvili, and H. Weinstein. 2012. Structural Intermedi-
ates in a Model of the Substrate Translocation Path of the Bacterial Glutamate
Transporter GltPh. J. Phys. Chem. B. 116:5372–5383.
126. Grazioso, G., V. Limongelli, D. Branduardi, E. Novellino, C. De Micheli, A.
Cavalli, and M. Parrinello. 2012. Investigating the Mechanism of Substrate Uptake
and Release in the Glutamate Transporter Homologue GltPh Through Metadynam-
ics Simulations. J. Am. Chem. Soc. 134:453–463.
127. Kramers, H. A. 1940. Brownian Motion in a Field of Force and the Diffusion
Model of Chemical Reactions. Physica 7:284–304.
128. Berry, R. S., S. A. Rice, and J. Ross. Physical Chemistry, Oxford University
Press, Oxford, 2000.
223
129. Ryan, R. M., N. C. Kortt, T. Sirivanta, and R. J. Vandenberg. 2010. The
position of an arginine residue influences substrate affinity and K+ coupling in the
human glutamate transporter, EAAT1. J. Neurochem. 114:565–575.
130. Huang, S., R. M. Ryan, and R. J. Vandenberg RJ. 2009. The role of cation
binding in determining substrate selectivity of glutamate transporters. J. Biol.
Chem. 284:4510–4515.
131. Bergles, D. E., A. V. Tzingounis, and C. E. Jahr CE. 2002. Comparison of
coupled and uncoupled currents during glutamate uptake by GLT-1 transporters.
J. Neurosci. 22:10153–10162.
132. Zhang, Y., A. Bendahan, R. Zarbiv, M. P. Kavanaugh, and B. I. Kanner.
1998. Molecular determinant of ion selectivity of an (Na+ + K+)-coupled rat brain
glutamate transporter. Proc. Natl. Acad. Sci. USA 95:751–755.
133. Tao, Z., and C. Grewer. 2007. Cooperation of the conserved aspartate 439
and bound amino acid substrate is important for high-affinity Na+ binding to the
glutamate transporter EAAC1. J. Gen. Physiol. 129:331–344.
134. Borre, L., and B. I. Kanner BI. 2001. Coupled, but not uncoupled, fluxes in a
neuronal glutamate transporter can be activated by lithium ions. J. Biol. Chem.
276:40396–40401.
135. Tao, Z., and C. Grewer. 2005. The conserved histidine 295 does not con-
tribute to proton cotransport by the glutamate transporter EAAC1. Biochemistry
44:3466–3476.
136. Teichman, S., S. Qu, and B. I. Kanner. 2012, Conserved asparagine residue
located in binding pocket controls cation selectivity and substrate interactions in
neuronal glutamate transporters. J. Biol. Chem. 287:17198–17205.
137. Grewer, C., N. Watzke, T. Rauen, and A. Bicho. 2003. Is the glutamate residue
glu-373 the proton acceptor of the excitatory amino acid carrier 1? J. Biol. Chem.
278:2585–2592.
138. Rosental, N., A. Gameiro, C. Grewer, and B. I. Kanner. 2011. A conserved as-
partate residue located at the end of the binding pocket controls cation interactions
in brain glutamate transporters. J. Biol. Chem. 286:41381–41390.
139. Borre, L., and B. I. Kanner. 2004. Arginine 445 controls the coupling be-
tween glutamate and cations in the neuronal transporter EAAC-1. J. Biol. Chem.
279:2513–2519.
140. Teichman, S., S. Qu, and B. I. Kanner. 2009. The equivalent of a thallium
binding residue from an archaeal homolog controls cation interactions in brain
glutamate transporters. Proc. Natl. Acad. Sci. USA 106:14297–14302.
224 Chapter 11 Bibliography
141. Mwaura, J., Z. Tao, H. James, T. Albers, A. Schwartz et al.. 2012. Protonation
state of a conserved acidic amino acid involved in Na+ binding to the glutamate
transporter EAAC1. ACS Chem. Neurosci. 3:1073–1083.
142. Tao, Z., A. Gameiro, and C. Grewer. 2008. Thallium ions can replace both
sodium and potassium ions in the glutamate transporter excitatory amino acid
carrier 1. Biochemistry 47:12923–12930.
143. Zomot, E., and I. Bahar. 2013. Intracellular gating in an inward-facing state of
aspartate transporter Glt(Ph) is regulated by the movements of the helical hairpin
HP2. J. Biol. Chem. 288:8231–8237.
144. Heinzelmann, G., T. Bastug, and S. Kuyucak. 2013. Mechanism and energetics
of ligand release in the aspartate transporter GltPh. J. Phys. Chem. B 117:5486–
5496.
145. Watzke, N., T. Rauen, E. Bamberg, and C. Grewer. 2000. On the mechanism of
proton transport by the neuronal excitatory amino acid carrier 1. J. Gen. Physiol.
116:609–621.
146. Koch, H. P., J. M. Hubbard, and H. P. Larsson. 2007. Voltage-independent
sodium-binding events reported by the 4B-4C loop in the human glutamate trans-
porter excitatory amino acid transporter 3. J. Biol. Chem. 282:24547–24553.
147. Frillingos, S., M. L. Ujwal, J. Z. Sun, H. R. Kaback. 1997. The role of helix VIII
in the lactose permease of Escherichia coli. 1. Cys-scanning mutagenesis. Protein
Sci. 6:431–437.
148. Koch, H. P., H. P. Larsson. 2005. Small-scale molecular motions accomplish
glutamate uptake in human glutamate transporters. J. Neurosci. 25:1730–1736.
149. Lev, B, and S. Y. Noskov. 2013. Role of protein matrix rigidity and local
polarization effects in the monovalent cation selectivity of crystallographic sites in
the Na-coupled aspartate transporter GltPh. Phys. Chem. Chem. Phys. 15:2397–
2404.
150. Wang, H., A. M. Rascoe, D. C. Holley, E. Gouaux, and M. P. Kavanaugh.
2013. Novel dicarboxylate selectivity in an insect glutamate transporter homolog.
PLoS ONE 8:e70947.
151. Jensen, S., A. Guskov, S. Rempel, I. Hanelt, and D. J. Slotboom DJ. 2013.
Crystal structure of a substrate-free aspartate transporter. Nat. Struct. Mol. Biol.
20:1224–1226.
152. Grewer, C., N. Watzke, M. Wiessner, and T. Rauen T. 2000. Glutamate
translocation of the neuronal glutamate transporter EAAC1 occurs within mil-
liseconds. Proc. Natl. Acad. Sci. USA 97:9706–9711.
225
153. Akyuz, N., R. B. Altman, S. C. Blanchard, and O. Boudker. 2013. Transport
dynamics in a glutamate transporter homologue. Nature 502:114–118.
154. Erkens, G. B., I. Ha¨nelt, J. M. H. Goudsmits, D. J. Slotboom, and A. M. van
Oijen. 2013. Unsynchronised subunit motion in single trimeric sodium-coupled
aspartate transporters. Nature 502:119–123.
155. Klauda, J. B., R. M. Venable, J. A. Freites, J. W. O’Connor, D. J. Tobias, et al.
2012. Update of the CHARMM all-atom additive force field for lipids: validation
on six lipid types. J. Phys. Chem. B 114:7830–7843.
156. Reyes, N., S. Oh, and O. Boudker. 2013. Binding thermodynamics of a gluta-
mate transporter homolog. Nat. Struct. Mol. Biol. 20: 634–641.
157. Heinzelmann, G., P. C. Chen, and S. Kuyucak. 2014. Computation of standard
binding free energies of polar and charged ligands to the glutamate receptor GluA2.
J. Phys. Chem. B 118:1813–1824.
158. Limongelli, V., M. Bonomi, and M. Parrinello. 2013. Funnel metadynamics as
accurate binding free-energy method. Proc. Natl. Acad. Sci. USA 110:6358–6363.
159. Roux, B., O. S. Andersen, and T. A. Allen. 2008. Comment on Free energy
simulations of single and double ion occupancy in gramicidin A J. Chem. Phys
128:227101.
160. Mim, C., Z. Tao, and C. Grewer. 2007. Two conformational changes are asso-
ciated with glutamate translocation by the glutamate transporter EAAC1. Bio-
chemistry 46:9007–9018.
161. Heinzelmann, G., and S. Kuyucak. 2014. Molecular dynamics simulations of
the mammalian glutamate transporter EAAT3. PLoS One. In press.
162. Antosiewicz, J., J. A. McCammon, and M. K. Gilson. 1996. The determinants
of pKa’s in proteins. Biochemistry. 35:7819–7833.
163. Luzhkov, V. B., and J. Aqvist. 2000. A computational study of ion binding
and protonation states in the KcsA potassiun channel. Biochim. Biophys. Acta.
1481:360–370.
164. Berneche, S., and B. Roux. 2002. The ionization state and the conformation of
Glu-71 in the KcsA K+ channel. Biophys. J. 82:772–780.
165. Nina, M., D. Beglov, and B. Roux. 1997. Atomic radii for continuum electro-
statics calculations based on molecular dynamics free energy simulations. J. Phys.
Chem. 101:5239–5248.
166. Kollman, P. A. 1993. Free energy calculations: applications to chemical and
biochemical phenomena. Chem. Rev. 93:2395–2417.
226 Chapter 11 Bibliography
167. Nozaki, Y., and C. Tanford. Intrinsic Dissociation Constants of Aspartyl and
Glutamyl Carboxyl Groups. 1967. J. Biol. Chem. 242:4731–4735.
168. Bashford, D., and M. Karplus. 1990. pKas of ionizable groups in proteins:
atomic detail from a continuum, electrostatic model. Biochemistry. 29:10219–
10225.
169. Vindigni, A. 1999. Energetic Dissection of Specificity in Serine Proteases.
Comb. Chem. High Throughput Screening 2:139–153.
170. Cheng, A. C., V. Calabro, and A. D. Frankel. 2001. Design of RNA-Binding
Proteins and Ligands. Curr. Opin. Struct. Biol. 11:478–484.
171. Mobley, D. L., and P. V. Klimovich. 2012. Perspective: Alchemical Free Energy
Calculations for Drug Discovery. J. Chem. Phys. 137:230901.
172. Wang, J., W. Wang, P. A. Kollman, and D. A. Case. 2006. Automatic Atom
Type and Bond Type Perception in Molecular Mechanical Calculations. J. Mol.
Graphics Modell. 25:247–260.
173. Vanommeslaeghe, K., and A. D. MacKerell. 2012. Automation of the
CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typ-
ing. J. Chem. Inf. Model. 52:3144–3154
174. Vanommeslaeghe, K., E. P. Raman, and A. D. MacKerell. 2012. Automation
of the CHARMM General Force Field (CGenFF) II: Assignment of Bonded Pa-
rameters and Partial Atomic Charges. J. Chem. Inf. Model. 52:3155–3168.
175. Gohlke, H., and K. Klebe. 2002. Approaches to the Description and Prediction
of the Binding Affinity of Small-Molecule Ligands to Macromolecular Receptors.
Angew. Chem. Int. Ed. 41:2644–2676.
176. Warren, G. L., C. W. Andrews, A. M. Capelli, B. Clarke, J. LaLonde, M.
H. Lambert, M. Lindvall, N. Nevins, S. Semis, S. Senger, et al.. 2006. A Critical
Assessment of Docking Programs and Scoring Functions. J. Med. Chem. 49:5912–
5931.
177. Gilson, M. K., and H. X. Zhou. 2007. Calculation of Protein-Ligand Binding
Energies. Annu. Rev. Biophys. Biomol. Struct. 36:21–42.
178. Deng, Y., and B. Roux. 2009. Computations of Standard Binding Free Energies
with Molecular Dynamics Simulations. J. Phys. Chem. B 113:2234–2246.
179. Christ, C. D., A. E. Mark, and W. F. van Gunsteren. 2010. Basic Ingredients
of Free Energy Calculations. J. Comput. Chem. 31:1569–1582.
180. Chipot, C., and A. Pohorille. 2007. Free Energy Calculations. Theory and Ap-
plications in Chemistry and Biology; Springer Verlag, Berlin.
227
181. Lelivre, T., M. Rousset, and G. Stoltz. 2010. Free Energy Computations: A
Mathematical Perspective; Imperial College Press, London.
182. Chipot, C. 2013. Frontiers in Free-Energy Calculations of Biological Systems.
Wiley Interdiscip. Rev. Comput. Mol. Sci. 4:71–89.
183. Shirts, M. R., J. Pitera, W. C. Swope, and V. S. Pande. 2003. Extremely Precise
Free Energy Calculations of Amino Acid Side Chain Analogs: Comparison of
Common Molecular Mechanics Force Fields for Proteins. J. Chem. Phys. 119:5740–
5761.
184. Deng, Y., and B. Roux. 2004. Hydration of Amino Acid Side Chains: Nonpolar
and Electrostatic Contributions Calculated from Staged Molecular Dynamics Free
Energy Simulations with Explicit Water Molecules. J. Phys. Chem. B 108:16567–
16576.
185. Mann, G., and J. Hermans. 2000. Modeling Protein-Small Molecule Interac-
tions: Structure and Thermodynamics of Noble Gases Binding in a Cavity in
Mutant Phage T4 Lysozyme L99A. J. Mol. Biol. 302:979–989.
186. Fujitani, H., Y. Tanida, M. Ito, G. Jayachandran, C. D. Snow, M. R. Shirts, E.
J. Sorin, and V. S. Pande. 2005. Direct Calculation of the Binding Free Energies
of FKBP Ligands. J. Chem. Phys. 123:084108.
187. Oostenbrink, C., and W. F. van Gunsteren. 2005. Free Energies of Ligand Bind-
ing for Structurally Diverse Compounds. Proc. Natl. Acad. Sci. USA 102:6750–
6754.
188. Mobley, D. L., J. D. Chodera, and K. A. Dill. 2006. On the Use of Orientational
Restraints and Symmetry Corrections in Alchemical Free Energy Calculations. J.
Chem. Phys. 125:084902.
189. Wang, J., Y. Deng, and B. Roux. 2006. Absolute Binding Free Energy Calcula-
tions Using Molecular Dynamics Simulations with Restraining Potentials. Biophys.
J. 91:2798–2814.
190. Mobley, D., E. Dumont, J. Chodera, and K. Dill. 2007. Comparison of Charge
Models for Fixed-Charge Force Fields: Small-Molecule Hydration Free Energies
in Explicit Solvent. J. Phys. Chem. B 111:2242–2254.
191. Mobley, D. L., A. P. Graves, J. D. Chodera, A. C. McReynolds, B. K. Shoichet,
and K. A. Dill. 2007. Predicting Absolute Ligand Binding Free Energies to a Simple
Model Site. J. Mol. Biol. 371:1118–1134.
192. Hermans, J., and L. Wang. 1997. Inclusion of Loss of Translational and Rota-
tional Freedom in Theoretical Estimates of Free Energies of Binding. Application
228 Chapter 11 Bibliography
to a Complex of Benzene and Mutant T4 Lysozyme. J. Am. Chem. Soc. 119:2707–
2714.
193. Chang, C. A., W. Chen, and M. K. Gilson. 2007. Ligand Configurational En-
tropy and Protein Binding. Proc. Natl. Acad. Sci. USA 104:1534–1539.
194. Gumbart, J. C., B. Roux, and C. Chipot. 2013. Standard Binding Free Ener-
gies from Computer Simulations: What Is the Best Strategy? J. Chem. Theory
Comput. 9:794–802.
195. Bastug, T., P. C. Chen, S. M. Patra, and S. Kuyucak. 2008. Potential of Mean
Force Calculations of Ligand Binding to Ion Channels from Jarzynski’s Equality
and Umbrella Sampling. J. Chem. Phys. 128:155104.
196. Chen, P. C., and S. Kuyucak. 2009. Mechanism and Energetics of Charybdo-
toxin Unbinding from a Potassium Channel from Molecular Dynamics Simulations.
Biophys. J. 96:2577–2588.
197. Doudou, S., N. A. Burton, and R. H. Henchman. 2009. Standard Free Energy
of Binding form a One-Dimensional Potential of Mean Force. J. Chem. Theory
Comput. 5:909–918.
198. Buch, I., S. K. Sadiq, and G. De Fabritiis. 2011. Optimized Potential of Mean
Force Calculations for Standard Binding Free Energies. J. Chem. Theory Comput.
7:1765–1772.
199. Chen, R., and S. H. Chung. 2012. Structural Basis of the Selective Block of
Kv1.2 by Maurotoxin from Computer Simulations. PLoS One 7:e47253.
200. Gumbart, J. C., B. Roux, and C. Chipot. 2013. Efficient Determination of
Protein-Protein Standard Binding Free Energies from First Principles. J. Chem.
Theory Comput. 9:3789–3798.
201. Dixit, S. B, and C. Chipot. 2001. Can Absolute Free Energies of Association
Be Estimated from Molecular Mechanical Simulations? The Biotin–Streptavidin
System Revisited. J. Phys. Chem. A 105:9795–9799.
202. Rocklin, G. J., S. E. Boyce, M. Fischer, I. Fish, D. L. Mobley, B. K. Shoichet,
and K. A. Dill. 2013. Blind Prediction of Charged Ligand Binding Affinities in a
Model Binding Site. J. Mol. Biol. 425:4569–4583.
203. Rashid, M. H., G. Heinzelmann, R. Huq, R. B. Tajhya, S. C. Chang, S.
Chhabra, M. W. Pennington, C. Beeton, R. S. Norton, and S. Kuyucak. 2013.
A Potent and Selective Peptide Blocker of the Kv1.3 Channel: Prediction from
Free-Energy Simulations and Experimental Confirmation. PLoS One 8:e78712.
229
204. Brauner-Osborne, H., J. Egebjerg, E. O. Nielsen, U. Madsen, and P.
Krogsgaard-Larsen. 2000. Ligands for Glutamate Receptors: Design and Ther-
apeutic Prospects. J. Med. Chem. 43:2609–2645.
205. O’Neill, M. J., and J. M. Witkin. 2007. AMPA Receptor Potentiators: Appli-
cation for Depression and Parkinson’s Disease. Curr. Drug Targets 8:603–620.
206. Ahmed, A. H., M. D. Thompson, M. K. Fenwick, B. Romero, A. P. Loh, D. E.
Jane, H. Sondermann, and R. E. Oswald. 2009. Mechanisms of Antagonism of the
GluR2 AMPA Receptor: Structure and Dynamics of the Complex of two Willardi-
ine Antagonists with the Glutamate Binding Domain. Biochemistry 48:3894–3903.
207. Armstrong, N., and E. Gouaux. 2000. Mechanisms for Activation and Antago-
nism of an AMPA-Sensitive Glutamate Receptor: Crystal Structures of the GluR2
Ligand Binding Core. Neuron 28:165-181.
208. Hogner, A., J. S. Kastrup, R. Jin, T. Liljefors, M. L. Mayer, J. Egebjerg, I.
K. Larsen, and E. Gouaux. 2002. Structural Basis for AMPA Receptor Activation
and Ligand Selectivity: Crystal Structures of Five Agonist Complexes with the
GluR2 Ligand-Binding Core. J. Mol. Biol. 322:93–109.
209. Menuz, K., R. M. Stroud, R. A. Nicoll, and F. A. Hays. 2007. TARP Auxil-
iary Subunits Switch AMPA Receptor Antagonists into Partial Agonists. Science
318:815–817.
210. Jo, S., W. Jiang, H. S. Lee, B. Roux, and W. Im. 2012. CHARMM-GUI Ligand
Binder for Absolute Binding Free Energy Calculations and Its Application. J.
Chem. Inf. Model. 53:267–277.
211. Kofke, D. A., and P. T. Cummings. 1998. Precision and Accuracy of Staged
Free-Energy Perturbation Methods for Computing the Chemical Potential by
Molecular Simulation. Fluid Phase Equilib. 150:41–49.
212. Bennett, C. H. 1976. Efficient Estimation of Free Energy Differences from
Monte Carlo Data. J. Comput. Phys. 22:245–268.
213. Pohorille, A., C. Jarzynski, and C. Chipot. 2010. Good Practices in Free-Energy
Calculations. J. Phys. Chem. B 114:10235–10253.
214. Mobley, D. L., J. D. Chodera, and K. A. Dill. 2007. Confine-and-Release
Method: Obtaining Correct Binding Free Energies in the Presence of Protein
Conformational Change. J. Chem. Theory Comput. 3:1231–1235.
215. Wulff, H., P. A. Calabresi, R. Allie, S. Yun, M. Pennington et al. 2003. The
voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS.
J. Clin. Invest. 111:1703–1713.
230 Chapter 11 Bibliography
216. Castaneda, O., V. Sotolongo, A. M. Amor, R. Stocklin R, A. J. Anderson, et
al.. 1995. Characterization of a potassium channel toxin from the Caribbean Sea
anemone Stichodactyla helianthus. Toxicon 33:603–613.
217. Kalman, K., M. W. Pennington, M. D. Lanigan, A. Nguyen, H. Rauer, et
al. 1998. ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide. J.
Biol. Chem. 273: 32697–32707.
218. Chi, V., M. W. Pennington, R. S. Norton, E. J. Tarcha, L. M. Londono, et al.
2012. Development of a sea anemone toxin as an immunomodulator for therapy of
autoimmune diseases. Toxicon 59:529–546.
219. Beeton, C, H. Wulff, S. Singh, S. Botsko, G. Crossley, et al. 2003. A novel fluo-
rescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically
activated T lymphocytes. J. Biol. Chem. 278:9928–9937.
220. Beeton, C., M. W. Pennington, H. Wulff, S. Singh, D. Nugent, et al. 2005. Tar-
geting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels
for therapy of autoimmune diseases. Molec. Pharmacol. 67:1369–1381.
221. Pennington, M. W., C. Beeton, C. A. Galea, B. J. Smith, V. Chi, et al. 2009.
Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lym-
phocytes. Molec. Pharmacol. 75:762–773.
222. Pennington, M. W., M. H. Rashid, R. B. Tajhya, C. Beeton, S. Kuyucak,
and R. S. Norton. 2012. A C-terminally amidated analogue of ShK is a potent
and selective blocker of the voltage-gated potassium channel Kv1.3. FEBS Letters
586:3996–4001.
223. Pennington, M. W., V. M. Mahnir, I. Khaytin, I. Zaydenberg, M. E. Byrnes,
and W. R. Kem. 1996. An essential binding surface for ShK toxin interaction with
rat brain potassium channels. Biochemistry 35:16407–16411.
224. Rauer, H., M. W. Pennington, M. Cahalan, and K. G. Chandy. 1999. Struc-
tural conservation of the pores of calcium-activated and voltage-gated potassium
channels determined by a sea anemone toxin. J. Biol. Chem. 274:21885–21892.
225. Grissmer, S., A. N. Nguyen, J. Aiyar, D. C. Hanson, R. J. Mather, et al.
1994. Pharmacological characterization of five cloned voltage-gated K+ channels,
types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol.
Pharmacol. 45:1227–1234.
226. Flugel, A., M. Willem, T. Berkowicz, and H. Wekerle. 1999. Gene transfer into
CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T
cells illuminate brain autoimmune responses. Nat. Medicine. 5:843–847.
231
227. Beeton, C., and K. G. Chandy. 2007. Induction and monitoring of adoptive
delayed-type hypersensitivity in rats. J. Vis. Exp. 8:325.
228. Matheu, M. P., C. Beeton, A. Garcia, V. Chi, S. Rangaraju, et al. 2008. Imaging
of effector memory T cells during a delayed-type hypersensitivity reaction and
suppression by Kv1.3 channel block. Immunity 29:602–614.
229. Beeton, C., H. Wulff, J. Barbaria, O. Clot-Faybesse, M. W. Pennington, et al.
2001. Selective blockade of T lymphocyte K+ channels ameliorates experimental
autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Natl. Acad.
Sci. USA 98:13942–13947
230. Chang, S. C., C. A. Galea, E. W. Leung, R. B. Tajhya, C. Beeton, et al. 2012.
Expression and isotopic labelling of the potassium channel blocker ShK toxin as a
thioredoxin fusion protein in bacteria. Toxicon 60:840–850.
231. Beeton, C., and K. G. Chandy. 2007. Induction and monitoring of active de-
layed type hypersensitivity (DTH) in rats. J. Vis. Exp. 6:237.
232. Tudor, J. E., P. K. Pallaghy, M. W. Pennington, and R. S. Norto. 1996. Solution
structure of ShK toxin, a novel potassium channel inhibitor from a sea anemone.
Nat. Struct. Biol. 3:317–320.
233. Tudor, J. E., M. W. Pennington, and R. S. Norton. 1998. Ionisation be-
haviour and solution properties of the potassium-channel blocker ShK toxin. Eur.
J. Biochem. 251:133–141.
Author’s Biography
Germano Heinzelmann was born in Joinville, Brazil, in June 28th, 1982. He obtained
his Bachelor’s degree and Master’s degree in Physics from Universidade Federal de
Santa catarina (UFSC), located in Floriano´polis, Brazil. He was then offered an
international Ph.D. scholarship at the University of Sydney, starting his studies in
2010. Since May, 2010, he has been doing research under his supervisor Prof. Serdar
Kuyucak.
